55	PC13_devel	10329687.s2	We have cloned the human Na+-dependent multivitamin transporter (SMVT), which transports the water-soluble vitamins pantothenate, biotin, and lipoate, from a placental choriocarcinoma cell line (JAR).	25-63	Na+-dependent multivitamin transporter	SLC5A6 protein, human	C1449152	T116|T123	Gene_or_gene_product	116-128	pantothenate	pantothenate	C0178793	T116|T121|T127	Simple_chemical	158-183	placental choriocarcinoma	Placental Choriocarcinoma	C0855173	T191	-694	Regulation	Forward	FALSE	NA
56	PC13_devel	10329687.s2	We have cloned the human Na+-dependent multivitamin transporter (SMVT), which transports the water-soluble vitamins pantothenate, biotin, and lipoate, from a placental choriocarcinoma cell line (JAR).	25-63	Na+-dependent multivitamin transporter	SLC5A6 protein, human	C1449152	T116|T123	Gene_or_gene_product	130-136	biotin	Biotin	C0005575	T109|T121|T127	Simple_chemical	158-183	placental choriocarcinoma	Placental Choriocarcinoma	C0855173	T191	-694	Regulation	Forward	FALSE	NA
57	PC13_devel	10329687.s2	We have cloned the human Na+-dependent multivitamin transporter (SMVT), which transports the water-soluble vitamins pantothenate, biotin, and lipoate, from a placental choriocarcinoma cell line (JAR).	25-63	Na+-dependent multivitamin transporter	SLC5A6 protein, human	C1449152	T116|T123	Gene_or_gene_product	142-149	lipoate	lipoate	C0178731	T109|T127	Simple_chemical	158-183	placental choriocarcinoma	Placental Choriocarcinoma	C0855173	T191	-694	Regulation	Forward	FALSE	NA
59	PC13_devel	10329687.s2	We have cloned the human Na+-dependent multivitamin transporter (SMVT), which transports the water-soluble vitamins pantothenate, biotin, and lipoate, from a placental choriocarcinoma cell line (JAR).	65-69	SMVT	SLC5A6 protein, human	C1449152	T116|T123	Gene_or_gene_product	116-128	pantothenate	pantothenate	C0178793	T116|T121|T127	Simple_chemical	158-183	placental choriocarcinoma	Placental Choriocarcinoma	C0855173	T191	-694	Regulation	Forward	FALSE	NA
60	PC13_devel	10329687.s2	We have cloned the human Na+-dependent multivitamin transporter (SMVT), which transports the water-soluble vitamins pantothenate, biotin, and lipoate, from a placental choriocarcinoma cell line (JAR).	65-69	SMVT	SLC5A6 protein, human	C1449152	T116|T123	Gene_or_gene_product	130-136	biotin	Biotin	C0005575	T109|T121|T127	Simple_chemical	158-183	placental choriocarcinoma	Placental Choriocarcinoma	C0855173	T191	-694	Regulation	Forward	FALSE	NA
61	PC13_devel	10329687.s2	We have cloned the human Na+-dependent multivitamin transporter (SMVT), which transports the water-soluble vitamins pantothenate, biotin, and lipoate, from a placental choriocarcinoma cell line (JAR).	65-69	SMVT	SLC5A6 protein, human	C1449152	T116|T123	Gene_or_gene_product	142-149	lipoate	lipoate	C0178731	T109|T127	Simple_chemical	158-183	placental choriocarcinoma	Placental Choriocarcinoma	C0855173	T191	-694	Regulation	Forward	FALSE	NA
121	PC13_devel	10998368.s2	Transfection-deletion experiments, DNase I protection by E2F1 and gel mobility-shift experiments locate E2F1 activation sites to two regions on either side of the transcription start site.	35-42	DNase I	Deoxyribonuclease I	C0011519	T116|T126	Gene_or_gene_product	57-61	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	13-21	deletion	Deletion	C1442161	T049	-660	Regulation	Backward	FALSE	NA
287	PC13_devel	11402328.s0	The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.	130-145	large T-antigen	Large T-Antigen	C0023043	T116|T129	Gene_or_gene_product	177-180	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	76-89	breast cancer	Breast Cancer	C0006142	T191	-734	Binding	NA	FALSE	NA
288	PC13_devel	11402328.s0	The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.	130-145	large T-antigen	Large T-Antigen	C0023043	T116|T129	Gene_or_gene_product	177-180	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	76-89	breast cancer	Breast Cancer	C0678222	T191	-734	Binding	NA	FALSE	NA
289	PC13_devel	11402328.s0	The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.	130-145	large T-antigen	Large T-Antigen	C0023043	T116|T129	Gene_or_gene_product	185-188	pRb	Retinoblastoma Protein	C0080113	T116|T123	Gene_or_gene_product	76-89	breast cancer	Breast Cancer	C0006142	T191	-734	Binding	NA	FALSE	NA
290	PC13_devel	11402328.s0	The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.	130-145	large T-antigen	Large T-Antigen	C0023043	T116|T129	Gene_or_gene_product	185-188	pRb	Retinoblastoma Protein	C0080113	T116|T123	Gene_or_gene_product	76-89	breast cancer	Breast Cancer	C0678222	T191	-734	Binding	NA	FALSE	NA
397	PC13_devel	11590175.s8	DFMO-induced NF-kappa B activation was accompanied by the translocation of p65 from the cytoplasm into the nucleus.	0-4	DFMO	Eflornithine	C0002260	T116|T121	Simple_chemical	13-23	NF-kappa B	NF-kappa B	C0079904	T116|T129	Complex	58-71	translocation	Translocation	C0040715	T049	-1000	Increase	Forward	TRUE	NA
409	PC13_devel	11756542.s9	Removal of the entire N terminus did not affect the ability of p130 to interact with E2F and to induce growth arrest.	63-67	p130	Retinoblastoma-Like Protein p130	C1529719	T116|T123	Gene_or_gene_product	85-88	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	103-116	growth arrest	Growth arrest	C0333951	T046	-1000	Binding	NA	FALSE	NA
414	PC13_devel	11807498.s4	Here we show that Sld2 (ref. 4) (also known as Drc1; ref. 5), one of the replication proteins of budding yeast (Saccharomyces cerevisiae), is phosphorylated in S phase in an S-Cdk-dependent manner, and mutant Sld2 lacking all the preferred Cdk phosphorylation sites (All-A) is defective in chromosomal DNA replication.	18-22	Sld2	SLD2 protein, S cerevisiae	C1308763	T116|T123	Gene_or_gene_product	174-179	S-Cdk	Cyclin-Dependent Kinases	C0243045	T116|T126	Gene_or_gene_product	202-208	mutant	Mutant	C0596988	T049	-660	Regulation	Backward	FALSE	NA
426	PC13_devel	11807498.s4	Here we show that Sld2 (ref. 4) (also known as Drc1; ref. 5), one of the replication proteins of budding yeast (Saccharomyces cerevisiae), is phosphorylated in S phase in an S-Cdk-dependent manner, and mutant Sld2 lacking all the preferred Cdk phosphorylation sites (All-A) is defective in chromosomal DNA replication.	47-51	Drc1	SLD2 protein, S cerevisiae	C1308763	T116|T123	Gene_or_gene_product	174-179	S-Cdk	Cyclin-Dependent Kinases	C0243045	T116|T126	Gene_or_gene_product	202-208	mutant	Mutant	C0596988	T049	-660	Regulation	Backward	FALSE	NA
431	PC13_devel	12024030.s1	Transcriptional silencing at the budding yeast silent mating type (HM) loci and telomeric DNA regions requires Sir2, a conserved NAD-dependent histone deacetylase, Sir3, Sir4, histones H3 and H4, and several DNA-binding proteins.	111-115	Sir2	SIR2 protein, S cerevisiae	C0255861	T116|T126	Gene_or_gene_product	129-132	NAD	Nicotinamide adenine dinucleotide (NAD)	C0027270	T114|T121|T123	Simple_chemical	16-25	silencing	silence	C0858952	T048	-827	Increase	Backward	FALSE	NA
455	PC13_devel	12024030.s4	We further show that the initial binding of the Sir2/Sir4 complex to DNA sites that nucleate silencing, accompanied by partial Sir2-dependent histone deacetylation, occurs independently of Sir3 and is likely to be the first step in assembly of silent chromatin at the HM loci and telomeres.	127-131	Sir2	SIR2 protein, S cerevisiae	C0255861	T116|T126	Gene_or_gene_product	142-149	histone	Histones	C0019652	T116|T123	Gene_or_gene_product	93-102	silencing	silence	C0858952	T048	-827	Regulation	Forward	FALSE	NA
465	PC13_devel	12024030.s6	At the rDNA repeats, we show that histone H3 and H4 tails are required for silencing and rDNA-associated H4 is hypoacetylated in a Sir2-dependent manner.	105-107	H4	Histone H4	C0019648	T116|T123	Gene_or_gene_product	131-135	Sir2	SIR2 protein, S cerevisiae	C0255861	T116|T126	Gene_or_gene_product	75-84	silencing	silence	C0858952	T048	-966	Regulation	Backward	FALSE	NA
476	PC13_devel	12139485.s0	An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase.	3-6	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	101-128	fructose-2,6-bisphosphatase	Fructose-2,6-bisphosphatase	C0060773	T116|T126	Gene_or_gene_product	51-64	proliferative	Proliferative	C0334094	T046	-694	Increase	Forward	FALSE	NA
477	PC13_devel	12139485.s0	An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase.	3-6	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	132-161	phosphatidylinositol 3-kinase	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	51-64	proliferative	Proliferative	C0334094	T046	-694	Increase	Forward	FALSE	NA
478	PC13_devel	12139485.s0	An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase.	3-6	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	76-100	6-phosphofructo-2-kinase	6-Phosphofructo-2-kinase	C0049700	T116|T126	Gene_or_gene_product	51-64	proliferative	Proliferative	C0334094	T046	-694	Increase	Forward	FALSE	NA
494	PC13_devel	12408816.s6	FKBP-rapamycin binds TORC1, and TORC1 disruption mimics rapamycin treatment, suggesting that TORC1 mediates the rapamycin-sensitive, TOR-shared pathway.	0-14	FKBP-rapamycin	TOR complex	C3820662	T026	Complex	21-26	TORC1	TOR complex 1	C3152111	T026	Complex	122-131	sensitive	Sensitive	C0020517	T046	-637	Binding	NA	FALSE	NA
527	PC13_devel	12766152.s4	Claspin localizes in the nuclei, but it only associates with Chk1 following replication stress or other types of DNA damage.	0-7	Claspin	CLSPN protein, human	C1447801	T116|T123	Gene_or_gene_product	61-65	Chk1	Checkpoint kinase 1	C0216510	T116|T126	Gene_or_gene_product	113-123	DNA damage	DNA Damage	C0012860	T049	-1000	Binding	NA	TRUE	NA
599	PC13_devel	14551908.s11	We can also explain the importance of axin degradation in amplifying and sharpening the Wnt signal, and we show that the dependence of axin degradation on APC is an essential part of an unappreciated regulatory loop that prevents the accumulation of beta-catenin at decreased APC concentrations.	135-139	axin	Axin Protein	C3178961	T116|T123	Gene_or_gene_product	155-158	APC	anaphase-promoting complex	C0526999	T116|T126	Gene_or_gene_product	121-131	dependence	Dependence	C0439857	T048	-1000	Decrease	Backward	FALSE	NA
680	PC13_devel	14703512.s9	Under activating conditions, a decrease in the affinity between Msg5 and Slt2 was observed, leading us to suggest that the mechanism by which Slt2 controls the action of Msg5 was via the modulation of protein-protein interactions.	142-146	Slt2	SLT2 protein, S cerevisiae	C0142629	T116|T123	Gene_or_gene_product	170-174	Msg5	MSG5 protein, S cerevisiae	C0251766	T116|T126	Gene_or_gene_product	17-27	conditions	condition	C0012634	T047	-827	Regulation	Forward	TRUE	NA
683	PC13_devel	14703512.s9	Under activating conditions, a decrease in the affinity between Msg5 and Slt2 was observed, leading us to suggest that the mechanism by which Slt2 controls the action of Msg5 was via the modulation of protein-protein interactions.	64-68	Msg5	MSG5 protein, S cerevisiae	C0251766	T116|T126	Gene_or_gene_product	73-77	Slt2	SLT2 protein, S cerevisiae	C0142629	T116|T123	Gene_or_gene_product	17-27	conditions	condition	C0012634	T047	-827	Binding	NA	TRUE	NA
874	PC13_devel	14749335.s6	Finally, we determined that CpG DNA-mediated up-regulation of NF-kappaB activity (but not mitogen-activated protein kinase activation) was inhibited by preincubation with PP1 or by expression of the truncated vavC mutant.	62-71	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	171-174	PP1	Protein Phosphatase 1	C1956003	T116|T126	Gene_or_gene_product	214-220	mutant	Mutant	C0596988	T049	-827	Decrease	Backward	FALSE	NA
906	PC13_devel	15140942.s1	The p53 tumor suppressor protein is phosphorylated and activated by several DNA damage-inducible kinases, such as ATM, and is a key effector of the DNA damage response by promoting cell cycle arrest or apoptosis.	4-7	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	114-117	ATM	Ataxia Telangiectasia Mutated Proteins	C0298973	T116|T126	Gene_or_gene_product	76-86	DNA damage	DNA Damage	C0012860	T049	-673	Increase	Backward	FALSE	NA
914	PC13_devel	15140942.s6	Cells containing mutant Nijmegen breakage syndrome protein (NBS1), a component of the Mre11-Rad50 DNA repair complex, also have attenuated p53 phosphorylation and apoptosis in response to E2F1 expression.	24-58	Nijmegen breakage syndrome protein	NBS1 protein, human	C0674679	T116|T123	Gene_or_gene_product	139-142	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	24-50	Nijmegen breakage syndrome	NIJMEGEN BREAKAGE SYNDROME	C0398791	T019|T047	-717	Regulation	Forward	FALSE	NA
918	PC13_devel	15140942.s6	Cells containing mutant Nijmegen breakage syndrome protein (NBS1), a component of the Mre11-Rad50 DNA repair complex, also have attenuated p53 phosphorylation and apoptosis in response to E2F1 expression.	60-64	NBS1	NBS1 protein, human	C0674679	T116|T123	Gene_or_gene_product	139-142	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	24-50	Nijmegen breakage syndrome	NIJMEGEN BREAKAGE SYNDROME	C0398791	T019|T047	-717	Regulation	Forward	FALSE	NA
941	PC13_devel	15140942.s8	Delayed gammaH2AX phosphorylation and absence of ATM autophosphorylation at Ser1981 suggest that E2F1 stimulates ATM through a unique mechanism that is distinct from agents that cause DNA double-strand breaks.	97-101	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	113-116	ATM	Ataxia Telangiectasia Mutated Proteins	C0298973	T116|T126	Gene_or_gene_product	184-208	DNA double-strand breaks	DNA double strand Breaks	C1511667	T049	-1000	Increase	Forward	TRUE	NA
942	PC13_devel	15140942.s8	Delayed gammaH2AX phosphorylation and absence of ATM autophosphorylation at Ser1981 suggest that E2F1 stimulates ATM through a unique mechanism that is distinct from agents that cause DNA double-strand breaks.	97-101	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	113-116	ATM	Ataxia Telangiectasia Mutated Proteins	C0298973	T116|T126	Gene_or_gene_product	38-45	absence	Absence	C1689985	T190	-1000	Increase	Forward	FALSE	NA
953	PC13_devel	15210709.s0	Direct binding of apoptosis signal-regulating kinase 1 to retinoblastoma protein: novel links between apoptotic signaling and cell cycle machinery.	18-54	apoptosis signal-regulating kinase 1	MAP Kinase Kinase Kinase 5	C0532128	T116|T126	Gene_or_gene_product	58-80	retinoblastoma protein	Retinoblastoma Protein	C0080113	T116|T123	Gene_or_gene_product	137-146	machinery	Machinery	C0337246	T037	-827	Binding	NA	TRUE	NA
966	PC13_devel	15210709.s5	Overexpression of Rb inhibited ASK1-induced apoptosis; in addition, an ASK1 mutant incapable of binding Rb could not induce apoptosis, indicating that ASK1 has to overcome the antiapoptotic properties of Rb to kill cells.	71-75	ASK1	MAP Kinase Kinase Kinase 5	C0532128	T116|T126	Gene_or_gene_product	104-106	Rb	Retinoblastoma Protein	C0080113	T116|T123	Gene_or_gene_product	76-82	mutant	Mutant	C0596988	T049	-660	Binding	NA	TRUE	NA
971	PC13_devel	1533881.s0	p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.	0-4	p105	Nuclear Factor NF-kappa-B p105 Subunit	C2986465	T116|T123	Gene_or_gene_product	95-100	v-Rel	Oncogene Proteins v-rel	C0069522	T192|T129|T116	Gene_or_gene_product	116-127	transformed	Transformed	C1510411	T046	-645	Binding	NA	TRUE	NA
1002	PC13_devel	1533881.s8	However, in vitro association with p105 by v-Rel does not necessarily correlate with transformation, since one nontransforming v-Rel mutant can associate with p105 in vitro.	35-39	p105	Nuclear Factor NF-kappa-B p105 Subunit	C2986465	T116|T123	Gene_or_gene_product	43-48	v-Rel	Oncogene Proteins v-rel	C0069522	T192|T129|T116	Gene_or_gene_product	133-139	mutant	Mutant	C0596988	T049	-804	Regulation	Backward	FALSE	NA
1003	PC13_devel	1533881.s8	However, in vitro association with p105 by v-Rel does not necessarily correlate with transformation, since one nontransforming v-Rel mutant can associate with p105 in vitro.	35-39	p105	Nuclear Factor NF-kappa-B p105 Subunit	C2986465	T116|T123	Gene_or_gene_product	43-48	v-Rel	Oncogene Proteins v-rel	C0069522	T192|T129|T116	Gene_or_gene_product	85-99	transformation	Transformation	C1510411	T046	-1000	Regulation	Backward	FALSE	negation
1010	PC13_devel	15580623.s6	Upon overexpression, E2F4 repressed FGFR1 promoter activity in a dose-dependent manner in myoblasts and Drosophila SL2 cells, and mutation of the E2F4 binding site increased FGFR1 promoter activity and reduced E2F4-mediated repression.	174-179	FGFR1	Fibroblast Growth Factor Receptor 1	C0170936	T116|T126|T192	Gene_or_gene_product	210-214	E2F4	E2F4 Transcription Factor	C0291135	T116|T123	Gene_or_gene_product	130-138	mutation	Mutation	C1705285	T049	-1000	Decrease	Backward	TRUE	NA
1014	PC13_devel	15580623.s6	Upon overexpression, E2F4 repressed FGFR1 promoter activity in a dose-dependent manner in myoblasts and Drosophila SL2 cells, and mutation of the E2F4 binding site increased FGFR1 promoter activity and reduced E2F4-mediated repression.	21-25	E2F4	E2F4 Transcription Factor	C0291135	T116|T123	Gene_or_gene_product	36-41	FGFR1	Fibroblast Growth Factor Receptor 1	C0170936	T116|T126|T192	Gene_or_gene_product	130-138	mutation	Mutation	C1705285	T049	-1000	Decrease	Forward	FALSE	NA
1041	PC13_devel	15657077.s8	Overexpression of TRIP6 potentiates NF-kappaB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-kappaB activation by TNF, IL-1, TLR2 or Nod1.	168-177	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	192-195	TNF	Tumor Necrosis Factors	C0041368	T116|T129	Gene_or_gene_product	95-119	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-1000	Decrease	Backward	TRUE	NA
1045	PC13_devel	15657077.s8	Overexpression of TRIP6 potentiates NF-kappaB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-kappaB activation by TNF, IL-1, TLR2 or Nod1.	168-177	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	197-201	IL-1	Interleukin-1	C0021755	T116|T129	Gene_or_gene_product	95-119	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-1000	Decrease	Backward	TRUE	NA
1049	PC13_devel	15657077.s8	Overexpression of TRIP6 potentiates NF-kappaB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-kappaB activation by TNF, IL-1, TLR2 or Nod1.	168-177	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	203-207	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Gene_or_gene_product	95-119	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-1000	Decrease	Backward	TRUE	NA
1053	PC13_devel	15657077.s8	Overexpression of TRIP6 potentiates NF-kappaB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-kappaB activation by TNF, IL-1, TLR2 or Nod1.	168-177	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	211-215	Nod1	Nod1 Signaling Adaptor Protein	C1720990	T116|T123	Gene_or_gene_product	95-119	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-1000	Decrease	Backward	TRUE	NA
1149	PC13_devel	15657077.s8	Overexpression of TRIP6 potentiates NF-kappaB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-kappaB activation by TNF, IL-1, TLR2 or Nod1.	36-45	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	60-63	TNF	Tumor Necrosis Factors	C0041368	T116|T129	Gene_or_gene_product	95-119	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-1000	Increase	Backward	FALSE	NA
1153	PC13_devel	15657077.s8	Overexpression of TRIP6 potentiates NF-kappaB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-kappaB activation by TNF, IL-1, TLR2 or Nod1.	36-45	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	65-69	IL-1	Interleukin-1	C0021755	T116|T129	Gene_or_gene_product	95-119	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-1000	Increase	Backward	FALSE	NA
1157	PC13_devel	15657077.s8	Overexpression of TRIP6 potentiates NF-kappaB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-kappaB activation by TNF, IL-1, TLR2 or Nod1.	36-45	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	71-75	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Gene_or_gene_product	95-119	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-1000	Increase	Backward	FALSE	NA
1161	PC13_devel	15657077.s8	Overexpression of TRIP6 potentiates NF-kappaB activation by TNF, IL-1, TLR2 or Nod1, whereas a dominant negative mutant or RNA-interference construct of TRIP6 inhibits NF-kappaB activation by TNF, IL-1, TLR2 or Nod1.	36-45	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	79-83	Nod1	Nod1 Signaling Adaptor Protein	C1720990	T116|T123	Gene_or_gene_product	95-119	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-1000	Increase	Backward	FALSE	NA
1285	PC13_devel	15735718.s0	Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.	13-16	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	20-23	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	34-44	DNA damage	DNA Damage	C0012860	T049	-1000	Increase	Backward	TRUE	NA
1297	PC13_devel	15735718.s0	Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.	20-23	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	59-63	Cdk4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	34-44	DNA damage	DNA Damage	C0012860	T049	-1000	Decrease	Forward	TRUE	NA
1301	PC13_devel	15735718.s0	Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities.	20-23	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	68-72	Cdk2	cyclin-dependent kinase 2	C1533646	T116|T126	Gene_or_gene_product	34-44	DNA damage	DNA Damage	C0012860	T049	-1000	Decrease	Forward	TRUE	NA
1310	PC13_devel	15735718.s4	Our previous studies established that treatment of human cancer cells with low effective concentrations of DAP specifically activates the G(1)-phase checkpoint and simultaneously inhibit Cdk4 and Cdk2 activities.	107-110	DAP	(diaminocyclohexane)(diacetato)(dichloro)platinum	C0768090	T109|T121	Simple_chemical	187-191	Cdk4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	57-63	cancer	CANCER	C0006826	T191	-827	Decrease	Forward	TRUE	NA
1311	PC13_devel	15735718.s4	Our previous studies established that treatment of human cancer cells with low effective concentrations of DAP specifically activates the G(1)-phase checkpoint and simultaneously inhibit Cdk4 and Cdk2 activities.	107-110	DAP	(diaminocyclohexane)(diacetato)(dichloro)platinum	C0768090	T109|T121	Simple_chemical	187-191	Cdk4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	57-63	cancer	Cancer	C1306459	T191	-827	Decrease	Forward	TRUE	NA
1315	PC13_devel	15735718.s4	Our previous studies established that treatment of human cancer cells with low effective concentrations of DAP specifically activates the G(1)-phase checkpoint and simultaneously inhibit Cdk4 and Cdk2 activities.	107-110	DAP	(diaminocyclohexane)(diacetato)(dichloro)platinum	C0768090	T109|T121	Simple_chemical	196-200	Cdk2	cyclin-dependent kinase 2	C1533646	T116|T126	Gene_or_gene_product	57-63	cancer	CANCER	C0006826	T191	-827	Decrease	Forward	TRUE	NA
1316	PC13_devel	15735718.s4	Our previous studies established that treatment of human cancer cells with low effective concentrations of DAP specifically activates the G(1)-phase checkpoint and simultaneously inhibit Cdk4 and Cdk2 activities.	107-110	DAP	(diaminocyclohexane)(diacetato)(dichloro)platinum	C0768090	T109|T121	Simple_chemical	196-200	Cdk2	cyclin-dependent kinase 2	C1533646	T116|T126	Gene_or_gene_product	57-63	cancer	Cancer	C1306459	T191	-827	Decrease	Forward	TRUE	NA
1393	PC13_devel	15735718.s7	Conversely, inhibition of p21 induction by cycloheximide or by p21 gene deletion prevents DAP-induced inhibition of Cdk4 and Cdk2 activities.	26-29	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	43-56	cycloheximide	Cycloheximide	C0010572	T109|T195	Simple_chemical	67-80	gene deletion	Gene Deletion	C1442161	T049	-901	Decrease	Backward	FALSE	NA
1396	PC13_devel	15735718.s7	Conversely, inhibition of p21 induction by cycloheximide or by p21 gene deletion prevents DAP-induced inhibition of Cdk4 and Cdk2 activities.	43-56	cycloheximide	Cycloheximide	C0010572	T109|T195	Simple_chemical	116-120	Cdk4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	67-80	gene deletion	Gene Deletion	C1442161	T049	-901	Decrease	Forward	FALSE	NA
1397	PC13_devel	15735718.s7	Conversely, inhibition of p21 induction by cycloheximide or by p21 gene deletion prevents DAP-induced inhibition of Cdk4 and Cdk2 activities.	43-56	cycloheximide	Cycloheximide	C0010572	T109|T195	Simple_chemical	125-129	Cdk2	cyclin-dependent kinase 2	C1533646	T116|T126	Gene_or_gene_product	67-80	gene deletion	Gene Deletion	C1442161	T049	-901	Decrease	Forward	FALSE	NA
1403	PC13_devel	15735718.s7	Conversely, inhibition of p21 induction by cycloheximide or by p21 gene deletion prevents DAP-induced inhibition of Cdk4 and Cdk2 activities.	90-93	DAP	(diaminocyclohexane)(diacetato)(dichloro)platinum	C0768090	T109|T121	Simple_chemical	116-120	Cdk4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	67-80	gene deletion	Gene Deletion	C1442161	T049	-901	Increase	Forward	TRUE	NA
1404	PC13_devel	15735718.s7	Conversely, inhibition of p21 induction by cycloheximide or by p21 gene deletion prevents DAP-induced inhibition of Cdk4 and Cdk2 activities.	90-93	DAP	(diaminocyclohexane)(diacetato)(dichloro)platinum	C0768090	T109|T121	Simple_chemical	125-129	Cdk2	cyclin-dependent kinase 2	C1533646	T116|T126	Gene_or_gene_product	67-80	gene deletion	Gene Deletion	C1442161	T049	-901	Increase	Forward	TRUE	NA
1405	PC13_devel	15735718.s9	Together, these findings establish that activation of the p53-p21 pathway is responsible for the DAP-induced G(1)-phase checkpoint response and provide the first solid evidence that p21 induction by p53 during a DNA damage-induced G(1)-phase checkpoint response inhibits both Cdk4 and Cdk2 activities.	182-185	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	199-202	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	216-222	damage	Damage	C0010957	T037	-799	Increase	Backward	TRUE	NA
1417	PC13_devel	15735718.s9	Together, these findings establish that activation of the p53-p21 pathway is responsible for the DAP-induced G(1)-phase checkpoint response and provide the first solid evidence that p21 induction by p53 during a DNA damage-induced G(1)-phase checkpoint response inhibits both Cdk4 and Cdk2 activities.	199-202	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	276-280	Cdk4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	216-222	damage	Damage	C0010957	T037	-799	Decrease	Forward	TRUE	NA
1421	PC13_devel	15735718.s9	Together, these findings establish that activation of the p53-p21 pathway is responsible for the DAP-induced G(1)-phase checkpoint response and provide the first solid evidence that p21 induction by p53 during a DNA damage-induced G(1)-phase checkpoint response inhibits both Cdk4 and Cdk2 activities.	199-202	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	285-289	Cdk2	cyclin-dependent kinase 2	C1533646	T116|T126	Gene_or_gene_product	216-222	damage	Damage	C0010957	T037	-799	Decrease	Forward	TRUE	NA
1538	PC13_devel	16107689.s1	In Saccharomyces cerevisiae, the repressor Crt1 and the global corepressor Ssn6-Tup1 repress the DNA damage-inducible ribonucleotide reductase (RNR) genes.	43-47	Crt1	RFX1 protein, S cerevisiae	C2713479	T116|T123	Gene_or_gene_product	118-142	ribonucleotide reductase	Ribonucleotide Reductase	C0035547	T116|T126	Gene_or_gene_product	97-107	DNA damage	DNA Damage	C0012860	T049	-660	Decrease	Forward	FALSE	NA
1539	PC13_devel	16107689.s1	In Saccharomyces cerevisiae, the repressor Crt1 and the global corepressor Ssn6-Tup1 repress the DNA damage-inducible ribonucleotide reductase (RNR) genes.	43-47	Crt1	RFX1 protein, S cerevisiae	C2713479	T116|T123	Gene_or_gene_product	144-147	RNR	Ribonucleotide Reductase	C0035547	T116|T126	Gene_or_gene_product	97-107	DNA damage	DNA Damage	C0012860	T049	-660	Decrease	Forward	FALSE	NA
1556	PC13_devel	16143108.s6	HCP 1 protein was iron regulated and localized to the brush-border membrane of duodenal enterocytes in iron deficiency.	0-5	HCP 1	Proton-Coupled Folate Transporter, human	C1612271	T116|T123	Gene_or_gene_product	18-22	iron	Iron	C0302583	T121|T123|T196	Simple_chemical	103-118	iron deficiency	IRON DEFICIENCY	C0240066	T047	-1000	Regulation	Backward	TRUE	NA
1562	PC13_devel	16303557.s1	BACKGROUND: In the absence of Wnt stimulation, the transcriptional cofactor beta-catenin is destabilized via phosphorylation by protein kinase GSK3beta in complex with Axin family members.	76-88	beta-catenin	beta catenin	C0105770	T116|T123	Gene_or_gene_product	143-151	GSK3beta	glycogen synthase kinase 3 beta	C0244988	T116|T126	Gene_or_gene_product	19-26	absence	Absence	C1689985	T190	-1000	Regulation	Backward	TRUE	NA
1673	PC13_devel	16303557.s7	We also show that direct activation of G proteins in vivo with GTPgammaS in the absence of exogenous Wnt will disrupt GSK3beta/Axin2 complexes and stabilize beta-catenin.	39-49	G proteins	GTP-Binding Proteins	C0086376	T116|T126	Gene_or_gene_product	63-72	GTPgammaS	Guanosine 5'-O-(3-Thiotriphosphate)	C0079469	T114|T121	Gene_or_gene_product	80-87	absence	Absence	C1689985	T190	-1000	Increase	Backward	TRUE	NA
1676	PC13_devel	16303557.s7	We also show that direct activation of G proteins in vivo with GTPgammaS in the absence of exogenous Wnt will disrupt GSK3beta/Axin2 complexes and stabilize beta-catenin.	63-72	GTPgammaS	Guanosine 5'-O-(3-Thiotriphosphate)	C0079469	T114|T121	Gene_or_gene_product	157-169	beta-catenin	beta catenin	C0105770	T116|T123	Gene_or_gene_product	80-87	absence	Absence	C1689985	T190	-1000	Regulation	Forward	TRUE	NA
1698	PC13_devel	16303557.s8	Finally, we demonstrate an association of Galpha(o) with Fz that is also very rapidly (t1/2 < 1 min) perturbed upon Wnt-3a stimulation and that the Wnt-dependent effects on both GSK3beta/Axin2 and Galpha(o)/Fz are pertussis-toxin sensitive.	42-51	Galpha(o)	Guanine Nucleotide-Binding Protein G(o) Subunit Alpha	C3814802	T116	Gene_or_gene_product	57-59	Fz	Frizzled Receptors	C1564903	T192|T116	Gene_or_gene_product	230-239	sensitive	Sensitive	C0020517	T046	-827	Binding	NA	TRUE	NA
1700	PC13_devel	16303557.s8	Finally, we demonstrate an association of Galpha(o) with Fz that is also very rapidly (t1/2 < 1 min) perturbed upon Wnt-3a stimulation and that the Wnt-dependent effects on both GSK3beta/Axin2 and Galpha(o)/Fz are pertussis-toxin sensitive.	57-59	Fz	Frizzled Receptors	C1564903	T192|T116	Gene_or_gene_product	116-122	Wnt-3a	Wnt3A Protein	C0148810	T116|T123	Gene_or_gene_product	230-239	sensitive	Sensitive	C0020517	T046	-827	Regulation	Backward	TRUE	NA
1714	PC13_devel	16365046.s2	Consecutive phosphatidyl inositol kinase-like kinase (PIKK)-dependent and PIKK-independent steps in activation of Rad53 are key steps for controlling and transmitting diverse downstream responses to DNA damage.	12-52	phosphatidyl inositol kinase-like kinase	phosphatidylinositol 3'-kinase-associated serine kinase	C0760772	T116|T126	Gene_or_gene_product	114-119	Rad53	RAD53 protein, S cerevisiae	C0084611	T116|T126	Gene_or_gene_product	199-209	DNA damage	DNA Damage	C0012860	T049	-1000	Increase	Forward	TRUE	NA
1717	PC13_devel	16365046.s2	Consecutive phosphatidyl inositol kinase-like kinase (PIKK)-dependent and PIKK-independent steps in activation of Rad53 are key steps for controlling and transmitting diverse downstream responses to DNA damage.	54-58	PIKK	phosphatidylinositol 3'-kinase-associated serine kinase	C0760772	T116|T126	Gene_or_gene_product	114-119	Rad53	RAD53 protein, S cerevisiae	C0084611	T116|T126	Gene_or_gene_product	199-209	DNA damage	DNA Damage	C0012860	T049	-1000	Increase	Forward	TRUE	NA
1719	PC13_devel	16365046.s2	Consecutive phosphatidyl inositol kinase-like kinase (PIKK)-dependent and PIKK-independent steps in activation of Rad53 are key steps for controlling and transmitting diverse downstream responses to DNA damage.	74-78	PIKK	phosphatidylinositol 3'-kinase-associated serine kinase	C0760772	T116|T126	Gene_or_gene_product	114-119	Rad53	RAD53 protein, S cerevisiae	C0084611	T116|T126	Gene_or_gene_product	199-209	DNA damage	DNA Damage	C0012860	T049	-1000	Regulation	Forward	TRUE	NA
1752	PC13_devel	16571800.s9	Pulse-chase experiments revealed that IE2-86 but not IE1-72 or several loss-of-function IE2-86 mutants increased the half-life of p53 and reduced the half-life of mdm2.	38-44	IE2-86	IE2 protein, Cytomegalovirus	C0123190	T116|T123	Gene_or_gene_product	130-133	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	95-102	mutants	mutants	C0596988	T049	-812	Increase	Forward	FALSE	NA
1753	PC13_devel	16571800.s9	Pulse-chase experiments revealed that IE2-86 but not IE1-72 or several loss-of-function IE2-86 mutants increased the half-life of p53 and reduced the half-life of mdm2.	38-44	IE2-86	IE2 protein, Cytomegalovirus	C0123190	T116|T123	Gene_or_gene_product	163-167	mdm2	mdm2 protein	C0127306	T116|T123	Gene_or_gene_product	95-102	mutants	mutants	C0596988	T049	-812	Decrease	Forward	FALSE	NA
1788	PC13_devel	16765349.s0	Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis.	10-13	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	52-65	cyclin E/CDK2	cyclin E1-CDK2 complex	C3269081	T026	Complex	92-100	lymphoma	LYMPHOMA	C0024299	T191	-629	Binding	NA	TRUE	NA
1839	PC13_devel	16765349.s7	Data presented here suggest a novel RA-signaling, by which RA-induced p21 induction and complex formation with cyclin E/CDK2 diverts CDK2 function from normally driving proliferation to alternatively promoting apoptosis.	59-61	RA	Tretinoin	C0040845	T109|T121|T131	Simple_chemical	111-124	cyclin E/CDK2	cyclin E1-CDK2 complex	C3269081	T026	Complex	169-182	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Forward	TRUE	NA
1841	PC13_devel	16765349.s7	Data presented here suggest a novel RA-signaling, by which RA-induced p21 induction and complex formation with cyclin E/CDK2 diverts CDK2 function from normally driving proliferation to alternatively promoting apoptosis.	59-61	RA	Tretinoin	C0040845	T109|T121|T131	Simple_chemical	70-73	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	169-182	proliferation	Proliferation	C0334094	T046	-1000	Increase	Forward	TRUE	NA
1842	PC13_devel	16765349.s7	Data presented here suggest a novel RA-signaling, by which RA-induced p21 induction and complex formation with cyclin E/CDK2 diverts CDK2 function from normally driving proliferation to alternatively promoting apoptosis.	70-73	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	111-124	cyclin E/CDK2	cyclin E1-CDK2 complex	C3269081	T026	Complex	169-182	proliferation	Proliferation	C0334094	T046	-1000	Binding	NA	TRUE	NA
1855	PC13_devel	17204938.s7	In addition, genotoxic agents increased nuclear p53 immunoreactivity, whereas STS produced rapid cytoplasmic p53 accumulation.	78-81	STS	Staurosporine	C0075193	T109|T121	Simple_chemical	109-112	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	13-22	genotoxic	genotoxicity	C0598309	T049	-623	Regulation	Forward	FALSE	NA
1858	PC13_devel	17254966.s0	Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.	0-3	Cdk	Cyclin-Dependent Kinases	C0243045	T116|T126	Gene_or_gene_product	41-48	p27Kip1	cyclin-dependent kinase inhibitor 1B	C0169665	T116|T123	Gene_or_gene_product	75-84	oncogenic	Oncogenesis	C0007621	T191	-589	Decrease	Backward	TRUE	NA
1859	PC13_devel	17254966.s0	Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.	0-3	Cdk	Cyclin-Dependent Kinases	C0243045	T116|T126	Gene_or_gene_product	41-48	p27Kip1	cyclin-dependent kinase inhibitor 1B	C0169665	T116|T123	Gene_or_gene_product	75-84	oncogenic	Oncogenesis	C0596263	T191	-589	Decrease	Backward	TRUE	NA
1901	PC13_devel	17363249.s7	A phosphorylation-site mutation (Sho1(S166E)) diminishes the formation of Sho1-oligomers, dampens activation of the Hog1 kinase, and impairs growth in high-salt or sorbitol conditions.	33-44	Sho1(S166E)	SHO1 protein, S cerevisiae	C1137600	T116|T123	Gene_or_gene_product	116-120	Hog1	HOG1 protein, S cerevisiae	C0257532	T116|T126	Gene_or_gene_product	173-183	conditions	condition	C0012634	T047	-827	Decrease	Forward	TRUE	NA
1902	PC13_devel	17363249.s7	A phosphorylation-site mutation (Sho1(S166E)) diminishes the formation of Sho1-oligomers, dampens activation of the Hog1 kinase, and impairs growth in high-salt or sorbitol conditions.	33-44	Sho1(S166E)	SHO1 protein, S cerevisiae	C1137600	T116|T123	Gene_or_gene_product	116-120	Hog1	HOG1 protein, S cerevisiae	C0257532	T116|T126	Gene_or_gene_product	23-31	mutation	Mutation	C1705285	T049	-827	Decrease	Forward	TRUE	NA
1907	PC13_devel	17363249.s7	A phosphorylation-site mutation (Sho1(S166E)) diminishes the formation of Sho1-oligomers, dampens activation of the Hog1 kinase, and impairs growth in high-salt or sorbitol conditions.	33-44	Sho1(S166E)	SHO1 protein, S cerevisiae	C1137600	T116|T123	Gene_or_gene_product	74-78	Sho1	SHO1 protein, S cerevisiae	C1137600	T116|T123	Gene_or_gene_product	173-183	conditions	condition	C0012634	T047	-827	Regulation	Forward	TRUE	NA
1908	PC13_devel	17363249.s7	A phosphorylation-site mutation (Sho1(S166E)) diminishes the formation of Sho1-oligomers, dampens activation of the Hog1 kinase, and impairs growth in high-salt or sorbitol conditions.	33-44	Sho1(S166E)	SHO1 protein, S cerevisiae	C1137600	T116|T123	Gene_or_gene_product	74-78	Sho1	SHO1 protein, S cerevisiae	C1137600	T116|T123	Gene_or_gene_product	23-31	mutation	Mutation	C1705285	T049	-827	Regulation	Forward	TRUE	NA
1916	PC13_devel	17517883.s3	PRAS40 binding to raptor was severely inhibited by mutation of PRAS40 (Phe(129) to Ala).	0-6	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	18-24	raptor	Regulatory-Associated Protein of mTOR	C3538725	T116	Gene_or_gene_product	51-59	mutation	Mutation	C1705285	T049	-1000	Binding	NA	TRUE	NA
1927	PC13_devel	17517883.s5	PRAS40 binding to raptor was also abolished by mutation of the major mTORC1 phosphorylation site, Ser(183), to Asp.	0-6	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	18-24	raptor	Regulatory-Associated Protein of mTOR	C3538725	T116	Gene_or_gene_product	47-55	mutation	Mutation	C1705285	T049	-1000	Binding	NA	TRUE	NA
1936	PC13_devel	17517883.s6	PRAS40 (Ser(183)) was phosphorylated in intact cells; this phosphorylation was inhibited by rapamycin, by 2-deoxyglucose, and by overexpression of the tuberous sclerosis complex heterodimer.	0-6	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	106-120	2-deoxyglucose	2-deoxyglucose	C4049845	T109	Simple_chemical	151-177	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-756	Regulation	Backward	TRUE	NA
1939	PC13_devel	17517883.s6	PRAS40 (Ser(183)) was phosphorylated in intact cells; this phosphorylation was inhibited by rapamycin, by 2-deoxyglucose, and by overexpression of the tuberous sclerosis complex heterodimer.	0-6	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	92-101	rapamycin	Sirolimus	C0072980	T109|T195	Simple_chemical	151-177	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-756	Regulation	Backward	TRUE	NA
1954	PC13_devel	17517883.s8	Overexpressed PRAS40 suppressed the phosphorylation of S6K1 and 4E-BP1 at their rapamycin-sensitive phosphorylation sites, and reciprocally, overexpression of S6K1 or 4E-BP1 suppressed phosphorylation of PRAS40 (Ser(183)) and its binding to raptor.	14-20	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	55-59	S6K1	Ribosomal Protein S6 Kinase Beta-1	C2827383	T116|T126	Gene_or_gene_product	90-99	sensitive	Sensitive	C0020517	T046	-645	Regulation	Forward	TRUE	NA
1955	PC13_devel	17517883.s8	Overexpressed PRAS40 suppressed the phosphorylation of S6K1 and 4E-BP1 at their rapamycin-sensitive phosphorylation sites, and reciprocally, overexpression of S6K1 or 4E-BP1 suppressed phosphorylation of PRAS40 (Ser(183)) and its binding to raptor.	14-20	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	64-70	4E-BP1	EIF4EBP1 protein, human	C0254260	T116|T123	Gene_or_gene_product	90-99	sensitive	Sensitive	C0020517	T046	-645	Regulation	Forward	TRUE	NA
1965	PC13_devel	17517883.s8	Overexpressed PRAS40 suppressed the phosphorylation of S6K1 and 4E-BP1 at their rapamycin-sensitive phosphorylation sites, and reciprocally, overexpression of S6K1 or 4E-BP1 suppressed phosphorylation of PRAS40 (Ser(183)) and its binding to raptor.	204-210	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	241-247	raptor	Regulatory-Associated Protein of mTOR	C3538725	T116	Gene_or_gene_product	90-99	sensitive	Sensitive	C0020517	T046	-645	Binding	NA	FALSE	NA
2052	PC13_devel	18653893.s4	An acetylation-mimicking mutation of a conserved lysine in cohesin's Smc3 subunit makes Eco1 dispensable for cell growth, and we show that Smc3 is acetylated in an Eco1-dependent manner during DNA replication to promote sister chromatid cohesion.	139-143	Smc3	SMC3 protein, human	C0535219	T116|T123	Gene_or_gene_product	164-168	Eco1	ECO1 protein, S cerevisiae	C0765084	T116|T126	Gene_or_gene_product	25-33	mutation	Mutation	C1705285	T049	-827	Regulation	Backward	FALSE	NA
2095	PC13_devel	19303885.s2	The role of MDM2 in down-regulating the p53 response in unstressed conditions and in the post-stress recovery phase is well documented.	12-16	MDM2	mdm2 protein	C0127306	T116|T123	Gene_or_gene_product	40-43	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	67-77	conditions	condition	C0012634	T047	-827	Decrease	Forward	FALSE	NA
2111	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	108-113	IAP-2	Plasminogen Activator Inhibitor 2	C0030191	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Regulation	Backward	FALSE	NA
2112	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	108-113	IAP-2	Plasminogen Activator Inhibitor 2	C0030191	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	143-151	invasion	Invasion	C2699153	T046	-1000	Regulation	Backward	FALSE	NA
2113	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	108-113	IAP-2	Plasminogen Activator Inhibitor 2	C0030191	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	116-129	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Backward	FALSE	NA
2120	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	131-140	cyclin D1	Cyclin D1	C0174680	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Regulation	Backward	FALSE	NA
2121	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	131-140	cyclin D1	Cyclin D1	C0174680	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	143-151	invasion	Invasion	C2699153	T046	-1000	Regulation	Backward	FALSE	NA
2122	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	131-140	cyclin D1	Cyclin D1	C0174680	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	116-129	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Backward	FALSE	NA
2126	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	153-158	MMP-9	Matrix Metalloproteinase 9	C0165519	T116|T126	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Regulation	Backward	FALSE	NA
2127	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	153-158	MMP-9	Matrix Metalloproteinase 9	C0165519	T116|T126	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	143-151	invasion	Invasion	C2699153	T046	-1000	Regulation	Backward	FALSE	NA
2128	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	153-158	MMP-9	Matrix Metalloproteinase 9	C0165519	T116|T126	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	116-129	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Backward	FALSE	NA
2129	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	179-183	VEGF	Vascular Endothelial Growth Factor A	C0078058	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Regulation	Backward	FALSE	NA
2130	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	179-183	VEGF	Vascular Endothelial Growth Factor A	C0078058	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	143-151	invasion	Invasion	C2699153	T046	-1000	Regulation	Backward	FALSE	NA
2131	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	179-183	VEGF	Vascular Endothelial Growth Factor A	C0078058	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	116-129	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Backward	FALSE	NA
2132	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	108-113	IAP-2	Plasminogen Activator Inhibitor 2	C0030191	T116|T123	Gene_or_gene_product	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
2133	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	108-113	IAP-2	Plasminogen Activator Inhibitor 2	C0030191	T116|T123	Gene_or_gene_product	143-151	invasion	Invasion	C2699153	T046	-1000	Decrease	Forward	FALSE	NA
2134	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	108-113	IAP-2	Plasminogen Activator Inhibitor 2	C0030191	T116|T123	Gene_or_gene_product	116-129	proliferation	Proliferation	C0334094	T046	-1000	Decrease	Forward	FALSE	NA
2135	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	131-140	cyclin D1	Cyclin D1	C0174680	T116|T123	Gene_or_gene_product	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
2136	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	131-140	cyclin D1	Cyclin D1	C0174680	T116|T123	Gene_or_gene_product	143-151	invasion	Invasion	C2699153	T046	-1000	Decrease	Forward	FALSE	NA
2137	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	131-140	cyclin D1	Cyclin D1	C0174680	T116|T123	Gene_or_gene_product	116-129	proliferation	Proliferation	C0334094	T046	-1000	Decrease	Forward	FALSE	NA
2138	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	153-158	MMP-9	Matrix Metalloproteinase 9	C0165519	T116|T126	Gene_or_gene_product	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
2139	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	153-158	MMP-9	Matrix Metalloproteinase 9	C0165519	T116|T126	Gene_or_gene_product	143-151	invasion	Invasion	C2699153	T046	-1000	Decrease	Forward	FALSE	NA
2140	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	153-158	MMP-9	Matrix Metalloproteinase 9	C0165519	T116|T126	Gene_or_gene_product	116-129	proliferation	Proliferation	C0334094	T046	-1000	Decrease	Forward	FALSE	NA
2141	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	179-183	VEGF	Vascular Endothelial Growth Factor A	C0078058	T116|T123	Gene_or_gene_product	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
2142	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	179-183	VEGF	Vascular Endothelial Growth Factor A	C0078058	T116|T123	Gene_or_gene_product	143-151	invasion	Invasion	C2699153	T046	-1000	Decrease	Forward	FALSE	NA
2143	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	179-183	VEGF	Vascular Endothelial Growth Factor A	C0078058	T116|T123	Gene_or_gene_product	116-129	proliferation	Proliferation	C0334094	T046	-1000	Decrease	Forward	FALSE	NA
2147	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	82-87	Bcl-2	BCL2 protein, human	C4042483	T116	Gene_or_gene_product	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
2148	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	82-87	Bcl-2	BCL2 protein, human	C4042483	T116	Gene_or_gene_product	143-151	invasion	Invasion	C2699153	T046	-1000	Decrease	Forward	FALSE	NA
2149	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	82-87	Bcl-2	BCL2 protein, human	C4042483	T116	Gene_or_gene_product	116-129	proliferation	Proliferation	C0334094	T046	-1000	Decrease	Forward	FALSE	NA
2150	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	89-95	Bcl-xL	BCL-XL Protein	C0288330	T116|T123	Gene_or_gene_product	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
2151	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	89-95	Bcl-xL	BCL-XL Protein	C0288330	T116|T123	Gene_or_gene_product	143-151	invasion	Invasion	C2699153	T046	-1000	Decrease	Forward	FALSE	NA
2152	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	89-95	Bcl-xL	BCL-XL Protein	C0288330	T116|T123	Gene_or_gene_product	116-129	proliferation	Proliferation	C0334094	T046	-1000	Decrease	Forward	FALSE	NA
2153	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	97-102	IAP-1	Plasminogen Activator Inhibitor 1	C0030190	T116|T123	Gene_or_gene_product	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
2154	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	97-102	IAP-1	Plasminogen Activator Inhibitor 1	C0030190	T116|T123	Gene_or_gene_product	143-151	invasion	Invasion	C2699153	T046	-1000	Decrease	Forward	FALSE	NA
2155	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	5-13	limonoid	Limonins	C1136129	T109	Simple_chemical	97-102	IAP-1	Plasminogen Activator Inhibitor 1	C0030190	T116|T123	Gene_or_gene_product	116-129	proliferation	Proliferation	C0334094	T046	-1000	Decrease	Forward	FALSE	NA
2168	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	82-87	Bcl-2	BCL2 protein, human	C4042483	T116	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Regulation	Backward	FALSE	NA
2169	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	82-87	Bcl-2	BCL2 protein, human	C4042483	T116	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	143-151	invasion	Invasion	C2699153	T046	-1000	Regulation	Backward	FALSE	NA
2170	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	82-87	Bcl-2	BCL2 protein, human	C4042483	T116	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	116-129	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Backward	FALSE	NA
2189	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	89-95	Bcl-xL	BCL-XL Protein	C0288330	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Regulation	Backward	FALSE	NA
2190	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	89-95	Bcl-xL	BCL-XL Protein	C0288330	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	143-151	invasion	Invasion	C2699153	T046	-1000	Regulation	Backward	FALSE	NA
2191	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	89-95	Bcl-xL	BCL-XL Protein	C0288330	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	116-129	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Backward	FALSE	NA
2207	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	97-102	IAP-1	Plasminogen Activator Inhibitor 1	C0030190	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	165-177	angiogenesis	angiogenesis	C1519670	T191	-1000	Regulation	Backward	FALSE	NA
2208	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	97-102	IAP-1	Plasminogen Activator Inhibitor 1	C0030190	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	143-151	invasion	Invasion	C2699153	T046	-1000	Regulation	Backward	FALSE	NA
2209	PC13_devel	20829362.s3	This limonoid abrogated the expression of proteins associated with cell survival (Bcl-2, Bcl-xL, IAP-1, and IAP-2), proliferation (cyclin D1), invasion (MMP-9), and angiogenesis (VEGF), all regulated by nuclear factor (NF)-kappaB.	97-102	IAP-1	Plasminogen Activator Inhibitor 1	C0030190	T116|T123	Gene_or_gene_product	203-229	nuclear factor (NF)-kappaB	NF-kappa B	C0079904	T129|T116	Complex	116-129	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Backward	FALSE	NA
2222	PC13_devel	20829362.s6	We found that suppression of NF-kappaB activation by nimbolide was caused by inhibition of IkappaB kinase (IKK), which led to suppression of IkappaBalpha phosphorylation and degradation, nuclear translocation, DNA binding, and gene transcription.	29-38	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	53-62	nimbolide	nimbolide	C0068773	T109	Simple_chemical	126-137	suppression	Suppression	C0221103	T046	-1000	Increase	Backward	FALSE	NA
2223	PC13_devel	20829362.s6	We found that suppression of NF-kappaB activation by nimbolide was caused by inhibition of IkappaB kinase (IKK), which led to suppression of IkappaBalpha phosphorylation and degradation, nuclear translocation, DNA binding, and gene transcription.	29-38	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	53-62	nimbolide	nimbolide	C0068773	T109	Simple_chemical	14-25	suppression	Suppression	C0221103	T046	-1000	Increase	Backward	FALSE	NA
2240	PC13_devel	20966071.s1	The DNA binding activity of NF-kappaB is critical for VCAM-1 expression during inflammation.	28-37	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	54-60	VCAM-1	Vascular Cell Adhesion Molecule-1	C0078056	T116|T129	Gene_or_gene_product	79-91	inflammation	INFLAMMATION	C0021368	T046	-1000	Increase	Forward	TRUE	NA
2530	PC13_devel	22056382.s6	Mechanistically, Tnf-alpha stimulation resulted in phosphorylation of histone H3 at the Hes1 promoter, and this signal was lost with Ikk2 deletion.	17-26	Tnf-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	70-80	histone H3	Histone H3	C0019647	T116|T123	Gene_or_gene_product	138-146	deletion	Deletion	C1442161	T049	-861	Regulation	Forward	TRUE	reverse
2538	PC13_devel	22093097.s0	Notch1 promotes glioma cell migration and invasion by stimulating beta-catenin and NF-kappaB signaling via AKT activation.	0-6	Notch1	Receptor, Notch1	C0144507	T192|T116	Gene_or_gene_product	107-110	AKT	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Gene_or_gene_product	16-22	glioma	GLIOMA	C0017638	T191	-660	Increase	Forward	FALSE	NA
2539	PC13_devel	22093097.s0	Notch1 promotes glioma cell migration and invasion by stimulating beta-catenin and NF-kappaB signaling via AKT activation.	0-6	Notch1	Receptor, Notch1	C0144507	T192|T116	Gene_or_gene_product	107-110	AKT	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Gene_or_gene_product	42-50	invasion	Invasion	C2699153	T046	-1000	Increase	Forward	FALSE	NA
2568	PC13_devel	22093097.s4	Increased nuclear localization of beta-catenin and p50 as well as enhanced IKKalpha/AKT interaction were also observed in glioma tissues.	75-83	IKKalpha	conserved helix-loop-helix ubiquitous kinase	C0754623	T116|T123	Gene_or_gene_product	84-87	AKT	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Gene_or_gene_product	122-128	glioma	GLIOMA	C0017638	T191	-694	Binding	NA	TRUE	NA
2670	PC13_devel	22949302.s4	The results indicated that treatment with oroxylin A inhibited NF-kappaB p65 nuclear translocation and phosphorylation of IkappaBalpha and IKKalpha/beta in both human colon tumor HCT116 cells and human monocytes THP-1 cells.	42-52	oroxylin A	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	C0658374	T109|T121	Simple_chemical	122-134	IkappaBalpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Gene_or_gene_product	167-178	colon tumor	Colon Tumour	C0009375	T191	-673	Regulation	Forward	TRUE	NA
2671	PC13_devel	22949302.s4	The results indicated that treatment with oroxylin A inhibited NF-kappaB p65 nuclear translocation and phosphorylation of IkappaBalpha and IKKalpha/beta in both human colon tumor HCT116 cells and human monocytes THP-1 cells.	42-52	oroxylin A	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	C0658374	T109|T121	Simple_chemical	139-147	IKKalpha	conserved helix-loop-helix ubiquitous kinase	C0754623	T116|T123	Gene_or_gene_product	167-178	colon tumor	Colon Tumour	C0009375	T191	-673	Regulation	Forward	TRUE	NA
2672	PC13_devel	22949302.s4	The results indicated that treatment with oroxylin A inhibited NF-kappaB p65 nuclear translocation and phosphorylation of IkappaBalpha and IKKalpha/beta in both human colon tumor HCT116 cells and human monocytes THP-1 cells.	42-52	oroxylin A	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	C0658374	T109|T121	Simple_chemical	148-152	beta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	167-178	colon tumor	Colon Tumour	C0009375	T191	-673	Regulation	Forward	TRUE	NA
2674	PC13_devel	22949302.s4	The results indicated that treatment with oroxylin A inhibited NF-kappaB p65 nuclear translocation and phosphorylation of IkappaBalpha and IKKalpha/beta in both human colon tumor HCT116 cells and human monocytes THP-1 cells.	42-52	oroxylin A	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	C0658374	T109|T121	Simple_chemical	73-76	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	167-178	colon tumor	Colon Tumour	C0009375	T191	-673	Regulation	Forward	TRUE	NA
2712	PC13_devel	7912658.s1	P-glycoproteins (P-gps) encoded by the mouse mdr2 and mdr3 genes were expressed in secretory vesicles (SVs) from the yeast mutant sec6-4, and their capacity to function as a lipid translocase/flippase was tested.	0-15	P-glycoproteins	P-Glycoproteins	C0069906	T116|T123	Gene_or_gene_product	45-49	mdr2	multidrug resistance protein 3	C0380509	T116|T123	Gene_or_gene_product	123-129	mutant	Mutant	C0596988	T049	-812	Increase	Backward	TRUE	NA
2713	PC13_devel	7912658.s1	P-glycoproteins (P-gps) encoded by the mouse mdr2 and mdr3 genes were expressed in secretory vesicles (SVs) from the yeast mutant sec6-4, and their capacity to function as a lipid translocase/flippase was tested.	0-15	P-glycoproteins	P-Glycoproteins	C0069906	T116|T123	Gene_or_gene_product	54-58	mdr3	multidrug resistance protein 3	C0380509	T116|T123	Gene_or_gene_product	123-129	mutant	Mutant	C0596988	T049	-812	Increase	Backward	TRUE	NA
2720	PC13_devel	7912658.s1	P-glycoproteins (P-gps) encoded by the mouse mdr2 and mdr3 genes were expressed in secretory vesicles (SVs) from the yeast mutant sec6-4, and their capacity to function as a lipid translocase/flippase was tested.	17-22	P-gps	P-Glycoproteins	C0069906	T116|T123	Gene_or_gene_product	45-49	mdr2	multidrug resistance protein 3	C0380509	T116|T123	Gene_or_gene_product	123-129	mutant	Mutant	C0596988	T049	-812	Increase	Backward	TRUE	NA
2721	PC13_devel	7912658.s1	P-glycoproteins (P-gps) encoded by the mouse mdr2 and mdr3 genes were expressed in secretory vesicles (SVs) from the yeast mutant sec6-4, and their capacity to function as a lipid translocase/flippase was tested.	17-22	P-gps	P-Glycoproteins	C0069906	T116|T123	Gene_or_gene_product	54-58	mdr3	multidrug resistance protein 3	C0380509	T116|T123	Gene_or_gene_product	123-129	mutant	Mutant	C0596988	T049	-812	Increase	Backward	TRUE	NA
2795	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	10-14	Mdr2	multidrug resistance protein 3	C0380509	T116|T123	Gene_or_gene_product	24-26	PC	Phosphatidylcholines	C1959616	T109|T123|T121	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Increase	Forward	FALSE	NA
2813	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	133-137	P-gp	P-Glycoproteins	C0069906	T116|T123	Gene_or_gene_product	148-157	verapamil	Verapamil	C0042523	T109|T121	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Regulation	Backward	FALSE	NA
2825	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	24-26	PC	Phosphatidylcholines	C1959616	T109|T123|T121	Simple_chemical	116-124	vanadate	Vanadates	C0042305	T197	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Regulation	Backward	FALSE	NA
2829	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	24-26	PC	Phosphatidylcholines	C1959616	T109|T123|T121	Simple_chemical	148-157	verapamil	Verapamil	C0042523	T109|T121	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Regulation	Backward	FALSE	NA
2831	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	24-26	PC	Phosphatidylcholines	C1959616	T109|T123|T121	Simple_chemical	239-249	colchicine	Colchicine	C0009262	T109|T121	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Regulation	Backward	FALSE	NA
2833	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	24-26	PC	Phosphatidylcholines	C1959616	T109|T123|T121	Simple_chemical	254-265	vinblastine	Vinblastine	C0042670	T109|T121|T123	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Regulation	Backward	FALSE	NA
2835	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	24-26	PC	Phosphatidylcholines	C1959616	T109|T123|T121	Simple_chemical	54-57	ATP	Adenosine Triphosphate	C0001480	T114|T121|T123	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Regulation	Backward	FALSE	NA
2837	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	24-26	PC	Phosphatidylcholines	C1959616	T109|T123|T121	Simple_chemical	62-66	Mg2+	Magnesium Cation	C2346927	T121|T196	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Regulation	Backward	FALSE	NA
2867	PC13_devel	7912658.s5	Increased Mdr2-mediated PC translocation was strictly ATP and Mg2+ dependent, was abrogated by the ATPase inhibitor vanadate and the P-gp modulator verapamil, but was insensitive to the presence of excess of the multidrug resistance drugs colchicine and vinblastine.	99-105	ATPase	Adenosine Triphosphatases	C0001473	T116|T126	Gene_or_gene_product	116-124	vanadate	Vanadates	C0042305	T197	Simple_chemical	27-40	translocation	Translocation	C0040715	T049	-804	Decrease	Backward	FALSE	NA
2920	PC13_devel	9250682.s4	PAG608 transcripts are induced by DNA damage in a p53-dependent manner.	0-6	PAG608	PAG608 protein, rat	C1430892	T116|T123	Gene_or_gene_product	50-53	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	34-44	DNA damage	DNA Damage	C0012860	T049	-1000	Increase	Backward	TRUE	NA
2968	PC13_devel	9889122.s6	The irradiation-induced decrease in Cdc25 activity was suppressed by wortmannin, an inhibitor of phosphatidylinositol (PI) 3-kinases, and was dependent on the function of the gene that is mutated in ataxia telangiectasia.	36-41	Cdc25	cdc25 Phosphatases	C0246769	T116|T126	Gene_or_gene_product	188-220	mutated in ataxia telangiectasia	ATM protein, human	C3711796	T116|T126	Gene_or_gene_product	199-220	ataxia telangiectasia	ATAXIA-TELANGIECTASIA	C0004135	T047	-1000	Decrease	Backward	FALSE	NA
2969	PC13_devel	9889122.s6	The irradiation-induced decrease in Cdc25 activity was suppressed by wortmannin, an inhibitor of phosphatidylinositol (PI) 3-kinases, and was dependent on the function of the gene that is mutated in ataxia telangiectasia.	36-41	Cdc25	cdc25 Phosphatases	C0246769	T116|T126	Gene_or_gene_product	188-220	mutated in ataxia telangiectasia	ATM protein, human	C3711796	T116|T126	Gene_or_gene_product	188-195	mutated	Mutated	C1705285	T049	-1000	Decrease	Backward	FALSE	NA
2970	PC13_devel	9889122.s6	The irradiation-induced decrease in Cdc25 activity was suppressed by wortmannin, an inhibitor of phosphatidylinositol (PI) 3-kinases, and was dependent on the function of the gene that is mutated in ataxia telangiectasia.	36-41	Cdc25	cdc25 Phosphatases	C0246769	T116|T126	Gene_or_gene_product	69-79	wortmannin	wortmannin	C0078517	T109|T121|T123	Simple_chemical	199-220	ataxia telangiectasia	ATAXIA-TELANGIECTASIA	C0004135	T047	-1000	Increase	Backward	TRUE	NA
2971	PC13_devel	9889122.s6	The irradiation-induced decrease in Cdc25 activity was suppressed by wortmannin, an inhibitor of phosphatidylinositol (PI) 3-kinases, and was dependent on the function of the gene that is mutated in ataxia telangiectasia.	36-41	Cdc25	cdc25 Phosphatases	C0246769	T116|T126	Gene_or_gene_product	69-79	wortmannin	wortmannin	C0078517	T109|T121|T123	Simple_chemical	188-195	mutated	Mutated	C1705285	T049	-1000	Increase	Backward	TRUE	NA
2976	PC13_devel	9889122.s6	The irradiation-induced decrease in Cdc25 activity was suppressed by wortmannin, an inhibitor of phosphatidylinositol (PI) 3-kinases, and was dependent on the function of the gene that is mutated in ataxia telangiectasia.	69-79	wortmannin	wortmannin	C0078517	T109|T121|T123	Simple_chemical	97-132	phosphatidylinositol (PI) 3-kinases	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	199-220	ataxia telangiectasia	ATAXIA-TELANGIECTASIA	C0004135	T047	-1000	Decrease	Forward	TRUE	NA
2977	PC13_devel	9889122.s6	The irradiation-induced decrease in Cdc25 activity was suppressed by wortmannin, an inhibitor of phosphatidylinositol (PI) 3-kinases, and was dependent on the function of the gene that is mutated in ataxia telangiectasia.	69-79	wortmannin	wortmannin	C0078517	T109|T121|T123	Simple_chemical	97-132	phosphatidylinositol (PI) 3-kinases	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	188-195	mutated	Mutated	C1705285	T049	-1000	Decrease	Forward	TRUE	NA
9247	PC13_train	10085159.s4	We report here that the Cdc6p protein is degraded in a Cdc4-dependent manner, suggesting that phosphorylated Cdc6 is specifically recognized by the ubiquitin-mediated proteolysis machinery.	24-29	Cdc6p	CDC6 protein, S cerevisiae	C0081951	T116|T123	Gene_or_gene_product	55-59	Cdc4	CDC4 protein, S cerevisiae	C1664711	T116|T123	Gene_or_gene_product	179-188	machinery	Machinery	C0337246	T037	-812	Decrease	Backward	FALSE	NA
9251	PC13_train	10224130.s5	Inhibition of phosphorylation by dominant negative mutants of PKCzeta or p21(ras) results in loss of RelA transcriptional activity without interfering with DNA binding.	62-69	PKCzeta	protein kinase C zeta	C0256813	T116|T126	Gene_or_gene_product	101-105	RelA	Transcription Factor RelA	C0214222	T116|T123	Gene_or_gene_product	33-58	dominant negative mutants	Dominant-Negative Mutant	C1512032	T049	-983	Regulation	Forward	TRUE	NA
9254	PC13_train	10224130.s5	Inhibition of phosphorylation by dominant negative mutants of PKCzeta or p21(ras) results in loss of RelA transcriptional activity without interfering with DNA binding.	73-76	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	101-105	RelA	Transcription Factor RelA	C0214222	T116|T123	Gene_or_gene_product	33-58	dominant negative mutants	Dominant-Negative Mutant	C1512032	T049	-983	Regulation	Forward	TRUE	NA
9256	PC13_train	10224130.s5	Inhibition of phosphorylation by dominant negative mutants of PKCzeta or p21(ras) results in loss of RelA transcriptional activity without interfering with DNA binding.	77-80	ras	Proto-Oncogene Proteins p21(ras)	C0080058	T116|T126	Gene_or_gene_product	101-105	RelA	Transcription Factor RelA	C0214222	T116|T123	Gene_or_gene_product	33-58	dominant negative mutants	Dominant-Negative Mutant	C1512032	T049	-983	Regulation	Forward	TRUE	NA
9258	PC13_train	10346818.s3	Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation.	14-19	TRAF2	TNF receptor-associated factor 2	C0258441	T116|T123	Gene_or_gene_product	38-41	JNK	JNK Mitogen-Activated Protein Kinases	C0248813	T116|T126	Gene_or_gene_product	62-69	absence	Absence	C1689985	T190	-1000	Increase	Forward	TRUE	NA
9259	PC13_train	10346818.s3	Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation.	14-19	TRAF2	TNF receptor-associated factor 2	C0258441	T116|T123	Gene_or_gene_product	43-46	p38	mitogen-activated protein kinase p38	C1120843	T116|T126	Gene_or_gene_product	62-69	absence	Absence	C1689985	T190	-1000	Increase	Forward	TRUE	NA
9260	PC13_train	10346818.s3	Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation.	14-19	TRAF2	TNF receptor-associated factor 2	C0258441	T116|T123	Gene_or_gene_product	51-54	IKK	IkappaB kinase	C0663914	T116|T126	Complex	62-69	absence	Absence	C1689985	T190	-1000	Increase	Forward	TRUE	NA
9262	PC13_train	10346818.s3	Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation.	23-28	TRAF6	TNF receptor-associated factor 6	C0530129	T116|T123	Gene_or_gene_product	38-41	JNK	JNK Mitogen-Activated Protein Kinases	C0248813	T116|T126	Gene_or_gene_product	62-69	absence	Absence	C1689985	T190	-1000	Increase	Forward	TRUE	NA
9263	PC13_train	10346818.s3	Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation.	23-28	TRAF6	TNF receptor-associated factor 6	C0530129	T116|T123	Gene_or_gene_product	43-46	p38	mitogen-activated protein kinase p38	C1120843	T116|T126	Gene_or_gene_product	62-69	absence	Absence	C1689985	T190	-1000	Increase	Forward	TRUE	NA
9264	PC13_train	10346818.s3	Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation.	23-28	TRAF6	TNF receptor-associated factor 6	C0530129	T116|T123	Gene_or_gene_product	51-54	IKK	IkappaB kinase	C0663914	T116|T126	Complex	62-69	absence	Absence	C1689985	T190	-1000	Increase	Forward	TRUE	NA
9308	PC13_train	10364168.s7	Coexpression together with membrane CD14 enhances sPGN signal transmission through TLR2.	36-40	CD14	CD14 Antigen	C0108768	T116|T129|T192	Gene_or_gene_product	83-87	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Gene_or_gene_product	62-74	transmission	Transmission	C0242781	T046	-827	Increase	Backward	FALSE	NA
9671	PC13_train	10421629.s6	Thus, Wnt signaling lowers Axin's affinity for beta-catenin, thereby disengaging beta-catenin from the degradation machinery.	27-31	Axin	Axin Protein	C3178961	T116|T123	Gene_or_gene_product	47-59	beta-catenin	beta catenin	C0105770	T116|T123	Gene_or_gene_product	115-124	machinery	Machinery	C0337246	T037	-861	Binding	NA	TRUE	NA
9715	PC13_train	10487762.s7	Additionally, we have identified another subunit of the complex as the product of TRA1, an ATM-related essential gene homologous to human TRRAP, an essential cofactor for c-Myc- and E2F-mediated oncogenic transformation.	82-86	TRA1	TRA1 protein, S cerevisiae	C1452520	T028	Gene_or_gene_product	91-94	ATM	Ataxia Telangiectasia Mutated Proteins	C0298973	T116|T126	Gene_or_gene_product	195-204	oncogenic	Oncogenesis	C0007621	T191	-574	Regulation	Backward	FALSE	NA
9716	PC13_train	10487762.s7	Additionally, we have identified another subunit of the complex as the product of TRA1, an ATM-related essential gene homologous to human TRRAP, an essential cofactor for c-Myc- and E2F-mediated oncogenic transformation.	82-86	TRA1	TRA1 protein, S cerevisiae	C1452520	T028	Gene_or_gene_product	91-94	ATM	Ataxia Telangiectasia Mutated Proteins	C0298973	T116|T126	Gene_or_gene_product	195-204	oncogenic	Oncogenesis	C0596263	T191	-574	Regulation	Backward	FALSE	NA
9717	PC13_train	10487762.s7	Additionally, we have identified another subunit of the complex as the product of TRA1, an ATM-related essential gene homologous to human TRRAP, an essential cofactor for c-Myc- and E2F-mediated oncogenic transformation.	82-86	TRA1	TRA1 protein, S cerevisiae	C1452520	T028	Gene_or_gene_product	91-94	ATM	Ataxia Telangiectasia Mutated Proteins	C0298973	T116|T126	Gene_or_gene_product	205-219	transformation	Transformation	C1510411	T046	-812	Regulation	Backward	FALSE	NA
10151	PC13_train	10542212.s7	In this study, we show that IL-10 functions to block NF-kappaB activity at two levels: 1) through the suppression of IKK activity and 2) through the inhibition of NF-kappaB DNA binding activity.	28-33	IL-10	Interleukin-10	C0085295	T116|T129	Gene_or_gene_product	53-62	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	102-113	suppression	Suppression	C0221103	T046	-1000	Decrease	Forward	FALSE	NA
10223	PC13_train	10574991.s9	Biosynthesis of GPI in the Pig-n knockout cells was not affected by YW3548/BE49385A, and yeast overexpressing MCD4 was highly resistant to YW3548/BE49385A, suggesting that Pig-n and Mcd4p are targets of this drug.	110-114	MCD4	MCD4 protein, S cerevisiae	C0765034	T192|T116	Gene_or_gene_product	139-145	YW3548	YW 3548	C0668879	T109	Simple_chemical	33-41	knockout	Knockout	C1522225	T050	-645	Regulation	Backward	TRUE	NA
10324	PC13_train	10639137.s5	Remarkably, the Golgi-localized EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone, which suggests that the complex represents the biologically relevant form of the enzyme(s).	32-36	EXT1	EXT1 protein	C0537447	T116|T126	Gene_or_gene_product	37-41	EXT2	Exostosin-2	C0529768	T116|T123	Gene_or_gene_product	50-59	possesses	possesses	C0850310	T048	-1000	Binding	NA	FALSE	NA
10340	PC13_train	10642555.s3	uH2B was not detected in rad6 mutants, which are defective for the ubiquitin-conjugating enzyme Ubc2, thus identifying Rad6 as the major cellular activity that ubiquitinates H2B in yeast.	67-76	ubiquitin	Ubiquitin	C0041538	T116|T123	Gene_or_gene_product	96-100	Ubc2	Ubiquitin-Conjugating Enzymes	C0084913	T116|T126	Gene_or_gene_product	30-37	mutants	mutants	C0596988	T049	-861	Binding	NA	FALSE	NA
10358	PC13_train	10777476.s7	The rate constant of reduction of compound II to the ferric native enzyme at 15 degrees C is (5.5 +/- 0.1) x 10(2) m(-1) s(-1) at pH 7 and (8.9 +/- 1.6) x 10(4) m(-1) s(-1) at pH 5. pH dependence studies suggest that both complex formation between the ferric enzyme and nitrite and nitrite oxidation by compounds I and II are controlled by a residue with a pK(a) of (4.3 +/- 0.3).	282-289	nitrite	nitrite ion	C3848529	T121|T123|T197	Simple_chemical	303-314	compounds I	Peroxidase	C0027021	T116|T126	Gene_or_gene_product	185-195	dependence	Dependence	C0439857	T048	-660	Regulation	Backward	TRUE	NA
10359	PC13_train	10777476.s7	The rate constant of reduction of compound II to the ferric native enzyme at 15 degrees C is (5.5 +/- 0.1) x 10(2) m(-1) s(-1) at pH 7 and (8.9 +/- 1.6) x 10(4) m(-1) s(-1) at pH 5. pH dependence studies suggest that both complex formation between the ferric enzyme and nitrite and nitrite oxidation by compounds I and II are controlled by a residue with a pK(a) of (4.3 +/- 0.3).	282-289	nitrite	nitrite ion	C3848529	T121|T123|T197	Simple_chemical	319-321	II	Peroxidase	C0027021	T116|T126	Gene_or_gene_product	185-195	dependence	Dependence	C0439857	T048	-660	Regulation	Backward	TRUE	NA
10370	PC13_train	10811867.s2	In vivo and in vitro studies indicate that the BTK protein is essential for B cell survival, cell cycle progression, and proliferation in response to B cell antigen receptor (BCR) stimulation.	47-50	BTK	Agammaglobulinaemia tyrosine kinase	C0218158	T116|T126	Gene_or_gene_product	150-173	B cell antigen receptor	Receptors, Antigen, B-Cell	C0034789	T192|T129|T116	Complex	121-134	proliferation	Proliferation	C0334094	T046	-1000	Increase	Forward	FALSE	NA
10371	PC13_train	10811867.s2	In vivo and in vitro studies indicate that the BTK protein is essential for B cell survival, cell cycle progression, and proliferation in response to B cell antigen receptor (BCR) stimulation.	47-50	BTK	Agammaglobulinaemia tyrosine kinase	C0218158	T116|T126	Gene_or_gene_product	175-178	BCR	Receptors, Antigen, B-Cell	C0034789	T192|T129|T116	Complex	121-134	proliferation	Proliferation	C0334094	T046	-1000	Increase	Forward	FALSE	NA
10374	PC13_train	10811867.s4	We now demonstrate that a null mutation in btk known to cause the xid phenotype prevents BCR-induced activation of NF-kappaB.	89-92	BCR	Receptors, Antigen, B-Cell	C0034789	T192|T129|T116	Complex	115-124	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	31-39	mutation	Mutation	C1705285	T049	-861	Increase	Forward	TRUE	reverse
10375	PC13_train	10811867.s6	This mutation also interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation.	111-120	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	131-143	IkappaBalpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Gene_or_gene_product	5-13	mutation	Mutation	C1705285	T049	-1000	Decrease	Backward	FALSE	NA
10378	PC13_train	10811867.s6	This mutation also interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation.	35-38	BCR	Receptors, Antigen, B-Cell	C0034789	T192|T129|T116	Complex	62-76	IkappaB kinase	IkappaB kinase	C0663914	T116|T126	Complex	5-13	mutation	Mutation	C1705285	T049	-1000	Increase	Forward	TRUE	reverse
10379	PC13_train	10811867.s6	This mutation also interferes with BCR-directed activation of IkappaB kinase (IKK), which normally targets the NF-kappaB inhibitor IkappaBalpha for degradation.	35-38	BCR	Receptors, Antigen, B-Cell	C0034789	T192|T129|T116	Complex	78-81	IKK	IkappaB kinase	C0663914	T116|T126	Complex	5-13	mutation	Mutation	C1705285	T049	-1000	Increase	Forward	TRUE	reverse
10434	PC13_train	10899305.s3	Nuclear PI3K translocation has been demonstrated to be related to an analogous translocation of a PtdIns(3,4,5)P(3) activated PKC, the zeta isozyme.	98-115	PtdIns(3,4,5)P(3)	phosphatidylinositol 3,4,5-triphosphate	C0070794	T109	Simple_chemical	126-129	PKC	Protein Kinase C	C0033634	T116|T126	Gene_or_gene_product	79-92	translocation	Translocation	C0040715	T049	-861	Increase	Forward	TRUE	NA
10442	PC13_train	10899305.s7	Enzyme translocation was blocked by the specific PI3K inhibitor, LY294002, as well as cell entry into S-phase.	49-53	PI3K	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	65-73	LY294002	LY 294002	C0251991	T109|T121	Simple_chemical	7-20	translocation	Translocation	C0040715	T049	-861	Decrease	Backward	FALSE	NA
10468	PC13_train	10975521.s3	The critical target of SCF(Met30) is the transcription factor Met4, as deletion of MET4 suppresses the lethality of met30 mutants.	23-33	SCF(Met30)	SCF-Met30/Pof1 ubiquitin ligase complex	C3893618	T026	Complex	62-66	Met4	MET4 protein, S cerevisiae	C1448677	T116|T123	Gene_or_gene_product	71-79	deletion	Deletion	C1442161	T049	-1000	Regulation	Forward	TRUE	NA
10469	PC13_train	10975521.s3	The critical target of SCF(Met30) is the transcription factor Met4, as deletion of MET4 suppresses the lethality of met30 mutants.	23-33	SCF(Met30)	SCF-Met30/Pof1 ubiquitin ligase complex	C3893618	T026	Complex	62-66	Met4	MET4 protein, S cerevisiae	C1448677	T116|T123	Gene_or_gene_product	122-129	mutants	mutants	C0596988	T049	-861	Regulation	Forward	TRUE	NA
10491	PC13_train	11101877.s5	Dominant-negative Rac1N17, but not dominant-negative Cdc42N17, block nuclear factor-kappa B (NF-kappa B) transactivation.	18-25	Rac1N17	rac1 GTP-Binding Protein	C0139880	T116|T126	Gene_or_gene_product	69-91	nuclear factor-kappa B	NF-kappa B	C0079904	T129|T116	Complex	0-17	Dominant-negative	Dominant Negative	C1512032	T049	-734	Decrease	Forward	TRUE	NA
10493	PC13_train	11101877.s5	Dominant-negative Rac1N17, but not dominant-negative Cdc42N17, block nuclear factor-kappa B (NF-kappa B) transactivation.	18-25	Rac1N17	rac1 GTP-Binding Protein	C0139880	T116|T126	Gene_or_gene_product	69-91	nuclear factor-kappa B	NF-kappa B	C0079904	T129|T116	Complex	35-52	dominant-negative	Dominant Negative	C1512032	T049	-694	Decrease	Forward	FALSE	NA
10494	PC13_train	11101877.s5	Dominant-negative Rac1N17, but not dominant-negative Cdc42N17, block nuclear factor-kappa B (NF-kappa B) transactivation.	18-25	Rac1N17	rac1 GTP-Binding Protein	C0139880	T116|T126	Gene_or_gene_product	93-103	NF-kappa B	NF-kappa B	C0079904	T116|T129	Complex	0-17	Dominant-negative	Dominant Negative	C1512032	T049	-734	Decrease	Forward	TRUE	NA
10496	PC13_train	11101877.s5	Dominant-negative Rac1N17, but not dominant-negative Cdc42N17, block nuclear factor-kappa B (NF-kappa B) transactivation.	18-25	Rac1N17	rac1 GTP-Binding Protein	C0139880	T116|T126	Gene_or_gene_product	93-103	NF-kappa B	NF-kappa B	C0079904	T116|T129	Complex	35-52	dominant-negative	Dominant Negative	C1512032	T049	-694	Decrease	Forward	FALSE	NA
10526	PC13_train	11139340.s2	It was originally reported that induction of KILLER/DR5 mRNA following DNA damage was p53-dependent, but some drugs that induce apoptosis can upregulate KILLER/DR5 mRNA expression in cell lines with mutated p53.	45-51	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	86-89	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	71-81	DNA damage	DNA Damage	C0012860	T049	-1000	Regulation	Backward	TRUE	NA
10527	PC13_train	11139340.s2	It was originally reported that induction of KILLER/DR5 mRNA following DNA damage was p53-dependent, but some drugs that induce apoptosis can upregulate KILLER/DR5 mRNA expression in cell lines with mutated p53.	45-51	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	86-89	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	199-206	mutated	Mutated	C1705285	T049	-694	Regulation	Backward	TRUE	NA
10534	PC13_train	11139340.s2	It was originally reported that induction of KILLER/DR5 mRNA following DNA damage was p53-dependent, but some drugs that induce apoptosis can upregulate KILLER/DR5 mRNA expression in cell lines with mutated p53.	52-55	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	86-89	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	71-81	DNA damage	DNA Damage	C0012860	T049	-1000	Regulation	Backward	TRUE	NA
10535	PC13_train	11139340.s2	It was originally reported that induction of KILLER/DR5 mRNA following DNA damage was p53-dependent, but some drugs that induce apoptosis can upregulate KILLER/DR5 mRNA expression in cell lines with mutated p53.	52-55	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	86-89	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	199-206	mutated	Mutated	C1705285	T049	-694	Regulation	Backward	TRUE	NA
10548	PC13_train	11139340.s4	beta-Lapachone, a topoisomerase inhibitor, increased KILLER/DR5 mRNA in colon cancer cell lines with wild-type p53 but not with mutant p53.	0-14	beta-Lapachone	beta-lapachone	C0053471	T109|T121	Gene_or_gene_product	53-59	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	72-84	colon cancer	COLON CANCER	C0007102	T191	-861	Increase	Forward	TRUE	NA
10549	PC13_train	11139340.s4	beta-Lapachone, a topoisomerase inhibitor, increased KILLER/DR5 mRNA in colon cancer cell lines with wild-type p53 but not with mutant p53.	0-14	beta-Lapachone	beta-lapachone	C0053471	T109|T121	Gene_or_gene_product	53-59	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	72-84	colon cancer	COLON CANCER	C0699790	T191	-861	Increase	Forward	TRUE	NA
10550	PC13_train	11139340.s4	beta-Lapachone, a topoisomerase inhibitor, increased KILLER/DR5 mRNA in colon cancer cell lines with wild-type p53 but not with mutant p53.	0-14	beta-Lapachone	beta-lapachone	C0053471	T109|T121	Gene_or_gene_product	53-59	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	128-134	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
10551	PC13_train	11139340.s4	beta-Lapachone, a topoisomerase inhibitor, increased KILLER/DR5 mRNA in colon cancer cell lines with wild-type p53 but not with mutant p53.	0-14	beta-Lapachone	beta-lapachone	C0053471	T109|T121	Gene_or_gene_product	60-63	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	72-84	colon cancer	COLON CANCER	C0007102	T191	-861	Increase	Forward	TRUE	NA
10552	PC13_train	11139340.s4	beta-Lapachone, a topoisomerase inhibitor, increased KILLER/DR5 mRNA in colon cancer cell lines with wild-type p53 but not with mutant p53.	0-14	beta-Lapachone	beta-lapachone	C0053471	T109|T121	Gene_or_gene_product	60-63	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	72-84	colon cancer	COLON CANCER	C0699790	T191	-861	Increase	Forward	TRUE	NA
10553	PC13_train	11139340.s4	beta-Lapachone, a topoisomerase inhibitor, increased KILLER/DR5 mRNA in colon cancer cell lines with wild-type p53 but not with mutant p53.	0-14	beta-Lapachone	beta-lapachone	C0053471	T109|T121	Gene_or_gene_product	60-63	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	128-134	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
10574	PC13_train	11139340.s5	In contrast, betulinic acid, a novel chemotherapeutic compound, induced apoptosis and KILLER/DR5 mRNA in melanoma and glioblastoma cells through a p53-independent mechanism.	13-27	betulinic acid	betulinic acid	C0053530	T109|T121	Simple_chemical	86-92	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	118-130	glioblastoma	Glioblastoma	C0017636	T191	-694	Increase	Forward	TRUE	NA
10575	PC13_train	11139340.s5	In contrast, betulinic acid, a novel chemotherapeutic compound, induced apoptosis and KILLER/DR5 mRNA in melanoma and glioblastoma cells through a p53-independent mechanism.	13-27	betulinic acid	betulinic acid	C0053530	T109|T121	Simple_chemical	86-92	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	105-113	melanoma	MELANOMA	C0025202	T191	-1000	Increase	Forward	TRUE	NA
10576	PC13_train	11139340.s5	In contrast, betulinic acid, a novel chemotherapeutic compound, induced apoptosis and KILLER/DR5 mRNA in melanoma and glioblastoma cells through a p53-independent mechanism.	13-27	betulinic acid	betulinic acid	C0053530	T109|T121	Simple_chemical	93-96	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	118-130	glioblastoma	Glioblastoma	C0017636	T191	-694	Increase	Forward	TRUE	NA
10577	PC13_train	11139340.s5	In contrast, betulinic acid, a novel chemotherapeutic compound, induced apoptosis and KILLER/DR5 mRNA in melanoma and glioblastoma cells through a p53-independent mechanism.	13-27	betulinic acid	betulinic acid	C0053530	T109|T121	Simple_chemical	93-96	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	105-113	melanoma	MELANOMA	C0025202	T191	-1000	Increase	Forward	TRUE	NA
10632	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	105-117	colon cancer	COLON CANCER	C0007102	T191	-861	Increase	Forward	TRUE	NA
10633	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	105-117	colon cancer	COLON CANCER	C0699790	T191	-861	Increase	Forward	TRUE	NA
10634	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	71-83	glioblastoma	Glioblastoma	C0017636	T191	-1000	Increase	Forward	TRUE	NA
10635	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	134-140	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
10636	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	85-99	ovarian cancer	OVARIAN CANCER	C1140680	T191	-1000	Increase	Forward	TRUE	NA
10637	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	85-99	ovarian cancer	ovarian cancer	C0029925	T191	-1000	Increase	Forward	TRUE	NA
10638	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	105-117	colon cancer	COLON CANCER	C0007102	T191	-861	Increase	Forward	TRUE	NA
10639	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	105-117	colon cancer	COLON CANCER	C0699790	T191	-861	Increase	Forward	TRUE	NA
10640	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	71-83	glioblastoma	Glioblastoma	C0017636	T191	-1000	Increase	Forward	TRUE	NA
10641	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	134-140	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
10642	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	85-99	ovarian cancer	OVARIAN CANCER	C1140680	T191	-1000	Increase	Forward	TRUE	NA
10643	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	29-42	dexamethasone	Dexamethasone	C0011777	T109|T121	Simple_chemical	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	85-99	ovarian cancer	ovarian cancer	C0029925	T191	-1000	Increase	Forward	TRUE	NA
10650	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	105-117	colon cancer	COLON CANCER	C0007102	T191	-861	Decrease	Backward	TRUE	NA
10651	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	105-117	colon cancer	COLON CANCER	C0699790	T191	-861	Decrease	Backward	TRUE	NA
10652	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	71-83	glioblastoma	Glioblastoma	C0017636	T191	-1000	Decrease	Backward	TRUE	NA
10653	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	134-140	mutant	Mutant	C0596988	T049	-694	Decrease	Backward	TRUE	NA
10654	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	85-99	ovarian cancer	OVARIAN CANCER	C1140680	T191	-1000	Decrease	Backward	TRUE	NA
10655	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	52-58	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	85-99	ovarian cancer	ovarian cancer	C0029925	T191	-1000	Decrease	Backward	TRUE	NA
10668	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	105-117	colon cancer	COLON CANCER	C0007102	T191	-861	Decrease	Backward	TRUE	NA
10669	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	105-117	colon cancer	COLON CANCER	C0699790	T191	-861	Decrease	Backward	TRUE	NA
10670	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	71-83	glioblastoma	Glioblastoma	C0017636	T191	-1000	Decrease	Backward	TRUE	NA
10671	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	134-140	mutant	Mutant	C0596988	T049	-694	Decrease	Backward	TRUE	NA
10672	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	85-99	ovarian cancer	OVARIAN CANCER	C1140680	T191	-1000	Decrease	Backward	TRUE	NA
10673	PC13_train	11139340.s6	The synthetic glucocorticoid dexamethasone elevated KILLER/DR5 mRNA in glioblastoma, ovarian cancer, and colon cancer cell lines with mutant p53 undergoing apoptosis, and this induction was inhibited by the transcriptional inhibitor actinomycin D.	59-62	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	233-246	actinomycin D	Dactinomycin	C0010934	T116|T195	Gene_or_gene_product	85-99	ovarian cancer	ovarian cancer	C0029925	T191	-1000	Decrease	Backward	TRUE	NA
10680	PC13_train	11139340.s8	Finally, the cytokine interferon-gamma (IFN-gamma) induced apoptosis and KILLER/DR5 in cell lines with mutant p53, and the induction of KILLER/DR5 mRNA by IFN-gamma was delayed in cells lacking wild-type STAT1, a transcription factor implicated in IFN-gamma signaling.	136-142	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	155-164	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Gene_or_gene_product	103-109	mutant	Mutant	C0596988	T049	-694	Increase	Backward	FALSE	NA
10683	PC13_train	11139340.s8	Finally, the cytokine interferon-gamma (IFN-gamma) induced apoptosis and KILLER/DR5 in cell lines with mutant p53, and the induction of KILLER/DR5 mRNA by IFN-gamma was delayed in cells lacking wild-type STAT1, a transcription factor implicated in IFN-gamma signaling.	143-146	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	155-164	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Gene_or_gene_product	103-109	mutant	Mutant	C0596988	T049	-694	Increase	Backward	FALSE	NA
10696	PC13_train	11139340.s8	Finally, the cytokine interferon-gamma (IFN-gamma) induced apoptosis and KILLER/DR5 in cell lines with mutant p53, and the induction of KILLER/DR5 mRNA by IFN-gamma was delayed in cells lacking wild-type STAT1, a transcription factor implicated in IFN-gamma signaling.	22-38	interferon-gamma	Interferon Type II	C0021745	T116|T121|T129	Gene_or_gene_product	73-79	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	103-109	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
10697	PC13_train	11139340.s8	Finally, the cytokine interferon-gamma (IFN-gamma) induced apoptosis and KILLER/DR5 in cell lines with mutant p53, and the induction of KILLER/DR5 mRNA by IFN-gamma was delayed in cells lacking wild-type STAT1, a transcription factor implicated in IFN-gamma signaling.	22-38	interferon-gamma	Interferon Type II	C0021745	T116|T121|T129	Gene_or_gene_product	80-83	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	103-109	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
10704	PC13_train	11139340.s8	Finally, the cytokine interferon-gamma (IFN-gamma) induced apoptosis and KILLER/DR5 in cell lines with mutant p53, and the induction of KILLER/DR5 mRNA by IFN-gamma was delayed in cells lacking wild-type STAT1, a transcription factor implicated in IFN-gamma signaling.	40-49	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Gene_or_gene_product	73-79	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	103-109	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
10705	PC13_train	11139340.s8	Finally, the cytokine interferon-gamma (IFN-gamma) induced apoptosis and KILLER/DR5 in cell lines with mutant p53, and the induction of KILLER/DR5 mRNA by IFN-gamma was delayed in cells lacking wild-type STAT1, a transcription factor implicated in IFN-gamma signaling.	40-49	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Gene_or_gene_product	80-83	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	103-109	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
10721	PC13_train	11139340.s9	Similarly, the induction of KILLER/DR5 mRNA by the cytokine TNF-alpha was also delayed in cell lines with mutated STAT1.	28-34	KILLER	TNFRSF10B gene	C1336644	T028	Gene_or_gene_product	60-69	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	106-113	mutated	Mutated	C1705285	T049	-694	Increase	Backward	TRUE	NA
10723	PC13_train	11139340.s9	Similarly, the induction of KILLER/DR5 mRNA by the cytokine TNF-alpha was also delayed in cell lines with mutated STAT1.	35-38	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	60-69	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	106-113	mutated	Mutated	C1705285	T049	-694	Increase	Backward	TRUE	NA
10775	PC13_train	11278681.s8	Sites of Mps1p phosphorylation and Ser(36) are located within the N-terminal globular domain of Spc110p, which resides at the inner plaque of the SPB and binds the Tub4p complex.	96-103	Spc110p	SPC110 protein, S cerevisiae	C0133246	T116|T123	Gene_or_gene_product	164-169	Tub4p	gamma-tubulin small complex, spindle pole body	C2265272	T026	Complex	132-138	plaque	Plaque	C0011389	T047	-861	Binding	NA	TRUE	NA
10776	PC13_train	11278681.s8	Sites of Mps1p phosphorylation and Ser(36) are located within the N-terminal globular domain of Spc110p, which resides at the inner plaque of the SPB and binds the Tub4p complex.	96-103	Spc110p	SPC110 protein, S cerevisiae	C0133246	T116|T123	Gene_or_gene_product	164-169	Tub4p	gamma-tubulin small complex, spindle pole body	C2265272	T026	Complex	132-138	plaque	plaque	C0333463	T020	-861	Binding	NA	TRUE	NA
10834	PC13_train	11313986.s0	Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.	18-24	Cdc25A	cdc25A Phosphatase	C0538918	T116	Gene_or_gene_product	66-68	E7	Papillomavirus Transforming Protein E7	C1335333	T116|T123	Gene_or_gene_product	37-65	human papillomavirus Type 16	human papilloma virus type 16	C2047226	T047	-734	Regulation	Backward	FALSE	NA
11163	PC13_train	11420729.s7	E2F is controlled by the retinoblastoma tumor suppressor protein Rb.	0-3	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	65-67	Rb	Retinoblastoma Protein	C0080113	T116|T123	Gene_or_gene_product	25-39	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-637	Regulation	Backward	FALSE	NA
11203	PC13_train	11441107.s0	Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.	15-35	Toll-like receptor 2	Toll-Like Receptor 2	C0754728	T116|T192	Gene_or_gene_product	40-41	6	E2F6 Transcription Factor	C0672706	T116|T123	Gene_or_gene_product	77-89	tuberculosis	TUBERCULOSIS	C0041296	T047	-660	Binding	NA	FALSE	NA
11208	PC13_train	11441107.s0	Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.	40-41	6	E2F6 Transcription Factor	C0672706	T116|T123	Gene_or_gene_product	122-157	outer surface protein A lipoprotein	OspA protein	C0134235	T129|T116|T121	Gene_or_gene_product	77-89	tuberculosis	TUBERCULOSIS	C0041296	T047	-660	Regulation	Backward	FALSE	NA
11256	PC13_train	11441107.s7	Dominant negative constructs of TLR2 or TLR6 inhibit the responses of STF and OspA-L as well as PSM in TLR2-transfected HMEC, supporting the concept of functional cooperation between TLR2 and TLR6 for all these TLR2 ligands.	183-187	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Gene_or_gene_product	192-196	TLR6	Toll-like receptor 6	C0768454	T116|T129|T192	Gene_or_gene_product	0-17	Dominant negative	Dominant Negative	C1512032	T049	-734	Binding	NA	FALSE	NA
11292	PC13_train	11441107.s7	Dominant negative constructs of TLR2 or TLR6 inhibit the responses of STF and OspA-L as well as PSM in TLR2-transfected HMEC, supporting the concept of functional cooperation between TLR2 and TLR6 for all these TLR2 ligands.	32-36	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Gene_or_gene_product	78-84	OspA-L	OspA protein	C0134235	T129|T116|T121	Gene_or_gene_product	0-17	Dominant negative	Dominant Negative	C1512032	T049	-734	Decrease	Forward	FALSE	NA
11296	PC13_train	11441107.s7	Dominant negative constructs of TLR2 or TLR6 inhibit the responses of STF and OspA-L as well as PSM in TLR2-transfected HMEC, supporting the concept of functional cooperation between TLR2 and TLR6 for all these TLR2 ligands.	32-36	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Gene_or_gene_product	96-99	PSM	phenol-soluble modulin	C0963806	T129|T116	Complex	0-17	Dominant negative	Dominant Negative	C1512032	T049	-734	Decrease	Forward	FALSE	NA
11320	PC13_train	11441107.s7	Dominant negative constructs of TLR2 or TLR6 inhibit the responses of STF and OspA-L as well as PSM in TLR2-transfected HMEC, supporting the concept of functional cooperation between TLR2 and TLR6 for all these TLR2 ligands.	40-44	TLR6	Toll-like receptor 6	C0768454	T116|T129|T192	Gene_or_gene_product	78-84	OspA-L	OspA protein	C0134235	T129|T116|T121	Gene_or_gene_product	0-17	Dominant negative	Dominant Negative	C1512032	T049	-734	Decrease	Forward	FALSE	NA
11324	PC13_train	11441107.s7	Dominant negative constructs of TLR2 or TLR6 inhibit the responses of STF and OspA-L as well as PSM in TLR2-transfected HMEC, supporting the concept of functional cooperation between TLR2 and TLR6 for all these TLR2 ligands.	40-44	TLR6	Toll-like receptor 6	C0768454	T116|T129|T192	Gene_or_gene_product	96-99	PSM	phenol-soluble modulin	C0963806	T129|T116	Complex	0-17	Dominant negative	Dominant Negative	C1512032	T049	-734	Decrease	Forward	FALSE	NA
11558	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	14-36	promyelocytic leukemia	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	137-140	PML	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-660	Decrease	Backward	FALSE	NA
11559	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	14-36	promyelocytic leukemia	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	137-140	PML	Promyelocytic leukemia	C2745900	T191	-660	Decrease	Backward	FALSE	NA
11560	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	14-36	promyelocytic leukemia	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	76-79	PML	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-734	Decrease	Backward	FALSE	NA
11561	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	14-36	promyelocytic leukemia	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	76-79	PML	Promyelocytic leukemia	C2745900	T191	-734	Decrease	Backward	FALSE	NA
11562	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	14-36	promyelocytic leukemia	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	94-122	acute promyelocytic leukemia	Acute promyelocytic leukaemia	C0023487	T191	-923	Decrease	Backward	TRUE	NA
11563	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	14-36	promyelocytic leukemia	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	14-36	promyelocytic leukemia	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-660	Decrease	Backward	FALSE	NA
11564	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	14-36	promyelocytic leukemia	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	14-36	promyelocytic leukemia	Promyelocytic leukemia	C2745900	T191	-660	Decrease	Backward	FALSE	NA
11593	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	38-41	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	137-140	PML	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-660	Decrease	Backward	FALSE	NA
11594	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	38-41	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	137-140	PML	Promyelocytic leukemia	C2745900	T191	-660	Decrease	Backward	FALSE	NA
11595	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	38-41	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	76-79	PML	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-734	Decrease	Backward	FALSE	NA
11596	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	38-41	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	76-79	PML	Promyelocytic leukemia	C2745900	T191	-734	Decrease	Backward	FALSE	NA
11597	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	38-41	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	94-122	acute promyelocytic leukemia	Acute promyelocytic leukaemia	C0023487	T191	-923	Decrease	Backward	TRUE	NA
11598	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	38-41	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	14-36	promyelocytic leukemia	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-660	Decrease	Backward	FALSE	NA
11599	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	38-41	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	14-36	promyelocytic leukemia	Promyelocytic leukemia	C2745900	T191	-660	Decrease	Backward	FALSE	NA
11621	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	43-71	retinoic acid receptor-alpha	retinoic acid receptor alpha	C0140279	T192|T116	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	137-140	PML	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-660	Decrease	Backward	FALSE	NA
11622	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	43-71	retinoic acid receptor-alpha	retinoic acid receptor alpha	C0140279	T192|T116	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	137-140	PML	Promyelocytic leukemia	C2745900	T191	-660	Decrease	Backward	FALSE	NA
11623	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	43-71	retinoic acid receptor-alpha	retinoic acid receptor alpha	C0140279	T192|T116	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	76-79	PML	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-734	Decrease	Backward	FALSE	NA
11624	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	43-71	retinoic acid receptor-alpha	retinoic acid receptor alpha	C0140279	T192|T116	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	76-79	PML	Promyelocytic leukemia	C2745900	T191	-734	Decrease	Backward	FALSE	NA
11625	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	43-71	retinoic acid receptor-alpha	retinoic acid receptor alpha	C0140279	T192|T116	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	94-122	acute promyelocytic leukemia	Acute promyelocytic leukaemia	C0023487	T191	-923	Decrease	Backward	TRUE	NA
11626	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	43-71	retinoic acid receptor-alpha	retinoic acid receptor alpha	C0140279	T192|T116	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	14-36	promyelocytic leukemia	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-660	Decrease	Backward	FALSE	NA
11627	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	43-71	retinoic acid receptor-alpha	retinoic acid receptor alpha	C0140279	T192|T116	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	14-36	promyelocytic leukemia	Promyelocytic leukemia	C2745900	T191	-660	Decrease	Backward	FALSE	NA
11642	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	76-79	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	137-140	PML	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-660	Decrease	Backward	FALSE	NA
11643	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	76-79	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	137-140	PML	Promyelocytic leukemia	C2745900	T191	-660	Decrease	Backward	FALSE	NA
11644	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	76-79	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	76-79	PML	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-734	Decrease	Backward	FALSE	NA
11645	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	76-79	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	76-79	PML	Promyelocytic leukemia	C2745900	T191	-734	Decrease	Backward	FALSE	NA
11646	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	76-79	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	94-122	acute promyelocytic leukemia	Acute promyelocytic leukaemia	C0023487	T191	-923	Decrease	Backward	TRUE	NA
11647	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	76-79	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	14-36	promyelocytic leukemia	LEUKEMIA, PROMYELOCYTIC	C0023487	T191	-660	Decrease	Backward	FALSE	NA
11648	PC13_train	11454693.s0	Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.	76-79	PML	Probable Transcription Factor PML	C0146495	T116|T123	Gene_or_gene_product	141-161	peptide nucleic acid	Peptide Nucleic Acids	C0600500	T114	Simple_chemical	14-36	promyelocytic leukemia	Promyelocytic leukemia	C2745900	T191	-660	Decrease	Backward	FALSE	NA
11738	PC13_train	11562353.s9	Analysis of Fkh1p and Fkh2p binding to promoter targets in vivo by use of mutant strains indicated that the two proteins compete for promoter-occupancy at a number of target promoters.	12-17	Fkh1p	Fkh1 protein, S cerevisiae	C1143153	T116|T123	Gene_or_gene_product	22-27	Fkh2p	Fkh2 protein, S cerevisiae	C1143200	T116|T123	Gene_or_gene_product	74-80	mutant	Mutant	C0596988	T049	-694	Binding	NA	TRUE	NA
11739	PC13_train	11562353.s9	Analysis of Fkh1p and Fkh2p binding to promoter targets in vivo by use of mutant strains indicated that the two proteins compete for promoter-occupancy at a number of target promoters.	12-17	Fkh1p	Fkh1 protein, S cerevisiae	C1143153	T116|T123	Gene_or_gene_product	22-27	Fkh2p	Fkh2 protein, S cerevisiae	C1143200	T116|T123	Gene_or_gene_product	81-88	strains	Strains	C0080194	T037	-861	Binding	NA	TRUE	NA
11759	PC13_train	11691836.s2	The eIF4E-binding proteins (4E-BPs) interdict translation initiation by binding to the translation factor eIF4E, and preventing recruitment of the translation machinery to mRNA.	28-34	4E-BPs	EIF4EBP1 protein, human	C0254260	T116|T123	Gene_or_gene_product	106-111	eIF4E	Eukaryotic Initiation Factor-4E	C0058988	T116|T123	Gene_or_gene_product	159-168	machinery	Machinery	C0337246	T037	-861	Binding	NA	FALSE	NA
11761	PC13_train	11691836.s2	The eIF4E-binding proteins (4E-BPs) interdict translation initiation by binding to the translation factor eIF4E, and preventing recruitment of the translation machinery to mRNA.	4-26	eIF4E-binding proteins	EIF4EBP1 protein, human	C0254260	T116|T123	Gene_or_gene_product	106-111	eIF4E	Eukaryotic Initiation Factor-4E	C0058988	T116|T123	Gene_or_gene_product	159-168	machinery	Machinery	C0337246	T037	-861	Binding	NA	FALSE	NA
11845	PC13_train	11726501.s5	Conversely, point mutations altering the conserved WD40 motifs of Bub3, which might be involved in the formation of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with Mad2, Mad3 and Cdc20, as well as proper checkpoint response.	66-70	Bub3	BUB3 protein, human	C1448668	T116|T123	Gene_or_gene_product	208-212	Mad2	MAD2 protein, S cerevisiae	C3711585	T116|T123	Gene_or_gene_product	12-27	point mutations	Point Mutations	C0162735	T049	-1000	Binding	NA	TRUE	NA
11846	PC13_train	11726501.s5	Conversely, point mutations altering the conserved WD40 motifs of Bub3, which might be involved in the formation of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with Mad2, Mad3 and Cdc20, as well as proper checkpoint response.	66-70	Bub3	BUB3 protein, human	C1448668	T116|T123	Gene_or_gene_product	214-218	Mad3	MAD3 protein, S cerevisiae	C0913599	T116	Gene_or_gene_product	12-27	point mutations	Point Mutations	C0162735	T049	-1000	Binding	NA	TRUE	NA
11847	PC13_train	11726501.s5	Conversely, point mutations altering the conserved WD40 motifs of Bub3, which might be involved in the formation of a beta-propeller fold devoted to protein-protein interactions, disrupt its association with Mad2, Mad3 and Cdc20, as well as proper checkpoint response.	66-70	Bub3	BUB3 protein, human	C1448668	T116|T123	Gene_or_gene_product	223-228	Cdc20	Cdc20 Proteins	C3658348	T116|T123	Gene_or_gene_product	12-27	point mutations	Point Mutations	C0162735	T049	-1000	Binding	NA	TRUE	NA
11853	PC13_train	11801686.s11	A dominant-negative MyD88 construct also inhibited cHSP60-induced NF-kappaB activation.	20-25	MyD88	Myeloid Differentiation Primary Response Protein Myd88	C2983365	T116	Gene_or_gene_product	66-75	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	2-19	dominant-negative	Dominant Negative	C1512032	T049	-734	Decrease	Forward	TRUE	NA
11854	PC13_train	11801686.s11	A dominant-negative MyD88 construct also inhibited cHSP60-induced NF-kappaB activation.	51-57	cHSP60	Chaperonin 60	C0109272	T116|T123	Gene_or_gene_product	66-75	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	2-19	dominant-negative	Dominant Negative	C1512032	T049	-734	Increase	Forward	TRUE	NA
11865	PC13_train	11801686.s8	In human vascular EC which express Toll-like receptor 4 (TLR4) mRNA and protein, nonsignaling TLR4 constructs that act as dominant negative blocked cHSP60-mediated NF-kappaB activation.	148-154	cHSP60	Chaperonin 60	C0109272	T116|T123	Gene_or_gene_product	164-173	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	122-139	dominant negative	Dominant Negative	C1512032	T049	-645	Increase	Forward	TRUE	NA
11892	PC13_train	11836257.s3	We recently demonstrated that exogenously added HSP70 possesses potent cytokine activity, with the ability to bind with high affinity to the plasma membrane, elicit a rapid intracellular Ca(2+) flux, activate NF-kappaB, and up-regulate the expression of pro-inflammatory cytokines in human monocytes.	48-53	HSP70	Heat-Shock Proteins 70	C0243043	T116|T123	Gene_or_gene_product	187-193	Ca(2+)	Calcium ion	C0596235	T121|T196	Simple_chemical	54-63	possesses	possesses	C0850310	T048	-1000	Regulation	Forward	FALSE	NA
11893	PC13_train	11836257.s3	We recently demonstrated that exogenously added HSP70 possesses potent cytokine activity, with the ability to bind with high affinity to the plasma membrane, elicit a rapid intracellular Ca(2+) flux, activate NF-kappaB, and up-regulate the expression of pro-inflammatory cytokines in human monocytes.	48-53	HSP70	Heat-Shock Proteins 70	C0243043	T116|T123	Gene_or_gene_product	209-218	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	54-63	possesses	possesses	C0850310	T048	-1000	Increase	Forward	FALSE	NA
11913	PC13_train	11847219.s8	SC58125, a PGHS-2-selective inhibitor, could attenuate the induction of mPGES, suggesting a dependence of this enzyme on PGHS-2 activity.	0-7	SC58125	SC 58125	C0291813	T109|T121	Simple_chemical	11-17	PGHS-2	cyclooxygenase 2	C0387583	T116|T126	Gene_or_gene_product	92-102	dependence	Dependence	C0439857	T048	-1000	Decrease	Forward	FALSE	NA
11915	PC13_train	11847219.s8	SC58125, a PGHS-2-selective inhibitor, could attenuate the induction of mPGES, suggesting a dependence of this enzyme on PGHS-2 activity.	0-7	SC58125	SC 58125	C0291813	T109|T121	Simple_chemical	72-77	mPGES	Microsomal Prostaglandin E Synthase Family	C4321492	T116|T126	Gene_or_gene_product	92-102	dependence	Dependence	C0439857	T048	-1000	Decrease	Forward	FALSE	NA
11918	PC13_train	11847219.s8	SC58125, a PGHS-2-selective inhibitor, could attenuate the induction of mPGES, suggesting a dependence of this enzyme on PGHS-2 activity.	72-77	mPGES	Microsomal Prostaglandin E Synthase Family	C4321492	T116|T126	Gene_or_gene_product	121-127	PGHS-2	cyclooxygenase 2	C0387583	T116|T126	Gene_or_gene_product	92-102	dependence	Dependence	C0439857	T048	-1000	Increase	Backward	FALSE	NA
11927	PC13_train	11909531.s8	In contrast, MyD88(S) behaves as a dominant-negative inhibitor of IL-1- and LPS-, but not TNF-induced, NF-kappaB activation.	13-21	MyD88(S)	Myeloid Differentiation Primary Response Protein Myd88	C2983365	T116	Gene_or_gene_product	103-112	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	35-52	dominant-negative	Dominant Negative	C1512032	T049	-734	Decrease	Forward	FALSE	NA
11935	PC13_train	11909531.s8	In contrast, MyD88(S) behaves as a dominant-negative inhibitor of IL-1- and LPS-, but not TNF-induced, NF-kappaB activation.	66-70	IL-1	Interleukin-1	C0021755	T116|T129	Gene_or_gene_product	103-112	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	35-52	dominant-negative	Dominant Negative	C1512032	T049	-734	Increase	Forward	TRUE	NA
11941	PC13_train	11909531.s8	In contrast, MyD88(S) behaves as a dominant-negative inhibitor of IL-1- and LPS-, but not TNF-induced, NF-kappaB activation.	76-79	LPS	Lipopolysaccharides	C0023810	T109	Simple_chemical	103-112	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	35-52	dominant-negative	Dominant Negative	C1512032	T049	-734	Increase	Forward	TRUE	NA
11945	PC13_train	11909531.s8	In contrast, MyD88(S) behaves as a dominant-negative inhibitor of IL-1- and LPS-, but not TNF-induced, NF-kappaB activation.	90-93	TNF	Tumor Necrosis Factors	C0041368	T116|T129	Gene_or_gene_product	103-112	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	35-52	dominant-negative	Dominant Negative	C1512032	T049	-734	Increase	Forward	FALSE	negation
11949	PC13_train	11909979.s1	Using mouse knockouts for mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 and a double knockout of both MSK1 and MSK2, we show that these protein kinases are required for the stress-induced phosphorylation of transcription factors CREB and ATF1 in primary embryonic fibroblasts.	119-123	MSK1	mitogen and stress-activated protein kinase 1	C0762649	T116|T126	Gene_or_gene_product	246-250	CREB	Cyclic AMP-Responsive DNA-Binding Protein	C0056695	T116|T123	Gene_or_gene_product	102-110	knockout	Knockout	C1522225	T050	-861	Regulation	Forward	FALSE	NA
11951	PC13_train	11909979.s1	Using mouse knockouts for mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 and a double knockout of both MSK1 and MSK2, we show that these protein kinases are required for the stress-induced phosphorylation of transcription factors CREB and ATF1 in primary embryonic fibroblasts.	119-123	MSK1	mitogen and stress-activated protein kinase 1	C0762649	T116|T126	Gene_or_gene_product	246-250	CREB	Cyclic AMP-Responsive DNA-Binding Protein	C0056695	T116|T123	Gene_or_gene_product	12-21	knockouts	Knockout	C1522225	T050	-827	Regulation	Forward	TRUE	NA
11952	PC13_train	11909979.s1	Using mouse knockouts for mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 and a double knockout of both MSK1 and MSK2, we show that these protein kinases are required for the stress-induced phosphorylation of transcription factors CREB and ATF1 in primary embryonic fibroblasts.	119-123	MSK1	mitogen and stress-activated protein kinase 1	C0762649	T116|T126	Gene_or_gene_product	255-259	ATF1	Cyclic AMP-Dependent Transcription Factor ATF-1	C2984895	T116|T123	Gene_or_gene_product	102-110	knockout	Knockout	C1522225	T050	-861	Regulation	Forward	FALSE	NA
11954	PC13_train	11909979.s1	Using mouse knockouts for mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 and a double knockout of both MSK1 and MSK2, we show that these protein kinases are required for the stress-induced phosphorylation of transcription factors CREB and ATF1 in primary embryonic fibroblasts.	119-123	MSK1	mitogen and stress-activated protein kinase 1	C0762649	T116|T126	Gene_or_gene_product	255-259	ATF1	Cyclic AMP-Dependent Transcription Factor ATF-1	C2984895	T116|T123	Gene_or_gene_product	12-21	knockouts	Knockout	C1522225	T050	-827	Regulation	Forward	TRUE	NA
11955	PC13_train	11909979.s1	Using mouse knockouts for mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 and a double knockout of both MSK1 and MSK2, we show that these protein kinases are required for the stress-induced phosphorylation of transcription factors CREB and ATF1 in primary embryonic fibroblasts.	128-132	MSK2	RPS6KA4 protein, human	C1431465	T116|T126	Gene_or_gene_product	246-250	CREB	Cyclic AMP-Responsive DNA-Binding Protein	C0056695	T116|T123	Gene_or_gene_product	102-110	knockout	Knockout	C1522225	T050	-861	Regulation	Forward	FALSE	NA
11957	PC13_train	11909979.s1	Using mouse knockouts for mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 and a double knockout of both MSK1 and MSK2, we show that these protein kinases are required for the stress-induced phosphorylation of transcription factors CREB and ATF1 in primary embryonic fibroblasts.	128-132	MSK2	RPS6KA4 protein, human	C1431465	T116|T126	Gene_or_gene_product	246-250	CREB	Cyclic AMP-Responsive DNA-Binding Protein	C0056695	T116|T123	Gene_or_gene_product	12-21	knockouts	Knockout	C1522225	T050	-827	Regulation	Forward	TRUE	NA
11958	PC13_train	11909979.s1	Using mouse knockouts for mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 and a double knockout of both MSK1 and MSK2, we show that these protein kinases are required for the stress-induced phosphorylation of transcription factors CREB and ATF1 in primary embryonic fibroblasts.	128-132	MSK2	RPS6KA4 protein, human	C1431465	T116|T126	Gene_or_gene_product	255-259	ATF1	Cyclic AMP-Dependent Transcription Factor ATF-1	C2984895	T116|T123	Gene_or_gene_product	102-110	knockout	Knockout	C1522225	T050	-861	Regulation	Forward	FALSE	NA
11960	PC13_train	11909979.s1	Using mouse knockouts for mitogen- and stress-activated protein kinase 1 (MSK1) and MSK2 and a double knockout of both MSK1 and MSK2, we show that these protein kinases are required for the stress-induced phosphorylation of transcription factors CREB and ATF1 in primary embryonic fibroblasts.	128-132	MSK2	RPS6KA4 protein, human	C1431465	T116|T126	Gene_or_gene_product	255-259	ATF1	Cyclic AMP-Dependent Transcription Factor ATF-1	C2984895	T116|T123	Gene_or_gene_product	12-21	knockouts	Knockout	C1522225	T050	-827	Regulation	Forward	TRUE	NA
12037	PC13_train	11909979.s4	The knockout of both MSK1 and MSK2 resulted in a 50% reduction in c-fos and junB gene transcription in response to anisomycin or UV-C radiation but only a small reduction in response to tetradecanoyl phorbol acetate or epidermal growth factor in fibroblasts.	66-71	c-fos	Proto-Oncogene Proteins c-fos	C0085301	T116|T123	Gene_or_gene_product	115-125	anisomycin	Anisomycin	C0003082	T109|T195	Simple_chemical	4-12	knockout	Knockout	C1522225	T050	-1000	Decrease	Backward	TRUE	NA
12039	PC13_train	11909979.s4	The knockout of both MSK1 and MSK2 resulted in a 50% reduction in c-fos and junB gene transcription in response to anisomycin or UV-C radiation but only a small reduction in response to tetradecanoyl phorbol acetate or epidermal growth factor in fibroblasts.	66-71	c-fos	Proto-Oncogene Proteins c-fos	C0085301	T116|T123	Gene_or_gene_product	186-215	tetradecanoyl phorbol acetate	Tetradecanoylphorbol Acetate	C0039654	T109|T121|T131	Simple_chemical	4-12	knockout	Knockout	C1522225	T050	-1000	Decrease	Backward	TRUE	NA
12041	PC13_train	11909979.s4	The knockout of both MSK1 and MSK2 resulted in a 50% reduction in c-fos and junB gene transcription in response to anisomycin or UV-C radiation but only a small reduction in response to tetradecanoyl phorbol acetate or epidermal growth factor in fibroblasts.	66-71	c-fos	Proto-Oncogene Proteins c-fos	C0085301	T116|T123	Gene_or_gene_product	219-242	epidermal growth factor	Epidermal Growth Factor	C0242275	T116|T121|T125	Gene_or_gene_product	4-12	knockout	Knockout	C1522225	T050	-1000	Decrease	Backward	TRUE	NA
12045	PC13_train	11909979.s4	The knockout of both MSK1 and MSK2 resulted in a 50% reduction in c-fos and junB gene transcription in response to anisomycin or UV-C radiation but only a small reduction in response to tetradecanoyl phorbol acetate or epidermal growth factor in fibroblasts.	76-80	junB	jun B Proteins	C0086495	T116|T123	Gene_or_gene_product	115-125	anisomycin	Anisomycin	C0003082	T109|T195	Simple_chemical	4-12	knockout	Knockout	C1522225	T050	-1000	Decrease	Backward	TRUE	NA
12047	PC13_train	11909979.s4	The knockout of both MSK1 and MSK2 resulted in a 50% reduction in c-fos and junB gene transcription in response to anisomycin or UV-C radiation but only a small reduction in response to tetradecanoyl phorbol acetate or epidermal growth factor in fibroblasts.	76-80	junB	jun B Proteins	C0086495	T116|T123	Gene_or_gene_product	186-215	tetradecanoyl phorbol acetate	Tetradecanoylphorbol Acetate	C0039654	T109|T121|T131	Simple_chemical	4-12	knockout	Knockout	C1522225	T050	-1000	Decrease	Backward	TRUE	NA
12049	PC13_train	11909979.s4	The knockout of both MSK1 and MSK2 resulted in a 50% reduction in c-fos and junB gene transcription in response to anisomycin or UV-C radiation but only a small reduction in response to tetradecanoyl phorbol acetate or epidermal growth factor in fibroblasts.	76-80	junB	jun B Proteins	C0086495	T116|T123	Gene_or_gene_product	219-242	epidermal growth factor	Epidermal Growth Factor	C0242275	T116|T121|T125	Gene_or_gene_product	4-12	knockout	Knockout	C1522225	T050	-1000	Decrease	Backward	TRUE	NA
12061	PC13_train	11959842.s8	p107/p130 deficiency triggered a dramatic loss of E2F4 nuclear localization as well as transcriptional derepression, which is suggested by nucleosome mapping studies to be the result of localized hyperacetylation of nucleosomes proximal to E2F-binding sites.	0-4	p107	Retinoblastoma-Like Protein p107	C0599575	T116|T123	Gene_or_gene_product	50-54	E2F4	E2F4 Transcription Factor	C0291135	T116|T123	Gene_or_gene_product	10-20	deficiency	Deficiency	C0162429	T047	-827	Regulation	Forward	FALSE	NA
12069	PC13_train	11959842.s8	p107/p130 deficiency triggered a dramatic loss of E2F4 nuclear localization as well as transcriptional derepression, which is suggested by nucleosome mapping studies to be the result of localized hyperacetylation of nucleosomes proximal to E2F-binding sites.	5-9	p130	Retinoblastoma-Like Protein p130	C1529719	T116|T123	Gene_or_gene_product	50-54	E2F4	E2F4 Transcription Factor	C0291135	T116|T123	Gene_or_gene_product	10-20	deficiency	Deficiency	C0162429	T047	-827	Regulation	Forward	FALSE	NA
12081	PC13_train	11959850.s6	Additional contacts between the C-lobe of the Cdk and the N-terminal helix of the cyclin then induce the isomerization of the Cdk into a fully mature form by promoting the exposure of the T-loop for phosphorylation by CAK and the formation of the substrate binding site.	46-49	Cdk	Cyclin-Dependent Kinases	C0243045	T116|T126	Gene_or_gene_product	82-88	cyclin	Cyclins	C0079183	T116|T123	Gene_or_gene_product	172-180	exposure	Exposure NOS	C0274281	T037	-1000	Binding	NA	FALSE	NA
12272	PC13_train	12119352.s6	These results support a model in which CpG signaling is mediated through TLR-9 but not DNA-PK, and suggest that wortmannin-sensitive member(s) of the PI3-kinase family play a critical role in shuttling CpG DNA to TLR-9.	112-122	wortmannin	wortmannin	C0078517	T109|T121|T123	Simple_chemical	150-160	PI3-kinase	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	123-132	sensitive	Sensitive	C0020517	T046	-660	Regulation	Forward	FALSE	NA
12300	PC13_train	12368233.s4	Through an expression cloning approach, we identified E2F-1 as a repressor of the hTERT gene in human tumor cells.	54-59	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	82-87	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	102-107	tumor	Tumour NOS	C0027651	T191	-827	Decrease	Forward	TRUE	NA
12303	PC13_train	12368233.s6	In contrast to the repressor function of E2F-1 in human tumor cells, we demonstrated that E2F-1 is an activator of the hTERT gene in normal human somatic cells.	90-95	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	119-124	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	56-61	tumor	Tumour NOS	C0027651	T191	-827	Increase	Forward	FALSE	NA
12307	PC13_train	12368233.s8	E2F-1, E2F-2, and E2F-3 (but not E2F-4 and E2F-5) repressed hTERT promoter activity in human tumor cells, whereas they activated it in normal somatic cells.	0-5	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	60-65	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	93-98	tumor	Tumour NOS	C0027651	T191	-827	Decrease	Forward	TRUE	NA
12308	PC13_train	12368233.s8	E2F-1, E2F-2, and E2F-3 (but not E2F-4 and E2F-5) repressed hTERT promoter activity in human tumor cells, whereas they activated it in normal somatic cells.	0-5	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	60-65	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	93-98	tumor	Tumour NOS	C0027651	T191	-827	Increase	Forward	FALSE	NA
12312	PC13_train	12368233.s8	E2F-1, E2F-2, and E2F-3 (but not E2F-4 and E2F-5) repressed hTERT promoter activity in human tumor cells, whereas they activated it in normal somatic cells.	18-23	E2F-3	E2F3 Transcription Factor	C1529674	T116|T123	Gene_or_gene_product	60-65	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	93-98	tumor	Tumour NOS	C0027651	T191	-827	Decrease	Forward	TRUE	NA
12313	PC13_train	12368233.s8	E2F-1, E2F-2, and E2F-3 (but not E2F-4 and E2F-5) repressed hTERT promoter activity in human tumor cells, whereas they activated it in normal somatic cells.	18-23	E2F-3	E2F3 Transcription Factor	C1529674	T116|T123	Gene_or_gene_product	60-65	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	93-98	tumor	Tumour NOS	C0027651	T191	-827	Increase	Forward	FALSE	NA
12320	PC13_train	12368233.s8	E2F-1, E2F-2, and E2F-3 (but not E2F-4 and E2F-5) repressed hTERT promoter activity in human tumor cells, whereas they activated it in normal somatic cells.	7-12	E2F-2	E2F2 Transcription Factor	C0249367	T116|T123	Gene_or_gene_product	60-65	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	93-98	tumor	Tumour NOS	C0027651	T191	-827	Decrease	Forward	TRUE	NA
12321	PC13_train	12368233.s8	E2F-1, E2F-2, and E2F-3 (but not E2F-4 and E2F-5) repressed hTERT promoter activity in human tumor cells, whereas they activated it in normal somatic cells.	7-12	E2F-2	E2F2 Transcription Factor	C0249367	T116|T123	Gene_or_gene_product	60-65	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	93-98	tumor	Tumour NOS	C0027651	T191	-827	Increase	Forward	FALSE	NA
12328	PC13_train	12368233.s9	These contrasting effects of E2F transcription factors on the hTERT promoter could underlie the paradoxical biological activities of E2F, which can both promote and inhibit cellular proliferation and tumorigenesis.	29-32	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	62-67	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	173-195	cellular proliferation	Cellular proliferation	C0020507	T046	-1000	Regulation	Forward	FALSE	NA
12332	PC13_train	12368233.s9	These contrasting effects of E2F transcription factors on the hTERT promoter could underlie the paradoxical biological activities of E2F, which can both promote and inhibit cellular proliferation and tumorigenesis.	29-32	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	62-67	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	200-213	tumorigenesis	Tumorigenesis	C0007621	T191	-1000	Regulation	Forward	FALSE	NA
12333	PC13_train	12368233.s9	These contrasting effects of E2F transcription factors on the hTERT promoter could underlie the paradoxical biological activities of E2F, which can both promote and inhibit cellular proliferation and tumorigenesis.	29-32	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	62-67	hTERT	Telomerase	C0087071	T116|T126	Gene_or_gene_product	200-213	tumorigenesis	Tumorigenesis	C0596263	T191	-1000	Regulation	Forward	FALSE	NA
12378	PC13_train	12455995.s1	The Rho-type GTPase, Cdc42, has been implicated in a variety of functions in the yeast life cycle, including septin organization for cytokinesis, pheromone response, and haploid invasive growth.	21-26	Cdc42	cdc42 GTP-Binding Protein	C0082645	T116|T126	Gene_or_gene_product	109-115	septin	Septins	C2936338	T116|T126	Gene_or_gene_product	178-193	invasive growth	invasive growth	C1156244	T046	-901	Increase	Forward	FALSE	NA
12414	PC13_train	12459251.s10	Further extending its role in gene regulation, cyclin D interacts with histone acetylases such as P/CAF or NcoA/SRC1a but also with components of the transcriptional machinery such as TAF(II)250.	47-55	cyclin D	Cyclin D	C0388730	T116|T123	Gene_or_gene_product	107-111	NcoA	nuclear receptor coactivator 1	C0384189	T116|T123	Gene_or_gene_product	166-175	machinery	Machinery	C0337246	T037	-861	Binding	NA	FALSE	NA
12415	PC13_train	12459251.s10	Further extending its role in gene regulation, cyclin D interacts with histone acetylases such as P/CAF or NcoA/SRC1a but also with components of the transcriptional machinery such as TAF(II)250.	47-55	cyclin D	Cyclin D	C0388730	T116|T123	Gene_or_gene_product	112-117	SRC1a	Src1 protein, S cerevisiae	C2605170	T116|T123	Gene_or_gene_product	166-175	machinery	Machinery	C0337246	T037	-861	Binding	NA	FALSE	NA
12416	PC13_train	12459251.s10	Further extending its role in gene regulation, cyclin D interacts with histone acetylases such as P/CAF or NcoA/SRC1a but also with components of the transcriptional machinery such as TAF(II)250.	47-55	cyclin D	Cyclin D	C0388730	T116|T123	Gene_or_gene_product	184-194	TAF(II)250	TAF1 protein, human	C1146629	T116|T123	Gene_or_gene_product	166-175	machinery	Machinery	C0337246	T037	-861	Binding	NA	FALSE	NA
12417	PC13_train	12459251.s10	Further extending its role in gene regulation, cyclin D interacts with histone acetylases such as P/CAF or NcoA/SRC1a but also with components of the transcriptional machinery such as TAF(II)250.	47-55	cyclin D	Cyclin D	C0388730	T116|T123	Gene_or_gene_product	71-89	histone acetylases	histone acetyltransferase	C0062773	T116|T126	Gene_or_gene_product	166-175	machinery	Machinery	C0337246	T037	-861	Binding	NA	FALSE	NA
12418	PC13_train	12459251.s10	Further extending its role in gene regulation, cyclin D interacts with histone acetylases such as P/CAF or NcoA/SRC1a but also with components of the transcriptional machinery such as TAF(II)250.	47-55	cyclin D	Cyclin D	C0388730	T116|T123	Gene_or_gene_product	98-103	P/CAF	p300/CBP-Associated Factor	C0390904	T116|T126	Gene_or_gene_product	166-175	machinery	Machinery	C0337246	T037	-861	Binding	NA	FALSE	NA
12432	PC13_train	12482958.s0	The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.	30-35	Pdcd4	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	47-90	eukaryotic translation initiation factor 4A	Eukaryotic Initiation Factor-4A	C0058984	T116|T123	Gene_or_gene_product	4-18	transformation	Transformation	C1510411	T046	-660	Binding	NA	FALSE	NA
12439	PC13_train	12482958.s10	The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G.	122-127	eIF4A	Eukaryotic Initiation Factor-4A	C0058984	T116|T123	Gene_or_gene_product	158-163	eIF4G	Eukaryotic Initiation Factor-4G	C0058990	T116|T123	Gene_or_gene_product	140-152	dissociation	Dissociation	C0086168	T048	-827	Binding	NA	FALSE	NA
12459	PC13_train	12482958.s10	The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G.	183-188	eIF4A	Eukaryotic Initiation Factor-4A	C0058984	T116|T123	Gene_or_gene_product	225-230	eIF4G	Eukaryotic Initiation Factor-4G	C0058990	T116|T123	Gene_or_gene_product	140-152	dissociation	Dissociation	C0086168	T048	-827	Binding	NA	FALSE	NA
12467	PC13_train	12482958.s10	The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G.	23-28	Pdcd4	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	158-163	eIF4G	Eukaryotic Initiation Factor-4G	C0058990	T116|T123	Gene_or_gene_product	140-152	dissociation	Dissociation	C0086168	T048	-827	Regulation	Forward	FALSE	NA
12471	PC13_train	12482958.s10	The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G.	23-28	Pdcd4	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	183-188	eIF4A	Eukaryotic Initiation Factor-4A	C0058984	T116|T123	Gene_or_gene_product	140-152	dissociation	Dissociation	C0086168	T048	-827	Regulation	Forward	FALSE	NA
12479	PC13_train	12482958.s10	The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G.	23-28	Pdcd4	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	88-93	eIF4A	Eukaryotic Initiation Factor-4A	C0058984	T116|T123	Gene_or_gene_product	140-152	dissociation	Dissociation	C0086168	T048	-827	Decrease	Forward	FALSE	NA
12500	PC13_train	12482958.s11	Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding and consequent inhibition of translation are required for Pdcd4 transrepression of AP-1.	0-5	Pdcd4	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	17-22	eIF4A	Eukaryotic Initiation Factor-4A	C0058984	T116|T123	Gene_or_gene_product	40-54	transformation	Transformation	C1510411	T046	-660	Binding	NA	FALSE	NA
12504	PC13_train	12482958.s11	Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding and consequent inhibition of translation are required for Pdcd4 transrepression of AP-1.	158-163	Pdcd4	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	183-187	AP-1	Transcription Factor AP-1	C0085828	T116|T123	Gene_or_gene_product	40-54	transformation	Transformation	C1510411	T046	-660	Decrease	Forward	FALSE	NA
12511	PC13_train	12482958.s11	Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding and consequent inhibition of translation are required for Pdcd4 transrepression of AP-1.	80-85	Pdcd4	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	86-91	eIF4A	Eukaryotic Initiation Factor-4A	C0058984	T116|T123	Gene_or_gene_product	40-54	transformation	Transformation	C1510411	T046	-660	Binding	NA	FALSE	NA
12517	PC13_train	12482958.s7	In contrast, Pdcd4(D418A), a mutant inactivated for binding to eIF4A, failed to inhibit cap-dependent or IRES-dependent translation or AP-1 transactivation.	13-25	Pdcd4(D418A)	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	135-139	AP-1	Transcription Factor AP-1	C0085828	T116|T123	Gene_or_gene_product	29-35	mutant	Mutant	C0596988	T049	-1000	Decrease	Forward	TRUE	NA
12521	PC13_train	12482958.s7	In contrast, Pdcd4(D418A), a mutant inactivated for binding to eIF4A, failed to inhibit cap-dependent or IRES-dependent translation or AP-1 transactivation.	13-25	Pdcd4(D418A)	Programmed Cell Death Protein 4	C2986637	T116	Gene_or_gene_product	63-68	eIF4A	Eukaryotic Initiation Factor-4A	C0058984	T116|T123	Gene_or_gene_product	29-35	mutant	Mutant	C0596988	T049	-1000	Binding	NA	TRUE	NA
12528	PC13_train	12511557.s2	Their protein products, hamartin and tuberin, respectively, form a functional complex that affects cell growth, differentiation, and proliferation.	24-32	hamartin	tuberous sclerosis complex 1 protein	C4317139	T116|T123	Gene_or_gene_product	37-44	tuberin	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	133-146	proliferation	Proliferation	C0334094	T046	-1000	Binding	NA	FALSE	NA
12536	PC13_train	12511557.s4	As cyclin D1 can be regulated through the canonical Wnt/beta-catenin signaling pathway, we hypothesize that the cell proliferative effects of hamartin and tuberin are partly mediated through beta-catenin.	142-150	hamartin	tuberous sclerosis complex 1 protein	C4317139	T116|T123	Gene_or_gene_product	191-203	beta-catenin	beta catenin	C0105770	T116|T123	Gene_or_gene_product	112-130	cell proliferative	Cellular proliferative	C0020507	T046	-698	Increase	Forward	FALSE	NA
12537	PC13_train	12511557.s4	As cyclin D1 can be regulated through the canonical Wnt/beta-catenin signaling pathway, we hypothesize that the cell proliferative effects of hamartin and tuberin are partly mediated through beta-catenin.	155-162	tuberin	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	191-203	beta-catenin	beta catenin	C0105770	T116|T123	Gene_or_gene_product	112-130	cell proliferative	Cellular proliferative	C0020507	T046	-698	Increase	Forward	FALSE	NA
12593	PC13_train	12586352.s8	Furthermore, coexpression of these ABIN-1 mutants interfered in a dominant negative manner with the NF-kappa B inhibiting function of ABIN-1, whereas the A20-mediated inhibition was unaffected.	100-110	NF-kappa B	NF-kappa B	C0079904	T116|T129	Complex	134-140	ABIN-1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	66-83	dominant negative	Dominant Negative	C1512032	T049	-734	Decrease	Backward	TRUE	reverse
12594	PC13_train	12586352.s8	Furthermore, coexpression of these ABIN-1 mutants interfered in a dominant negative manner with the NF-kappa B inhibiting function of ABIN-1, whereas the A20-mediated inhibition was unaffected.	100-110	NF-kappa B	NF-kappa B	C0079904	T116|T129	Complex	134-140	ABIN-1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	42-49	mutants	mutants	C0596988	T049	-827	Decrease	Backward	TRUE	reverse
12595	PC13_train	12586352.s8	Furthermore, coexpression of these ABIN-1 mutants interfered in a dominant negative manner with the NF-kappa B inhibiting function of ABIN-1, whereas the A20-mediated inhibition was unaffected.	100-110	NF-kappa B	NF-kappa B	C0079904	T116|T129	Complex	154-157	A20	Tumor Necrosis Factor alpha-Induced Protein 3	C4255033	T116	Gene_or_gene_product	66-83	dominant negative	Dominant Negative	C1512032	T049	-734	Decrease	Backward	FALSE	negation
12596	PC13_train	12586352.s8	Furthermore, coexpression of these ABIN-1 mutants interfered in a dominant negative manner with the NF-kappa B inhibiting function of ABIN-1, whereas the A20-mediated inhibition was unaffected.	100-110	NF-kappa B	NF-kappa B	C0079904	T116|T129	Complex	154-157	A20	Tumor Necrosis Factor alpha-Induced Protein 3	C4255033	T116	Gene_or_gene_product	42-49	mutants	mutants	C0596988	T049	-827	Decrease	Backward	FALSE	negation
12615	PC13_train	12611887.s10	We conclude that in addition to cyclins E and A, E2F family members can also activate one member of the D-type cyclins, further contributing to the ability of the stimulatory E2F family members to drive cellular proliferation.	32-41	cyclins E	Cyclin E	C0111429	T116|T123	Gene_or_gene_product	104-118	D-type cyclins	Cyclin D	C0388730	T116|T123	Gene_or_gene_product	203-225	cellular proliferation	Cellular proliferation	C0020507	T046	-1000	Increase	Forward	FALSE	NA
12619	PC13_train	12611887.s10	We conclude that in addition to cyclins E and A, E2F family members can also activate one member of the D-type cyclins, further contributing to the ability of the stimulatory E2F family members to drive cellular proliferation.	46-47	A	Cyclin A	C0079184	T116|T123	Gene_or_gene_product	104-118	D-type cyclins	Cyclin D	C0388730	T116|T123	Gene_or_gene_product	203-225	cellular proliferation	Cellular proliferation	C0020507	T046	-1000	Increase	Forward	FALSE	NA
12622	PC13_train	12611887.s10	We conclude that in addition to cyclins E and A, E2F family members can also activate one member of the D-type cyclins, further contributing to the ability of the stimulatory E2F family members to drive cellular proliferation.	49-52	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	104-118	D-type cyclins	Cyclin D	C0388730	T116|T123	Gene_or_gene_product	203-225	cellular proliferation	Cellular proliferation	C0020507	T046	-1000	Increase	Forward	FALSE	NA
12640	PC13_train	12611887.s6	Second, all of the growth-stimulatory members of the E2F family (E2F1, -2, and -3A) potently activate a cyclin D3 promoter reporter, whereas growth-restraining members of the family (E2F4, -5, and -6) have little effect.	104-113	cyclin D3	cyclin D3	C0173532	T116	Gene_or_gene_product	183-187	E2F4	E2F4 Transcription Factor	C0291135	T116|T123	Gene_or_gene_product	141-159	growth-restraining	Growth arrest	C0333951	T046	-688	Regulation	Backward	FALSE	NA
12641	PC13_train	12611887.s6	Second, all of the growth-stimulatory members of the E2F family (E2F1, -2, and -3A) potently activate a cyclin D3 promoter reporter, whereas growth-restraining members of the family (E2F4, -5, and -6) have little effect.	104-113	cyclin D3	cyclin D3	C0173532	T116	Gene_or_gene_product	189-191	-5	E2F5 Transcription Factor	C1529676	T116|T123	Gene_or_gene_product	141-159	growth-restraining	Growth arrest	C0333951	T046	-688	Regulation	Backward	FALSE	NA
12642	PC13_train	12611887.s6	Second, all of the growth-stimulatory members of the E2F family (E2F1, -2, and -3A) potently activate a cyclin D3 promoter reporter, whereas growth-restraining members of the family (E2F4, -5, and -6) have little effect.	104-113	cyclin D3	cyclin D3	C0173532	T116	Gene_or_gene_product	197-199	-6	E2F6 Transcription Factor	C0672706	T116|T123	Gene_or_gene_product	141-159	growth-restraining	Growth arrest	C0333951	T046	-688	Regulation	Backward	FALSE	NA
12653	PC13_train	12611887.s6	Second, all of the growth-stimulatory members of the E2F family (E2F1, -2, and -3A) potently activate a cyclin D3 promoter reporter, whereas growth-restraining members of the family (E2F4, -5, and -6) have little effect.	65-69	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	104-113	cyclin D3	cyclin D3	C0173532	T116	Gene_or_gene_product	141-159	growth-restraining	Growth arrest	C0333951	T046	-688	Increase	Forward	FALSE	NA
12659	PC13_train	12611887.s6	Second, all of the growth-stimulatory members of the E2F family (E2F1, -2, and -3A) potently activate a cyclin D3 promoter reporter, whereas growth-restraining members of the family (E2F4, -5, and -6) have little effect.	71-73	-2	E2F2 Transcription Factor	C0249367	T116|T123	Gene_or_gene_product	104-113	cyclin D3	cyclin D3	C0173532	T116	Gene_or_gene_product	141-159	growth-restraining	Growth arrest	C0333951	T046	-688	Increase	Forward	FALSE	NA
12664	PC13_train	12611887.s6	Second, all of the growth-stimulatory members of the E2F family (E2F1, -2, and -3A) potently activate a cyclin D3 promoter reporter, whereas growth-restraining members of the family (E2F4, -5, and -6) have little effect.	79-82	-3A	E2F3a Transcription Factor	C1564499	T116|T123	Gene_or_gene_product	104-113	cyclin D3	cyclin D3	C0173532	T116	Gene_or_gene_product	141-159	growth-restraining	Growth arrest	C0333951	T046	-688	Increase	Forward	FALSE	NA
12755	PC13_train	12618428.s13	These data suggest that 14-3-3beta binding negatively regulates RSK1 activity to maintain signal specificity and that association/dissociation of the 14-3-3beta-RSK1 complex is likely to be important for mitogen-mediated RSK1 activation.	24-34	14-3-3beta	14-3-3 Protein, beta Isoform	C0283919	T116|T123	Gene_or_gene_product	64-68	RSK1	Ribosomal Protein S6 Kinase	C0073337	T116|T126	Gene_or_gene_product	130-142	dissociation	Dissociation	C0086168	T048	-861	Binding	NA	FALSE	NA
12764	PC13_train	12618428.s6	Binding of RSK1 to 14-3-3beta was maximal under basal conditions and decreased significantly upon mitogen stimulation.	11-15	RSK1	Ribosomal Protein S6 Kinase	C0073337	T116|T126	Gene_or_gene_product	19-29	14-3-3beta	14-3-3 Protein, beta Isoform	C0283919	T116|T123	Gene_or_gene_product	54-64	conditions	condition	C0012634	T047	-827	Binding	NA	FALSE	NA
12795	PC13_train	12636916.s5	Induction of septin ring dynamics in telophase is triggered by the translocation of Rts1, a kinetochore-associated regulatory subunit of PP2A phosphatase, to the bud neck and correlates with Rts1-dependent dephosphorylation of Shs1.	191-195	Rts1	Rts1 protein, S cerevisiae	C3710651	T116|T126	Gene_or_gene_product	227-231	Shs1	SHS1 protein, S cerevisiae	C0759956	T116|T123	Gene_or_gene_product	67-80	translocation	Translocation	C0040715	T049	-1000	Regulation	Forward	FALSE	NA
12796	PC13_train	12636916.s5	Induction of septin ring dynamics in telophase is triggered by the translocation of Rts1, a kinetochore-associated regulatory subunit of PP2A phosphatase, to the bud neck and correlates with Rts1-dependent dephosphorylation of Shs1.	84-88	Rts1	Rts1 protein, S cerevisiae	C3710651	T116|T126	Gene_or_gene_product	137-141	PP2A	Protein Phosphatase 2A	C1704708	T116|T126	Complex	67-80	translocation	Translocation	C0040715	T049	-1000	Regulation	Forward	FALSE	NA
12801	PC13_train	12636916.s5	Induction of septin ring dynamics in telophase is triggered by the translocation of Rts1, a kinetochore-associated regulatory subunit of PP2A phosphatase, to the bud neck and correlates with Rts1-dependent dephosphorylation of Shs1.	92-103	kinetochore	Kinetochores	C0242609	T026	Cellular_component	137-141	PP2A	Protein Phosphatase 2A	C1704708	T116|T126	Complex	67-80	translocation	Translocation	C0040715	T049	-1000	Regulation	Forward	FALSE	NA
12806	PC13_train	12642668.s3	To investigate the role of sulfhydryls in MD-2 structure and function, we created 17 single and multiple Cys substitution mutants.	27-38	sulfhydryls	Sulfhydryl Compounds	C0038734	T109	Simple_chemical	42-46	MD-2	Lymphocyte Antigen 96	C1527521	T129|T116	Gene_or_gene_product	122-129	mutants	mutants	C0596988	T049	-812	Regulation	Forward	FALSE	NA
12855	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	48-57	cisplatin	Cisplatin	C0008838	T121|T197	Simple_chemical	191-194	JNK	JNK Mitogen-Activated Protein Kinases	C0248813	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12856	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	48-57	cisplatin	Cisplatin	C0008838	T121|T197	Simple_chemical	196-199	p38	mitogen-activated protein kinase p38	C1120843	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12857	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	48-57	cisplatin	Cisplatin	C0008838	T121|T197	Simple_chemical	205-242	extracellular signal-regulated kinase	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12858	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	48-57	cisplatin	Cisplatin	C0008838	T121|T197	Simple_chemical	244-247	ERK	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12865	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	59-72	actinomycin D	Dactinomycin	C0010934	T116|T195	Simple_chemical	191-194	JNK	JNK Mitogen-Activated Protein Kinases	C0248813	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12866	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	59-72	actinomycin D	Dactinomycin	C0010934	T116|T195	Simple_chemical	196-199	p38	mitogen-activated protein kinase p38	C1120843	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12867	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	59-72	actinomycin D	Dactinomycin	C0010934	T116|T195	Simple_chemical	205-242	extracellular signal-regulated kinase	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12868	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	59-72	actinomycin D	Dactinomycin	C0010934	T116|T195	Simple_chemical	244-247	ERK	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12874	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	74-77	MMS	Methyl Methanesulfonate	C0025706	T109|T121|T131	Simple_chemical	191-194	JNK	JNK Mitogen-Activated Protein Kinases	C0248813	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12875	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	74-77	MMS	Methyl Methanesulfonate	C0025706	T109|T121|T131	Simple_chemical	196-199	p38	mitogen-activated protein kinase p38	C1120843	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12876	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	74-77	MMS	Methyl Methanesulfonate	C0025706	T109|T121|T131	Simple_chemical	205-242	extracellular signal-regulated kinase	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12877	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	74-77	MMS	Methyl Methanesulfonate	C0025706	T109|T121|T131	Simple_chemical	244-247	ERK	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12882	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	83-92	etoposide	Etoposide	C0015133	T109|T121	Simple_chemical	191-194	JNK	JNK Mitogen-Activated Protein Kinases	C0248813	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12883	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	83-92	etoposide	Etoposide	C0015133	T109|T121	Simple_chemical	196-199	p38	mitogen-activated protein kinase p38	C1120843	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12884	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	83-92	etoposide	Etoposide	C0015133	T109|T121	Simple_chemical	205-242	extracellular signal-regulated kinase	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12885	PC13_train	12663670.s3	We have observed that four DNA-damaging agents (cisplatin, actinomycin D, MMS, and etoposide), but not the cisplatin isomer, transplatin, which does not readily damage DNA, strongly activate JNK, p38, and extracellular signal-regulated kinase (ERK), and strongly increase phosphorylation and ATF2-dependent transcriptional activity.	83-92	etoposide	Etoposide	C0015133	T109|T121	Simple_chemical	244-247	ERK	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	161-167	damage	Damage	C0010957	T037	-1000	Increase	Forward	FALSE	NA
12931	PC13_train	12665581.s1	NPAT is an in vivo substrate of cyclin E-Cdk2 kinase and is thought to play a critical role in coordinated transcriptional activation of histone genes during the G(1)/S-phase transition and in S-phase entry in mammalian cells.	0-4	NPAT	NPAT protein, human	C0530328	T116|T123	Gene_or_gene_product	137-144	histone	Histones	C0019652	T116|T123	Gene_or_gene_product	175-185	transition	Transition	C0599156	T049	-827	Regulation	Forward	TRUE	NA
12934	PC13_train	12665581.s4	Consistently, we find that the E2F sites in the NPAT promoter are required for its activation during the G(1)/S-phase transition.	31-34	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	48-52	NPAT	NPAT protein, human	C0530328	T116|T123	Gene_or_gene_product	118-128	transition	Transition	C0599156	T049	-827	Increase	Forward	TRUE	NA
12951	PC13_train	12743037.s6	Hog1 interacts with the RNA Pol II and with general components of the transcription machinery.	0-4	Hog1	HOG1 protein, S cerevisiae	C0257532	T116|T126	Gene_or_gene_product	24-34	RNA Pol II	RNA Polymerase II	C0035679	T116|T126	Complex	84-93	machinery	Machinery	C0337246	T037	-861	Binding	NA	FALSE	NA
12962	PC13_train	12750288.s4	Differential levels of hdm2 mRNA and protein expression have been reported in several types of human malignancy, including breast cancers in which hdm2 expression correlates with positive estrogen receptor alpha (ERalpha) status.	147-151	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	188-211	estrogen receptor alpha	Estrogen Receptor alpha	C0665341	T116|T192	Gene_or_gene_product	123-137	breast cancers	breast cancers	C0006142	T191	-1000	Regulation	Backward	TRUE	NA
12963	PC13_train	12750288.s4	Differential levels of hdm2 mRNA and protein expression have been reported in several types of human malignancy, including breast cancers in which hdm2 expression correlates with positive estrogen receptor alpha (ERalpha) status.	147-151	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	188-211	estrogen receptor alpha	Estrogen Receptor alpha	C0665341	T116|T192	Gene_or_gene_product	101-111	malignancy	MALIGNANCY	C0006826	T191	-861	Regulation	Backward	TRUE	NA
12964	PC13_train	12750288.s4	Differential levels of hdm2 mRNA and protein expression have been reported in several types of human malignancy, including breast cancers in which hdm2 expression correlates with positive estrogen receptor alpha (ERalpha) status.	147-151	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	188-211	estrogen receptor alpha	Estrogen Receptor alpha	C0665341	T116|T192	Gene_or_gene_product	101-111	malignancy	Malignancy	C1306459	T191	-861	Regulation	Backward	TRUE	NA
12965	PC13_train	12750288.s4	Differential levels of hdm2 mRNA and protein expression have been reported in several types of human malignancy, including breast cancers in which hdm2 expression correlates with positive estrogen receptor alpha (ERalpha) status.	147-151	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	213-220	ERalpha	Estrogen Receptor alpha	C0665341	T116|T192	Gene_or_gene_product	123-137	breast cancers	breast cancers	C0006142	T191	-1000	Regulation	Backward	TRUE	NA
12966	PC13_train	12750288.s4	Differential levels of hdm2 mRNA and protein expression have been reported in several types of human malignancy, including breast cancers in which hdm2 expression correlates with positive estrogen receptor alpha (ERalpha) status.	147-151	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	213-220	ERalpha	Estrogen Receptor alpha	C0665341	T116|T192	Gene_or_gene_product	101-111	malignancy	MALIGNANCY	C0006826	T191	-861	Regulation	Backward	TRUE	NA
12967	PC13_train	12750288.s4	Differential levels of hdm2 mRNA and protein expression have been reported in several types of human malignancy, including breast cancers in which hdm2 expression correlates with positive estrogen receptor alpha (ERalpha) status.	147-151	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	213-220	ERalpha	Estrogen Receptor alpha	C0665341	T116|T192	Gene_or_gene_product	101-111	malignancy	Malignancy	C1306459	T191	-861	Regulation	Backward	TRUE	NA
12980	PC13_train	12750288.s6	Here, we show that the elevated level of hdm2 protein in ERalpha(+ve) breast cancer cell lines such as MCF-7 and T47D is because of transcription from the p53-inducible P2 promoter of hdm2.	155-158	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	184-188	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	113-117	T47D	T-47D	C3897399	T050	-1000	Increase	Forward	FALSE	NA
13031	PC13_train	12750288.s9	We show that hdm2-P2 activity in T47D cells is dependent on the integrity of both an evolutionarily conserved composite binding site for AP1 and ETS family transcription factors (AP1-ETS) and a nonconserved upstream (nnGGGGC)(5) repeat sequence.	13-17	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	137-140	AP1	Transcription Factor AP-1	C0085828	T116|T123	Gene_or_gene_product	33-37	T47D	T-47D	C3897399	T050	-861	Binding	NA	TRUE	NA
13033	PC13_train	12750288.s9	We show that hdm2-P2 activity in T47D cells is dependent on the integrity of both an evolutionarily conserved composite binding site for AP1 and ETS family transcription factors (AP1-ETS) and a nonconserved upstream (nnGGGGC)(5) repeat sequence.	13-17	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	179-182	AP1	Transcription Factor AP-1	C0085828	T116|T123	Gene_or_gene_product	33-37	T47D	T-47D	C3897399	T050	-861	Binding	NA	TRUE	NA
13034	PC13_train	12750288.s9	We show that hdm2-P2 activity in T47D cells is dependent on the integrity of both an evolutionarily conserved composite binding site for AP1 and ETS family transcription factors (AP1-ETS) and a nonconserved upstream (nnGGGGC)(5) repeat sequence.	13-17	hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	183-186	ETS	ETS Family Protein	C0919488	T116|T123	Gene_or_gene_product	33-37	T47D	T-47D	C3897399	T050	-861	Binding	NA	TRUE	NA
13045	PC13_train	12835412.s10	Inhibition of MRP4 by an MRP4-specific RNA interference construct or by indomethacin reversed this accumulation deficit.	14-18	MRP4	Multidrug Resistance-Associated Protein 4	C3538745	T116	Gene_or_gene_product	72-84	indomethacin	Indomethacin	C0021246	T109|T121	Simple_chemical	112-119	deficit	Deficit, NOS	C0162429	T047	-861	Decrease	Backward	FALSE	NA
13047	PC13_train	12835412.s4	In inside-out membrane vesicles derived from insect cells or HEK293 cells, MRP4 catalyzed the time- and ATP-dependent uptake of prostaglandin E1 (PGE1) and PGE2.	104-107	ATP	Adenosine Triphosphate	C0001480	T114|T121|T123	Simple_chemical	128-144	prostaglandin E1	Alprostadil	C0002335	T109|T121	Simple_chemical	23-31	vesicles	VESICLES	C0333262	T047	-812	Regulation	Forward	TRUE	NA
13048	PC13_train	12835412.s4	In inside-out membrane vesicles derived from insect cells or HEK293 cells, MRP4 catalyzed the time- and ATP-dependent uptake of prostaglandin E1 (PGE1) and PGE2.	104-107	ATP	Adenosine Triphosphate	C0001480	T114|T121|T123	Simple_chemical	146-150	PGE1	Alprostadil	C0002335	T109|T121	Simple_chemical	23-31	vesicles	VESICLES	C0333262	T047	-812	Regulation	Forward	TRUE	NA
13049	PC13_train	12835412.s4	In inside-out membrane vesicles derived from insect cells or HEK293 cells, MRP4 catalyzed the time- and ATP-dependent uptake of prostaglandin E1 (PGE1) and PGE2.	104-107	ATP	Adenosine Triphosphate	C0001480	T114|T121|T123	Simple_chemical	156-160	PGE2	Dinoprostone	C0012472	T109|T121|T125	Simple_chemical	23-31	vesicles	VESICLES	C0333262	T047	-812	Regulation	Forward	TRUE	NA
13059	PC13_train	12835412.s4	In inside-out membrane vesicles derived from insect cells or HEK293 cells, MRP4 catalyzed the time- and ATP-dependent uptake of prostaglandin E1 (PGE1) and PGE2.	75-79	MRP4	Multidrug Resistance-Associated Protein 4	C3538745	T116	Gene_or_gene_product	128-144	prostaglandin E1	Alprostadil	C0002335	T109|T121	Simple_chemical	23-31	vesicles	VESICLES	C0333262	T047	-812	Regulation	Forward	TRUE	NA
13060	PC13_train	12835412.s4	In inside-out membrane vesicles derived from insect cells or HEK293 cells, MRP4 catalyzed the time- and ATP-dependent uptake of prostaglandin E1 (PGE1) and PGE2.	75-79	MRP4	Multidrug Resistance-Associated Protein 4	C3538745	T116	Gene_or_gene_product	146-150	PGE1	Alprostadil	C0002335	T109|T121	Simple_chemical	23-31	vesicles	VESICLES	C0333262	T047	-812	Regulation	Forward	TRUE	NA
13061	PC13_train	12835412.s4	In inside-out membrane vesicles derived from insect cells or HEK293 cells, MRP4 catalyzed the time- and ATP-dependent uptake of prostaglandin E1 (PGE1) and PGE2.	75-79	MRP4	Multidrug Resistance-Associated Protein 4	C3538745	T116	Gene_or_gene_product	156-160	PGE2	Dinoprostone	C0012472	T109|T121|T125	Simple_chemical	23-31	vesicles	VESICLES	C0333262	T047	-812	Regulation	Forward	TRUE	NA
13096	PC13_train	12861053.s5	The defects in ATM-dependent activation of CHK2, S phase checkpoint control, IR-induced nuclear focus formation, and radiation sensitivity apparent in NBS cells were not corrected by expression of NBS1 mutants that lack an intact MRE11 binding domain, suggesting that formation of the NBS1-MRE11-RAD50 complex is required for the corresponding normal phenotypes.	15-18	ATM	Ataxia Telangiectasia Mutated Proteins	C0298973	T116|T126	Gene_or_gene_product	43-47	CHK2	checkpoint kinase 2	C0296594	T116|T126	Gene_or_gene_product	202-209	mutants	mutants	C0596988	T049	-861	Increase	Forward	FALSE	NA
13124	PC13_train	12861053.s8	Together, these data demonstrate that multiple functional domains of NBS1 are required for ATM-dependent activation of CHK2, nuclear focus formation, S phase checkpoint control, and cell survival after exposure to IR.	69-73	NBS1	NBS1 protein, human	C0674679	T116|T123	Gene_or_gene_product	119-123	CHK2	checkpoint kinase 2	C0296594	T116|T126	Gene_or_gene_product	202-210	exposure	Exposure NOS	C0274281	T037	-1000	Increase	Forward	TRUE	NA
13127	PC13_train	12861053.s8	Together, these data demonstrate that multiple functional domains of NBS1 are required for ATM-dependent activation of CHK2, nuclear focus formation, S phase checkpoint control, and cell survival after exposure to IR.	91-94	ATM	Ataxia Telangiectasia Mutated Proteins	C0298973	T116|T126	Gene_or_gene_product	119-123	CHK2	checkpoint kinase 2	C0296594	T116|T126	Gene_or_gene_product	202-210	exposure	Exposure NOS	C0274281	T037	-1000	Increase	Forward	TRUE	NA
13140	PC13_train	14507663.s7	Furthermore, we could detect MRP5 and ATP-dependent transport of [(3)H]cGMP in sarcolemma vesicles of human heart.	38-41	ATP	Adenosine Triphosphate	C0001480	T114|T121|T123	Simple_chemical	65-75	[(3)H]cGMP	Cyclic GMP	C0018338	T114|T123	Simple_chemical	90-98	vesicles	VESICLES	C0333262	T047	-861	Regulation	Forward	TRUE	NA
13281	PC13_train	14555292.s4	In the present study, we used selective pharmacological inhibitors to investigate the roles of phosphatidylinositol-3'-kinase (PI3-K), phospholipase C (PLC), calcium-dependent protein kinase C (PKC), extra-cellular signal regulated kinase (ERK), and nuclear translocation factor kappa B (NF-kappaB) on TLR2-mediated oxidative burst.	158-165	calcium	Calcium	C0006675	T121|T123|T196	Simple_chemical	176-192	protein kinase C	Protein Kinase C	C0033634	T116|T126	Gene_or_gene_product	258-271	translocation	Translocation	C0040715	T049	-629	Increase	Forward	FALSE	NA
13282	PC13_train	14555292.s4	In the present study, we used selective pharmacological inhibitors to investigate the roles of phosphatidylinositol-3'-kinase (PI3-K), phospholipase C (PLC), calcium-dependent protein kinase C (PKC), extra-cellular signal regulated kinase (ERK), and nuclear translocation factor kappa B (NF-kappaB) on TLR2-mediated oxidative burst.	158-165	calcium	Calcium	C0006675	T121|T123|T196	Simple_chemical	194-197	PKC	Protein Kinase C	C0033634	T116|T126	Gene_or_gene_product	258-271	translocation	Translocation	C0040715	T049	-629	Increase	Forward	FALSE	NA
13380	PC13_train	14715500.s2	To test this, we 1) determined the acute vasoactive effects of MA (1-1,000 micromol/l) in uncontracted and norepinephrine (NE; 1 micromol/l)-precontracted human blood vessels used for coronary artery bypass grafts [left internal mammary artery (LIMA), radial artery (RA), and right saphenous vein (RSV)]; 2) tested whether MA effects in LIMA and RSV were dependent on SSAO activity using the SSAO inhibitor semicarbazide (1 mmol/l, 15 min); 3) determined the effects of MA metabolites formaldehyde and hydrogen peroxide in LIMA and RSV; 4) tested whether the MA response was nitric oxide, prostaglandin, or hyperpolarization dependent; 5) measured the LIMA and RSV cGMP levels after MA exposure; and 6) quantified SSAO activity in LIMA, RA, and RSV.	323-325	MA	methylamine	C0066318	T109	Simple_chemical	368-372	SSAO	Amine Oxidase (Copper-Containing)	C0019587	T116|T126	Gene_or_gene_product	686-694	exposure	Exposure NOS	C0274281	T037	-861	Increase	Backward	FALSE	NA
13426	PC13_train	14715500.s2	To test this, we 1) determined the acute vasoactive effects of MA (1-1,000 micromol/l) in uncontracted and norepinephrine (NE; 1 micromol/l)-precontracted human blood vessels used for coronary artery bypass grafts [left internal mammary artery (LIMA), radial artery (RA), and right saphenous vein (RSV)]; 2) tested whether MA effects in LIMA and RSV were dependent on SSAO activity using the SSAO inhibitor semicarbazide (1 mmol/l, 15 min); 3) determined the effects of MA metabolites formaldehyde and hydrogen peroxide in LIMA and RSV; 4) tested whether the MA response was nitric oxide, prostaglandin, or hyperpolarization dependent; 5) measured the LIMA and RSV cGMP levels after MA exposure; and 6) quantified SSAO activity in LIMA, RA, and RSV.	392-396	SSAO	Amine Oxidase (Copper-Containing)	C0019587	T116|T126	Gene_or_gene_product	407-420	semicarbazide	Semicarbazides	C0036620	T109	Simple_chemical	686-694	exposure	Exposure NOS	C0274281	T037	-861	Decrease	Backward	FALSE	NA
13506	PC13_train	14715500.s2	To test this, we 1) determined the acute vasoactive effects of MA (1-1,000 micromol/l) in uncontracted and norepinephrine (NE; 1 micromol/l)-precontracted human blood vessels used for coronary artery bypass grafts [left internal mammary artery (LIMA), radial artery (RA), and right saphenous vein (RSV)]; 2) tested whether MA effects in LIMA and RSV were dependent on SSAO activity using the SSAO inhibitor semicarbazide (1 mmol/l, 15 min); 3) determined the effects of MA metabolites formaldehyde and hydrogen peroxide in LIMA and RSV; 4) tested whether the MA response was nitric oxide, prostaglandin, or hyperpolarization dependent; 5) measured the LIMA and RSV cGMP levels after MA exposure; and 6) quantified SSAO activity in LIMA, RA, and RSV.	559-561	MA	methylamine	C0066318	T109	Simple_chemical	575-587	nitric oxide	Nitric Oxide	C0028128	T121|T123|T197	Simple_chemical	686-694	exposure	Exposure NOS	C0274281	T037	-861	Increase	Backward	FALSE	NA
13508	PC13_train	14715500.s2	To test this, we 1) determined the acute vasoactive effects of MA (1-1,000 micromol/l) in uncontracted and norepinephrine (NE; 1 micromol/l)-precontracted human blood vessels used for coronary artery bypass grafts [left internal mammary artery (LIMA), radial artery (RA), and right saphenous vein (RSV)]; 2) tested whether MA effects in LIMA and RSV were dependent on SSAO activity using the SSAO inhibitor semicarbazide (1 mmol/l, 15 min); 3) determined the effects of MA metabolites formaldehyde and hydrogen peroxide in LIMA and RSV; 4) tested whether the MA response was nitric oxide, prostaglandin, or hyperpolarization dependent; 5) measured the LIMA and RSV cGMP levels after MA exposure; and 6) quantified SSAO activity in LIMA, RA, and RSV.	559-561	MA	methylamine	C0066318	T109	Simple_chemical	589-602	prostaglandin	Prostaglandins	C0033554	T109|T121|T125	Simple_chemical	686-694	exposure	Exposure NOS	C0274281	T037	-861	Increase	Backward	FALSE	NA
13579	PC13_train	15024086.s1	Eukaryotic elongation factor 2 (eEF2) kinase is an unusual calcium- and calmodulin-dependent protein kinase that is regulated by insulin through the rapamycin-sensitive mTOR pathway.	0-44	Eukaryotic elongation factor 2 (eEF2) kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	129-136	insulin	Insulin	C0021641	T116|T121|T125	Gene_or_gene_product	159-168	sensitive	Sensitive	C0020517	T046	-645	Regulation	Backward	FALSE	NA
13582	PC13_train	15024086.s1	Eukaryotic elongation factor 2 (eEF2) kinase is an unusual calcium- and calmodulin-dependent protein kinase that is regulated by insulin through the rapamycin-sensitive mTOR pathway.	0-44	Eukaryotic elongation factor 2 (eEF2) kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	59-66	calcium	Calcium	C0006675	T121|T123|T196	Simple_chemical	159-168	sensitive	Sensitive	C0020517	T046	-645	Increase	Backward	FALSE	NA
13583	PC13_train	15024086.s1	Eukaryotic elongation factor 2 (eEF2) kinase is an unusual calcium- and calmodulin-dependent protein kinase that is regulated by insulin through the rapamycin-sensitive mTOR pathway.	0-44	Eukaryotic elongation factor 2 (eEF2) kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	72-82	calmodulin	Calmodulin	C0006772	T116|T123	Gene_or_gene_product	159-168	sensitive	Sensitive	C0020517	T046	-645	Increase	Backward	FALSE	NA
13595	PC13_train	15024086.s2	Here we show that insulin decreases the ability of eEF2 kinase to bind calmodulin in a rapamycin-sensitive manner.	18-25	insulin	Insulin	C0021641	T116|T121|T125	Gene_or_gene_product	71-81	calmodulin	Calmodulin	C0006772	T116|T123	Gene_or_gene_product	97-106	sensitive	Sensitive	C0020517	T046	-660	Regulation	Forward	TRUE	NA
13597	PC13_train	15024086.s2	Here we show that insulin decreases the ability of eEF2 kinase to bind calmodulin in a rapamycin-sensitive manner.	51-62	eEF2 kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	71-81	calmodulin	Calmodulin	C0006772	T116|T123	Gene_or_gene_product	97-106	sensitive	Sensitive	C0020517	T046	-660	Binding	NA	TRUE	NA
13599	PC13_train	15024086.s2	Here we show that insulin decreases the ability of eEF2 kinase to bind calmodulin in a rapamycin-sensitive manner.	71-81	calmodulin	Calmodulin	C0006772	T116|T123	Gene_or_gene_product	87-96	rapamycin	Sirolimus	C0072980	T109|T195	Simple_chemical	97-106	sensitive	Sensitive	C0020517	T046	-660	Regulation	Backward	TRUE	NA
13601	PC13_train	15024086.s6	Mutation of this site to alanine strongly attenuates the effects of insulin and rapamycin both on the binding of calmodulin to eEF2 kinase and on eEF2 kinase activity.	113-123	calmodulin	Calmodulin	C0006772	T116|T123	Gene_or_gene_product	127-138	eEF2 kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	0-8	Mutation	Mutation	C1705285	T049	-1000	Binding	NA	FALSE	NA
13610	PC13_train	15024086.s6	Mutation of this site to alanine strongly attenuates the effects of insulin and rapamycin both on the binding of calmodulin to eEF2 kinase and on eEF2 kinase activity.	68-75	insulin	Insulin	C0021641	T116|T121|T125	Gene_or_gene_product	127-138	eEF2 kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	0-8	Mutation	Mutation	C1705285	T049	-1000	Regulation	Forward	TRUE	NA
13611	PC13_train	15024086.s6	Mutation of this site to alanine strongly attenuates the effects of insulin and rapamycin both on the binding of calmodulin to eEF2 kinase and on eEF2 kinase activity.	68-75	insulin	Insulin	C0021641	T116|T121|T125	Gene_or_gene_product	146-157	eEF2 kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	0-8	Mutation	Mutation	C1705285	T049	-1000	Regulation	Forward	TRUE	NA
13614	PC13_train	15024086.s6	Mutation of this site to alanine strongly attenuates the effects of insulin and rapamycin both on the binding of calmodulin to eEF2 kinase and on eEF2 kinase activity.	80-89	rapamycin	Sirolimus	C0072980	T109|T195	Simple_chemical	127-138	eEF2 kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	0-8	Mutation	Mutation	C1705285	T049	-1000	Regulation	Forward	TRUE	NA
13615	PC13_train	15024086.s6	Mutation of this site to alanine strongly attenuates the effects of insulin and rapamycin both on the binding of calmodulin to eEF2 kinase and on eEF2 kinase activity.	80-89	rapamycin	Sirolimus	C0072980	T109|T195	Simple_chemical	146-157	eEF2 kinase	calmodulin-dependent protein kinase III	C0054521	T116|T126	Gene_or_gene_product	0-8	Mutation	Mutation	C1705285	T049	-1000	Regulation	Forward	TRUE	NA
13830	PC13_train	15175242.s11	Our data also demonstrate a direct role for E2F in the oncogenic activation of Arf.	44-47	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	79-82	Arf	p14ARF Protein	C0384826	T116|T123	Gene_or_gene_product	55-75	oncogenic activation	Oncogene Activation	C1518575	T049	-964	Regulation	Forward	FALSE	NA
13839	PC13_train	15175242.s13	Thus, distinct E2F complexes directly contribute to the normal repression and oncogenic activation of Arf.	15-28	E2F complexes	E2F transcription factors	C0146462	T116|T123	Complex	102-105	Arf	p14ARF Protein	C0384826	T116|T123	Gene_or_gene_product	78-98	oncogenic activation	Oncogene Activation	C1518575	T049	-964	Decrease	Forward	FALSE	NA
13840	PC13_train	15175242.s13	Thus, distinct E2F complexes directly contribute to the normal repression and oncogenic activation of Arf.	15-28	E2F complexes	E2F transcription factors	C0146462	T116|T123	Complex	102-105	Arf	p14ARF Protein	C0384826	T116|T123	Gene_or_gene_product	78-98	oncogenic activation	Oncogene Activation	C1518575	T049	-964	Increase	Forward	FALSE	NA
13844	PC13_train	15175242.s3	Here, we show that E2F directly participates in the transcriptional control of Arf in both normal and transformed cells.	19-22	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	79-82	Arf	p14ARF Protein	C0384826	T116|T123	Gene_or_gene_product	102-113	transformed	Transformed	C1510411	T046	-694	Regulation	Forward	TRUE	NA
13925	PC13_train	15460900.s1	The p16INK4a tumor suppressor protein functions as an inhibitor of CDK4 and CDK6, the D-type cyclin-dependent kinases that initiate the phosphorylation of the retinoblastoma tumor suppressor protein, RB.	4-12	p16INK4a	Cyclin-Dependent Kinase Inhibitor p16	C0249880	T116|T123	Gene_or_gene_product	67-71	CDK4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	159-173	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-645	Decrease	Forward	FALSE	NA
13926	PC13_train	15460900.s1	The p16INK4a tumor suppressor protein functions as an inhibitor of CDK4 and CDK6, the D-type cyclin-dependent kinases that initiate the phosphorylation of the retinoblastoma tumor suppressor protein, RB.	4-12	p16INK4a	Cyclin-Dependent Kinase Inhibitor p16	C0249880	T116|T123	Gene_or_gene_product	76-80	CDK6	cyclin-dependent kinase 6	C0252132	T116|T126	Gene_or_gene_product	159-173	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-645	Decrease	Forward	FALSE	NA
13933	PC13_train	15460900.s1	The p16INK4a tumor suppressor protein functions as an inhibitor of CDK4 and CDK6, the D-type cyclin-dependent kinases that initiate the phosphorylation of the retinoblastoma tumor suppressor protein, RB.	86-117	D-type cyclin-dependent kinases	CDK4 protein, human	C1527860	T116|T126	Gene_or_gene_product	200-202	RB	Retinoblastoma Protein	C0080113	T116|T123	Gene_or_gene_product	159-173	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-645	Regulation	Forward	FALSE	NA
13979	PC13_train	15494392.s0	A role for 14-3-3 tau in E2F1 stabilization and DNA damage-induced apoptosis.	11-21	14-3-3 tau	14-3-3 Protein, tau Isoform	C0525587	T116|T123	Gene_or_gene_product	25-29	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	48-58	DNA damage	DNA Damage	C0012860	T049	-694	Regulation	Forward	FALSE	NA
13986	PC13_train	15494392.s6	14-3-3 tau interacts with ATM-phosphorylated E2F1 during DNA damage and inhibits E2F1 ubiquitination.	0-10	14-3-3 tau	14-3-3 Protein, tau Isoform	C0525587	T116|T123	Gene_or_gene_product	45-49	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	57-67	DNA damage	DNA Damage	C0012860	T049	-1000	Binding	NA	TRUE	NA
13990	PC13_train	15494392.s6	14-3-3 tau interacts with ATM-phosphorylated E2F1 during DNA damage and inhibits E2F1 ubiquitination.	0-10	14-3-3 tau	14-3-3 Protein, tau Isoform	C0525587	T116|T123	Gene_or_gene_product	81-85	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	57-67	DNA damage	DNA Damage	C0012860	T049	-1000	Regulation	Forward	FALSE	NA
14012	PC13_train	15494392.s8	14-3-3 tau is also required for expression and induction of E2F1 apoptotic targets, such as p73, Apaf-1, and caspases, during DNA damage.	0-10	14-3-3 tau	14-3-3 Protein, tau Isoform	C0525587	T116|T123	Gene_or_gene_product	109-117	caspases	caspase	C0010656	T116|T126	Gene_or_gene_product	126-136	DNA damage	DNA Damage	C0012860	T049	-1000	Increase	Forward	TRUE	NA
14014	PC13_train	15494392.s8	14-3-3 tau is also required for expression and induction of E2F1 apoptotic targets, such as p73, Apaf-1, and caspases, during DNA damage.	0-10	14-3-3 tau	14-3-3 Protein, tau Isoform	C0525587	T116|T123	Gene_or_gene_product	92-95	p73	tumor suppressor protein p73	C0665577	T116|T123	Gene_or_gene_product	126-136	DNA damage	DNA Damage	C0012860	T049	-1000	Increase	Forward	TRUE	NA
14015	PC13_train	15494392.s8	14-3-3 tau is also required for expression and induction of E2F1 apoptotic targets, such as p73, Apaf-1, and caspases, during DNA damage.	0-10	14-3-3 tau	14-3-3 Protein, tau Isoform	C0525587	T116|T123	Gene_or_gene_product	97-103	Apaf-1	apoptotic protease-activating factor 1	C0664613	T116|T123	Gene_or_gene_product	126-136	DNA damage	DNA Damage	C0012860	T049	-1000	Increase	Forward	TRUE	NA
14022	PC13_train	15494392.s9	Together, these data demonstrate a novel function for 14-3-3 tau in the regulation of E2F1 protein stability and apoptosis during DNA damage.	54-64	14-3-3 tau	14-3-3 Protein, tau Isoform	C0525587	T116|T123	Gene_or_gene_product	86-90	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	130-140	DNA damage	DNA Damage	C0012860	T049	-1000	Regulation	Forward	TRUE	NA
14052	PC13_train	15536069.s0	A novel repressive E2F6 complex containing the polycomb group protein, EPC1, that interacts with EZH2 in a proliferation-specific manner.	19-23	E2F6	E2F6 Transcription Factor	C0672706	T116|T123	Gene_or_gene_product	97-101	EZH2	Enhancer of Zeste Homolog 2 Protein	C4255172	T116|T126	Gene_or_gene_product	107-120	proliferation	Proliferation	C0334094	T046	-660	Binding	NA	TRUE	NA
14080	PC13_train	15558284.s3	We investigated whether signal-specific activation of mating and invasive growth involves regulation of the transcription factor Tec1 by Fus3 and Kss1.	129-133	Tec1	TEC1 protein, S cerevisiae	C1448656	T116|T123	Gene_or_gene_product	137-141	Fus3	FUS3 protein, S cerevisiae	C0170159	T116|T126	Gene_or_gene_product	65-80	invasive growth	invasive growth	C1156244	T046	-1000	Regulation	Backward	FALSE	negation
14081	PC13_train	15558284.s3	We investigated whether signal-specific activation of mating and invasive growth involves regulation of the transcription factor Tec1 by Fus3 and Kss1.	129-133	Tec1	TEC1 protein, S cerevisiae	C1448656	T116|T123	Gene_or_gene_product	146-150	Kss1	KSS1 protein, S cerevisiae	C0246847	T116|T126	Gene_or_gene_product	65-80	invasive growth	invasive growth	C1156244	T046	-1000	Regulation	Backward	FALSE	negation
14084	PC13_train	15558284.s6	We find that Kss1 controls the activity of Tec1 mainly during invasive growth by control of TEC1 gene expression.	13-17	Kss1	KSS1 protein, S cerevisiae	C0246847	T116|T126	Gene_or_gene_product	43-47	Tec1	TEC1 protein, S cerevisiae	C1448656	T116|T123	Gene_or_gene_product	62-77	invasive growth	invasive growth	C1156244	T046	-1000	Regulation	Forward	TRUE	NA
14085	PC13_train	15558284.s6	We find that Kss1 controls the activity of Tec1 mainly during invasive growth by control of TEC1 gene expression.	13-17	Kss1	KSS1 protein, S cerevisiae	C0246847	T116|T126	Gene_or_gene_product	92-96	TEC1	TEC1 protein, S cerevisiae	C1448656	T116|T123	Gene_or_gene_product	62-77	invasive growth	invasive growth	C1156244	T046	-1000	Regulation	Forward	TRUE	NA
14124	PC13_train	15701789.s6	Our observations demonstrate that Mad2p localization at NPCs is sensitive to nuclear levels of Ran and suggest that release of Mad2p from NPCs is closely linked with spindle assembly checkpoint activation in yeast.	34-39	Mad2p	MAD2 protein, S cerevisiae	C3711585	T116|T123	Gene_or_gene_product	95-98	Ran	ran GTP-Binding Protein	C0139916	T116|T123	Gene_or_gene_product	64-73	sensitive	Sensitive	C0020517	T046	-1000	Regulation	Backward	FALSE	NA
14143	PC13_train	15766563.s2	Axin2 is induced by E2F1 and therefore acts as a point of cross-talk between the pRb/E2F and Wnt/beta-catenin pathways: two of the most frequently deregulated pathways in human cancers.	0-5	Axin2	AXIN2 protein, human	C1454580	T116|T123	Gene_or_gene_product	20-24	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	177-184	cancers	Cancer	C1306459	T191	-861	Increase	Backward	FALSE	NA
14144	PC13_train	15766563.s2	Axin2 is induced by E2F1 and therefore acts as a point of cross-talk between the pRb/E2F and Wnt/beta-catenin pathways: two of the most frequently deregulated pathways in human cancers.	0-5	Axin2	AXIN2 protein, human	C1454580	T116|T123	Gene_or_gene_product	20-24	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	177-184	cancers	Cancers	C0006826	T191	-861	Increase	Backward	FALSE	NA
14177	PC13_train	15767663.s7	In contrast, the insulin-stimulated phosphorylation of the C-terminal site Ser64/65 is generally sensitive to rapamycin, as is phosphorylation of another well-characterized target for mTOR signaling, S6K1.	110-119	rapamycin	Sirolimus	C0072980	T109|T195	Simple_chemical	200-204	S6K1	Ribosomal Protein S6 Kinase Beta-1	C2827383	T116|T126	Gene_or_gene_product	97-106	sensitive	Sensitive	C0020517	T046	-861	Regulation	Forward	FALSE	NA
14198	PC13_train	15850991.s6	The G171V mutation prevents Dkk from binding to LRP5, thereby increasing LRP5 function; the result is high bone mass due to uncoupling of bone formation and resorption.	28-31	Dkk	Dickkopf-Related Protein 1	C2987134	T116	Gene_or_gene_product	48-52	LRP5	Low Density Lipoprotein Receptor-Related Protein-5	C0757661	T116|T192	Gene_or_gene_product	10-18	mutation	Mutation	C1705285	T049	-861	Binding	NA	TRUE	reverse
14360	PC13_train	15972957.s9	Collectively, our data provide further evidence that beta-catenin signaling plays a role in TSC pathogenesis in vivo and suggest a novel role of GSK3 in modulating the TSC1/TSC2 complex through TSC1 phosphorylation.	145-149	GSK3	Glycogen Synthase Kinase 3	C0244989	T116|T126	Gene_or_gene_product	194-198	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	96-108	pathogenesis	Pathogenesis	C0699748	T046	-861	Regulation	Forward	FALSE	NA
14397	PC13_train	15993039.s8	The lack of importance of PLD1 signaling in RhoA-mediated cytoskeletal reorganization is further supported by the observation that PLD1 depletion using an shRNA approach and tetracycline-induced overexpression of the wild-type and the catalytically inactive mutant of PLD1 in stable cell lines do not alter stress fiber and focal adhesion formation.	174-186	tetracycline	Tetracycline	C0039644	T109|T195	Simple_chemical	268-272	PLD1	Phospholipase D	C0031670	T116|T126	Gene_or_gene_product	258-264	mutant	Mutant	C0596988	T049	-827	Increase	Forward	FALSE	NA
14421	PC13_train	16107498.s2	Analysis of the human E2F6 promoter region revealed the presence of two putative E2F binding sites, both of which were found to be functionally critical because deletion or mutations of these sites abolished promoter activity.	22-26	E2F6	E2F6 Transcription Factor	C0672706	T116|T123	Gene_or_gene_product	81-84	E2F	E2F transcription factors	C0146462	T116|T123	Gene_or_gene_product	161-169	deletion	Deletion	C1442161	T049	-1000	Binding	NA	TRUE	reverse
14426	PC13_train	16107498.s4	Deletion or mutation of the putative E2F binding sites nullified the effects of E2F1 on the E2F6 promoter activity.	80-84	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	92-96	E2F6	E2F6 Transcription Factor	C0672706	T116|T123	Gene_or_gene_product	0-8	Deletion	Deletion	C1442161	T049	-1000	Regulation	Forward	TRUE	reverse
14427	PC13_train	16107498.s4	Deletion or mutation of the putative E2F binding sites nullified the effects of E2F1 on the E2F6 promoter activity.	80-84	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	92-96	E2F6	E2F6 Transcription Factor	C0672706	T116|T123	Gene_or_gene_product	12-20	mutation	Mutation	C1705285	T049	-1000	Regulation	Forward	TRUE	reverse
14435	PC13_train	16158053.s0	E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.	0-8	E2F-HDAC	Rb-E2F complex	C1523638	T026	Complex	65-69	ARHI	ARHI protein, human	C0763637	T116|T123	Gene_or_gene_product	73-86	breast cancer	Breast Cancer	C0006142	T191	-818	Decrease	Forward	TRUE	NA
14436	PC13_train	16158053.s0	E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.	0-8	E2F-HDAC	Rb-E2F complex	C1523638	T026	Complex	65-69	ARHI	ARHI protein, human	C0763637	T116|T123	Gene_or_gene_product	73-86	breast cancer	Breast Cancer	C0678222	T191	-818	Decrease	Forward	TRUE	NA
14455	PC13_train	16158053.s10	When SKBr3 cells were cotransfected with an ARHI/luciferase reporter and E2F-expression vectors, E2F1 and 4 reduced ARHI promoter activity 2-3-fold, and this reduction could be reversed by TSA treatment.	97-101	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	106-107	4	toll-like receptor 4	C1411976	T192|T116	Gene_or_gene_product	189-192	TSA	TSA	C1266025	T191	-694	Decrease	Forward	TRUE	reverse
14456	PC13_train	16158053.s10	When SKBr3 cells were cotransfected with an ARHI/luciferase reporter and E2F-expression vectors, E2F1 and 4 reduced ARHI promoter activity 2-3-fold, and this reduction could be reversed by TSA treatment.	97-101	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	116-120	ARHI	ARHI protein, human	C0763637	T116|T123	Gene_or_gene_product	189-192	TSA	TSA	C1266025	T191	-694	Decrease	Forward	TRUE	reverse
14493	PC13_train	16407284.s3	Here we carry out a detailed comparative analysis of the CN binding activity displayed by the PxIxIT and LxVP sites from different NFATs.	57-59	CN	NYS3 gene	C1417908	T028	Complex	131-136	NFATs	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	57-59	CN	CN	C0221023	T047	-660	Binding	NA	FALSE	NA
14494	PC13_train	16407284.s4	Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that NFATc1 binds CN in vitro more efficiently than does NFATc2.	108-110	CN	NYS3 gene	C1417908	T028	Complex	147-153	NFATc2	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Gene_or_gene_product	108-110	CN	CN	C0221023	T047	-804	Binding	NA	FALSE	NA
14495	PC13_train	16407284.s4	Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that NFATc1 binds CN in vitro more efficiently than does NFATc2.	108-110	CN	NYS3 gene	C1417908	T028	Complex	147-153	NFATc2	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Gene_or_gene_product	14-16	CN	CN	C0221023	T047	-637	Binding	NA	FALSE	NA
14532	PC13_train	16407284.s4	Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that NFATc1 binds CN in vitro more efficiently than does NFATc2.	95-101	NFATc1	Nuclear Factor of Activated T-Cells, Cytoplasmic 1	C2985456	T116	Gene_or_gene_product	108-110	CN	NYS3 gene	C1417908	T028	Complex	108-110	CN	CN	C0221023	T047	-804	Binding	NA	FALSE	NA
14533	PC13_train	16407284.s4	Dose-response CN binding experiments with GST fusion proteins of NFATc1 and NFATc2 showed that NFATc1 binds CN in vitro more efficiently than does NFATc2.	95-101	NFATc1	Nuclear Factor of Activated T-Cells, Cytoplasmic 1	C2985456	T116	Gene_or_gene_product	108-110	CN	NYS3 gene	C1417908	T028	Complex	14-16	CN	CN	C0221023	T047	-637	Binding	NA	FALSE	NA
14538	PC13_train	16407284.s5	This difference in binding appears to be caused by the different CN binding potencies of the corresponding LxVP sites; thus while the LxVPc2 peptide fused to GST did not bind CN, GST-LxVPc1 bound it more efficiently than did GST-PxIxITc1 or GST-PxIxITc2.	134-140	LxVPc2	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	175-177	CN	NYS3 gene	C1417908	T028	Complex	175-177	CN	CN	C0221023	T047	-1000	Binding	NA	FALSE	NA
14539	PC13_train	16407284.s5	This difference in binding appears to be caused by the different CN binding potencies of the corresponding LxVP sites; thus while the LxVPc2 peptide fused to GST did not bind CN, GST-LxVPc1 bound it more efficiently than did GST-PxIxITc1 or GST-PxIxITc2.	134-140	LxVPc2	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	175-177	CN	NYS3 gene	C1417908	T028	Complex	65-67	CN	CN	C0221023	T047	-645	Binding	NA	FALSE	NA
14582	PC13_train	16407284.s6	Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with CN much more potently than did wild-type NFATc2.	16-22	NFATc2	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Gene_or_gene_product	93-95	CN	NYS3 gene	C1417908	T028	Complex	93-95	CN	CN	C0221023	T047	-812	Binding	NA	FALSE	NA
14583	PC13_train	16407284.s6	Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with CN much more potently than did wild-type NFATc2.	16-22	NFATc2	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Gene_or_gene_product	93-95	CN	NYS3 gene	C1417908	T028	Complex	23-30	chimera	Chimera	C1318484	T019	-660	Binding	NA	TRUE	NA
14588	PC13_train	16407284.s6	Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with CN much more potently than did wild-type NFATc2.	93-95	CN	NYS3 gene	C1417908	T028	Complex	134-140	NFATc2	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Gene_or_gene_product	93-95	CN	CN	C0221023	T047	-812	Binding	NA	FALSE	NA
14589	PC13_train	16407284.s6	Furthermore, an NFATc2 chimera protein containing the LxVP motif from NFATc1 interacted with CN much more potently than did wild-type NFATc2.	93-95	CN	NYS3 gene	C1417908	T028	Complex	134-140	NFATc2	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Gene_or_gene_product	23-30	chimera	Chimera	C1318484	T019	-660	Binding	NA	FALSE	NA
14629	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	17-25	PxIxITc2	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	64-68	NFAT	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	61-63	CN	CN	C0221023	T047	-632	Regulation	Forward	FALSE	NA
14630	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	17-25	PxIxITc2	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	64-68	NFAT	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	96-98	CN	CN	C0221023	T047	-660	Regulation	Forward	FALSE	NA
14632	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	17-25	PxIxITc2	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	96-98	CN	NYS3 gene	C1417908	T028	Complex	61-63	CN	CN	C0221023	T047	-632	Decrease	Forward	FALSE	NA
14633	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	17-25	PxIxITc2	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	96-98	CN	NYS3 gene	C1417908	T028	Complex	96-98	CN	CN	C0221023	T047	-660	Decrease	Forward	FALSE	NA
14638	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	31-35	LxVP	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	64-68	NFAT	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	61-63	CN	CN	C0221023	T047	-632	Regulation	Forward	FALSE	NA
14639	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	31-35	LxVP	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	64-68	NFAT	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	96-98	CN	CN	C0221023	T047	-660	Regulation	Forward	FALSE	NA
14641	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	31-35	LxVP	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	96-98	CN	NYS3 gene	C1417908	T028	Complex	61-63	CN	CN	C0221023	T047	-632	Decrease	Forward	FALSE	NA
14642	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	31-35	LxVP	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	96-98	CN	NYS3 gene	C1417908	T028	Complex	96-98	CN	CN	C0221023	T047	-660	Decrease	Forward	FALSE	NA
14644	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	61-63	CN	NYS3 gene	C1417908	T028	Complex	64-68	NFAT	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	61-63	CN	CN	C0221023	T047	-632	Binding	NA	FALSE	NA
14645	PC13_train	16407284.s9	In contrast with PxIxITc2, the LxVP peptide not only blocked CN-NFAT binding but also inhibited CN phosphatase activity in vitro.	61-63	CN	NYS3 gene	C1417908	T028	Complex	64-68	NFAT	NFATC Transcription Factors	C0213011	T116|T123	Gene_or_gene_product	96-98	CN	CN	C0221023	T047	-660	Binding	NA	FALSE	NA
14678	PC13_train	16785567.s1	In this study, we investigated the signaling pathway involved in IL-6 production caused by peptidoglycan (PGN), a cell wall component of the Gram-positive bacterium, Staphylococcus aureus, in RAW 264.7 macrophages.	65-69	IL-6	Interleukin-6	C0021760	T116|T129	Gene_or_gene_product	106-109	PGN	Peptidoglycan	C0030958	T109|T123	Simple_chemical	166-187	Staphylococcus aureus	Staphylococcus aureus NOS	C1318973	T047	-1000	Increase	Backward	FALSE	NA
14680	PC13_train	16785567.s1	In this study, we investigated the signaling pathway involved in IL-6 production caused by peptidoglycan (PGN), a cell wall component of the Gram-positive bacterium, Staphylococcus aureus, in RAW 264.7 macrophages.	65-69	IL-6	Interleukin-6	C0021760	T116|T129	Gene_or_gene_product	91-104	peptidoglycan	Peptidoglycan	C0030958	T109|T123	Simple_chemical	166-187	Staphylococcus aureus	Staphylococcus aureus NOS	C1318973	T047	-1000	Increase	Backward	FALSE	NA
14686	PC13_train	16861226.s6	In addition, a gin4 mutant lacking the Elm1-dependent phosphorylation sites exhibited an impaired localization to the bud-neck and, as a result, induced a significant growth defect with an elongated bud morphology.	15-19	gin4	GIN4 protein, S cerevisiae	C1449110	T116|T126	Gene_or_gene_product	39-43	Elm1	ELM1 protein, S cerevisiae	C0916016	T116|T126	Gene_or_gene_product	20-26	mutant	Mutant	C0596988	T049	-660	Regulation	Backward	TRUE	NA
14718	PC13_train	17122856.s6	Furthermore, severe defects in cell division occur in the absence of Cdc5p-mediated phosphorylation of Ndd1p.	69-74	Cdc5p	CDC5 protein, S cerevisiae	C0527697	T116|T126	Gene_or_gene_product	103-108	Ndd1p	NDD1 protein, S cerevisiae	C1431824	T116|T123	Gene_or_gene_product	58-65	absence	Absence	C1689985	T190	-1000	Regulation	Forward	FALSE	NA
14735	PC13_train	17234339.s0	Suppression of p53-activated gene, PAG608, attenuates methamphetamine-induced neurotoxicity.	15-18	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	35-41	PAG608	PAG608 protein, rat	C1430892	T116|T123	Gene_or_gene_product	0-11	Suppression	Suppression	C0221103	T046	-1000	Increase	Forward	FALSE	NA
14736	PC13_train	17234339.s0	Suppression of p53-activated gene, PAG608, attenuates methamphetamine-induced neurotoxicity.	15-18	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	35-41	PAG608	PAG608 protein, rat	C1430892	T116|T123	Gene_or_gene_product	78-91	neurotoxicity	Neurotoxicity	C0235032	T037	-827	Increase	Forward	FALSE	NA
14849	PC13_train	17277771.s5	PRAS40 binds the mTOR kinase domain and its interaction with mTOR is induced under conditions that inhibit mTOR signalling, such as nutrient or serum deprivation or mitochondrial metabolic inhibition.	0-6	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	17-21	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	83-93	conditions	condition	C0012634	T047	-966	Binding	NA	TRUE	NA
14853	PC13_train	17277771.s5	PRAS40 binds the mTOR kinase domain and its interaction with mTOR is induced under conditions that inhibit mTOR signalling, such as nutrient or serum deprivation or mitochondrial metabolic inhibition.	0-6	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	61-65	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	83-93	conditions	condition	C0012634	T047	-966	Binding	NA	TRUE	NA
15122	PC13_train	17332736.s0	Phosphoinositide 3-kinase is required for high glucose-induced hypertrophy and p21WAF1 expression in LLC-PK1 cells.	0-25	Phosphoinositide 3-kinase	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	79-86	p21WAF1	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	63-74	hypertrophy	HYPERTROPHY	C0020564	T046	-812	Increase	Forward	FALSE	NA
15123	PC13_train	17332736.s0	Phosphoinositide 3-kinase is required for high glucose-induced hypertrophy and p21WAF1 expression in LLC-PK1 cells.	47-54	glucose	Glucose	C0017725	T109|T121|T123	Simple_chemical	79-86	p21WAF1	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	63-74	hypertrophy	HYPERTROPHY	C0020564	T046	-812	Increase	Forward	FALSE	NA
15178	PC13_train	17332736.s5	LY294002 (a PI3K inhibitor) attenuated high glucose-induced cell cycle-dependent (G(0)/G(1) phase) hypertrophy at 72 h while attenuating high glucose-induced p21(WAF1) gene transcription and protein expression at 36-48 h.	0-8	LY294002	LY 294002	C0251991	T109|T121	Simple_chemical	158-161	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	99-110	hypertrophy	HYPERTROPHY	C0020564	T046	-1000	Decrease	Forward	FALSE	NA
15179	PC13_train	17332736.s5	LY294002 (a PI3K inhibitor) attenuated high glucose-induced cell cycle-dependent (G(0)/G(1) phase) hypertrophy at 72 h while attenuating high glucose-induced p21(WAF1) gene transcription and protein expression at 36-48 h.	0-8	LY294002	LY 294002	C0251991	T109|T121	Simple_chemical	162-166	WAF1	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	99-110	hypertrophy	HYPERTROPHY	C0020564	T046	-1000	Decrease	Forward	FALSE	NA
15185	PC13_train	17332736.s5	LY294002 (a PI3K inhibitor) attenuated high glucose-induced cell cycle-dependent (G(0)/G(1) phase) hypertrophy at 72 h while attenuating high glucose-induced p21(WAF1) gene transcription and protein expression at 36-48 h.	142-149	glucose	Glucose	C0017725	T109|T121|T123	Simple_chemical	158-161	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	99-110	hypertrophy	HYPERTROPHY	C0020564	T046	-1000	Increase	Forward	FALSE	NA
15186	PC13_train	17332736.s5	LY294002 (a PI3K inhibitor) attenuated high glucose-induced cell cycle-dependent (G(0)/G(1) phase) hypertrophy at 72 h while attenuating high glucose-induced p21(WAF1) gene transcription and protein expression at 36-48 h.	142-149	glucose	Glucose	C0017725	T109|T121|T123	Simple_chemical	162-166	WAF1	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	99-110	hypertrophy	HYPERTROPHY	C0020564	T046	-1000	Increase	Forward	FALSE	NA
15192	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	134-137	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	159-172	cyclin E/cdk2	cyclin E1-CDK2 complex	C3269081	T026	Complex	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Binding	NA	FALSE	NA
15195	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	138-142	WAF1	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	159-172	cyclin E/cdk2	cyclin E1-CDK2 complex	C3269081	T026	Complex	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Binding	NA	FALSE	NA
15202	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	18-22	PI3K	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	159-172	cyclin E/cdk2	cyclin E1-CDK2 complex	C3269081	T026	Complex	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Regulation	Forward	FALSE	NA
15203	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	18-22	PI3K	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	182-190	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Gene_or_gene_product	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Increase	Forward	FALSE	NA
15204	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	18-22	PI3K	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	208-215	Smad2/3	SMAD2-SMAD3-SMAD4 protein complex	C4690230	T026	Gene_or_gene_product	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Increase	Forward	FALSE	NA
15206	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	18-22	PI3K	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	94-97	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Increase	Forward	FALSE	NA
15207	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	18-22	PI3K	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	98-102	WAF1	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Increase	Forward	FALSE	NA
15211	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	44-51	glucose	Glucose	C0017725	T109|T121|T123	Simple_chemical	159-172	cyclin E/cdk2	cyclin E1-CDK2 complex	C3269081	T026	Complex	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Regulation	Forward	FALSE	NA
15212	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	44-51	glucose	Glucose	C0017725	T109|T121|T123	Simple_chemical	182-190	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Gene_or_gene_product	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Increase	Forward	FALSE	NA
15213	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	44-51	glucose	Glucose	C0017725	T109|T121|T123	Simple_chemical	208-215	Smad2/3	SMAD2-SMAD3-SMAD4 protein complex	C4690230	T026	Gene_or_gene_product	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Increase	Forward	FALSE	NA
15214	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	44-51	glucose	Glucose	C0017725	T109|T121|T123	Simple_chemical	94-97	p21	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Increase	Forward	FALSE	NA
15215	PC13_train	17332736.s7	We concluded that PI3K is required for high glucose-induced cell cycle-dependent hypertrophy, p21(WAF1) transcription and expression, p21(WAF1) binding to the cyclin E/cdk2 complex, TGF-beta bioactivity, and Smad2/3 activity in LLC-PK1 cells.	44-51	glucose	Glucose	C0017725	T109|T121|T123	Simple_chemical	98-102	WAF1	oncoprotein p21	C0288472	T116|T123	Gene_or_gene_product	81-92	hypertrophy	HYPERTROPHY	C0020564	T046	-795	Increase	Forward	FALSE	NA
15228	PC13_train	17346240.s3	The last few years have seen a remarkable increase in our understanding of the canonical, growth factor-regulated pathway for mTOR activation, which is mediated by the class I PI3Ks (phosphoinositide 3-kinases), PKB (protein kinase B), TSC1/2 (the tuberous sclerosis complex) and the small GTPase, Rheb.	126-130	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	168-181	class I PI3Ks	Class I Phosphatidylinositol 3-Kinases	C2936422	T116|T126	Gene_or_gene_product	248-274	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-1000	Regulation	Backward	FALSE	NA
15229	PC13_train	17346240.s3	The last few years have seen a remarkable increase in our understanding of the canonical, growth factor-regulated pathway for mTOR activation, which is mediated by the class I PI3Ks (phosphoinositide 3-kinases), PKB (protein kinase B), TSC1/2 (the tuberous sclerosis complex) and the small GTPase, Rheb.	126-130	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	183-209	phosphoinositide 3-kinases	Phosphatidylinositol 3-Kinases	C2936824	T116|T126	Gene_or_gene_product	248-274	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-1000	Regulation	Backward	FALSE	NA
15230	PC13_train	17346240.s3	The last few years have seen a remarkable increase in our understanding of the canonical, growth factor-regulated pathway for mTOR activation, which is mediated by the class I PI3Ks (phosphoinositide 3-kinases), PKB (protein kinase B), TSC1/2 (the tuberous sclerosis complex) and the small GTPase, Rheb.	126-130	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	212-215	PKB	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Gene_or_gene_product	248-274	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-1000	Regulation	Backward	FALSE	NA
15231	PC13_train	17346240.s3	The last few years have seen a remarkable increase in our understanding of the canonical, growth factor-regulated pathway for mTOR activation, which is mediated by the class I PI3Ks (phosphoinositide 3-kinases), PKB (protein kinase B), TSC1/2 (the tuberous sclerosis complex) and the small GTPase, Rheb.	126-130	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	217-233	protein kinase B	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Gene_or_gene_product	248-274	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-1000	Regulation	Backward	FALSE	NA
15232	PC13_train	17346240.s3	The last few years have seen a remarkable increase in our understanding of the canonical, growth factor-regulated pathway for mTOR activation, which is mediated by the class I PI3Ks (phosphoinositide 3-kinases), PKB (protein kinase B), TSC1/2 (the tuberous sclerosis complex) and the small GTPase, Rheb.	126-130	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	236-240	TSC1	TSC1 protein, human	C0663937	T116|T123	Complex	248-274	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-1000	Regulation	Backward	FALSE	NA
15233	PC13_train	17346240.s3	The last few years have seen a remarkable increase in our understanding of the canonical, growth factor-regulated pathway for mTOR activation, which is mediated by the class I PI3Ks (phosphoinositide 3-kinases), PKB (protein kinase B), TSC1/2 (the tuberous sclerosis complex) and the small GTPase, Rheb.	126-130	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	248-274	tuberous sclerosis complex	TSC1-TSC2 complex location	C2247022	T026	Complex	248-274	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-1000	Regulation	Backward	FALSE	NA
15235	PC13_train	17346240.s3	The last few years have seen a remarkable increase in our understanding of the canonical, growth factor-regulated pathway for mTOR activation, which is mediated by the class I PI3Ks (phosphoinositide 3-kinases), PKB (protein kinase B), TSC1/2 (the tuberous sclerosis complex) and the small GTPase, Rheb.	126-130	mTOR	FKBP12-rapamycin associated protein	C0293060	T116|T123	Gene_or_gene_product	298-302	Rheb	Ras Homolog Enriched in Brain Protein	C4505340	T116|T123	Gene_or_gene_product	248-274	tuberous sclerosis complex	TUBEROUS SCLEROSIS COMPLEX	C0041341	T191	-1000	Regulation	Backward	FALSE	NA
15279	PC13_train	17346240.s8	Indeed, MAP4K3 is required for phosphorylation of known mTOR targets such as S6K1 (S6 kinase 1), and overexpression of MAP4K3 promotes the rapamycin-sensitive phosphorylation of these same targets.	77-81	S6K1	Ribosomal Protein S6 Kinase Beta-1	C2827383	T116|T126	Gene_or_gene_product	139-148	rapamycin	Sirolimus	C0072980	T109|T195	Simple_chemical	149-158	sensitive	Sensitive	C0020517	T046	-660	Regulation	Backward	FALSE	NA
15287	PC13_train	17346240.s8	Indeed, MAP4K3 is required for phosphorylation of known mTOR targets such as S6K1 (S6 kinase 1), and overexpression of MAP4K3 promotes the rapamycin-sensitive phosphorylation of these same targets.	83-94	S6 kinase 1	Ribosomal Protein S6 Kinase	C0073337	T116|T126	Gene_or_gene_product	139-148	rapamycin	Sirolimus	C0072980	T109|T195	Simple_chemical	149-158	sensitive	Sensitive	C0020517	T046	-660	Regulation	Backward	FALSE	NA
15349	PC13_train	17459880.s8	However, in vivo, we observed a gradient in the abundance of APC-associated Mnd2 in each strain that was proportional to the observed differences in sporulation and Clb5 levels.	61-64	APC	anaphase-promoting complex	C0526999	T116|T126	Complex	76-80	Mnd2	MND2 protein, S cerevisiae	C3711753	T116|T123	Gene_or_gene_product	89-95	strain	Strain	C0080194	T037	-1000	Binding	NA	TRUE	NA
15359	PC13_train	17471234.s11	Our study demonstrates that E2F-1 mediates apoptosis through transcriptional regulation of PAC1 and subsequent suppression of the ERK signaling.	28-33	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	91-95	PAC1	Procaspase Activating Compound-1 VO-100	C3889731	T109|T121	Gene_or_gene_product	111-122	suppression	Suppression	C0221103	T046	-861	Regulation	Forward	FALSE	NA
15361	PC13_train	17471234.s7	E2F-1 suppresses extracellular signal-regulated kinase (ERK) phosphorylation through PAC1 and causes cancer cell death by apoptosis following treatment with a chemotherapeutic agent N-4-hydroxyphenylretinamide (4-HPR).	0-5	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	17-54	extracellular signal-regulated kinase	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	101-107	cancer	CANCER	C0006826	T191	-660	Regulation	Forward	FALSE	NA
15362	PC13_train	17471234.s7	E2F-1 suppresses extracellular signal-regulated kinase (ERK) phosphorylation through PAC1 and causes cancer cell death by apoptosis following treatment with a chemotherapeutic agent N-4-hydroxyphenylretinamide (4-HPR).	0-5	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	17-54	extracellular signal-regulated kinase	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	101-107	cancer	Cancer	C1306459	T191	-660	Regulation	Forward	FALSE	NA
15367	PC13_train	17471234.s7	E2F-1 suppresses extracellular signal-regulated kinase (ERK) phosphorylation through PAC1 and causes cancer cell death by apoptosis following treatment with a chemotherapeutic agent N-4-hydroxyphenylretinamide (4-HPR).	0-5	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	56-59	ERK	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	101-107	cancer	CANCER	C0006826	T191	-660	Regulation	Forward	FALSE	NA
15368	PC13_train	17471234.s7	E2F-1 suppresses extracellular signal-regulated kinase (ERK) phosphorylation through PAC1 and causes cancer cell death by apoptosis following treatment with a chemotherapeutic agent N-4-hydroxyphenylretinamide (4-HPR).	0-5	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Gene_or_gene_product	56-59	ERK	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	101-107	cancer	Cancer	C1306459	T191	-660	Regulation	Forward	FALSE	NA
15395	PC13_train	17504936.s0	Ipl1p-dependent phosphorylation of Mad3p is required for the spindle checkpoint response to lack of tension at kinetochores.	0-5	Ipl1p	Aurora Kinase B	C1439287	T116|T126	Gene_or_gene_product	35-40	Mad3p	MAD3 protein, S cerevisiae	C0913599	T116	Gene_or_gene_product	100-107	tension	Tension	C0233494	T048	-1000	Regulation	Forward	FALSE	NA
15411	PC13_train	17504936.s5	Our data provide strong evidence for a distinct checkpoint pathway responding to lack of sister kinetochore tension, in which Ipl1p-dependent phosphorylation of Mad3p is a key step.	126-131	Ipl1p	Aurora Kinase B	C1439287	T116|T126	Gene_or_gene_product	161-166	Mad3p	MAD3 protein, S cerevisiae	C0913599	T116	Gene_or_gene_product	108-115	tension	Tension	C0233494	T048	-827	Regulation	Forward	FALSE	NA
15529	PC13_train	17604271.s7	Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and stimulated by Rheb in a rapamycin-sensitive manner.	11-17	PRAS40	AKT1S1 protein, human	C1450880	T116|T123	Gene_or_gene_product	21-27	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	130-139	sensitive	Sensitive	C0020517	T046	-660	Binding	NA	FALSE	NA
15534	PC13_train	17604271.s7	Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and stimulated by Rheb in a rapamycin-sensitive manner.	21-27	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	110-114	Rheb	Ras Homolog Enriched in Brain Protein	C4505340	T116|T123	Gene_or_gene_product	130-139	sensitive	Sensitive	C0020517	T046	-660	Regulation	Backward	FALSE	NA
15535	PC13_train	17604271.s7	Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and stimulated by Rheb in a rapamycin-sensitive manner.	21-27	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	120-129	rapamycin	Sirolimus	C0072980	T109|T195	Simple_chemical	130-139	sensitive	Sensitive	C0020517	T046	-660	Regulation	Backward	FALSE	NA
15536	PC13_train	17604271.s7	Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and stimulated by Rheb in a rapamycin-sensitive manner.	21-27	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	53-57	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	130-139	sensitive	Sensitive	C0020517	T046	-660	Regulation	Backward	FALSE	NA
15537	PC13_train	17604271.s7	Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and stimulated by Rheb in a rapamycin-sensitive manner.	21-27	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	58-59	2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	130-139	sensitive	Sensitive	C0020517	T046	-660	Regulation	Backward	FALSE	NA
15542	PC13_train	17604271.s7	Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and stimulated by Rheb in a rapamycin-sensitive manner.	53-57	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	84-90	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	130-139	sensitive	Sensitive	C0020517	T046	-660	Decrease	Forward	FALSE	NA
15545	PC13_train	17604271.s7	Binding of PRAS40 to 14-3-3 proteins is inhibited by TSC1/2 (negative regulators of mTORC1) and stimulated by Rheb in a rapamycin-sensitive manner.	58-59	2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	84-90	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	130-139	sensitive	Sensitive	C0020517	T046	-660	Decrease	Forward	FALSE	NA
15551	PC13_train	17652458.s6	Neither conditional alleles nor mutants of BIR1 that disrupt the interaction between Bir1p and Sli15p resulted in mono-attached kinetochores, suggesting that the Bir1p-Sli15p complex functions in anaphase and independently from Sli15p-Ipl1p complexes.	43-47	BIR1	Bir1 protein, S cerevisiae	C2744298	T116|T123	Gene_or_gene_product	128-140	kinetochores	Kinetochores	C0242609	T026	Cellular_component	32-39	mutants	mutants	C0596988	T049	-1000	Increase	Forward	FALSE	NA
15555	PC13_train	17652458.s6	Neither conditional alleles nor mutants of BIR1 that disrupt the interaction between Bir1p and Sli15p resulted in mono-attached kinetochores, suggesting that the Bir1p-Sli15p complex functions in anaphase and independently from Sli15p-Ipl1p complexes.	43-47	BIR1	Bir1 protein, S cerevisiae	C2744298	T116|T123	Gene_or_gene_product	95-101	Sli15p	Sli15 protein, S cerevisiae	C1433257	T116	Gene_or_gene_product	32-39	mutants	mutants	C0596988	T049	-1000	Regulation	Forward	FALSE	NA
15559	PC13_train	17652458.s6	Neither conditional alleles nor mutants of BIR1 that disrupt the interaction between Bir1p and Sli15p resulted in mono-attached kinetochores, suggesting that the Bir1p-Sli15p complex functions in anaphase and independently from Sli15p-Ipl1p complexes.	85-90	Bir1p	Bir1 protein, S cerevisiae	C2744298	T116|T123	Gene_or_gene_product	95-101	Sli15p	Sli15 protein, S cerevisiae	C1433257	T116	Gene_or_gene_product	32-39	mutants	mutants	C0596988	T049	-1000	Binding	NA	FALSE	NA
15575	PC13_train	17693255.s0	IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.	0-8	IKK beta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	24-28	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	35-47	inflammation	INFLAMMATION	C0021368	T046	-1000	Decrease	Forward	FALSE	NA
15576	PC13_train	17693255.s0	IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.	0-8	IKK beta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	24-28	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	9-20	suppression	Suppression	C0221103	T046	-827	Decrease	Forward	FALSE	NA
15577	PC13_train	17693255.s0	IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.	0-8	IKK beta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	24-28	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	52-70	tumor angiogenesis	Tumor Angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
15578	PC13_train	17693255.s0	IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.	0-8	IKK beta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	24-28	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	52-70	tumor angiogenesis	Tumour angiogenesis	C1537032	T191	-1000	Decrease	Forward	FALSE	NA
15611	PC13_train	17693255.s3	Here we show that IKKbeta, a major downstream kinase in the TNFalpha signaling pathway, physically interacts with and phosphorylates TSC1 at Ser487 and Ser511, resulting in suppression of TSC1.	18-25	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	133-137	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	173-184	suppression	Suppression	C0221103	T046	-1000	Binding	NA	FALSE	NA
15614	PC13_train	17693255.s3	Here we show that IKKbeta, a major downstream kinase in the TNFalpha signaling pathway, physically interacts with and phosphorylates TSC1 at Ser487 and Ser511, resulting in suppression of TSC1.	18-25	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	188-192	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	173-184	suppression	Suppression	C0221103	T046	-1000	Regulation	Forward	FALSE	NA
15623	PC13_train	17693255.s4	The IKKbeta-mediated TSC1 suppression activates the mTOR pathway, enhances angiogenesis, and results in tumor development.	4-11	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	21-25	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	75-87	angiogenesis	angiogenesis	C1519670	T191	-1000	Decrease	Forward	FALSE	NA
15624	PC13_train	17693255.s4	The IKKbeta-mediated TSC1 suppression activates the mTOR pathway, enhances angiogenesis, and results in tumor development.	4-11	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	21-25	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	26-37	suppression	Suppression	C0221103	T046	-812	Decrease	Forward	FALSE	NA
15625	PC13_train	17693255.s4	The IKKbeta-mediated TSC1 suppression activates the mTOR pathway, enhances angiogenesis, and results in tumor development.	4-11	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Gene_or_gene_product	21-25	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	104-109	tumor	Tumour NOS	C0027651	T191	-694	Decrease	Forward	FALSE	NA
15737	PC13_train	18092340.s2	Exposure to chlorambucil, fludarabine, and Nutlin-3 induced p53 accumulation and variably affected cell cycle progression in SKW6.4 lymphoblastoid cells.	12-24	chlorambucil	Chlorambucil	C0008163	T109|T121	Simple_chemical	60-63	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	0-8	Exposure	Exposure NOS	C0274281	T037	-1000	Increase	Forward	FALSE	NA
15739	PC13_train	18092340.s2	Exposure to chlorambucil, fludarabine, and Nutlin-3 induced p53 accumulation and variably affected cell cycle progression in SKW6.4 lymphoblastoid cells.	26-37	fludarabine	fludarabine	C0059985	T114|T121	Simple_chemical	60-63	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	0-8	Exposure	Exposure NOS	C0274281	T037	-1000	Increase	Forward	FALSE	NA
15740	PC13_train	18092340.s2	Exposure to chlorambucil, fludarabine, and Nutlin-3 induced p53 accumulation and variably affected cell cycle progression in SKW6.4 lymphoblastoid cells.	43-51	Nutlin-3	nutlin 3	C1435338	T109	Simple_chemical	60-63	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	0-8	Exposure	Exposure NOS	C0274281	T037	-1000	Increase	Forward	FALSE	NA
15756	PC13_train	18198340.s0	Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling.	70-75	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	85-91	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	0-7	Hypoxia	HYPOXIA	C0242184	T046	-1000	Regulation	Forward	TRUE	NA
15758	PC13_train	18198340.s2	Genetic studies have shown the tuberous sclerosis tumor suppressors TSC1/2 and the REDD1 protein to be essential for hypoxia regulation of TORC1 activity in Drosophila and in mammalian cells.	68-72	TSC1	TSC1 protein, human	C0663937	T116|T123	Gene_or_gene_product	139-144	TORC1	TOR complex 1	C3152111	T026	Gene_or_gene_product	117-124	hypoxia	HYPOXIA	C0242184	T046	-694	Regulation	Forward	FALSE	NA
15761	PC13_train	18198340.s2	Genetic studies have shown the tuberous sclerosis tumor suppressors TSC1/2 and the REDD1 protein to be essential for hypoxia regulation of TORC1 activity in Drosophila and in mammalian cells.	73-74	2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	139-144	TORC1	TOR complex 1	C3152111	T026	Gene_or_gene_product	117-124	hypoxia	HYPOXIA	C0242184	T046	-694	Regulation	Forward	FALSE	NA
15763	PC13_train	18198340.s2	Genetic studies have shown the tuberous sclerosis tumor suppressors TSC1/2 and the REDD1 protein to be essential for hypoxia regulation of TORC1 activity in Drosophila and in mammalian cells.	83-88	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	139-144	TORC1	TOR complex 1	C3152111	T026	Gene_or_gene_product	117-124	hypoxia	HYPOXIA	C0242184	T046	-694	Regulation	Forward	FALSE	NA
15765	PC13_train	18198340.s4	Here, we demonstrate that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing TSC2 from its growth factor-induced association with inhibitory 14-3-3 proteins.	100-104	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	164-170	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	26-33	hypoxia	HYPOXIA	C0242184	T046	-1000	Binding	NA	TRUE	NA
15771	PC13_train	18198340.s4	Here, we demonstrate that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing TSC2 from its growth factor-induced association with inhibitory 14-3-3 proteins.	38-43	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	53-68	mammalian TORC1	TOR complex 1	C3152111	T026	Complex	26-33	hypoxia	HYPOXIA	C0242184	T046	-1000	Decrease	Forward	FALSE	NA
15773	PC13_train	18198340.s4	Here, we demonstrate that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing TSC2 from its growth factor-induced association with inhibitory 14-3-3 proteins.	38-43	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	70-76	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	26-33	hypoxia	HYPOXIA	C0242184	T046	-1000	Decrease	Forward	FALSE	NA
15788	PC13_train	18198340.s5	Endogenous REDD1 is required for both dissociation of endogenous TSC2/14-3-3 and inhibition of mTORC1 in response to hypoxia.	11-16	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	95-101	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	38-50	dissociation	Dissociation	C0086168	T048	-1000	Decrease	Forward	FALSE	NA
15789	PC13_train	18198340.s5	Endogenous REDD1 is required for both dissociation of endogenous TSC2/14-3-3 and inhibition of mTORC1 in response to hypoxia.	11-16	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	95-101	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	117-124	hypoxia	HYPOXIA	C0242184	T046	-1000	Decrease	Forward	TRUE	NA
15813	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	0-5	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	32-38	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	78-90	dissociation	Dissociation	C0086168	T048	-799	Binding	NA	FALSE	NA
15814	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	0-5	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	32-38	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	173-180	hypoxia	HYPOXIA	C0242184	T046	-694	Binding	NA	FALSE	NA
15815	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	0-5	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	32-38	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	125-132	mutants	mutants	C0596988	T049	-861	Binding	NA	FALSE	NA
15816	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	0-5	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	32-38	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	6-13	mutants	mutants	C0596988	T049	-861	Binding	NA	TRUE	reverse
15825	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	0-5	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	95-101	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	78-90	dissociation	Dissociation	C0086168	T048	-799	Decrease	Forward	FALSE	NA
15826	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	0-5	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	95-101	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	173-180	hypoxia	HYPOXIA	C0242184	T046	-694	Decrease	Forward	FALSE	NA
15827	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	0-5	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	95-101	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	125-132	mutants	mutants	C0596988	T049	-861	Decrease	Forward	FALSE	NA
15828	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	0-5	REDD1	DDIT4 gene	C1428430	T028	Gene_or_gene_product	95-101	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	6-13	mutants	mutants	C0596988	T049	-861	Decrease	Forward	TRUE	reverse
15831	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	120-124	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	150-156	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	78-90	dissociation	Dissociation	C0086168	T048	-799	Binding	NA	FALSE	NA
15832	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	120-124	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	150-156	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	173-180	hypoxia	HYPOXIA	C0242184	T046	-694	Binding	NA	FALSE	NA
15833	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	120-124	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	150-156	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	125-132	mutants	mutants	C0596988	T049	-861	Binding	NA	TRUE	reverse
15834	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	120-124	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	150-156	14-3-3	14-3-3 Proteins	C0090388	T116|T123	Gene_or_gene_product	6-13	mutants	mutants	C0596988	T049	-861	Binding	NA	FALSE	NA
15837	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	120-124	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	194-200	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	78-90	dissociation	Dissociation	C0086168	T048	-799	Regulation	Forward	FALSE	NA
15838	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	120-124	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	194-200	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	173-180	hypoxia	HYPOXIA	C0242184	T046	-694	Regulation	Forward	FALSE	NA
15839	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	120-124	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	194-200	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	125-132	mutants	mutants	C0596988	T049	-861	Regulation	Forward	TRUE	reverse
15840	PC13_train	18198340.s6	REDD1 mutants that fail to bind 14-3-3 are defective in eliciting TSC2/14-3-3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1.	120-124	TSC2	tuberous sclerosis complex 2 protein	C0291147	T116|T123	Gene_or_gene_product	194-200	mTORC1	mechanistic target of rapamycin complex 1	C3888046	T116	Complex	6-13	mutants	mutants	C0596988	T049	-861	Regulation	Forward	FALSE	NA
15926	PC13_train	18310316.s0	Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin.	35-38	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	119-128	cisplatin	Cisplatin	C0008838	T121|T197	Simple_chemical	62-70	melanoma	MELANOMA	C0025202	T191	-660	Increase	Backward	FALSE	NA
15962	PC13_train	18310316.s3	We therefore examined whether p53 isoforms were present in melanoma and whether they may contribute to aberrant p53 function in melanoma.	30-33	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	112-115	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	128-136	melanoma	MELANOMA	C0025202	T191	-1000	Regulation	Forward	FALSE	negation
15963	PC13_train	18310316.s3	We therefore examined whether p53 isoforms were present in melanoma and whether they may contribute to aberrant p53 function in melanoma.	30-33	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	112-115	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	59-67	melanoma	MELANOMA	C0025202	T191	-1000	Regulation	Forward	FALSE	NA
15986	PC13_train	18409048.s0	Inhibitory effect of citral on NO production by suppression of iNOS expression and NF-kappa B activation in RAW264.7 cells.	21-27	citral	citral	C0055809	T109|T121	Simple_chemical	63-67	iNOS	Nitric Oxide Synthase Type II	C1533698	T116|T126	Gene_or_gene_product	48-59	suppression	Suppression	C0221103	T046	-1000	Regulation	Forward	FALSE	NA
15987	PC13_train	18409048.s0	Inhibitory effect of citral on NO production by suppression of iNOS expression and NF-kappa B activation in RAW264.7 cells.	21-27	citral	citral	C0055809	T109|T121	Simple_chemical	83-93	NF-kappa B	NF-kappa B	C0079904	T116|T129	Complex	48-59	suppression	Suppression	C0221103	T046	-1000	Regulation	Forward	FALSE	NA
16062	PC13_train	18710949.s13	Constitutive activation of PKB and Abl or Src family kinases in cancers would drive p27 phosphorylation, increase cyclin D1-Cdk4 assembly and activation, and reduce the cyclin E-Cdk2 inhibitory function of p27.	169-182	cyclin E-Cdk2	cyclin E1-CDK2 complex	C3269081	T026	Complex	206-209	p27	cyclin-dependent kinase inhibitor 1B	C0169665	T116|T123	Gene_or_gene_product	64-71	cancers	Cancer	C1306459	T191	-1000	Decrease	Backward	TRUE	reverse
16063	PC13_train	18710949.s13	Constitutive activation of PKB and Abl or Src family kinases in cancers would drive p27 phosphorylation, increase cyclin D1-Cdk4 assembly and activation, and reduce the cyclin E-Cdk2 inhibitory function of p27.	169-182	cyclin E-Cdk2	cyclin E1-CDK2 complex	C3269081	T026	Complex	206-209	p27	cyclin-dependent kinase inhibitor 1B	C0169665	T116|T123	Gene_or_gene_product	64-71	cancers	Cancers	C0006826	T191	-1000	Decrease	Backward	TRUE	reverse
16115	PC13_train	18710949.s6	Mutant p27 allele products lacking phosphorylation at T157 and T198 bound poorly to cellular cyclin D1 and Cdk4.	7-10	p27	cyclin-dependent kinase inhibitor 1B	C0169665	T116|T123	Gene_or_gene_product	107-111	Cdk4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	0-6	Mutant	Mutant	C0596988	T049	-645	Binding	NA	TRUE	NA
16118	PC13_train	18710949.s6	Mutant p27 allele products lacking phosphorylation at T157 and T198 bound poorly to cellular cyclin D1 and Cdk4.	7-10	p27	cyclin-dependent kinase inhibitor 1B	C0169665	T116|T123	Gene_or_gene_product	93-102	cyclin D1	Cyclin D1	C0174680	T116|T123	Gene_or_gene_product	0-6	Mutant	Mutant	C0596988	T049	-645	Binding	NA	TRUE	NA
16447	PC13_train	19374191.s4	We have also shown that Tax, the HTLV-1-encoded potent transcriptional activator, strongly induces the expression of CCL22, a CCR4 ligand, which promotes the cell-dependent transmission of HTLV-1 from HTLV-1-infected T cells to CCR4+ target T cells by inducing close cell-to-cell interactions.	24-27	Tax	Paclitaxel	C0144576	T109|T121	Gene_or_gene_product	117-122	CCL22	CCL22 protein, human	C0674299	T116|T129	Gene_or_gene_product	173-185	transmission	Transmission	C0242781	T046	-827	Increase	Forward	FALSE	NA
16448	PC13_train	19374191.s4	We have also shown that Tax, the HTLV-1-encoded potent transcriptional activator, strongly induces the expression of CCL22, a CCR4 ligand, which promotes the cell-dependent transmission of HTLV-1 from HTLV-1-infected T cells to CCR4+ target T cells by inducing close cell-to-cell interactions.	24-27	Tax	Paclitaxel	C0144576	T109|T121	Gene_or_gene_product	126-130	CCR4	C-C Chemokine Receptor Type 4, human	C4284283	T116|T192	Gene_or_gene_product	173-185	transmission	Transmission	C0242781	T046	-827	Increase	Forward	FALSE	NA
16452	PC13_train	19376776.s11	Taken together, Notch1 signaling sensitizes TRAIL-induced apoptosis in HCC cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.	147-150	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	161-164	DR5	TNFRSF10B protein, human	C1527752	T116|T192	Gene_or_gene_product	71-74	HCC	HCC	C2239176	T191	-694	Increase	Forward	TRUE	NA
16464	PC13_train	19376776.s11	Taken together, Notch1 signaling sensitizes TRAIL-induced apoptosis in HCC cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.	95-98	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Gene_or_gene_product	113-116	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	71-74	HCC	HCC	C2239176	T191	-694	Decrease	Forward	TRUE	NA
16468	PC13_train	19376776.s11	Taken together, Notch1 signaling sensitizes TRAIL-induced apoptosis in HCC cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.	99-103	Hdm2	MDM2 protein, human	C0971008	T116|T123	Gene_or_gene_product	113-116	p53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	71-74	HCC	HCC	C2239176	T191	-694	Decrease	Forward	TRUE	NA
16580	PC13_train	19379726.s0	Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.	0-27	Pyrrolidine dithiocarbamate	pyrrolidine dithiocarbamate	C0163305	T109|T121	Simple_chemical	31-40	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	104-124	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-645	Decrease	Forward	TRUE	NA
16581	PC13_train	19379726.s0	Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.	0-27	Pyrrolidine dithiocarbamate	pyrrolidine dithiocarbamate	C0163305	T109|T121	Simple_chemical	64-69	MMP-1	Interstitial Collagenase	C0127082	T116|T126	Gene_or_gene_product	104-124	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-645	Increase	Forward	TRUE	NA
16582	PC13_train	19379726.s0	Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.	0-27	Pyrrolidine dithiocarbamate	pyrrolidine dithiocarbamate	C0163305	T109|T121	Simple_chemical	74-80	MMP-13	Matrix Metalloproteinase 13	C0255672	T116|T126	Gene_or_gene_product	104-124	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-645	Increase	Forward	TRUE	NA
16596	PC13_train	19379726.s2	The objective of this study was to determine the effects of the NF-kappaB inhibitor pyrrolidine dithiocarbamate (PDTC) on the expression of MMPs in IL-1beta-stimulated fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis patients.	113-117	PDTC	prolinedithiocarbamate	C0084183	T109|T121	Simple_chemical	140-144	MMPs	Matrix Metalloproteinases	C0623362	T116|T126	Gene_or_gene_product	207-227	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-734	Regulation	Forward	FALSE	negation
16599	PC13_train	19379726.s2	The objective of this study was to determine the effects of the NF-kappaB inhibitor pyrrolidine dithiocarbamate (PDTC) on the expression of MMPs in IL-1beta-stimulated fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis patients.	64-73	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	113-117	PDTC	prolinedithiocarbamate	C0084183	T109|T121	Simple_chemical	207-227	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-734	Decrease	Backward	FALSE	negation
16602	PC13_train	19379726.s2	The objective of this study was to determine the effects of the NF-kappaB inhibitor pyrrolidine dithiocarbamate (PDTC) on the expression of MMPs in IL-1beta-stimulated fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis patients.	64-73	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	84-111	pyrrolidine dithiocarbamate	pyrrolidine dithiocarbamate	C0163305	T109|T121	Simple_chemical	207-227	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-734	Decrease	Backward	FALSE	negation
16604	PC13_train	19379726.s2	The objective of this study was to determine the effects of the NF-kappaB inhibitor pyrrolidine dithiocarbamate (PDTC) on the expression of MMPs in IL-1beta-stimulated fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis patients.	84-111	pyrrolidine dithiocarbamate	pyrrolidine dithiocarbamate	C0163305	T109|T121	Simple_chemical	140-144	MMPs	Matrix Metalloproteinases	C0623362	T116|T126	Gene_or_gene_product	207-227	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-734	Regulation	Forward	FALSE	negation
16610	PC13_train	19379726.s5	However, PDTC-mediated repression of IL-6 and VEGF expression was not observed in TNF-alpha-stimulated rheumatoid arthritis FLSs.	9-13	PDTC	prolinedithiocarbamate	C0084183	T109|T121	Simple_chemical	37-41	IL-6	Interleukin-6	C0021760	T116|T129	Gene_or_gene_product	103-123	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-660	Decrease	Forward	FALSE	negation
16611	PC13_train	19379726.s5	However, PDTC-mediated repression of IL-6 and VEGF expression was not observed in TNF-alpha-stimulated rheumatoid arthritis FLSs.	9-13	PDTC	prolinedithiocarbamate	C0084183	T109|T121	Simple_chemical	46-50	VEGF	Vascular Endothelial Growth Factor A	C0078058	T116|T123	Gene_or_gene_product	103-123	rheumatoid arthritis	RHEUMATOID ARTHRITIS	C0003873	T047	-660	Decrease	Forward	FALSE	negation
16755	PC13_train	19837266.s4	To investigate its relevance in childhood acute lymphoblastic leukemia (ALL) susceptibility, we genotyped 114 cases and 414 newborn controls from Wales (UK) for polymorphisms in TP53 (R72P), its negative regulator MDM2 (single-nucleotide polymorphism SNP309, rs2279744), and selected HLA complex genes whose products interact with TP53.	178-182	TP53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	214-218	MDM2	mdm2 protein	C0127306	T116|T123	Gene_or_gene_product	32-70	childhood acute lymphoblastic leukemia	childhood Acute lymphoblastic leukaemia	C0023452	T191	-771	Decrease	Backward	FALSE	negation
16760	PC13_train	19837266.s4	To investigate its relevance in childhood acute lymphoblastic leukemia (ALL) susceptibility, we genotyped 114 cases and 414 newborn controls from Wales (UK) for polymorphisms in TP53 (R72P), its negative regulator MDM2 (single-nucleotide polymorphism SNP309, rs2279744), and selected HLA complex genes whose products interact with TP53.	284-287	HLA	HLA Complex	C4049595	T116|T129	Complex	331-335	TP53	Protein p53	C0080055	T116|T123	Gene_or_gene_product	32-70	childhood acute lymphoblastic leukemia	childhood Acute lymphoblastic leukaemia	C0023452	T191	-771	Binding	NA	FALSE	negation
16808	PC13_train	21042750.s8	Our studies suggest that IRS-2 plays a significant role by activating, at least in part, NF-kappaB via PI3K/Akt pathway in IGF-1-induced responses in breast cancer cells and the crosstalk between nuclear IRS-2 and NF-kappaB might be responsible for transcriptional progression of the breast cancer cells.	204-209	IRS-2	Insulin Receptor Substrate-2 Protein	C0381451	T116|T123	Gene_or_gene_product	214-223	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	265-276	progression	Progression	C0242656	T046	-861	Binding	NA	FALSE	NA
16815	PC13_train	21042750.s8	Our studies suggest that IRS-2 plays a significant role by activating, at least in part, NF-kappaB via PI3K/Akt pathway in IGF-1-induced responses in breast cancer cells and the crosstalk between nuclear IRS-2 and NF-kappaB might be responsible for transcriptional progression of the breast cancer cells.	25-30	IRS-2	Insulin Receptor Substrate-2 Protein	C0381451	T116|T123	Gene_or_gene_product	89-98	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	265-276	progression	Progression	C0242656	T046	-861	Regulation	Forward	FALSE	NA
16832	PC13_train	21078404.s3	Most of the known pathophysiological effects of Ang II are mediated through Ang type1 receptors (AT(1)Rs), and the up-regulation of AT(1)Rs is one of important causes by which Ang II can contribute to cardiovascular diseases.	48-54	Ang II	angiotensin II	C0003009	T116|T123|T121	Gene_or_gene_product	76-95	Ang type1 receptors	Receptor, Angiotensin, Type 1	C0529330	T192|T116	Gene_or_gene_product	201-224	cardiovascular diseases	Cardiovascular Diseases	C0007222	T047	-1000	Regulation	Backward	FALSE	NA
16833	PC13_train	21078404.s3	Most of the known pathophysiological effects of Ang II are mediated through Ang type1 receptors (AT(1)Rs), and the up-regulation of AT(1)Rs is one of important causes by which Ang II can contribute to cardiovascular diseases.	48-54	Ang II	angiotensin II	C0003009	T116|T123|T121	Gene_or_gene_product	76-95	Ang type1 receptors	Receptor, Angiotensin, Type 1	C0529330	T192|T116	Gene_or_gene_product	18-36	pathophysiological	Pathophysiology	C0277785	T046	-589	Regulation	Backward	FALSE	NA
16835	PC13_train	21078404.s3	Most of the known pathophysiological effects of Ang II are mediated through Ang type1 receptors (AT(1)Rs), and the up-regulation of AT(1)Rs is one of important causes by which Ang II can contribute to cardiovascular diseases.	48-54	Ang II	angiotensin II	C0003009	T116|T123|T121	Gene_or_gene_product	97-104	AT(1)Rs	Receptor, Angiotensin, Type 1	C0529330	T192|T116	Gene_or_gene_product	201-224	cardiovascular diseases	Cardiovascular Diseases	C0007222	T047	-1000	Regulation	Backward	FALSE	NA
16836	PC13_train	21078404.s3	Most of the known pathophysiological effects of Ang II are mediated through Ang type1 receptors (AT(1)Rs), and the up-regulation of AT(1)Rs is one of important causes by which Ang II can contribute to cardiovascular diseases.	48-54	Ang II	angiotensin II	C0003009	T116|T123|T121	Gene_or_gene_product	97-104	AT(1)Rs	Receptor, Angiotensin, Type 1	C0529330	T192|T116	Gene_or_gene_product	18-36	pathophysiological	Pathophysiology	C0277785	T046	-589	Regulation	Backward	FALSE	NA
16861	PC13_train	21106746.s0	The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection.	4-23	activator protein 1	Transcription Factor AP-1	C0085828	T116|T123	Complex	171-182	NF-{kappa}B	NF-kappa B	C0079904	T129|T116	Complex	196-211	acute infection	Acute infection	C0275518	T047	-1000	Binding	NA	TRUE	NA
16886	PC13_train	21145111.s1	Interleukin (IL)-23 is an essential cytokine involved in the expansion of a novel CD4(+) T helper subset known as Th17, which has been implicated in the pathogenesis of periodontitis recently.	0-19	Interleukin (IL)-23	interleukin-23	C0963088	T116|T123	Complex	82-85	CD4	CD4 Antigens	C0003323	T116|T129|T192	Gene_or_gene_product	153-165	pathogenesis	Pathogenesis	C0699748	T046	-1000	Increase	Forward	FALSE	NA
16887	PC13_train	21145111.s1	Interleukin (IL)-23 is an essential cytokine involved in the expansion of a novel CD4(+) T helper subset known as Th17, which has been implicated in the pathogenesis of periodontitis recently.	0-19	Interleukin (IL)-23	interleukin-23	C0963088	T116|T123	Complex	82-85	CD4	CD4 Antigens	C0003323	T116|T129|T192	Gene_or_gene_product	169-182	periodontitis	PERIODONTITIS	C0031099	T047	-861	Increase	Forward	FALSE	NA
16945	PC13_train	21145111.s9	Taken together, our findings suggest that disruption of the interaction between IL-17 and IL-23 may be a potential therapeutic approach in the treatment of periodontitis.	80-85	IL-17	Interleukin-17	C0384648	T116|T129	Complex	90-95	IL-23	interleukin-23	C0963088	T116|T123	Complex	156-169	periodontitis	PERIODONTITIS	C0031099	T047	-1000	Binding	NA	FALSE	NA
17042	PC13_train	21262351.s8	The N-terminal region of p65 is necessary for both the interaction with Keap1 and its transcriptional suppression activity.	25-28	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	72-77	Keap1	Kelch-Like ECH-Associated Protein 1	C3810577	T116	Gene_or_gene_product	102-113	suppression	Suppression	C0221103	T046	-660	Binding	NA	FALSE	NA
17071	PC13_train	21334713.s8	In conclusion, our results suggest that overexpressions of Forkhead Box M1 transcription factor and nuclear factor-kappaB and the possible interaction between them may play important roles in the development and progression of laryngeal squamous cell carcinoma, and Forkhead Box M1 transcription factor and nuclear factor-kappaB may serve as useful prognostic markers for laryngeal squamous cell carcinoma.	59-74	Forkhead Box M1	Forkhead Box Protein M1	C3539737	T116|T123	Gene_or_gene_product	100-121	nuclear factor-kappaB	NF-kappa B	C0079904	T129|T116	Complex	227-260	laryngeal squamous cell carcinoma	Laryngeal Squamous Cell Carcinoma	C0280324	T191	-1000	Binding	NA	FALSE	NA
17072	PC13_train	21334713.s8	In conclusion, our results suggest that overexpressions of Forkhead Box M1 transcription factor and nuclear factor-kappaB and the possible interaction between them may play important roles in the development and progression of laryngeal squamous cell carcinoma, and Forkhead Box M1 transcription factor and nuclear factor-kappaB may serve as useful prognostic markers for laryngeal squamous cell carcinoma.	59-74	Forkhead Box M1	Forkhead Box Protein M1	C3539737	T116|T123	Gene_or_gene_product	100-121	nuclear factor-kappaB	NF-kappa B	C0079904	T129|T116	Complex	372-405	laryngeal squamous cell carcinoma	Laryngeal Squamous Cell Carcinoma	C0280324	T191	-1000	Binding	NA	FALSE	NA
17073	PC13_train	21334713.s8	In conclusion, our results suggest that overexpressions of Forkhead Box M1 transcription factor and nuclear factor-kappaB and the possible interaction between them may play important roles in the development and progression of laryngeal squamous cell carcinoma, and Forkhead Box M1 transcription factor and nuclear factor-kappaB may serve as useful prognostic markers for laryngeal squamous cell carcinoma.	59-74	Forkhead Box M1	Forkhead Box Protein M1	C3539737	T116|T123	Gene_or_gene_product	100-121	nuclear factor-kappaB	NF-kappa B	C0079904	T129|T116	Complex	212-223	progression	Progression	C0242656	T046	-1000	Binding	NA	FALSE	NA
17080	PC13_train	21346255.s10	Coimmunoprecipitation confirmed that C/EBPalpha, its AML variants, or C/EBPbeta disrupt interaction between p50 and HDACs dependent on the C/EBP basic region.	108-111	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Gene_or_gene_product	116-121	HDACs	Histone Deacetylase	C0019643	T116|T126	Gene_or_gene_product	53-56	AML	AML	C0023467	T191	-694	Binding	NA	FALSE	NA
17084	PC13_train	21346255.s10	Coimmunoprecipitation confirmed that C/EBPalpha, its AML variants, or C/EBPbeta disrupt interaction between p50 and HDACs dependent on the C/EBP basic region.	37-47	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	116-121	HDACs	Histone Deacetylase	C0019643	T116|T126	Gene_or_gene_product	53-56	AML	AML	C0023467	T191	-694	Regulation	Forward	FALSE	NA
17088	PC13_train	21346255.s10	Coimmunoprecipitation confirmed that C/EBPalpha, its AML variants, or C/EBPbeta disrupt interaction between p50 and HDACs dependent on the C/EBP basic region.	70-79	C/EBPbeta	CCAAT-Enhancer-Binding Protein-beta	C0209548	T116|T123	Gene_or_gene_product	116-121	HDACs	Histone Deacetylase	C0019643	T116|T126	Gene_or_gene_product	53-56	AML	AML	C0023467	T191	-694	Regulation	Forward	FALSE	NA
17094	PC13_train	21346255.s11	These findings suggest that C/EBPs displace HDACs from p50 homodimers bound to antiapoptotic genes, contributing to NF-kappaB dysregulation in leukemia, and that the C/EBPalpha:p50 complex is a potential therapeutic target.	28-34	C/EBPs	CCAAT-Enhancer-Binding Proteins	C0108685	T116|T123	Gene_or_gene_product	55-69	p50 homodimers	NF-kappa B p50 Subunit	C0132348	T116|T123	Complex	143-151	leukemia	LEUKAEMIA	C0023418	T191	-1000	Regulation	Forward	TRUE	NA
17102	PC13_train	21346255.s2	We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP.	30-40	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	132-136	BCL2	BCL2 protein, human	C4042483	T116	Gene_or_gene_product	48-51	AML	AML	C0023467	T191	-694	Increase	Forward	FALSE	NA
17103	PC13_train	21346255.s2	We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP.	30-40	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	132-136	BCL2	BCL2 protein, human	C4042483	T116	Gene_or_gene_product	52-59	mutants	mutants	C0596988	T049	-861	Increase	Forward	FALSE	NA
17104	PC13_train	21346255.s2	We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP.	30-40	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	141-145	FLIP	CASP8 and FADD-Like Apoptosis Regulator Protein	C3468040	T116|T123	Gene_or_gene_product	48-51	AML	AML	C0023467	T191	-694	Increase	Forward	FALSE	NA
17105	PC13_train	21346255.s2	We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP.	30-40	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	141-145	FLIP	CASP8 and FADD-Like Apoptosis Regulator Protein	C3468040	T116|T123	Gene_or_gene_product	52-59	mutants	mutants	C0596988	T049	-861	Increase	Forward	FALSE	NA
17106	PC13_train	21346255.s2	We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP.	30-40	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	75-84	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	48-51	AML	AML	C0023467	T191	-694	Increase	Forward	FALSE	NA
17107	PC13_train	21346255.s2	We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP.	30-40	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	75-84	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	52-59	mutants	mutants	C0596988	T049	-861	Increase	Forward	FALSE	NA
17108	PC13_train	21346255.s2	We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP.	30-40	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	85-88	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Gene_or_gene_product	48-51	AML	AML	C0023467	T191	-694	Increase	Forward	FALSE	NA
17109	PC13_train	21346255.s2	We have previously shown that C/EBPalpha or its AML mutants synergize with NF-kappaB p50 to activate antiapoptotic genes, including BCL2 and FLIP.	30-40	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	85-88	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Gene_or_gene_product	52-59	mutants	mutants	C0596988	T049	-861	Increase	Forward	FALSE	NA
17126	PC13_train	21346255.s4	We now report that C/EBPalpha or C/EBPalpha leucine zipper AML mutants bind in vivo to the nfkb1 (p50) promoter and induce its expression even in the presence of cycloheximide.	19-29	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	91-96	nfkb1	Nuclear Factor NF-kappa-B p105 Subunit	C2986465	T116|T123	Gene_or_gene_product	59-62	AML	AML	C0023467	T191	-632	Binding	NA	FALSE	NA
17127	PC13_train	21346255.s4	We now report that C/EBPalpha or C/EBPalpha leucine zipper AML mutants bind in vivo to the nfkb1 (p50) promoter and induce its expression even in the presence of cycloheximide.	19-29	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	91-96	nfkb1	Nuclear Factor NF-kappa-B p105 Subunit	C2986465	T116|T123	Gene_or_gene_product	63-70	mutants	mutants	C0596988	T049	-799	Binding	NA	FALSE	NA
17128	PC13_train	21346255.s4	We now report that C/EBPalpha or C/EBPalpha leucine zipper AML mutants bind in vivo to the nfkb1 (p50) promoter and induce its expression even in the presence of cycloheximide.	19-29	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	98-101	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Gene_or_gene_product	59-62	AML	AML	C0023467	T191	-632	Binding	NA	FALSE	NA
17129	PC13_train	21346255.s4	We now report that C/EBPalpha or C/EBPalpha leucine zipper AML mutants bind in vivo to the nfkb1 (p50) promoter and induce its expression even in the presence of cycloheximide.	19-29	C/EBPalpha	CCAAT/Enhancer Binding Protein Alpha	C0378310	T116|T123	Gene_or_gene_product	98-101	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Gene_or_gene_product	63-70	mutants	mutants	C0596988	T049	-799	Binding	NA	FALSE	NA
17197	PC13_train	21408173.s7	Our results show that a glaucoma-associated mutant of optineurin, H486R, is altered in its interaction with CYLD.	66-71	H486R	OPTN protein, human	C0914894	T116|T123	Gene_or_gene_product	108-112	CYLD	Deubiquitinating Enzyme CYLD	C4318634	T116|T126	Gene_or_gene_product	24-32	glaucoma	GLAUCOMA	C0017601	T047	-660	Binding	NA	TRUE	NA
17198	PC13_train	21408173.s7	Our results show that a glaucoma-associated mutant of optineurin, H486R, is altered in its interaction with CYLD.	66-71	H486R	OPTN protein, human	C0914894	T116|T123	Gene_or_gene_product	108-112	CYLD	Deubiquitinating Enzyme CYLD	C4318634	T116|T126	Gene_or_gene_product	44-50	mutant	Mutant	C0596988	T049	-827	Binding	NA	TRUE	NA
17218	PC13_train	21408173.s8	Unlike wild-type optineurin, the H486R mutant did not inhibit tumour necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.	33-38	H486R	OPTN protein, human	C0914894	T116|T123	Gene_or_gene_product	110-119	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	39-45	mutant	Mutant	C0596988	T049	-861	Decrease	Forward	TRUE	reverse
17230	PC13_train	21408173.s8	Unlike wild-type optineurin, the H486R mutant did not inhibit tumour necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.	62-90	tumour necrosis factor alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	110-119	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	39-45	mutant	Mutant	C0596988	T049	-861	Increase	Forward	FALSE	NA
17238	PC13_train	21408173.s8	Unlike wild-type optineurin, the H486R mutant did not inhibit tumour necrosis factor alpha (TNFalpha)-induced NF-kappaB activation.	92-100	TNFalpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	110-119	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	39-45	mutant	Mutant	C0596988	T049	-861	Increase	Forward	FALSE	NA
17241	PC13_train	21408173.s9	CYLD mediated inhibition of TNFalpha-induced NF-kappaB activation was abrogated by expression of the H486R mutant.	0-4	CYLD	Deubiquitinating Enzyme CYLD	C4318634	T116|T126	Gene_or_gene_product	45-54	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	107-113	mutant	Mutant	C0596988	T049	-861	Decrease	Forward	TRUE	NA
17243	PC13_train	21408173.s9	CYLD mediated inhibition of TNFalpha-induced NF-kappaB activation was abrogated by expression of the H486R mutant.	28-36	TNFalpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	45-54	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	107-113	mutant	Mutant	C0596988	T049	-861	Increase	Forward	TRUE	NA
17283	PC13_train	21734074.s6	The biological consequence of IL-33/NF-kappaB complex formation was reduction in NF-kappaB p65 binding to its cognate DNA and impairment of p65-triggered transactivation.	81-90	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	91-94	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	126-136	impairment	Impairment	C0684336	T046	-1000	Binding	NA	FALSE	NA
17292	PC13_train	21859840.s3	Our recent studies have shown that high levels of phosphorylated FADD (p-FADD) in tumor cells correlate with increased activation of the antiapoptotic transcription factor NF-kappaB and is a biomarker for aggressive disease and poor clinical outcome.	65-69	FADD	Fas-Associated Death Domain Protein	C0296346	T116|T123	Gene_or_gene_product	172-181	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	205-215	aggressive	aggressive	C0001807	T048	-694	Regulation	Forward	TRUE	NA
17293	PC13_train	21859840.s3	Our recent studies have shown that high levels of phosphorylated FADD (p-FADD) in tumor cells correlate with increased activation of the antiapoptotic transcription factor NF-kappaB and is a biomarker for aggressive disease and poor clinical outcome.	65-69	FADD	Fas-Associated Death Domain Protein	C0296346	T116|T123	Gene_or_gene_product	172-181	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	216-223	disease	Disease	C0012634	T047	-861	Regulation	Forward	TRUE	NA
17296	PC13_train	21859840.s3	Our recent studies have shown that high levels of phosphorylated FADD (p-FADD) in tumor cells correlate with increased activation of the antiapoptotic transcription factor NF-kappaB and is a biomarker for aggressive disease and poor clinical outcome.	73-77	FADD	Fas-Associated Death Domain Protein	C0296346	T116|T123	Gene_or_gene_product	172-181	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	205-215	aggressive	aggressive	C0001807	T048	-694	Regulation	Forward	TRUE	NA
17297	PC13_train	21859840.s3	Our recent studies have shown that high levels of phosphorylated FADD (p-FADD) in tumor cells correlate with increased activation of the antiapoptotic transcription factor NF-kappaB and is a biomarker for aggressive disease and poor clinical outcome.	73-77	FADD	Fas-Associated Death Domain Protein	C0296346	T116|T123	Gene_or_gene_product	172-181	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	216-223	disease	Disease	C0012634	T047	-861	Regulation	Forward	TRUE	NA
17299	PC13_train	21859840.s7	NSC 47147 was shown to decrease levels of p-FADD and NF-kappaB activity such that combination therapy leads to greater induction of apoptosis and enhanced tumor control than either agent alone.	0-9	NSC 47147	Prodigiosin	C0033259	T109|T121|T130	Simple_chemical	44-48	FADD	Fas-Associated Death Domain Protein	C0296346	T116|T123	Gene_or_gene_product	155-160	tumor	Tumour NOS	C0027651	T191	-660	Decrease	Forward	TRUE	NA
17300	PC13_train	21859840.s7	NSC 47147 was shown to decrease levels of p-FADD and NF-kappaB activity such that combination therapy leads to greater induction of apoptosis and enhanced tumor control than either agent alone.	0-9	NSC 47147	Prodigiosin	C0033259	T109|T121|T130	Simple_chemical	53-62	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	155-160	tumor	Tumour NOS	C0027651	T191	-660	Decrease	Forward	TRUE	NA
17307	PC13_train	21983831.s0	The kinase GLK controls autoimmunity and NF-kappaB signaling by activating the kinase PKC-theta in T cells.	11-14	GLK	MAP4K3 protein, human	C2742126	T116|T126	Gene_or_gene_product	86-95	PKC-theta	Protein Kinase C-theta	C4319709	T116|T126	Gene_or_gene_product	24-36	autoimmunity	Autoimmunity	C0004364	T047	-1000	Increase	Forward	FALSE	NA
17308	PC13_train	21983831.s0	The kinase GLK controls autoimmunity and NF-kappaB signaling by activating the kinase PKC-theta in T cells.	11-14	GLK	MAP4K3 protein, human	C2742126	T116|T126	Gene_or_gene_product	86-95	PKC-theta	Protein Kinase C-theta	C4319709	T116|T126	Gene_or_gene_product	24-36	autoimmunity	Autoimmunity	C0004368	T046	-1000	Increase	Forward	FALSE	NA
17320	PC13_train	21983831.s6	Thus, GLK is a direct activator of PKC-theta, and activation of GLK-PKC-theta-IKK could be used as new diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus.	6-9	GLK	MAP4K3 protein, human	C2742126	T116|T126	Gene_or_gene_product	35-44	PKC-theta	Protein Kinase C-theta	C4319709	T116|T126	Gene_or_gene_product	153-181	systemic lupus erythematosus	Lupus Erythematosus, Systemic	C0024141	T047	-1000	Increase	Forward	TRUE	NA
17321	PC13_train	21983831.s6	Thus, GLK is a direct activator of PKC-theta, and activation of GLK-PKC-theta-IKK could be used as new diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus.	6-9	GLK	MAP4K3 protein, human	C2742126	T116|T126	Gene_or_gene_product	64-67	GLK	MAP4K3 protein, human	C2742126	T116|T126	Gene_or_gene_product	153-181	systemic lupus erythematosus	Lupus Erythematosus, Systemic	C0024141	T047	-1000	Increase	Forward	TRUE	NA
17322	PC13_train	21983831.s6	Thus, GLK is a direct activator of PKC-theta, and activation of GLK-PKC-theta-IKK could be used as new diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus.	6-9	GLK	MAP4K3 protein, human	C2742126	T116|T126	Gene_or_gene_product	68-77	PKC-theta	Protein Kinase C-theta	C4319709	T116|T126	Gene_or_gene_product	153-181	systemic lupus erythematosus	Lupus Erythematosus, Systemic	C0024141	T047	-1000	Increase	Forward	TRUE	NA
17323	PC13_train	21983831.s6	Thus, GLK is a direct activator of PKC-theta, and activation of GLK-PKC-theta-IKK could be used as new diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus.	6-9	GLK	MAP4K3 protein, human	C2742126	T116|T126	Gene_or_gene_product	78-81	IKK	IkappaB kinase	C0663914	T116|T126	Complex	153-181	systemic lupus erythematosus	Lupus Erythematosus, Systemic	C0024141	T047	-1000	Increase	Forward	TRUE	NA
17348	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	37-42	TNIP1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	138-141	Nef	Gene Products, nef	C0017280	T116|T123	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Binding	NA	TRUE	NA
17350	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	37-42	TNIP1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	176-184	TNFalpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
17351	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	37-42	TNIP1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	232-241	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	87-90	HIV	HIV	C0019693	T047	-694	Binding	NA	FALSE	NA
17352	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	37-42	TNIP1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	294-317	retinoic acid receptors	Retinoic Acid Receptor	C0140278	T116|T192	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
17353	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	37-42	TNIP1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	322-365	peroxisome proliferator-activated receptors	Peroxisome Proliferator-Activated Receptors	C0166418	T116|T192	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
17354	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	37-42	TNIP1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	367-371	PPAR	Peroxisome Proliferator-Activated Receptors	C0166418	T192|T116	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
17355	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	6-35	TNFAIP3 interacting protein 1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	138-141	Nef	Gene Products, nef	C0017280	T116|T123	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Binding	NA	TRUE	NA
17357	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	6-35	TNFAIP3 interacting protein 1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	176-184	TNFalpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
17358	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	6-35	TNFAIP3 interacting protein 1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	232-241	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	87-90	HIV	HIV	C0019693	T047	-694	Binding	NA	FALSE	NA
17359	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	6-35	TNFAIP3 interacting protein 1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	294-317	retinoic acid receptors	Retinoic Acid Receptor	C0140278	T116|T192	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
17360	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	6-35	TNFAIP3 interacting protein 1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	322-365	peroxisome proliferator-activated receptors	Peroxisome Proliferator-Activated Receptors	C0166418	T116|T192	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
17361	PC13_train	22001530.s1	Human TNFAIP3 interacting protein 1 (TNIP1) has diverse functions including support of HIV replication through its interaction with viral Nef and matrix proteins, reduction of TNFalpha-induced signaling through its interaction with NF-kappaB pathway proteins, and corepression of agonist-bound retinoic acid receptors and peroxisome proliferator-activated receptors (PPAR).	6-35	TNFAIP3 interacting protein 1	TNIP1 protein, human	C0762912	T116	Gene_or_gene_product	367-371	PPAR	Peroxisome Proliferator-Activated Receptors	C0166418	T192|T116	Gene_or_gene_product	87-90	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
17462	PC13_train	22065579.s1	Growth factors, insulin, oxidative stress, and cytokines activate ERK1/2 by PKCdelta and MEK1/2.	16-23	insulin	Insulin	C0021641	T116|T121|T125	Gene_or_gene_product	76-84	PKCdelta	Protein Kinase C-delta	C0217250	T116|T126	Gene_or_gene_product	25-41	oxidative stress	Oxidative Stress	C0242606	T049	-1000	Increase	Forward	FALSE	NA
17463	PC13_train	22065579.s1	Growth factors, insulin, oxidative stress, and cytokines activate ERK1/2 by PKCdelta and MEK1/2.	16-23	insulin	Insulin	C0021641	T116|T121|T125	Gene_or_gene_product	89-95	MEK1/2	Extracellular Signal Regulated Kinases	C0600388	T116|T126	Gene_or_gene_product	25-41	oxidative stress	Oxidative Stress	C0242606	T049	-1000	Increase	Forward	FALSE	NA
17568	PC13_train	22139845.s0	The p65 subunit of NF-kappaB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).	4-7	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	208-211	Sp1	Sp1 Transcription Factor	C0080245	T116|T123	Gene_or_gene_product	84-95	scleroderma	SCLERODERMA	C0011644	T047	-694	Regulation	Forward	TRUE	NA
17569	PC13_train	22139845.s0	The p65 subunit of NF-kappaB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).	4-7	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	208-211	Sp1	Sp1 Transcription Factor	C0080245	T116|T123	Gene_or_gene_product	84-95	scleroderma	scleroderma	C0036421	T047	-694	Regulation	Forward	TRUE	NA
17573	PC13_train	22139845.s0	The p65 subunit of NF-kappaB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).	4-7	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	217-220	Sp3	Sp3 Transcription Factor	C0172659	T116|T123	Gene_or_gene_product	84-95	scleroderma	SCLERODERMA	C0011644	T047	-694	Regulation	Forward	TRUE	NA
17574	PC13_train	22139845.s0	The p65 subunit of NF-kappaB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).	4-7	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	217-220	Sp3	Sp3 Transcription Factor	C0172659	T116|T123	Gene_or_gene_product	84-95	scleroderma	scleroderma	C0036421	T047	-694	Regulation	Forward	TRUE	NA
17578	PC13_train	22139845.s0	The p65 subunit of NF-kappaB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).	4-7	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	38-44	COL1A1	type I collagen alpha 1	C0972255	T116|T123	Gene_or_gene_product	84-95	scleroderma	SCLERODERMA	C0011644	T047	-694	Decrease	Forward	TRUE	NA
17579	PC13_train	22139845.s0	The p65 subunit of NF-kappaB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).	4-7	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	38-44	COL1A1	type I collagen alpha 1	C0972255	T116|T123	Gene_or_gene_product	84-95	scleroderma	scleroderma	C0036421	T047	-694	Decrease	Forward	TRUE	NA
17622	PC13_train	22139845.s8	Finally, the knockdown of Sp1/Sp3/c-Krox prevents the p65 inhibitory effect on COL1A1 transcription in ANF, whereas only the siRNAs targeting Sp3 and c-Krox provoked the same effect in SF, suggesting that particular interactions are characteristic of the scleroderma phenotype.	54-57	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	79-85	COL1A1	type I collagen alpha 1	C0972255	T116|T123	Gene_or_gene_product	255-266	scleroderma	SCLERODERMA	C0011644	T047	-694	Regulation	Forward	TRUE	reverse
17623	PC13_train	22139845.s8	Finally, the knockdown of Sp1/Sp3/c-Krox prevents the p65 inhibitory effect on COL1A1 transcription in ANF, whereas only the siRNAs targeting Sp3 and c-Krox provoked the same effect in SF, suggesting that particular interactions are characteristic of the scleroderma phenotype.	54-57	p65	RELA protein, human	C1567060	T116|T123	Gene_or_gene_product	79-85	COL1A1	type I collagen alpha 1	C0972255	T116|T123	Gene_or_gene_product	255-266	scleroderma	scleroderma	C0036421	T047	-694	Regulation	Forward	TRUE	reverse
17688	PC13_train	22144899.s8	Infections in a disease-relevant intestinal model confirm key NF-kappaB inhibitory roles for the NleB1/NleE1 effectors, with other studies providing insights on host targets.	62-71	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	103-108	NleE1	NleE protein, E coli	C1999436	T116|T123	Gene_or_gene_product	0-10	Infections	Infections	C3714514	T046	-1000	Decrease	Backward	TRUE	NA
17689	PC13_train	22144899.s8	Infections in a disease-relevant intestinal model confirm key NF-kappaB inhibitory roles for the NleB1/NleE1 effectors, with other studies providing insights on host targets.	62-71	NF-kappaB	NF-kappa B	C0079904	T116|T129	Complex	97-102	NleB1	NleB protein, E coli	C2973685	T116|T123	Gene_or_gene_product	0-10	Infections	Infections	C3714514	T046	-1000	Decrease	Backward	TRUE	NA
17777	PC13_train	2581505.s2	It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations.	130-139	amiloride	Amiloride	C0002502	T109|T121	Simple_chemical	181-188	cations	Cations	C0007447	T104	Simple_chemical	140-149	sensitive	Sensitive	C0020517	T046	-637	Regulation	Forward	FALSE	NA
17779	PC13_train	2581505.s2	It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations.	61-64	Li+	lithium cation	C3495095	T121|T196	Simple_chemical	130-139	amiloride	Amiloride	C0002502	T109|T121	Simple_chemical	140-149	sensitive	Sensitive	C0020517	T046	-637	Regulation	Backward	FALSE	NA
17783	PC13_train	2581505.s2	It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations.	61-64	Li+	lithium cation	C3495095	T121|T196	Simple_chemical	69-73	NH+4	Ammonium	C0002611	T197	Simple_chemical	140-149	sensitive	Sensitive	C0020517	T046	-637	Binding	NA	FALSE	NA
17789	PC13_train	2581505.s2	It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations.	69-73	NH+4	Ammonium	C0002611	T197	Simple_chemical	130-139	amiloride	Amiloride	C0002502	T109|T121	Simple_chemical	140-149	sensitive	Sensitive	C0020517	T046	-637	Regulation	Backward	FALSE	NA
17797	PC13_train	2581505.s2	It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations.	89-92	Na+	Sodium Cation	C0597484	T196	Simple_chemical	130-139	amiloride	Amiloride	C0002502	T109|T121	Simple_chemical	140-149	sensitive	Sensitive	C0020517	T046	-637	Regulation	Backward	FALSE	NA
17801	PC13_train	2581505.s2	It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations.	89-92	Na+	Sodium Cation	C0597484	T196	Simple_chemical	97-99	H+	Protons	C0033727	T196	Simple_chemical	140-149	sensitive	Sensitive	C0020517	T046	-637	Binding	NA	FALSE	NA
17803	PC13_train	2581505.s2	It has a tightly coupled 1:1 stoichiometry, has affinity for Li+ and NH+4 in addition to Na+ and H+, and can function in multiple amiloride-sensitive exchange modes involving these cations.	97-99	H+	Protons	C0033727	T196	Simple_chemical	130-139	amiloride	Amiloride	C0002502	T109|T121	Simple_chemical	140-149	sensitive	Sensitive	C0020517	T046	-637	Regulation	Backward	FALSE	NA
17806	PC13_train	2581505.s4	The most important kinetic property of the Na+-H+ exchanger is its greater than first-order dependence on [H+]i.	43-59	Na+-H+ exchanger	Sodium-Hydrogen Antiporter	C0074785	T116|T123	Gene_or_gene_product	106-111	[H+]i	Protons	C0033727	T196	Simple_chemical	92-102	dependence	Dependence	C0439857	T048	-827	Increase	Backward	FALSE	NA
17815	PC13_train	3759988.s9	These results also show propionyl-CoA must be formed during the metabolism of alpha-ketoisovalerate and that extra-mitochondrial free carnitine rapidly interacts with matrix short-chain aliphatic acyl-CoA generated from alpha-keto acids of branched-chain amino acids and pyruvate in the presence and absence of malate.	134-143	carnitine	Carnitine	C0007258	T116|T121	Simple_chemical	196-204	acyl-CoA	Acyl Coenzyme A	C0001374	T114|T123	Simple_chemical	300-307	absence	Absence	C1689985	T190	-1000	Binding	NA	TRUE	NA
17917	PC13_train	8078588.s2	Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4.	107-111	CDK6	cyclin-dependent kinase 6	C0252132	T116|T126	Gene_or_gene_product	157-164	p16INK4	Cyclin-Dependent Kinase Inhibitor p16	C0249880	T116|T123	Gene_or_gene_product	7-18	progression	Progression	C0242656	T046	-861	Decrease	Backward	FALSE	NA
17922	PC13_train	8078588.s2	Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4.	98-102	CDK4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Gene_or_gene_product	157-164	p16INK4	Cyclin-Dependent Kinase Inhibitor p16	C0249880	T116|T123	Gene_or_gene_product	7-18	progression	Progression	C0242656	T046	-861	Decrease	Backward	FALSE	NA
17954	PC13_train	8497280.s11	The constitutive transcription of SWI4 in SWI6 mutant cells occurs at an intermediate level, which indicates that SWI6 is required for the full activation and repression of SWI4 transcription through the cell cycle.	114-118	SWI6	SWI6 protein, S cerevisiae	C0169218	T116|T123	Gene_or_gene_product	173-177	SWI4	SWI4 protein, S cerevisiae	C0075673	T116|T123	Gene_or_gene_product	47-53	mutant	Mutant	C0596988	T049	-660	Decrease	Forward	FALSE	NA
17955	PC13_train	8497280.s11	The constitutive transcription of SWI4 in SWI6 mutant cells occurs at an intermediate level, which indicates that SWI6 is required for the full activation and repression of SWI4 transcription through the cell cycle.	114-118	SWI6	SWI6 protein, S cerevisiae	C0169218	T116|T123	Gene_or_gene_product	173-177	SWI4	SWI4 protein, S cerevisiae	C0075673	T116|T123	Gene_or_gene_product	47-53	mutant	Mutant	C0596988	T049	-660	Increase	Forward	FALSE	NA
17961	PC13_train	8497280.s12	It also suggests that there is another pathway which can activate SWI4 transcription in the absence of SWI6.	66-70	SWI4	SWI4 protein, S cerevisiae	C0075673	T116|T123	Gene_or_gene_product	103-107	SWI6	SWI6 protein, S cerevisiae	C0169218	T116|T123	Gene_or_gene_product	92-99	absence	Absence	C1689985	T190	-1000	Increase	Backward	FALSE	NA
18023	PC13_train	9430701.s1	Cytosolic phospholipase A2 (cPLA2) is a calcium-sensitive 85-kDa enzyme that hydrolyzes arachidonic acid-containing membrane phospholipids to initiate the biosynthesis of eicosanoids and platelet-activating factor, potent inflammatory mediators.	0-26	Cytosolic phospholipase A2	Cytosolic Phospholipase A2	C1333201	T116|T126	Gene_or_gene_product	125-138	phospholipids	Phospholipids	C0031676	T109|T123	Simple_chemical	48-57	sensitive	Sensitive	C0020517	T046	-637	Regulation	Forward	FALSE	NA
18027	PC13_train	9430701.s1	Cytosolic phospholipase A2 (cPLA2) is a calcium-sensitive 85-kDa enzyme that hydrolyzes arachidonic acid-containing membrane phospholipids to initiate the biosynthesis of eicosanoids and platelet-activating factor, potent inflammatory mediators.	0-26	Cytosolic phospholipase A2	Cytosolic Phospholipase A2	C1333201	T116|T126	Gene_or_gene_product	40-47	calcium	Calcium	C0006675	T121|T123|T196	Simple_chemical	48-57	sensitive	Sensitive	C0020517	T046	-637	Regulation	Backward	FALSE	NA
18036	PC13_train	9430701.s1	Cytosolic phospholipase A2 (cPLA2) is a calcium-sensitive 85-kDa enzyme that hydrolyzes arachidonic acid-containing membrane phospholipids to initiate the biosynthesis of eicosanoids and platelet-activating factor, potent inflammatory mediators.	28-33	cPLA2	Cytosolic Phospholipase A2	C1333201	T116|T126	Gene_or_gene_product	125-138	phospholipids	Phospholipids	C0031676	T109|T123	Simple_chemical	48-57	sensitive	Sensitive	C0020517	T046	-637	Regulation	Forward	FALSE	NA
18039	PC13_train	9430701.s1	Cytosolic phospholipase A2 (cPLA2) is a calcium-sensitive 85-kDa enzyme that hydrolyzes arachidonic acid-containing membrane phospholipids to initiate the biosynthesis of eicosanoids and platelet-activating factor, potent inflammatory mediators.	28-33	cPLA2	Cytosolic Phospholipase A2	C1333201	T116|T126	Gene_or_gene_product	40-47	calcium	Calcium	C0006675	T121|T123|T196	Simple_chemical	48-57	sensitive	Sensitive	C0020517	T046	-637	Regulation	Backward	FALSE	NA
18047	PC13_train	9430701.s1	Cytosolic phospholipase A2 (cPLA2) is a calcium-sensitive 85-kDa enzyme that hydrolyzes arachidonic acid-containing membrane phospholipids to initiate the biosynthesis of eicosanoids and platelet-activating factor, potent inflammatory mediators.	88-104	arachidonic acid	Arachidonic Acid	C0003695	T109	Simple_chemical	125-138	phospholipids	Phospholipids	C0031676	T109|T123	Simple_chemical	48-57	sensitive	Sensitive	C0020517	T046	-637	Binding	NA	FALSE	NA
18056	PC13_train	9564042.s5	Treatment of cells with N-acetyl-L-cysteine also inhibited serum withdrawal-, TNF-alpha- and hydrogen peroxide-induced activation of ASK1 as well as apoptosis.	24-43	N-acetyl-L-cysteine	Acetylcysteine	C0001047	T116|T121	Simple_chemical	133-137	ASK1	MAP Kinase Kinase Kinase 5	C0532128	T116|T126	Gene_or_gene_product	65-75	withdrawal	Withdrawal	C2825032	T048	-861	Decrease	Forward	FALSE	NA
18059	PC13_train	9564042.s5	Treatment of cells with N-acetyl-L-cysteine also inhibited serum withdrawal-, TNF-alpha- and hydrogen peroxide-induced activation of ASK1 as well as apoptosis.	78-87	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Gene_or_gene_product	133-137	ASK1	MAP Kinase Kinase Kinase 5	C0532128	T116|T126	Gene_or_gene_product	65-75	withdrawal	Withdrawal	C2825032	T048	-861	Increase	Forward	FALSE	NA
18061	PC13_train	9564042.s5	Treatment of cells with N-acetyl-L-cysteine also inhibited serum withdrawal-, TNF-alpha- and hydrogen peroxide-induced activation of ASK1 as well as apoptosis.	93-110	hydrogen peroxide	Hydrogen Peroxide	C0020281	T121|T130|T197	Simple_chemical	133-137	ASK1	MAP Kinase Kinase Kinase 5	C0532128	T116|T126	Gene_or_gene_product	65-75	withdrawal	Withdrawal	C2825032	T048	-861	Increase	Forward	FALSE	NA
18078	PC13_train	9676430.s1	The human lymphoid cell activation antigen CD39 is a known E-type apyrase that hydrolyzes extracellular ATP and ADP, a function important in homotypic adhesion, platelet aggregation, and removal by activated lymphocytes of the lytic effect of ATP.	59-73	E-type apyrase	Apyrase	C0003652	T116|T126	Gene_or_gene_product	104-107	ATP	Adenosine Triphosphate	C0001480	T114|T121|T123	Simple_chemical	151-159	adhesion	ADHESION	C0001511	T046	-861	Regulation	Forward	TRUE	NA
18079	PC13_train	9676430.s1	The human lymphoid cell activation antigen CD39 is a known E-type apyrase that hydrolyzes extracellular ATP and ADP, a function important in homotypic adhesion, platelet aggregation, and removal by activated lymphocytes of the lytic effect of ATP.	59-73	E-type apyrase	Apyrase	C0003652	T116|T126	Gene_or_gene_product	104-107	ATP	Adenosine Triphosphate	C0001480	T114|T121|T123	Simple_chemical	227-232	lytic	Lytic	C0024348	T046	-694	Regulation	Forward	FALSE	NA
18080	PC13_train	9676430.s1	The human lymphoid cell activation antigen CD39 is a known E-type apyrase that hydrolyzes extracellular ATP and ADP, a function important in homotypic adhesion, platelet aggregation, and removal by activated lymphocytes of the lytic effect of ATP.	59-73	E-type apyrase	Apyrase	C0003652	T116|T126	Gene_or_gene_product	112-115	ADP	Adenosine Diphosphate	C0001459	T114|T123	Simple_chemical	151-159	adhesion	ADHESION	C0001511	T046	-861	Regulation	Forward	TRUE	NA
18081	PC13_train	9676430.s1	The human lymphoid cell activation antigen CD39 is a known E-type apyrase that hydrolyzes extracellular ATP and ADP, a function important in homotypic adhesion, platelet aggregation, and removal by activated lymphocytes of the lytic effect of ATP.	59-73	E-type apyrase	Apyrase	C0003652	T116|T126	Gene_or_gene_product	112-115	ADP	Adenosine Diphosphate	C0001459	T114|T123	Simple_chemical	227-232	lytic	Lytic	C0024348	T046	-694	Regulation	Forward	FALSE	NA
20000	GE11_devel	10089566.s8	Thus HIV-1 gp41-induced IL-10 up-regulation in monocytes may not involve NF-kappaB, MAPK, or PI 3-kinase activation, but rather may operate through activation of adenylate cyclase and pertussis-toxin-sensitive Gi/Go protein to effect p70(S6)-kinase activation.	11-15	gp41	glycoprotein 41	C0061649	T116	Protein	24-29	IL-10	Interleukin-10	C0085295	T116|T129	Protein	200-209	sensitive	Sensitive	C0020517	T046	-645	Increase	Forward	TRUE	NA
20001	GE11_devel	10229231.s6	Fas/FasL interaction initiates cell death in many other systems, and its dysregulation is a mechanism by which several pathologic conditions arise.	0-3	Fas	Fatty-acid synthase	C0015683	T116|T126	Protein	4-8	FasL	Tumor Necrosis Factor Ligand Superfamily Member 6	C0253023	T116|T123	Protein	111-129	several pathologic	Several pathologies	C0679225	T047	-698	Binding	NA	TRUE	NA
20002	GE11_devel	10229231.s6	Fas/FasL interaction initiates cell death in many other systems, and its dysregulation is a mechanism by which several pathologic conditions arise.	0-3	Fas	Fatty-acid synthase	C0015683	T116|T126	Protein	4-8	FasL	Tumor Necrosis Factor Ligand Superfamily Member 6	C0253023	T116|T123	Protein	130-140	conditions	condition	C0012634	T047	-793	Binding	NA	TRUE	NA
20004	GE11_devel	10409763.s1	A site in the Epstein-Barr virus (EBV) transforming protein LMP1 that constitutively associates with the tumor necrosis factor receptor 1 (TNFR1)-associated death domain protein TRADD to mediate NF-kappaB and c-Jun N-terminal kinase activation is critical for long-term lymphoblastoid cell proliferation.	60-64	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	105-177	tumor necrosis factor receptor 1 (TNFR1)-associated death domain protein	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	39-51	transforming	Transforming	C1510411	T046	-632	Binding	NA	FALSE	NA
20005	GE11_devel	10409763.s1	A site in the Epstein-Barr virus (EBV) transforming protein LMP1 that constitutively associates with the tumor necrosis factor receptor 1 (TNFR1)-associated death domain protein TRADD to mediate NF-kappaB and c-Jun N-terminal kinase activation is critical for long-term lymphoblastoid cell proliferation.	60-64	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	178-183	TRADD	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	39-51	transforming	Transforming	C1510411	T046	-632	Binding	NA	FALSE	NA
20006	GE11_devel	10409763.s8	Despite constitutive association with TRADD or RIP, LMP1 does not induce apoptosis in EBV-negative Burkitt lymphoma or human embryonic kidney 293 cells.	38-43	TRADD	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	52-56	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	99-115	Burkitt lymphoma	BURKITT LYMPHOMA	C0006413	T191	-861	Binding	NA	TRUE	NA
20007	GE11_devel	10455128.s9	NIK cannot phosphorylate IkappaB-alpha directly, but it appears to be a functionally important subunit, because mutated NIK inhibited stimulus-induced kappaB-dependent transcription more effectively than mutated IKK-alpha or -beta.	0-3	NIK	NF-kappaB-inducing kinase	C0249854	T116|T126	Protein	25-38	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	112-119	mutated	Mutated	C1705285	T049	-694	Regulation	Forward	FALSE	NA
20008	GE11_devel	10455128.s9	NIK cannot phosphorylate IkappaB-alpha directly, but it appears to be a functionally important subunit, because mutated NIK inhibited stimulus-induced kappaB-dependent transcription more effectively than mutated IKK-alpha or -beta.	0-3	NIK	NF-kappaB-inducing kinase	C0249854	T116|T126	Protein	25-38	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	204-211	mutated	Mutated	C1705285	T049	-660	Regulation	Forward	FALSE	NA
20009	GE11_devel	1675604.s1	The KBF1 factor, which binds to the enhancer A located in the promoter of the mouse MHC class I gene H-2Kb, is indistinguishable from the p50 DNA binding subunit of the transcription factor NF-kappa B, which regulates a series of genes involved in immune and inflammatory responses.	4-8	KBF1	Nuclear Factor NF-kappa-B p105 Subunit	C2986465	T116|T123	Protein	101-106	H-2Kb	H-2Kb protein, mouse	C1429282	T129|T116	Protein	259-281	inflammatory responses	inflammatory responses	C1155266	T046	-1000	Binding	NA	FALSE	NA
20010	GE11_devel	1680914.s6	These studies suggest that interaction of CD2 with its natural ligand, LFA-3, may play a role in regulation of HIV expression.	42-45	CD2	CD2 Antigens	C0108773	T116|T129|T192	Protein	71-76	LFA-3	Antigens, CD58	C0081942	T116|T129|T192	Protein	111-114	HIV	HIV	C0019693	T047	-694	Binding	NA	FALSE	NA
20021	GE11_devel	7499267.s5	Synergistic induction of the IL-6 gene by IFN-gamma and TNF-alpha, in monocytic cells, involved cooperation between the IRF-1 and NF kappa B p65 homodimers with concomitant removal of the negative effect of the retinoblastoma control element present in the IL-6 promoter.	120-125	IRF-1	Interferon Regulatory Factor 1	C0063700	T116|T123	Protein	29-33	IL-6	Interleukin-6	C0021760	T116|T129	Protein	211-225	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-645	Increase	Backward	FALSE	NA
20022	GE11_devel	7499267.s5	Synergistic induction of the IL-6 gene by IFN-gamma and TNF-alpha, in monocytic cells, involved cooperation between the IRF-1 and NF kappa B p65 homodimers with concomitant removal of the negative effect of the retinoblastoma control element present in the IL-6 promoter.	141-144	p65	RELA protein, human	C1567060	T116|T123	Protein	29-33	IL-6	Interleukin-6	C0021760	T116|T129	Protein	211-225	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-645	Increase	Backward	FALSE	NA
20023	GE11_devel	7499267.s5	Synergistic induction of the IL-6 gene by IFN-gamma and TNF-alpha, in monocytic cells, involved cooperation between the IRF-1 and NF kappa B p65 homodimers with concomitant removal of the negative effect of the retinoblastoma control element present in the IL-6 promoter.	42-51	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	29-33	IL-6	Interleukin-6	C0021760	T116|T129	Protein	211-225	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-645	Increase	Backward	FALSE	NA
20024	GE11_devel	7499267.s5	Synergistic induction of the IL-6 gene by IFN-gamma and TNF-alpha, in monocytic cells, involved cooperation between the IRF-1 and NF kappa B p65 homodimers with concomitant removal of the negative effect of the retinoblastoma control element present in the IL-6 promoter.	56-65	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	29-33	IL-6	Interleukin-6	C0021760	T116|T129	Protein	211-225	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-645	Increase	Backward	FALSE	NA
20031	GE11_devel	7747417.s4	However, unlike another tumor suppressor protein, p53, Rb did not have any significant effect on basal levels of transcription, suggesting that Rb specifically interacts with IE2 rather than other cellular factors involved in the general transcription machinery.	144-146	Rb	Retinoblastoma Protein	C0080113	T116|T123	Protein	175-178	IE2	IE2 protein, Cytomegalovirus	C0123190	T116|T123	Protein	252-261	machinery	Machinery	C0337246	T037	-827	Binding	NA	TRUE	NA
20032	GE11_devel	7760810.s8	GATA-1 and ER bind to each other in vitro in the absence of DNA.	0-6	GATA-1	GATA1 protein, human	C1530719	T116|T123	Protein	11-13	ER	Endoplasmic Reticulum	C0014239	T026	Protein	49-56	absence	Absence	C1689985	T190	-1000	Binding	NA	TRUE	NA
20046	GE11_devel	8617979.s9	Thus, the balance between an endogenously produced viral inducer (IL-1 beta ) and an inhibitor (IL-1ra) may represent an important pathway leading to modulation of HIV expression from monocytic cells.	66-75	IL-1 beta	Interleukin-1 beta	C0021753	T116|T129	Protein	96-102	IL-1ra	anakinra	C0245109	T116|T121	Protein	164-167	HIV	HIV	C0019693	T047	-694	Decrease	Forward	FALSE	NA
20047	GE11_devel	8617979.s9	Thus, the balance between an endogenously produced viral inducer (IL-1 beta ) and an inhibitor (IL-1ra) may represent an important pathway leading to modulation of HIV expression from monocytic cells.	96-102	IL-1ra	anakinra	C0245109	T116|T121	Protein	66-75	IL-1 beta	Interleukin-1 beta	C0021753	T116|T129	Protein	164-167	HIV	HIV	C0019693	T047	-694	Decrease	Backward	FALSE	NA
20048	GE11_devel	8622883.s1	The role of alterations of the MTS1 tumor suppressor gene on chromosome 9p21, which encodes p16, the inhibitor of cyclin-dependent-kinase-4 and 6, in tumorigenesis is not yet clear.	92-95	p16	Cyclin-Dependent Kinase Inhibitor p16	C0249880	T116|T123	Protein	114-139	cyclin-dependent-kinase-4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Protein	150-163	tumorigenesis	Tumorigenesis	C0007621	T191	-1000	Decrease	Forward	FALSE	NA
20049	GE11_devel	8622883.s1	The role of alterations of the MTS1 tumor suppressor gene on chromosome 9p21, which encodes p16, the inhibitor of cyclin-dependent-kinase-4 and 6, in tumorigenesis is not yet clear.	92-95	p16	Cyclin-Dependent Kinase Inhibitor p16	C0249880	T116|T123	Protein	114-139	cyclin-dependent-kinase-4	Cyclin-Dependent Kinase 4	C0246957	T116|T126	Protein	150-163	tumorigenesis	Tumorigenesis	C0596263	T191	-1000	Decrease	Forward	FALSE	NA
20050	GE11_devel	8622883.s1	The role of alterations of the MTS1 tumor suppressor gene on chromosome 9p21, which encodes p16, the inhibitor of cyclin-dependent-kinase-4 and 6, in tumorigenesis is not yet clear.	92-95	p16	Cyclin-Dependent Kinase Inhibitor p16	C0249880	T116|T123	Protein	144-145	6	E2F6 Transcription Factor	C0672706	T116|T123	Protein	150-163	tumorigenesis	Tumorigenesis	C0007621	T191	-1000	Decrease	Forward	FALSE	NA
20051	GE11_devel	8622883.s1	The role of alterations of the MTS1 tumor suppressor gene on chromosome 9p21, which encodes p16, the inhibitor of cyclin-dependent-kinase-4 and 6, in tumorigenesis is not yet clear.	92-95	p16	Cyclin-Dependent Kinase Inhibitor p16	C0249880	T116|T123	Protein	144-145	6	E2F6 Transcription Factor	C0672706	T116|T123	Protein	150-163	tumorigenesis	Tumorigenesis	C0596263	T191	-1000	Decrease	Forward	FALSE	NA
20052	GE11_devel	8622948.s7	Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.	10-14	IL-2	Interleukin-2	C0021756	T116|T129	Protein	138-142	IL-5	Interleukin-5	C0021759	T116|T129	Protein	37-50	proliferative	Proliferative	C0334094	T046	-694	Increase	Forward	FALSE	NA
20053	GE11_devel	8622948.s7	Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.	10-14	IL-2	Interleukin-2	C0021756	T116|T129	Protein	144-153	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	37-50	proliferative	Proliferative	C0334094	T046	-694	Increase	Forward	FALSE	NA
20054	GE11_devel	8622948.s7	Exogenous IL-2, which restitutes the proliferative response of the anti-CD3- and anti-CD28-treated Rel-/- T cells, restores production of IL-5, TNF-alpha, and IFN-gamma, but not IL-3 and GM-CSF expression to approximately normal levels.	10-14	IL-2	Interleukin-2	C0021756	T116|T129	Protein	159-168	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	37-50	proliferative	Proliferative	C0334094	T046	-694	Increase	Forward	FALSE	NA
20059	GE11_devel	8626752.s5	Similarly, STAT1-STAT3 heterocomplexes are coimmunoadsorbed from hypotonic cytosol.	11-16	STAT1	STAT1 protein	C0287920	T116|T123	Protein	17-22	STAT3	Stat3 protein	C0253050	T116|T123	Protein	65-74	hypotonic	HYPOTONIC	C0241938	T046	-694	Binding	NA	TRUE	NA
20062	GE11_devel	8901569.s6	Impaired silencing of gamma-globin expression identifies EKLF as the first transcription factor participating quantitatively in the gamma-globin to beta-globin switch.	57-61	EKLF	erythroid Kruppel-like factor	C0215398	T116|T123	Protein	132-144	gamma-globin	gamma-Globins	C0017033	T116|T123	Protein	9-18	silencing	silence	C0858952	T048	-827	Decrease	Forward	TRUE	NA
20063	GE11_devel	8901569.s6	Impaired silencing of gamma-globin expression identifies EKLF as the first transcription factor participating quantitatively in the gamma-globin to beta-globin switch.	57-61	EKLF	erythroid Kruppel-like factor	C0215398	T116|T123	Protein	148-159	beta-globin	beta-Globins	C0005221	T116|T123	Protein	9-18	silencing	silence	C0858952	T048	-827	Increase	Forward	TRUE	NA
20064	GE11_devel	9154298.s13	The increase in IL-6 luciferase activity occurs in the absence of the multiple response region, the area of the IL-6 promoter responsive to IL-1, TNF alpha, cyclic amp, and phorbol 12-myristate 13-acetate.	146-155	TNF alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	112-116	IL-6	Interleukin-6	C0021760	T116|T129	Protein	55-62	absence	Absence	C1689985	T190	-1000	Regulation	Backward	FALSE	NA
20065	GE11_devel	9171108.s7	Decreased transcriptional activation by N-terminal deletions of CIITA is correlated directly with their reduced binding to TAFII32.	64-69	CIITA	MHC2TA protein, human	C1435283	T116|T129	Protein	123-130	TAFII32	TAF9 protein, human	C0540760	T116|T123	Protein	51-60	deletions	Deletion	C1442161	T049	-793	Binding	NA	TRUE	reverse
20067	GE11_devel	9356494.s8	TRADD associated with wild-type LMP1 but not with isoleucine-mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV-transformed cells.	0-5	TRADD	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	32-36	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	147-158	transformed	Transformed	C1510411	T046	-660	Binding	NA	FALSE	NA
20068	GE11_devel	9356494.s8	TRADD associated with wild-type LMP1 but not with isoleucine-mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV-transformed cells.	0-5	TRADD	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	32-36	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	61-68	mutated	Mutated	C1705285	T049	-660	Binding	NA	FALSE	NA
20069	GE11_devel	9356494.s8	TRADD associated with wild-type LMP1 but not with isoleucine-mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV-transformed cells.	0-5	TRADD	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	69-73	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	147-158	transformed	Transformed	C1510411	T046	-660	Binding	NA	FALSE	NA
20070	GE11_devel	9356494.s8	TRADD associated with wild-type LMP1 but not with isoleucine-mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV-transformed cells.	0-5	TRADD	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	69-73	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	61-68	mutated	Mutated	C1705285	T049	-660	Binding	NA	FALSE	negation
20071	GE11_devel	9356494.s8	TRADD associated with wild-type LMP1 but not with isoleucine-mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV-transformed cells.	98-103	TRADD	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	135-139	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	147-158	transformed	Transformed	C1510411	T046	-660	Binding	NA	TRUE	NA
20072	GE11_devel	9356494.s8	TRADD associated with wild-type LMP1 but not with isoleucine-mutated LMP1 in mammalian cells, and TRADD constitutively associated with LMP1 in EBV-transformed cells.	98-103	TRADD	TNF Receptor-Associated Death Domain Protein	C0289012	T116|T123	Protein	135-139	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	61-68	mutated	Mutated	C1705285	T049	-660	Binding	NA	FALSE	NA
20073	GE11_devel	9372912.s3	Recently, cyclin E-Cdk2- and cyclin A-Cdk2-dependent phosphorylation of a single conserved serine residue (Ser5) in Id2 has been shown to occur during late G1-to-S phase transition of the cell cycle, and this neutralizes the function of Id2 in abrogating E-box-dependent bHLH homo- or heterodimer complex formation in vitro (E.Hara, M.Hall, and G.Peters, EMBO J.16:332-342, 1997).	10-18	cyclin E	Cyclin E	C0111429	T116|T123	Protein	116-119	Id2	Id2 protein	C1457879	T116|T123	Protein	170-180	transition	Transition	C0599156	T049	-799	Regulation	Forward	TRUE	NA
20074	GE11_devel	9372912.s3	Recently, cyclin E-Cdk2- and cyclin A-Cdk2-dependent phosphorylation of a single conserved serine residue (Ser5) in Id2 has been shown to occur during late G1-to-S phase transition of the cell cycle, and this neutralizes the function of Id2 in abrogating E-box-dependent bHLH homo- or heterodimer complex formation in vitro (E.Hara, M.Hall, and G.Peters, EMBO J.16:332-342, 1997).	19-23	Cdk2	cyclin-dependent kinase 2	C1533646	T116|T126	Protein	116-119	Id2	Id2 protein	C1457879	T116|T123	Protein	170-180	transition	Transition	C0599156	T049	-799	Regulation	Forward	TRUE	NA
20075	GE11_devel	9372912.s3	Recently, cyclin E-Cdk2- and cyclin A-Cdk2-dependent phosphorylation of a single conserved serine residue (Ser5) in Id2 has been shown to occur during late G1-to-S phase transition of the cell cycle, and this neutralizes the function of Id2 in abrogating E-box-dependent bHLH homo- or heterodimer complex formation in vitro (E.Hara, M.Hall, and G.Peters, EMBO J.16:332-342, 1997).	29-37	cyclin A	Cyclin A	C0079184	T116|T123	Protein	116-119	Id2	Id2 protein	C1457879	T116|T123	Protein	170-180	transition	Transition	C0599156	T049	-799	Regulation	Forward	TRUE	NA
20076	GE11_devel	9372912.s3	Recently, cyclin E-Cdk2- and cyclin A-Cdk2-dependent phosphorylation of a single conserved serine residue (Ser5) in Id2 has been shown to occur during late G1-to-S phase transition of the cell cycle, and this neutralizes the function of Id2 in abrogating E-box-dependent bHLH homo- or heterodimer complex formation in vitro (E.Hara, M.Hall, and G.Peters, EMBO J.16:332-342, 1997).	38-42	Cdk2	cyclin-dependent kinase 2	C1533646	T116|T126	Protein	116-119	Id2	Id2 protein	C1457879	T116|T123	Protein	170-180	transition	Transition	C0599156	T049	-799	Regulation	Forward	TRUE	NA
20077	GE11_devel	9619918.s3	Flow cytometry revealed that primary leukemia cells from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and the cells showed a proliferative response and an increase in IL-2Ralpha expression on culture with exogeneous IL-2.	235-239	IL-2	Interleukin-2	C0021756	T116|T129	Protein	186-196	IL-2Ralpha	Interleukin 2 Receptor, Alpha	C1101536	T116|T129|T192	Protein	144-157	proliferative	Proliferative	C0334094	T046	-694	Increase	Backward	FALSE	NA
20078	GE11_devel	9619918.s3	Flow cytometry revealed that primary leukemia cells from a patient with CD8+ T-PLL expressed IL-2Ralpha and beta chains, and the cells showed a proliferative response and an increase in IL-2Ralpha expression on culture with exogeneous IL-2.	235-239	IL-2	Interleukin-2	C0021756	T116|T129	Protein	186-196	IL-2Ralpha	Interleukin 2 Receptor, Alpha	C1101536	T116|T129|T192	Protein	79-82	PLL	PLL	C0023486	T191	-827	Increase	Backward	FALSE	NA
20079	GE11_devel	9733846.s8	Moreover, the apoptotic process was not related to Fas-Fas ligand interaction; however, an antagonistic anti-Fas MAb (ZB-4) enhanced apoptosis in HIV-infected cells without inducing apoptosis in uninfected cells.	51-54	Fas	Fatty-acid synthase	C0015683	T116|T126	Protein	55-65	Fas ligand	Tumor Necrosis Factor Ligand Superfamily Member 6	C0253023	T116|T123	Protein	146-149	HIV	HIV	C0019693	T047	-660	Binding	NA	FALSE	NA
20080	GE11_devel	9733846.s9	These observations demonstrate that CD4 signaling mediates HIV-induced apoptosis by a mechanism independent of Fas-Fas ligand interaction, does not require p56(lck) signaling, and may involve a critical region for CD4 dimerization.	111-114	Fas	Fatty-acid synthase	C0015683	T116|T126	Protein	115-125	Fas ligand	Tumor Necrosis Factor Ligand Superfamily Member 6	C0253023	T116|T123	Protein	59-62	HIV	HIV	C0019693	T047	-660	Binding	NA	FALSE	NA
20083	GE11_devel	PMC-1134658-08-Discussion.s43	The antiproliferative and death inducing effect of BMP-6 in B cells with concomitant upregulation of Id1 protein is therefore in line with the view that Id proteins are required for the induction of growth arrest and apoptosis in B-lymphocyte progenitors by TGF-beta [40].	51-56	BMP-6	bone morphogenetic protein 6	C0537467	T116|T123	Protein	101-104	Id1	Inhibitor of Differentiation Protein 1	C1571612	T116|T123	Protein	199-212	growth arrest	Growth arrest	C0333951	T046	-1000	Increase	Forward	FALSE	NA
20189	GE11_devel	PMC-2806624-00-TIAB.s2	In this study, we show that the transforming growth factor-beta (TGF-beta) induces the expression of the Runt-related transcription factors RUNX1 and RUNX3 in CD4+ T cells.	32-63	transforming growth factor-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	140-145	RUNX1	acute myeloid leukemia 1 protein	C0215508	T116|T123	Protein	105-109	Runt	runt	C0013336	T019|T047	-637	Increase	Forward	FALSE	NA
20190	GE11_devel	PMC-2806624-00-TIAB.s2	In this study, we show that the transforming growth factor-beta (TGF-beta) induces the expression of the Runt-related transcription factors RUNX1 and RUNX3 in CD4+ T cells.	32-63	transforming growth factor-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	150-155	RUNX3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	105-109	Runt	runt	C0013336	T019|T047	-637	Increase	Forward	FALSE	NA
20191	GE11_devel	PMC-2806624-00-TIAB.s2	In this study, we show that the transforming growth factor-beta (TGF-beta) induces the expression of the Runt-related transcription factors RUNX1 and RUNX3 in CD4+ T cells.	65-73	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	140-145	RUNX1	acute myeloid leukemia 1 protein	C0215508	T116|T123	Protein	105-109	Runt	runt	C0013336	T019|T047	-637	Increase	Forward	FALSE	NA
20192	GE11_devel	PMC-2806624-00-TIAB.s2	In this study, we show that the transforming growth factor-beta (TGF-beta) induces the expression of the Runt-related transcription factors RUNX1 and RUNX3 in CD4+ T cells.	65-73	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	150-155	RUNX3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	105-109	Runt	runt	C0013336	T019|T047	-637	Increase	Forward	FALSE	NA
20193	GE11_devel	PMC-2806624-01-INTRODUCTION.s23	Because of the involvement of RUNX mutations in different autoimmune diseases and the known interaction with TGF-beta, we investigated the impact of RUNX1 and RUNX3 on the expression of FOXP3 and subsequently on the development and function of iT reg cells.	149-154	RUNX1	acute myeloid leukemia 1 protein	C0215508	T116|T123	Protein	186-191	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	58-77	autoimmune diseases	Autoimmune Diseases	C0004364	T047	-901	Regulation	Forward	FALSE	NA
20194	GE11_devel	PMC-2806624-01-INTRODUCTION.s23	Because of the involvement of RUNX mutations in different autoimmune diseases and the known interaction with TGF-beta, we investigated the impact of RUNX1 and RUNX3 on the expression of FOXP3 and subsequently on the development and function of iT reg cells.	159-164	RUNX3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	186-191	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	58-77	autoimmune diseases	Autoimmune Diseases	C0004364	T047	-901	Regulation	Forward	FALSE	NA
20195	GE11_devel	PMC-2806624-01-INTRODUCTION.s23	Because of the involvement of RUNX mutations in different autoimmune diseases and the known interaction with TGF-beta, we investigated the impact of RUNX1 and RUNX3 on the expression of FOXP3 and subsequently on the development and function of iT reg cells.	30-34	RUNX	Core Binding Factor alpha Subunits	C0137833	T116|T123	Protein	109-117	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	58-77	autoimmune diseases	Autoimmune Diseases	C0004364	T047	-901	Binding	NA	FALSE	NA
20208	GE11_devel	PMC-2806624-07-DISCUSSION.s45	Derepression of Th2 cytokines might also account for some of the observed disease symptoms, as it was shown that T-bet first induces Runx3 in Th1 cells and then partners with Runx3 to direct lineage-specific gene activation.	113-118	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	133-138	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	74-81	disease	Disease	C0012634	T047	-660	Increase	Forward	FALSE	NA
20209	GE11_devel	PMC-2806624-07-DISCUSSION.s45	Derepression of Th2 cytokines might also account for some of the observed disease symptoms, as it was shown that T-bet first induces Runx3 in Th1 cells and then partners with Runx3 to direct lineage-specific gene activation.	113-118	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	133-138	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	82-90	symptoms	SYMPTOMS	C1457887	T184	-827	Increase	Forward	FALSE	NA
20210	GE11_devel	PMC-2806624-07-DISCUSSION.s45	Derepression of Th2 cytokines might also account for some of the observed disease symptoms, as it was shown that T-bet first induces Runx3 in Th1 cells and then partners with Runx3 to direct lineage-specific gene activation.	113-118	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	175-180	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	74-81	disease	Disease	C0012634	T047	-660	Binding	NA	FALSE	NA
20211	GE11_devel	PMC-2806624-07-DISCUSSION.s45	Derepression of Th2 cytokines might also account for some of the observed disease symptoms, as it was shown that T-bet first induces Runx3 in Th1 cells and then partners with Runx3 to direct lineage-specific gene activation.	113-118	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	175-180	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	82-90	symptoms	SYMPTOMS	C1457887	T184	-827	Binding	NA	FALSE	NA
20212	GE11_devel	PMC-2806624-07-DISCUSSION.s46	Runx3/Cbfbeta are both required for the activation of the Ifng gene and silencing of the Il4 gene in Th1 cells (Djuretic et al., 2007; Naoe et al., 2007).	0-5	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	58-62	Ifng	Interferon Type II	C0021745	T116|T121|T129	Protein	72-81	silencing	silence	C0858952	T048	-966	Increase	Forward	FALSE	NA
20213	GE11_devel	PMC-2806624-07-DISCUSSION.s46	Runx3/Cbfbeta are both required for the activation of the Ifng gene and silencing of the Il4 gene in Th1 cells (Djuretic et al., 2007; Naoe et al., 2007).	0-5	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	89-92	Il4	Interleukin-4	C0021758	T116|T129	Protein	72-81	silencing	silence	C0858952	T048	-966	Decrease	Forward	FALSE	NA
20214	GE11_devel	PMC-2806624-07-DISCUSSION.s46	Runx3/Cbfbeta are both required for the activation of the Ifng gene and silencing of the Il4 gene in Th1 cells (Djuretic et al., 2007; Naoe et al., 2007).	6-13	Cbfbeta	Core Binding Factor beta Subunit	C0285599	T116|T123	Protein	58-62	Ifng	Interferon Type II	C0021745	T116|T121|T129	Protein	72-81	silencing	silence	C0858952	T048	-966	Increase	Forward	FALSE	NA
20215	GE11_devel	PMC-2806624-07-DISCUSSION.s46	Runx3/Cbfbeta are both required for the activation of the Ifng gene and silencing of the Il4 gene in Th1 cells (Djuretic et al., 2007; Naoe et al., 2007).	6-13	Cbfbeta	Core Binding Factor beta Subunit	C0285599	T116|T123	Protein	89-92	Il4	Interleukin-4	C0021758	T116|T129	Protein	72-81	silencing	silence	C0858952	T048	-966	Decrease	Forward	FALSE	NA
20216	GE11_devel	PMC-2806624-07-DISCUSSION.s53	RUNX1 interacts physically with Foxp3 protein, and it was demonstrated that this interaction might be responsible for the suppression of IL-2 and IFN-gamma production and up-regulation of T reg cell-associated molecules (Ono et al., 2007).	0-5	RUNX1	acute myeloid leukemia 1 protein	C0215508	T116|T123	Protein	32-37	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	122-133	suppression	Suppression	C0221103	T046	-1000	Binding	NA	FALSE	NA
20228	GE11_train	10069428.s0	Evidence for suppressed activity of the transcription factor NFAT1 at its proximal binding element P0 in the IL-4 promoter associated with enhanced IL-4 gene transcription in T cells of atopic patients.	61-66	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	109-113	IL-4	Interleukin-4	C0021758	T116|T129	Protein	186-192	atopic	atopic	C0392707	T046	-694	Binding	NA	TRUE	NA
20244	GE11_train	10201929.s4	Interaction between immunoglobulin-like transcript-2/leukocyte Ig-like receptor 1 on NKL cells and HLA-B27 on target cells leads to an impairment of NKL natural cytotoxicity, which correlates with an absence of JunB, FosB, and c-Fos transcription, as well as an absence of their DNA-binding activity.	20-52	immunoglobulin-like transcript-2	Leukocyte Immunoglobulin-like Receptor B1	C4319688	T116	Protein	99-106	HLA-B27	HLA-B27 Antigen	C0019740	T116|T129	Protein	135-145	impairment	Impairment	C0684336	T046	-1000	Binding	NA	FALSE	NA
20245	GE11_train	10201929.s4	Interaction between immunoglobulin-like transcript-2/leukocyte Ig-like receptor 1 on NKL cells and HLA-B27 on target cells leads to an impairment of NKL natural cytotoxicity, which correlates with an absence of JunB, FosB, and c-Fos transcription, as well as an absence of their DNA-binding activity.	20-52	immunoglobulin-like transcript-2	Leukocyte Immunoglobulin-like Receptor B1	C4319688	T116	Protein	99-106	HLA-B27	HLA-B27 Antigen	C0019740	T116|T129	Protein	161-173	cytotoxicity	Cytotoxicity	C0596402	T049	-827	Binding	NA	FALSE	NA
20246	GE11_train	10201929.s4	Interaction between immunoglobulin-like transcript-2/leukocyte Ig-like receptor 1 on NKL cells and HLA-B27 on target cells leads to an impairment of NKL natural cytotoxicity, which correlates with an absence of JunB, FosB, and c-Fos transcription, as well as an absence of their DNA-binding activity.	20-52	immunoglobulin-like transcript-2	Leukocyte Immunoglobulin-like Receptor B1	C4319688	T116	Protein	99-106	HLA-B27	HLA-B27 Antigen	C0019740	T116|T129	Protein	200-207	absence	Absence	C1689985	T190	-1000	Binding	NA	FALSE	NA
20247	GE11_train	10201929.s4	Interaction between immunoglobulin-like transcript-2/leukocyte Ig-like receptor 1 on NKL cells and HLA-B27 on target cells leads to an impairment of NKL natural cytotoxicity, which correlates with an absence of JunB, FosB, and c-Fos transcription, as well as an absence of their DNA-binding activity.	20-52	immunoglobulin-like transcript-2	Leukocyte Immunoglobulin-like Receptor B1	C4319688	T116	Protein	99-106	HLA-B27	HLA-B27 Antigen	C0019740	T116|T129	Protein	262-269	absence	Absence	C1689985	T190	-1000	Binding	NA	FALSE	NA
20248	GE11_train	10201929.s4	Interaction between immunoglobulin-like transcript-2/leukocyte Ig-like receptor 1 on NKL cells and HLA-B27 on target cells leads to an impairment of NKL natural cytotoxicity, which correlates with an absence of JunB, FosB, and c-Fos transcription, as well as an absence of their DNA-binding activity.	53-81	leukocyte Ig-like receptor 1	LMIR1 protein, mouse	C1311182	T192|T116	Protein	99-106	HLA-B27	HLA-B27 Antigen	C0019740	T116|T129	Protein	135-145	impairment	Impairment	C0684336	T046	-1000	Binding	NA	FALSE	NA
20249	GE11_train	10201929.s4	Interaction between immunoglobulin-like transcript-2/leukocyte Ig-like receptor 1 on NKL cells and HLA-B27 on target cells leads to an impairment of NKL natural cytotoxicity, which correlates with an absence of JunB, FosB, and c-Fos transcription, as well as an absence of their DNA-binding activity.	53-81	leukocyte Ig-like receptor 1	LMIR1 protein, mouse	C1311182	T192|T116	Protein	99-106	HLA-B27	HLA-B27 Antigen	C0019740	T116|T129	Protein	161-173	cytotoxicity	Cytotoxicity	C0596402	T049	-827	Binding	NA	FALSE	NA
20250	GE11_train	10201929.s4	Interaction between immunoglobulin-like transcript-2/leukocyte Ig-like receptor 1 on NKL cells and HLA-B27 on target cells leads to an impairment of NKL natural cytotoxicity, which correlates with an absence of JunB, FosB, and c-Fos transcription, as well as an absence of their DNA-binding activity.	53-81	leukocyte Ig-like receptor 1	LMIR1 protein, mouse	C1311182	T192|T116	Protein	99-106	HLA-B27	HLA-B27 Antigen	C0019740	T116|T129	Protein	200-207	absence	Absence	C1689985	T190	-1000	Binding	NA	FALSE	NA
20251	GE11_train	10201929.s4	Interaction between immunoglobulin-like transcript-2/leukocyte Ig-like receptor 1 on NKL cells and HLA-B27 on target cells leads to an impairment of NKL natural cytotoxicity, which correlates with an absence of JunB, FosB, and c-Fos transcription, as well as an absence of their DNA-binding activity.	53-81	leukocyte Ig-like receptor 1	LMIR1 protein, mouse	C1311182	T192|T116	Protein	99-106	HLA-B27	HLA-B27 Antigen	C0019740	T116|T129	Protein	262-269	absence	Absence	C1689985	T190	-1000	Binding	NA	FALSE	NA
20252	GE11_train	10221643.s5	That is, a dominant negative GSK-3beta does not specifically activate Tcf transcription and stimuli (lithium or phytohemagglutinin) that inhibit GSK-3beta activity also do not activate Tcf reporter genes.	112-130	phytohemagglutinin	Phytohemagglutinins	C0031858	T116|T129|T130	Protein	145-154	GSK-3beta	glycogen synthase kinase 3 beta	C0244988	T116|T126	Protein	11-28	dominant negative	Dominant Negative	C1512032	T049	-694	Decrease	Forward	FALSE	NA
20256	GE11_train	10228008.s4	Reporter luciferase gene vectors containing the human gamma 3 ECS were used to transfect CL-01 cells, which have been shown to undergo Smu-->S gamma 3 DNA recombination, upon engagement of CD40 by CD40 ligand (CD40L) and exposure to IL-4.	189-193	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	197-208	CD40 ligand	CD40 Ligand	C0167627	T116|T129	Protein	221-229	exposure	Exposure NOS	C0274281	T037	-1000	Binding	NA	FALSE	NA
20257	GE11_train	10228008.s4	Reporter luciferase gene vectors containing the human gamma 3 ECS were used to transfect CL-01 cells, which have been shown to undergo Smu-->S gamma 3 DNA recombination, upon engagement of CD40 by CD40 ligand (CD40L) and exposure to IL-4.	189-193	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	210-215	CD40L	CD40 Ligand	C0167627	T116|T129	Protein	221-229	exposure	Exposure NOS	C0274281	T037	-1000	Binding	NA	FALSE	NA
20258	GE11_train	10228008.s5	In these transfected CL-01 cells, CD40:CD40L engagement and exposure to IL-4 synergistically induced gamma 3 ECS-dependent luciferase reporter gene activation.	34-38	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	39-44	CD40L	CD40 Ligand	C0167627	T116|T129	Protein	60-68	exposure	Exposure NOS	C0274281	T037	-1000	Binding	NA	FALSE	NA
20259	GE11_train	10228026.s0	Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion.	0-8	Thrombin	Thrombin	C0040018	T116|T121|T126	Protein	106-112	ICAM-1	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	139-147	adhesion	ADHESION	C0001511	T046	-861	Increase	Forward	FALSE	NA
20260	GE11_train	10228026.s0	Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion.	0-8	Thrombin	Thrombin	C0040018	T116|T121|T126	Protein	17-20	p65	RELA protein, human	C1567060	T116|T123	Protein	139-147	adhesion	ADHESION	C0001511	T046	-861	Regulation	Forward	FALSE	NA
20261	GE11_train	10228026.s1	We investigated the mechanisms by which proinflammatory mediator, thrombin, released during intravascular coagulation and tissue injury, induces ICAM-1 (CD54) expression in endothelial cells.	66-74	thrombin	Thrombin	C0040018	T116|T121|T126	Protein	145-151	ICAM-1	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	129-135	injury	INJURY	C3263723	T037	-861	Increase	Forward	FALSE	negation
20262	GE11_train	10228026.s1	We investigated the mechanisms by which proinflammatory mediator, thrombin, released during intravascular coagulation and tissue injury, induces ICAM-1 (CD54) expression in endothelial cells.	66-74	thrombin	Thrombin	C0040018	T116|T121|T126	Protein	145-151	ICAM-1	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	129-135	injury	Injury	C3263722	T037	-861	Increase	Forward	FALSE	negation
20263	GE11_train	10228026.s1	We investigated the mechanisms by which proinflammatory mediator, thrombin, released during intravascular coagulation and tissue injury, induces ICAM-1 (CD54) expression in endothelial cells.	66-74	thrombin	Thrombin	C0040018	T116|T121|T126	Protein	153-157	CD54	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	129-135	injury	INJURY	C3263723	T037	-861	Increase	Forward	FALSE	negation
20264	GE11_train	10228026.s1	We investigated the mechanisms by which proinflammatory mediator, thrombin, released during intravascular coagulation and tissue injury, induces ICAM-1 (CD54) expression in endothelial cells.	66-74	thrombin	Thrombin	C0040018	T116|T121|T126	Protein	153-157	CD54	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	129-135	injury	Injury	C3263722	T037	-861	Increase	Forward	FALSE	negation
20265	GE11_train	10228026.s7	These data indicate that thrombin activates endothelial ICAM-1 expression and polymorphonuclear leukocyte adhesion by NF-kappa Bp65 binding to the downstream NF-kappa B site of ICAM-1 promoter after proteolytically activated receptor-1 activation.	128-131	p65	RELA protein, human	C1567060	T116|T123	Protein	177-183	ICAM-1	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	106-114	adhesion	ADHESION	C0001511	T046	-827	Binding	NA	FALSE	NA
20266	GE11_train	10228026.s7	These data indicate that thrombin activates endothelial ICAM-1 expression and polymorphonuclear leukocyte adhesion by NF-kappa Bp65 binding to the downstream NF-kappa B site of ICAM-1 promoter after proteolytically activated receptor-1 activation.	25-33	thrombin	Thrombin	C0040018	T116|T121|T126	Protein	56-62	ICAM-1	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	106-114	adhesion	ADHESION	C0001511	T046	-827	Increase	Forward	FALSE	NA
20270	GE11_train	10229815.s1	CTLA-4 engagement by mAbs inhibits, while CD28 enhances, IL-2 production and proliferation upon T cell activation.	42-46	CD28	CD28 Antigens	C0075747	T116|T129|T192	Protein	57-61	IL-2	Interleukin-2	C0021756	T116|T129	Protein	77-90	proliferation	Proliferation	C0334094	T046	-1000	Increase	Forward	FALSE	NA
20271	GE11_train	10329626.s4	Both c-Rel and RelA induced jagged1 gene expression, whereas a mutant defective for transactivation did not.	15-19	RelA	Transcription Factor RelA	C0214222	T116|T123	Protein	28-35	jagged1	Jagged-1 Protein	C4085258	T192|T116	Protein	63-69	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
20272	GE11_train	10329626.s4	Both c-Rel and RelA induced jagged1 gene expression, whereas a mutant defective for transactivation did not.	5-10	c-Rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	28-35	jagged1	Jagged-1 Protein	C4085258	T192|T116	Protein	63-69	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	NA
20273	GE11_train	10329626.s5	Importantly, jagged1 transcripts were also upregulated by endogenous NF-kappaB activation and this effect was inhibited by a dominant mutant of IkappaBalpha, a physiological inhibitor of NF-kappaB.	144-156	IkappaBalpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	13-20	jagged1	Jagged-1 Protein	C4085258	T192|T116	Protein	134-140	mutant	Mutant	C0596988	T049	-861	Decrease	Backward	TRUE	NA
20274	GE11_train	10330189.s4	We have introduced a small deletion within beta-catenin (Delta19) that disrupts binding to LEF-1, E-cadherin, and APC but not axin.	43-55	beta-catenin	beta catenin	C0105770	T116|T123	Protein	114-117	APC	anaphase-promoting complex	C0526999	T116|T126	Protein	27-35	deletion	Deletion	C1442161	T049	-861	Binding	NA	TRUE	reverse
20276	GE11_train	10330189.s4	We have introduced a small deletion within beta-catenin (Delta19) that disrupts binding to LEF-1, E-cadherin, and APC but not axin.	43-55	beta-catenin	beta catenin	C0105770	T116|T123	Protein	91-96	LEF-1	lymphoid enhancer-binding factor 1	C0125440	T116|T123	Protein	27-35	deletion	Deletion	C1442161	T049	-861	Binding	NA	TRUE	reverse
20277	GE11_train	10330189.s4	We have introduced a small deletion within beta-catenin (Delta19) that disrupts binding to LEF-1, E-cadherin, and APC but not axin.	43-55	beta-catenin	beta catenin	C0105770	T116|T123	Protein	98-108	E-cadherin	E-Cadherin	C0042172	T116|T123	Protein	27-35	deletion	Deletion	C1442161	T049	-861	Binding	NA	TRUE	reverse
20278	GE11_train	10339475.s3	We found that overexpression of IkappaB-alpha in endothelial cells using a recombinant adenovirus prevented tumor necrosis factor-alpha (TNF-alpha)-induced degradation of IkappaB-alpha and suppressed the upregulation of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin mRNA and surface protein expression and the upregulation of transcripts for the chemokines monocyte chemoattractant protein 1 (MCP-1) and growth-related activity-alpha (GRO-alpha) by TNF-alpha.	108-135	tumor necrosis factor-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	171-184	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	87-97	adenovirus	Adenovirus	C0001486	T047	-861	Regulation	Forward	TRUE	reverse
20279	GE11_train	10339475.s3	We found that overexpression of IkappaB-alpha in endothelial cells using a recombinant adenovirus prevented tumor necrosis factor-alpha (TNF-alpha)-induced degradation of IkappaB-alpha and suppressed the upregulation of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin mRNA and surface protein expression and the upregulation of transcripts for the chemokines monocyte chemoattractant protein 1 (MCP-1) and growth-related activity-alpha (GRO-alpha) by TNF-alpha.	137-146	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	171-184	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	87-97	adenovirus	Adenovirus	C0001486	T047	-861	Regulation	Forward	TRUE	reverse
20280	GE11_train	10339475.s3	We found that overexpression of IkappaB-alpha in endothelial cells using a recombinant adenovirus prevented tumor necrosis factor-alpha (TNF-alpha)-induced degradation of IkappaB-alpha and suppressed the upregulation of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin mRNA and surface protein expression and the upregulation of transcripts for the chemokines monocyte chemoattractant protein 1 (MCP-1) and growth-related activity-alpha (GRO-alpha) by TNF-alpha.	506-515	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	414-448	monocyte chemoattractant protein 1	Monocyte Chemoattractant Protein-1	C0128897	T116|T129	Protein	87-97	adenovirus	Adenovirus	C0001486	T047	-861	Increase	Backward	TRUE	reverse
20281	GE11_train	10339475.s3	We found that overexpression of IkappaB-alpha in endothelial cells using a recombinant adenovirus prevented tumor necrosis factor-alpha (TNF-alpha)-induced degradation of IkappaB-alpha and suppressed the upregulation of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin mRNA and surface protein expression and the upregulation of transcripts for the chemokines monocyte chemoattractant protein 1 (MCP-1) and growth-related activity-alpha (GRO-alpha) by TNF-alpha.	506-515	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	450-455	MCP-1	Monocyte Chemoattractant Protein-1	C0128897	T116|T129	Protein	87-97	adenovirus	Adenovirus	C0001486	T047	-861	Increase	Backward	TRUE	reverse
20282	GE11_train	10339475.s3	We found that overexpression of IkappaB-alpha in endothelial cells using a recombinant adenovirus prevented tumor necrosis factor-alpha (TNF-alpha)-induced degradation of IkappaB-alpha and suppressed the upregulation of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin mRNA and surface protein expression and the upregulation of transcripts for the chemokines monocyte chemoattractant protein 1 (MCP-1) and growth-related activity-alpha (GRO-alpha) by TNF-alpha.	506-515	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	461-490	growth-related activity-alpha	Chemokine CXCL1	C3887572	T116|T123	Protein	87-97	adenovirus	Adenovirus	C0001486	T047	-861	Increase	Backward	TRUE	reverse
20283	GE11_train	10339475.s3	We found that overexpression of IkappaB-alpha in endothelial cells using a recombinant adenovirus prevented tumor necrosis factor-alpha (TNF-alpha)-induced degradation of IkappaB-alpha and suppressed the upregulation of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin mRNA and surface protein expression and the upregulation of transcripts for the chemokines monocyte chemoattractant protein 1 (MCP-1) and growth-related activity-alpha (GRO-alpha) by TNF-alpha.	506-515	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	492-501	GRO-alpha	Chemokine CXCL1	C3887572	T116|T123	Protein	87-97	adenovirus	Adenovirus	C0001486	T047	-861	Increase	Backward	TRUE	reverse
20285	GE11_train	10359895.s11	CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors binding to the -90/-79 sequence within the proximal IL-5 promoter are involved in suppression of IL-5 transcription in T cells.	28-32	Oct1	octamer transcription factor OTF-1	C0069117	T116|T123	Protein	116-120	IL-5	Interleukin-5	C0021759	T116|T129	Protein	146-157	suppression	Suppression	C0221103	T046	-1000	Binding	NA	FALSE	NA
20286	GE11_train	10359895.s11	CONCLUSION: We suggest that Oct1, YY1, and octamer-like factors binding to the -90/-79 sequence within the proximal IL-5 promoter are involved in suppression of IL-5 transcription in T cells.	34-37	YY1	YY1 Transcription Factor	C0903890	T116|T123	Protein	116-120	IL-5	Interleukin-5	C0021759	T116|T129	Protein	146-157	suppression	Suppression	C0221103	T046	-1000	Binding	NA	FALSE	NA
20287	GE11_train	10369255.s0	A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria [see comments]	28-33	OCT-1	octamer transcription factor OTF-1	C0069117	T116|T123	Protein	49-52	TNF	Tumor Necrosis Factors	C0041368	T116|T129	Protein	95-102	malaria	MALARIA	C0024530	T047	-861	Binding	NA	FALSE	NA
20288	GE11_train	10377075.s10	CONCLUSIONS: Human ECs express PPARalpha, a potentially important regulator of atherogenesis through its transcriptional control of VCAM-1 gene expression.	31-40	PPARalpha	PPAR alpha	C0166415	T116|T192	Protein	132-138	VCAM-1	Vascular Cell Adhesion Molecule-1	C0078056	T116|T129	Protein	79-92	atherogenesis	Atherogenesis	C1563937	T046	-1000	Regulation	Forward	FALSE	NA
20289	GE11_train	10423406.s11	We postulate that MBP-induced release of IL-8 by neutrophils may contribute to the pathophysiology of acute asthma and other inflammatory lung diseases.	18-21	MBP	Eosinophil Major Basic Protein	C0059406	T129|T116|T121	Protein	41-45	IL-8	Interleukin-8	C0079633	T116|T129	Protein	102-114	acute asthma	Acute asthma	C0582415	T047	-1000	Regulation	Forward	FALSE	NA
20290	GE11_train	10423406.s11	We postulate that MBP-induced release of IL-8 by neutrophils may contribute to the pathophysiology of acute asthma and other inflammatory lung diseases.	18-21	MBP	Eosinophil Major Basic Protein	C0059406	T129|T116|T121	Protein	41-45	IL-8	Interleukin-8	C0079633	T116|T129	Protein	138-151	lung diseases	Lung Diseases	C0024115	T047	-901	Regulation	Forward	FALSE	NA
20291	GE11_train	10423406.s11	We postulate that MBP-induced release of IL-8 by neutrophils may contribute to the pathophysiology of acute asthma and other inflammatory lung diseases.	18-21	MBP	Eosinophil Major Basic Protein	C0059406	T129|T116|T121	Protein	41-45	IL-8	Interleukin-8	C0079633	T116|T129	Protein	83-98	pathophysiology	Pathophysiology	C0277785	T046	-1000	Regulation	Forward	FALSE	NA
20294	GE11_train	10477716.s0	Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation.	78-105	tumor necrosis factor alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	45-58	interleukin-8	Interleukin-8	C0079633	T116|T129	Protein	135-144	sensitive	Sensitive	C0020517	T046	-645	Increase	Backward	FALSE	NA
20295	GE11_train	10477716.s6	TNFalpha treatment induces a rapid translocation of the 65 kD transcriptional activator NF-kappaB subunit, Rel A, whose binding in the nucleus occurs before changes in intracellular ROS.	0-8	TNFalpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	107-112	Rel A	Transcription Factor RelA	C0214222	T116|T123	Protein	35-48	translocation	Translocation	C0040715	T049	-861	Regulation	Forward	FALSE	NA
20296	GE11_train	10477716.s6	TNFalpha treatment induces a rapid translocation of the 65 kD transcriptional activator NF-kappaB subunit, Rel A, whose binding in the nucleus occurs before changes in intracellular ROS.	0-8	TNFalpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	107-112	Rel A	Transcription Factor RelA	C0214222	T116|T123	Protein	59-61	kD	KD	C0026691	T047	-629	Regulation	Forward	FALSE	NA
20297	GE11_train	10477716.s6	TNFalpha treatment induces a rapid translocation of the 65 kD transcriptional activator NF-kappaB subunit, Rel A, whose binding in the nucleus occurs before changes in intracellular ROS.	0-8	TNFalpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	107-112	Rel A	Transcription Factor RelA	C0214222	T116|T123	Protein	59-61	kD	KD	C1839259	T047	-629	Regulation	Forward	FALSE	NA
20301	GE11_train	10482545.s8	Furthermore, Tax-induced transactivation of the bcl-x promoter was also diminished by the mutant IkappaBalpha, which specifically inhibits NF-kappaB activity.	13-16	Tax	Paclitaxel	C0144576	T109|T121	Protein	48-53	bcl-x	bcl-x protein	C0219472	T116|T123	Protein	90-96	mutant	Mutant	C0596988	T049	-694	Increase	Forward	TRUE	reverse
20305	GE11_train	10482545.s8	Furthermore, Tax-induced transactivation of the bcl-x promoter was also diminished by the mutant IkappaBalpha, which specifically inhibits NF-kappaB activity.	97-109	IkappaBalpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	48-53	bcl-x	bcl-x protein	C0219472	T116|T123	Protein	90-96	mutant	Mutant	C0596988	T049	-694	Decrease	Backward	TRUE	NA
20321	GE11_train	1493333.s5	Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.	325-330	MAD-3	MAD3 protein, S cerevisiae	C0913599	T116	Protein	345-348	p65	RELA protein, human	C1567060	T116|T123	Protein	438-446	deletion	Deletion	C1442161	T049	-861	Binding	NA	FALSE	NA
20322	GE11_train	1493333.s5	Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.	325-330	MAD-3	MAD3 protein, S cerevisiae	C0913599	T116	Protein	345-348	p65	RELA protein, human	C1567060	T116|T123	Protein	76-83	mutants	mutants	C0596988	T049	-804	Binding	NA	FALSE	NA
20326	GE11_train	1493333.s5	Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.	542-545	p65	RELA protein, human	C1567060	T116|T123	Protein	587-592	MAD-3	MAD3 protein, S cerevisiae	C0913599	T116	Protein	438-446	deletion	Deletion	C1442161	T049	-861	Binding	NA	TRUE	reverse
20327	GE11_train	1493333.s5	Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.	542-545	p65	RELA protein, human	C1567060	T116|T123	Protein	587-592	MAD-3	MAD3 protein, S cerevisiae	C0913599	T116	Protein	76-83	mutants	mutants	C0596988	T049	-804	Binding	NA	FALSE	NA
20331	GE11_train	1493333.s5	Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.	637-640	p65	RELA protein, human	C1567060	T116|T123	Protein	770-773	p65	RELA protein, human	C1567060	T116|T123	Protein	438-446	deletion	Deletion	C1442161	T049	-861	Regulation	Forward	FALSE	NA
20332	GE11_train	1493333.s5	Results from in vivo expression studies performed with these NF-kappa B p65 mutants revealed the following: 1) I kappa B/MAD-3 completely inhibits NF-kappa B p65-dependent transcriptional activation mediated through the human immunodeficiency virus type 1 kappa B enhancer in human T lymphocytes, 2) the binding of I kappa B/MAD-3 to NF-kappa B p65 is sufficient to retarget NF-kappa B p65 from the nucleus to the cytoplasm, 3) selective deletion of the functional nuclear localization signal present in the Rel homology domain of NF-kappa B p65 disrupts its ability to engage I kappa B/MAD-3, and 4) the unique C-terminus of NF-kappa B p65 attenuates its own nuclear localization and contains sequences that are required for I kappa B-mediated inhibition of NF-kappa B p65 DNA binding activity.	637-640	p65	RELA protein, human	C1567060	T116|T123	Protein	770-773	p65	RELA protein, human	C1567060	T116|T123	Protein	76-83	mutants	mutants	C0596988	T049	-804	Regulation	Forward	FALSE	NA
20335	GE11_train	2196387.s4	Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes, the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer, is inhibited in the presence of CsA.	143-149	NFAT-1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	169-182	interleukin-2	Interleukin-2	C0021756	T116|T129	Protein	225-228	CsA	CSA	C0520680	T047	-1000	Binding	NA	TRUE	reverse
20338	GE11_train	7512565.s8	Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.	173-176	Sp1	Sp1 Transcription Factor	C0080245	T116|T123	Protein	236-240	CD14	CD14 Antigen	C0108768	T116|T129|T192	Protein	0-8	Mutation	Mutation	C1705285	T049	-1000	Regulation	Forward	FALSE	NA
20339	GE11_train	7522548.s3	Since kappa B motifs are present in VCAM-1 and intercellular adhesion molecule-1 (ICAM-1) promoters, we used PDTC to study the regulatory mechanisms of VCAM-1 and ICAM-1 induction and subsequent monocyte adhesion in TNF-treated human umbilical vein endothelial cells (HUVECs).	216-219	TNF	Tumor Necrosis Factors	C0041368	T116|T129	Protein	152-158	VCAM-1	Vascular Cell Adhesion Molecule-1	C0078056	T116|T129	Protein	204-212	adhesion	ADHESION	C0001511	T046	-827	Increase	Backward	FALSE	negation
20340	GE11_train	7522548.s3	Since kappa B motifs are present in VCAM-1 and intercellular adhesion molecule-1 (ICAM-1) promoters, we used PDTC to study the regulatory mechanisms of VCAM-1 and ICAM-1 induction and subsequent monocyte adhesion in TNF-treated human umbilical vein endothelial cells (HUVECs).	216-219	TNF	Tumor Necrosis Factors	C0041368	T116|T129	Protein	163-169	ICAM-1	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	204-212	adhesion	ADHESION	C0001511	T046	-827	Increase	Backward	FALSE	negation
20341	GE11_train	7524762.s2	In this report, we studied the role of SCL in the proliferation of human peripheral blood burst-forming unit-erythroid (BFU-E) and the effects of Steel factor on SCL expression in proliferating erythroid cells.	146-158	Steel factor	Stem Cell Factor	C0143630	T116|T123	Protein	162-165	SCL	TAL1 protein, human	C0378781	T116|T123	Protein	50-63	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Forward	FALSE	NA
20342	GE11_train	7534293.s1	The cell cycle-dependent transcription factor, E2F-1, regulates the cyclin-like species of the DNA repair enzyme uracil-DNA glycosylase (UDG) gene in human osteosarcoma (Saos-2) cells.	47-52	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	113-135	uracil-DNA glycosylase	uracil-DNA glycosylase	C0077845	T116|T126	Protein	156-168	osteosarcoma	OSTEOSARCOMA	C0029463	T191	-861	Regulation	Forward	TRUE	NA
20343	GE11_train	7534293.s1	The cell cycle-dependent transcription factor, E2F-1, regulates the cyclin-like species of the DNA repair enzyme uracil-DNA glycosylase (UDG) gene in human osteosarcoma (Saos-2) cells.	47-52	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	113-135	uracil-DNA glycosylase	uracil-DNA glycosylase	C0077845	T116|T126	Protein	156-168	osteosarcoma	osteosarcoma	C0585442	T191	-861	Regulation	Forward	TRUE	NA
20344	GE11_train	7534293.s1	The cell cycle-dependent transcription factor, E2F-1, regulates the cyclin-like species of the DNA repair enzyme uracil-DNA glycosylase (UDG) gene in human osteosarcoma (Saos-2) cells.	47-52	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	113-135	uracil-DNA glycosylase	uracil-DNA glycosylase	C0077845	T116|T126	Protein	170-174	Saos	SAO	C1862323	T047	-827	Regulation	Forward	TRUE	NA
20345	GE11_train	7534293.s1	The cell cycle-dependent transcription factor, E2F-1, regulates the cyclin-like species of the DNA repair enzyme uracil-DNA glycosylase (UDG) gene in human osteosarcoma (Saos-2) cells.	47-52	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	137-140	UDG	uracil-DNA glycosylase	C0077845	T116|T126	Protein	156-168	osteosarcoma	OSTEOSARCOMA	C0029463	T191	-861	Regulation	Forward	TRUE	NA
20346	GE11_train	7534293.s1	The cell cycle-dependent transcription factor, E2F-1, regulates the cyclin-like species of the DNA repair enzyme uracil-DNA glycosylase (UDG) gene in human osteosarcoma (Saos-2) cells.	47-52	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	137-140	UDG	uracil-DNA glycosylase	C0077845	T116|T126	Protein	156-168	osteosarcoma	osteosarcoma	C0585442	T191	-861	Regulation	Forward	TRUE	NA
20347	GE11_train	7534293.s1	The cell cycle-dependent transcription factor, E2F-1, regulates the cyclin-like species of the DNA repair enzyme uracil-DNA glycosylase (UDG) gene in human osteosarcoma (Saos-2) cells.	47-52	E2F-1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	137-140	UDG	uracil-DNA glycosylase	C0077845	T116|T126	Protein	170-174	Saos	SAO	C1862323	T047	-827	Regulation	Forward	TRUE	NA
20348	GE11_train	7540942.s2	We demonstrate that cross-linking CD30 with an anti-CD30-specific monoclonal antibody, which mimics the described biological activities of the CD30 ligand (CD30L), results in HIV expression.	34-38	CD30	Antigens, CD30	C0054950	T116|T129	Protein	143-154	CD30 ligand	CD30 Ligand	C0218093	T116	Protein	175-178	HIV	HIV	C0019693	T047	-694	Binding	NA	FALSE	NA
20349	GE11_train	7540942.s2	We demonstrate that cross-linking CD30 with an anti-CD30-specific monoclonal antibody, which mimics the described biological activities of the CD30 ligand (CD30L), results in HIV expression.	34-38	CD30	Antigens, CD30	C0054950	T116|T129	Protein	156-161	CD30L	CD30 Ligand	C0218093	T116	Protein	175-178	HIV	HIV	C0019693	T047	-694	Binding	NA	FALSE	NA
20350	GE11_train	7540942.s5	Thus, CD30-CD30L interactions mediate the induction of HIV expression by a kappa B-dependent pathway that is independent of TNF.	6-10	CD30	Antigens, CD30	C0054950	T116|T129	Protein	11-16	CD30L	CD30 Ligand	C0218093	T116	Protein	55-58	HIV	HIV	C0019693	T047	-694	Binding	NA	FALSE	NA
20361	GE11_train	7635985.s6	Congruous with the involvement of a Stat protein, IL-4 induced robust Janus kinase 3 (JAK3) activity in BL-2 cells.	50-54	IL-4	Interleukin-4	C0021758	T116|T129	Protein	70-84	Janus kinase 3	Janus kinase 3	C0253457	T116|T126	Protein	104-106	BL	BL	C0006413	T191	-660	Increase	Forward	TRUE	NA
20362	GE11_train	7635985.s6	Congruous with the involvement of a Stat protein, IL-4 induced robust Janus kinase 3 (JAK3) activity in BL-2 cells.	50-54	IL-4	Interleukin-4	C0021758	T116|T129	Protein	86-90	JAK3	Janus kinase 3	C0253457	T116|T126	Protein	104-106	BL	BL	C0006413	T191	-660	Increase	Forward	TRUE	NA
20363	GE11_train	7836389.s5	As a consequence of its effect on junB mRNA, IL-6 stimulated, in a biphasic fashion, the nuclear accumulation of the JunB protein.	45-49	IL-6	Interleukin-6	C0021760	T116|T129	Protein	117-121	JunB	jun B Proteins	C0086495	T116|T123	Protein	89-109	nuclear accumulation	Nuclear accumulation	C0544910	T049	-1000	Regulation	Forward	FALSE	NA
20364	GE11_train	7836389.s5	As a consequence of its effect on junB mRNA, IL-6 stimulated, in a biphasic fashion, the nuclear accumulation of the JunB protein.	45-49	IL-6	Interleukin-6	C0021760	T116|T129	Protein	34-38	junB	jun B Proteins	C0086495	T116|T123	Protein	89-109	nuclear accumulation	Nuclear accumulation	C0544910	T049	-1000	Regulation	Backward	FALSE	NA
20365	GE11_train	7843230.s11	TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.	0-9	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	140-143	p65	RELA protein, human	C1567060	T116|T123	Protein	123-136	translocation	Translocation	C0040715	T049	-1000	Regulation	Forward	FALSE	NA
20366	GE11_train	7843230.s11	TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.	0-9	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	148-153	c-rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	123-136	translocation	Translocation	C0040715	T049	-1000	Regulation	Forward	FALSE	NA
20367	GE11_train	7843230.s11	TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.	0-9	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	182-187	c-rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	123-136	translocation	Translocation	C0040715	T049	-1000	Regulation	Forward	FALSE	NA
20368	GE11_train	7843230.s11	TNF-alpha, therefore, emerges as the main factor responsible for a second phase of NF-kappa B regulation, controlling both translocation of p65 and c-rel, and new mRNA synthesis for c-rel and p105/p50.	0-9	TNF-alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	197-200	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Protein	123-136	translocation	Translocation	C0040715	T049	-1000	Regulation	Forward	FALSE	NA
20369	GE11_train	7843230.s8	Similarly, cycloheximide prevented the p65 and c-rel translocation and consequent formation of active binding heterodimers, at early and late times.	39-42	p65	RELA protein, human	C1567060	T116|T123	Protein	47-52	c-rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	53-66	translocation	Translocation	C0040715	T049	-827	Binding	NA	FALSE	NA
20370	GE11_train	7859735.s4	In this study, we show that an activation-deficient glucocorticoid receptor mutant is as effective as the wild-type receptor in repression of AP-1 activity, inhibition of interleukin-2 production, inhibition of c-myc expression and induction of apoptosis.	52-75	glucocorticoid receptor	Glucocorticoid Receptor	C0034809	T116|T192	Protein	171-184	interleukin-2	Interleukin-2	C0021756	T116|T129	Protein	76-82	mutant	Mutant	C0596988	T049	-804	Decrease	Forward	TRUE	NA
20371	GE11_train	7859735.s4	In this study, we show that an activation-deficient glucocorticoid receptor mutant is as effective as the wild-type receptor in repression of AP-1 activity, inhibition of interleukin-2 production, inhibition of c-myc expression and induction of apoptosis.	52-75	glucocorticoid receptor	Glucocorticoid Receptor	C0034809	T116|T192	Protein	211-216	c-myc	Oncogene protein C-MYC	C0314684	T116|T123	Protein	76-82	mutant	Mutant	C0596988	T049	-804	Decrease	Forward	TRUE	NA
20372	GE11_train	7859743.s6	In both T cells and HeLa cells HIV-1 Tat suppressed the expression of Mn-dependent superoxide dismutase (Mn-SOD), a mitochondrial enzyme that is part of the cellular defense system against oxidative stress.	37-40	Tat	tat Protein	C0039341	T116|T123	Protein	105-111	Mn-SOD	Manganese Superoxide Dismutase	C0024708	T116|T126	Protein	189-205	oxidative stress	Oxidative Stress	C0242606	T049	-1000	Decrease	Forward	FALSE	NA
20373	GE11_train	7859743.s6	In both T cells and HeLa cells HIV-1 Tat suppressed the expression of Mn-dependent superoxide dismutase (Mn-SOD), a mitochondrial enzyme that is part of the cellular defense system against oxidative stress.	37-40	Tat	tat Protein	C0039341	T116|T123	Protein	70-103	Mn-dependent superoxide dismutase	Manganese Superoxide Dismutase	C0024708	T116|T126	Protein	189-205	oxidative stress	Oxidative Stress	C0242606	T049	-1000	Decrease	Forward	FALSE	NA
20375	GE11_train	7929104.s4	This activation was due to the translocation of p65 and c-Rel NF.kappa B proteins from cytoplasmic stores to the nucleus, where they bound the kappa B sequence of the IL-2R alpha promoter either as p50.p65 or as p50.c-Rel heterodimers.	198-201	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Protein	202-205	p65	RELA protein, human	C1567060	T116|T123	Protein	31-44	translocation	Translocation	C0040715	T049	-1000	Binding	NA	FALSE	NA
20376	GE11_train	7929104.s4	This activation was due to the translocation of p65 and c-Rel NF.kappa B proteins from cytoplasmic stores to the nucleus, where they bound the kappa B sequence of the IL-2R alpha promoter either as p50.p65 or as p50.c-Rel heterodimers.	212-215	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Protein	216-221	c-Rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	31-44	translocation	Translocation	C0040715	T049	-1000	Binding	NA	FALSE	NA
20377	GE11_train	7929104.s4	This activation was due to the translocation of p65 and c-Rel NF.kappa B proteins from cytoplasmic stores to the nucleus, where they bound the kappa B sequence of the IL-2R alpha promoter either as p50.p65 or as p50.c-Rel heterodimers.	48-51	p65	RELA protein, human	C1567060	T116|T123	Protein	167-178	IL-2R alpha	IL2RA protein, human	C1700887	T192|T116	Protein	31-44	translocation	Translocation	C0040715	T049	-1000	Binding	NA	FALSE	NA
20378	GE11_train	7929104.s4	This activation was due to the translocation of p65 and c-Rel NF.kappa B proteins from cytoplasmic stores to the nucleus, where they bound the kappa B sequence of the IL-2R alpha promoter either as p50.p65 or as p50.c-Rel heterodimers.	56-61	c-Rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	167-178	IL-2R alpha	IL2RA protein, human	C1700887	T192|T116	Protein	31-44	translocation	Translocation	C0040715	T049	-1000	Binding	NA	FALSE	NA
20382	GE11_train	7964516.s3	This role for c-Myc in apoptosis is now confirmed in studies using a dominant negative form of its heterodimeric binding partner, Max, which we show here inhibits activation-induced apoptosis.	14-19	c-Myc	Oncogene protein C-MYC	C0314684	T116|T123	Protein	130-133	Max	Max protein	C0127092	T116|T123	Protein	69-86	dominant negative	Dominant Negative	C1512032	T049	-901	Binding	NA	FALSE	NA
20383	GE11_train	7964516.s4	Further, coexpression of a reciprocally mutant Myc protein capable of forming functional heterodimers with the mutant Max can compensate for the dominant negative activity and restore activation-induced apoptosis.	47-50	Myc	Proto-Oncogene Proteins c-myc	C0080065	T116|T123	Protein	118-121	Max	Max protein	C0127092	T116|T123	Protein	111-117	mutant	Mutant	C0596988	T049	-694	Binding	NA	TRUE	NA
20384	GE11_train	7964516.s4	Further, coexpression of a reciprocally mutant Myc protein capable of forming functional heterodimers with the mutant Max can compensate for the dominant negative activity and restore activation-induced apoptosis.	47-50	Myc	Proto-Oncogene Proteins c-myc	C0080065	T116|T123	Protein	118-121	Max	Max protein	C0127092	T116|T123	Protein	145-162	dominant negative	Dominant Negative	C1512032	T049	-734	Binding	NA	FALSE	NA
20386	GE11_train	8015552.s9	Hence, the PRL-induced biphasic expression of the IRF-1 gene appears to be controlled by separate PRL-responsive elements: elements in the first 0.2 kb of the IRF-1 promoter region act during early activation, and elements between 0.2 and 1.7 kb act in concert with the proximal 0.2-kb region during S phase progression.	11-14	PRL	Prolactin	C0033371	T116|T121|T125	Protein	50-55	IRF-1	Interferon Regulatory Factor 1	C0063700	T116|T123	Protein	308-319	progression	Progression	C0242656	T046	-827	Increase	Forward	FALSE	NA
20387	GE11_train	8015552.s9	Hence, the PRL-induced biphasic expression of the IRF-1 gene appears to be controlled by separate PRL-responsive elements: elements in the first 0.2 kb of the IRF-1 promoter region act during early activation, and elements between 0.2 and 1.7 kb act in concert with the proximal 0.2-kb region during S phase progression.	159-164	IRF-1	Interferon Regulatory Factor 1	C0063700	T116|T123	Protein	50-55	IRF-1	Interferon Regulatory Factor 1	C0063700	T116|T123	Protein	308-319	progression	Progression	C0242656	T046	-827	Regulation	Backward	FALSE	NA
20388	GE11_train	8015553.s4	We focused our studies on the role of Pit-1 and of PR as potential transcriptional regulators, since the POU domain protein Pit-1 is essential in the control of pituitary PRL expression, and progesterone induces decidual transformation of the endometrial stroma, a differentiation process during which the decidual PRL gene is activated.	124-129	Pit-1	Pituitary-Specific Positive Transcription Factor 1, human	C4521279	T116	Protein	171-174	PRL	Prolactin	C0033371	T116|T121|T125	Protein	161-170	pituitary	Pituitary	C0032002	T047	-660	Regulation	Forward	TRUE	NA
20389	GE11_train	8015553.s4	We focused our studies on the role of Pit-1 and of PR as potential transcriptional regulators, since the POU domain protein Pit-1 is essential in the control of pituitary PRL expression, and progesterone induces decidual transformation of the endometrial stroma, a differentiation process during which the decidual PRL gene is activated.	124-129	Pit-1	Pituitary-Specific Positive Transcription Factor 1, human	C4521279	T116	Protein	171-174	PRL	Prolactin	C0033371	T116|T121|T125	Protein	221-235	transformation	Transformation	C1510411	T046	-861	Regulation	Forward	FALSE	NA
20403	GE11_train	8196620.s7	In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.	50-52	TF	Transferrin	C0040679	T116|T123	Protein	136-141	c-Rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	34-44	conditions	condition	C0012634	T047	-779	Binding	NA	TRUE	NA
20404	GE11_train	8196620.s7	In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.	50-52	TF	Transferrin	C0040679	T116|T123	Protein	142-145	p65	RELA protein, human	C1567060	T116|T123	Protein	34-44	conditions	condition	C0012634	T047	-779	Binding	NA	TRUE	NA
20405	GE11_train	8196620.s7	In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.	50-52	TF	Transferrin	C0040679	T116|T123	Protein	93-96	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Protein	34-44	conditions	condition	C0012634	T047	-779	Binding	NA	TRUE	NA
20406	GE11_train	8196620.s7	In fact, under low-ionic-strength conditions, the TF complex did not migrate with translated p50/p65 dimers but instead comigrated with c-Rel/p65 dimers.	50-52	TF	Transferrin	C0040679	T116|T123	Protein	97-100	p65	RELA protein, human	C1567060	T116|T123	Protein	34-44	conditions	condition	C0012634	T047	-779	Binding	NA	TRUE	NA
20413	GE11_train	8493578.s4	Elf-1 binds exclusively to the underphosphorylated form of Rb and fails to bind to Rb mutants derived from patients with retinoblastoma.	0-5	Elf-1	ELF1 protein, human	C1622262	T116|T123	Protein	59-61	Rb	Retinoblastoma Protein	C0080113	T116|T123	Protein	121-135	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-1000	Binding	NA	FALSE	NA
20414	GE11_train	8493578.s4	Elf-1 binds exclusively to the underphosphorylated form of Rb and fails to bind to Rb mutants derived from patients with retinoblastoma.	0-5	Elf-1	ELF1 protein, human	C1622262	T116|T123	Protein	59-61	Rb	Retinoblastoma Protein	C0080113	T116|T123	Protein	86-93	mutants	mutants	C0596988	T049	-861	Binding	NA	FALSE	NA
20415	GE11_train	8493578.s4	Elf-1 binds exclusively to the underphosphorylated form of Rb and fails to bind to Rb mutants derived from patients with retinoblastoma.	0-5	Elf-1	ELF1 protein, human	C1622262	T116|T123	Protein	83-85	Rb	Retinoblastoma Protein	C0080113	T116|T123	Protein	121-135	retinoblastoma	RETINOBLASTOMA	C0035335	T191	-1000	Binding	NA	TRUE	reverse
20416	GE11_train	8493578.s4	Elf-1 binds exclusively to the underphosphorylated form of Rb and fails to bind to Rb mutants derived from patients with retinoblastoma.	0-5	Elf-1	ELF1 protein, human	C1622262	T116|T123	Protein	83-85	Rb	Retinoblastoma Protein	C0080113	T116|T123	Protein	86-93	mutants	mutants	C0596988	T049	-861	Binding	NA	TRUE	reverse
20417	GE11_train	8605359.s7	Moreover, deletion of either 5' or 3' NF-kappaB sites reduced IL-1alpha promoter activity in MT-2 cells and transactivation of the IL-1alpha promoter by exogenous NF-kappaB and Tax in Jurkat cells.	177-180	Tax	Paclitaxel	C0144576	T109|T121	Protein	131-140	IL-1alpha	IL1A protein, human	C1702299	T116|T123	Protein	10-18	deletion	Deletion	C1442161	T049	-1000	Increase	Backward	TRUE	reverse
20420	GE11_train	8613707.s3	Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.	236-245	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	278-282	iNOS	Nitric Oxide Synthase Type II	C1533698	T116|T126	Protein	301-308	absence	Absence	C1689985	T190	-1000	Increase	Forward	FALSE	NA
20424	GE11_train	8613707.s3	Two explanations for hyporesponsiveness of the human iNOS promoter to LPS +/- IFN-gamma were found: (1) multiple inactivating nucleotide substitutions in the human counterpart of the enhancer element that has been shown to regulate LPS/IFN-gamma induced expression of the mouse iNOS gene; and (2) and absence of one or more nuclear factors in human macrophages (e.g., an LPS-inducible nuclear factor-kappa B/Rel complex), that is (are) required for maximal expression of the gene.	78-87	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	53-57	iNOS	Nitric Oxide Synthase Type II	C1533698	T116|T126	Protein	301-308	absence	Absence	C1689985	T190	-1000	Regulation	Backward	FALSE	NA
20427	GE11_train	8628274.s7	Like IkappaBalpha, Tax-mediated breakdown of IkappaBbeta in transfected T lymphocytes is blocked either by cell-permeable proteasome inhibitors or by mutation Of IkappaBbeta at two serine residues present within its N-terminal region.	19-22	Tax	Paclitaxel	C0144576	T109|T121	Protein	45-56	IkappaBbeta	I kappa B beta protein	C0166033	T116|T123	Protein	150-158	mutation	Mutation	C1705285	T049	-1000	Regulation	Forward	TRUE	reverse
20428	GE11_train	8628274.s7	Like IkappaBalpha, Tax-mediated breakdown of IkappaBbeta in transfected T lymphocytes is blocked either by cell-permeable proteasome inhibitors or by mutation Of IkappaBbeta at two serine residues present within its N-terminal region.	19-22	Tax	Paclitaxel	C0144576	T109|T121	Protein	45-56	IkappaBbeta	I kappa B beta protein	C0166033	T116|T123	Protein	32-41	breakdown	breakdown	C1265875	T020	-827	Regulation	Forward	FALSE	NA
20436	GE11_train	8668213.s7	Recombinant NFAT1 can mediate transcription of the interleukin-2, interleukin-4, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA-sensitive transcription of these genes during the immune response.	201-206	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	114-162	granulocyte-macrophage colony-stimulating factor	Granulocyte-Macrophage Colony-Stimulating Factor	C0079460	T116|T129	Protein	226-229	CsA	CSA	C0520680	T047	-660	Increase	Backward	FALSE	NA
20437	GE11_train	8668213.s7	Recombinant NFAT1 can mediate transcription of the interleukin-2, interleukin-4, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA-sensitive transcription of these genes during the immune response.	201-206	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	114-162	granulocyte-macrophage colony-stimulating factor	Granulocyte-Macrophage Colony-Stimulating Factor	C0079460	T116|T129	Protein	230-239	sensitive	Sensitive	C0020517	T046	-660	Increase	Backward	FALSE	NA
20438	GE11_train	8668213.s7	Recombinant NFAT1 can mediate transcription of the interleukin-2, interleukin-4, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA-sensitive transcription of these genes during the immune response.	201-206	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	51-64	interleukin-2	Interleukin-2	C0021756	T116|T129	Protein	226-229	CsA	CSA	C0520680	T047	-660	Increase	Backward	FALSE	NA
20439	GE11_train	8668213.s7	Recombinant NFAT1 can mediate transcription of the interleukin-2, interleukin-4, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA-sensitive transcription of these genes during the immune response.	201-206	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	51-64	interleukin-2	Interleukin-2	C0021756	T116|T129	Protein	230-239	sensitive	Sensitive	C0020517	T046	-660	Increase	Backward	FALSE	NA
20440	GE11_train	8668213.s7	Recombinant NFAT1 can mediate transcription of the interleukin-2, interleukin-4, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA-sensitive transcription of these genes during the immune response.	201-206	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	66-79	interleukin-4	Interleukin-4	C0021758	T116|T129	Protein	226-229	CsA	CSA	C0520680	T047	-660	Increase	Backward	FALSE	NA
20441	GE11_train	8668213.s7	Recombinant NFAT1 can mediate transcription of the interleukin-2, interleukin-4, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA-sensitive transcription of these genes during the immune response.	201-206	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	66-79	interleukin-4	Interleukin-4	C0021758	T116|T129	Protein	230-239	sensitive	Sensitive	C0020517	T046	-660	Increase	Backward	FALSE	NA
20442	GE11_train	8668213.s7	Recombinant NFAT1 can mediate transcription of the interleukin-2, interleukin-4, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA-sensitive transcription of these genes during the immune response.	201-206	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	81-108	tumor necrosis factor alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	226-229	CsA	CSA	C0520680	T047	-660	Increase	Backward	FALSE	NA
20443	GE11_train	8668213.s7	Recombinant NFAT1 can mediate transcription of the interleukin-2, interleukin-4, tumor necrosis factor alpha, and granulocyte-macrophage colony-stimulating factor promoters in T cells, suggesting that NFAT1 contributes to the CsA-sensitive transcription of these genes during the immune response.	201-206	NFAT1	Nuclear Factor of Activated T-Cells, Cytoplasmic 2	C2985458	T116	Protein	81-108	tumor necrosis factor alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	230-239	sensitive	Sensitive	C0020517	T046	-660	Increase	Backward	FALSE	NA
20444	GE11_train	8757316.s1	The integrin alpha 4 beta 1 can provide a costimulus to induce IL-2 secretion and IL-2R expression leading to enhanced proliferation of purified, peripheral blood T cells.	4-27	integrin alpha 4 beta 1	Integrin alpha4beta1	C0209606	T192|T116	Protein	63-67	IL-2	Interleukin-2	C0021756	T116|T129	Protein	119-132	proliferation	Proliferation	C0334094	T046	-861	Regulation	Forward	FALSE	NA
20445	GE11_train	8757316.s1	The integrin alpha 4 beta 1 can provide a costimulus to induce IL-2 secretion and IL-2R expression leading to enhanced proliferation of purified, peripheral blood T cells.	4-27	integrin alpha 4 beta 1	Integrin alpha4beta1	C0209606	T192|T116	Protein	82-87	IL-2R	Interleukin 2 Receptor	C0034819	T116|T129|T192	Protein	119-132	proliferation	Proliferation	C0334094	T046	-861	Increase	Forward	FALSE	NA
20446	GE11_train	8790371.s2	In contrast, a high level of bcl-2 protects cells in vitro and in vivo from the viral protease and prevents cell death following HIV infection of human lymphocytes, while reducing the yields of viral structural proteins, infectivity, and tumor necrosis factor alpha.	29-34	bcl-2	BCL2 protein, human	C4042483	T116	Protein	238-265	tumor necrosis factor alpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	129-142	HIV infection	HIV Infection	C0019693	T047	-1000	Decrease	Forward	FALSE	NA
20454	GE11_train	8816454.s7	Along with our previous demonstration of both physical interactions between PTF gamma/PTF delta and TBP and the involvement of TFIIIB90 in the transcription of class III snRNA genes, these results are consistent with the notion that a TBP-containing complex related to TFIIIB is required for the transcription of class III snRNA genes, and acts through weak interaction with the four-subunit PTF.	76-85	PTF gamma	SNAPC1 protein, human	C1430231	T116|T123	Protein	100-103	TBP	TATA-Box Binding Protein	C0144555	T116|T123	Protein	353-357	weak	Weak	C3714552	T184	-694	Binding	NA	FALSE	NA
20455	GE11_train	8816454.s7	Along with our previous demonstration of both physical interactions between PTF gamma/PTF delta and TBP and the involvement of TFIIIB90 in the transcription of class III snRNA genes, these results are consistent with the notion that a TBP-containing complex related to TFIIIB is required for the transcription of class III snRNA genes, and acts through weak interaction with the four-subunit PTF.	86-95	PTF delta	SNAPC2 protein, human	C0389553	T116|T123	Protein	100-103	TBP	TATA-Box Binding Protein	C0144555	T116|T123	Protein	353-357	weak	Weak	C3714552	T184	-694	Binding	NA	FALSE	NA
20456	GE11_train	8871617.s6	Analysis of the expression of genes reported to regulate cytokine-induced proliferation demonstrated that both IL-2 and IL-12 induce c-myc mRNA accumulation in NK and T cells, whereas only IL-2 induces bcl-2 expression.	111-115	IL-2	Interleukin-2	C0021756	T116|T129	Protein	133-138	c-myc	Oncogene protein C-MYC	C0314684	T116|T123	Protein	74-87	proliferation	Proliferation	C0334094	T046	-827	Increase	Forward	FALSE	NA
20457	GE11_train	8871617.s6	Analysis of the expression of genes reported to regulate cytokine-induced proliferation demonstrated that both IL-2 and IL-12 induce c-myc mRNA accumulation in NK and T cells, whereas only IL-2 induces bcl-2 expression.	189-193	IL-2	Interleukin-2	C0021756	T116|T129	Protein	202-207	bcl-2	BCL2 protein, human	C4042483	T116	Protein	74-87	proliferation	Proliferation	C0334094	T046	-827	Increase	Forward	FALSE	NA
20458	GE11_train	8934542.s6	In the erythroleukemia cell line K562, due to the absence of Spi-B, only PU.1 bound to the Btk promoter.	73-77	PU.1	proto-oncogene protein Spi-1	C0246120	T116|T123	Protein	91-94	Btk	Agammaglobulinaemia tyrosine kinase	C0218158	T116|T126	Protein	50-57	absence	Absence	C1689985	T190	-1000	Binding	NA	TRUE	NA
20459	GE11_train	8934542.s6	In the erythroleukemia cell line K562, due to the absence of Spi-B, only PU.1 bound to the Btk promoter.	73-77	PU.1	proto-oncogene protein Spi-1	C0246120	T116|T123	Protein	91-94	Btk	Agammaglobulinaemia tyrosine kinase	C0218158	T116|T126	Protein	7-22	erythroleukemia	Erythroleukaemia	C0023440	T191	-645	Binding	NA	TRUE	NA
20473	GE11_train	9111040.s0	Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription.	19-25	NOTCH1	Receptor, Notch1	C0144507	T192|T116	Protein	152-162	RBP-Jkappa	Immunoglobulin J Recombination Signal Sequence-Binding Protein	C0139989	T116|T123	Protein	0-9	Oncogenic	Oncogenesis	C0007621	T191	-623	Binding	NA	TRUE	NA
20474	GE11_train	9111040.s0	Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription.	19-25	NOTCH1	Receptor, Notch1	C0144507	T192|T116	Protein	152-162	RBP-Jkappa	Immunoglobulin J Recombination Signal Sequence-Binding Protein	C0139989	T116|T123	Protein	0-9	Oncogenic	Oncogenesis	C0596263	T191	-623	Binding	NA	TRUE	NA
20475	GE11_train	9133417.s5	Deletion of this sequence abolishes the capacity of CD40 to induce expression of CD23, ICAM-1, and lymphotoxin-alpha genes in B cells.	52-56	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	81-85	CD23	CD23 Antigen	C0123242	T116|T129|T192	Protein	0-8	Deletion	Deletion	C1442161	T049	-1000	Increase	Forward	TRUE	reverse
20476	GE11_train	9133417.s5	Deletion of this sequence abolishes the capacity of CD40 to induce expression of CD23, ICAM-1, and lymphotoxin-alpha genes in B cells.	52-56	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	87-93	ICAM-1	Intercellular adhesion molecule 1	C0063695	T116|T129	Protein	0-8	Deletion	Deletion	C1442161	T049	-1000	Increase	Forward	TRUE	reverse
20477	GE11_train	9133417.s5	Deletion of this sequence abolishes the capacity of CD40 to induce expression of CD23, ICAM-1, and lymphotoxin-alpha genes in B cells.	52-56	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	99-116	lymphotoxin-alpha	Tumor Necrosis Factor-Beta	C0024320	T116|T129	Protein	0-8	Deletion	Deletion	C1442161	T049	-1000	Increase	Forward	TRUE	reverse
20478	GE11_train	9177216.s6	A TBP mutant defective in interaction with TBP-associated factor TAFII250 also failed to mediate transactivation through the CIITA activation domain.	2-5	TBP	TATA-Box Binding Protein	C0144555	T116|T123	Protein	65-73	TAFII250	TAF1 protein, human	C1146629	T116|T123	Protein	6-12	mutant	Mutant	C0596988	T049	-660	Binding	NA	TRUE	reverse
20479	GE11_train	9177217.s0	Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.	99-104	CIITA	MHC2TA protein, human	C1435283	T116|T129	Protein	109-113	RFX5	RFX5 protein, human	C0297437	T116|T123	Protein	39-71	type II bare lymphocyte syndrome	BARE LYMPHOCYTE SYNDROME, TYPE II	C2931418	T047	-723	Binding	NA	TRUE	NA
20480	GE11_train	9218843.s4	We also found that IL-2 protects T cell clones from IL-2 deprivation apoptosis accompanying active proliferation and enhanced expression of P53, Rb and Bcl-xL proteins.	19-23	IL-2	Interleukin-2	C0021756	T116|T129	Protein	140-143	P53	Protein p53	C0080055	T116|T123	Protein	99-112	proliferation	Proliferation	C0334094	T046	-861	Increase	Forward	FALSE	NA
20481	GE11_train	9218843.s4	We also found that IL-2 protects T cell clones from IL-2 deprivation apoptosis accompanying active proliferation and enhanced expression of P53, Rb and Bcl-xL proteins.	19-23	IL-2	Interleukin-2	C0021756	T116|T129	Protein	145-147	Rb	Retinoblastoma Protein	C0080113	T116|T123	Protein	99-112	proliferation	Proliferation	C0334094	T046	-861	Increase	Forward	FALSE	NA
20482	GE11_train	9218843.s4	We also found that IL-2 protects T cell clones from IL-2 deprivation apoptosis accompanying active proliferation and enhanced expression of P53, Rb and Bcl-xL proteins.	19-23	IL-2	Interleukin-2	C0021756	T116|T129	Protein	152-158	Bcl-xL	BCL-XL Protein	C0288330	T116|T123	Protein	99-112	proliferation	Proliferation	C0334094	T046	-861	Increase	Forward	FALSE	NA
20483	GE11_train	9233623.s6	Bacterially expressed RP1 protein revealed specific binding to wild-type but not to mutated APC protein.	22-25	RP1	MAPRE2 protein, human	C3849158	T116|T123	Protein	92-95	APC	anaphase-promoting complex	C0526999	T116|T126	Protein	84-91	mutated	Mutated	C1705285	T049	-660	Binding	NA	FALSE	negation
20485	GE11_train	9341193.s1	Transcriptional up-regulation of the c-sis/platelet-derived growth factor-B (PDGF-B) proto-oncogene by the Tax protein of human T-cell leukemia virus type 1 has been implicated as one possible mechanism of cellular transformation by human T-cell leukemia virus type 1.	107-110	Tax	Paclitaxel	C0144576	T109|T121	Protein	37-42	c-sis	Becaplermin	C0379135	T116|T121|T123	Protein	206-229	cellular transformation	Cellular Transformation	C1510411	T046	-1000	Increase	Backward	FALSE	NA
20486	GE11_train	9341193.s1	Transcriptional up-regulation of the c-sis/platelet-derived growth factor-B (PDGF-B) proto-oncogene by the Tax protein of human T-cell leukemia virus type 1 has been implicated as one possible mechanism of cellular transformation by human T-cell leukemia virus type 1.	107-110	Tax	Paclitaxel	C0144576	T109|T121	Protein	43-75	platelet-derived growth factor-B	Platelet-Derived Growth Factor Subunit B, human	C3887785	T116|T123	Protein	206-229	cellular transformation	Cellular Transformation	C1510411	T046	-1000	Increase	Backward	FALSE	NA
20487	GE11_train	9341193.s1	Transcriptional up-regulation of the c-sis/platelet-derived growth factor-B (PDGF-B) proto-oncogene by the Tax protein of human T-cell leukemia virus type 1 has been implicated as one possible mechanism of cellular transformation by human T-cell leukemia virus type 1.	107-110	Tax	Paclitaxel	C0144576	T109|T121	Protein	77-83	PDGF-B	Platelet-Derived Growth Factor Subunit B, human	C3887785	T116|T123	Protein	206-229	cellular transformation	Cellular Transformation	C1510411	T046	-1000	Increase	Backward	FALSE	NA
20488	GE11_train	9343210.s7	Furthermore, deletion and mutation analyses of the VCAM-1 promoter performed with chloramphenicol acetyltransferase constructs revealed that Tax was trans activating the VCAM-1 promoter via two NF-kappaB sites present at bp -72 and -57 in the VCAM-1 gene promoter, with both of them being required for the Tax-induced expression of this adhesion molecule.	141-144	Tax	Paclitaxel	C0144576	T109|T121	Protein	243-249	VCAM-1	Vascular Cell Adhesion Molecule-1	C0078056	T116|T129	Protein	13-21	deletion	Deletion	C1442161	T049	-1000	Binding	NA	FALSE	NA
20489	GE11_train	9343210.s7	Furthermore, deletion and mutation analyses of the VCAM-1 promoter performed with chloramphenicol acetyltransferase constructs revealed that Tax was trans activating the VCAM-1 promoter via two NF-kappaB sites present at bp -72 and -57 in the VCAM-1 gene promoter, with both of them being required for the Tax-induced expression of this adhesion molecule.	306-309	Tax	Paclitaxel	C0144576	T109|T121	Protein	243-249	VCAM-1	Vascular Cell Adhesion Molecule-1	C0078056	T116|T129	Protein	13-21	deletion	Deletion	C1442161	T049	-1000	Increase	Backward	FALSE	NA
20490	GE11_train	9343210.s9	Collectively, these results therefore suggest that the exclusive Tax-induced expression of VCAM-1 on T cells may represent a pivotal event in the progression of HTLV-1-associated diseases.	65-68	Tax	Paclitaxel	C0144576	T109|T121	Protein	91-97	VCAM-1	Vascular Cell Adhesion Molecule-1	C0078056	T116|T129	Protein	146-157	progression	Progression	C0242656	T046	-1000	Increase	Forward	TRUE	NA
20491	GE11_train	9398163.s7	Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.	86-90	ATF1	Cyclic AMP-Dependent Transcription Factor ATF-1	C2984895	T116|T123	Protein	133-135	H4	Histone H4	C0019648	T116|T123	Protein	14-24	mutational	Mutation	C1705285	T049	-574	Increase	Forward	FALSE	NA
20495	GE11_train	9414129.s3	We describe here a heterodimeric binding complex of NF-kappaB subunits (c-Rel and p65) which is identical to the one obtained using the HIV-LTR-kappaB site as recognition sequence and different from the one (c-Rel and p50) observed with nuclear extracts from Mo T-lymphoid HTLV-II infected cells.	208-213	c-Rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	218-221	p50	NF-kappa B p50 Subunit	C0132348	T116|T123	Protein	136-139	HIV	HIV	C0019693	T047	-645	Binding	NA	FALSE	NA
20496	GE11_train	9414129.s3	We describe here a heterodimeric binding complex of NF-kappaB subunits (c-Rel and p65) which is identical to the one obtained using the HIV-LTR-kappaB site as recognition sequence and different from the one (c-Rel and p50) observed with nuclear extracts from Mo T-lymphoid HTLV-II infected cells.	72-77	c-Rel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	82-85	p65	RELA protein, human	C1567060	T116|T123	Protein	136-139	HIV	HIV	C0019693	T047	-645	Binding	NA	FALSE	NA
20503	GE11_train	9464836.s1	Interleukin-12 is produced in response to infection with bacteria or parasites or to bacterial constituents such as LPS in monocytes/macrophages and dendritic cells, and also generated by the interaction between activated T cells and antigen-presenting cells via CD40-CD40 ligand (CD40L).	263-267	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	268-279	CD40 ligand	CD40 Ligand	C0167627	T116|T129	Protein	42-51	infection	INFECTION	C3714514	T046	-1000	Binding	NA	FALSE	NA
20504	GE11_train	9464836.s1	Interleukin-12 is produced in response to infection with bacteria or parasites or to bacterial constituents such as LPS in monocytes/macrophages and dendritic cells, and also generated by the interaction between activated T cells and antigen-presenting cells via CD40-CD40 ligand (CD40L).	263-267	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	268-279	CD40 ligand	CD40 Ligand	C0167627	T116|T129	Protein	42-51	infection	Infection, NOS	C0009450	T047	-1000	Binding	NA	FALSE	NA
20505	GE11_train	9464836.s1	Interleukin-12 is produced in response to infection with bacteria or parasites or to bacterial constituents such as LPS in monocytes/macrophages and dendritic cells, and also generated by the interaction between activated T cells and antigen-presenting cells via CD40-CD40 ligand (CD40L).	263-267	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	281-286	CD40L	CD40 Ligand	C0167627	T116|T129	Protein	116-119	LPS	LPS	C0175697	T019|T047	-1000	Binding	NA	FALSE	NA
20506	GE11_train	9464836.s1	Interleukin-12 is produced in response to infection with bacteria or parasites or to bacterial constituents such as LPS in monocytes/macrophages and dendritic cells, and also generated by the interaction between activated T cells and antigen-presenting cells via CD40-CD40 ligand (CD40L).	263-267	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	281-286	CD40L	CD40 Ligand	C0167627	T116|T129	Protein	42-51	infection	INFECTION	C3714514	T046	-1000	Binding	NA	FALSE	NA
20507	GE11_train	9464836.s1	Interleukin-12 is produced in response to infection with bacteria or parasites or to bacterial constituents such as LPS in monocytes/macrophages and dendritic cells, and also generated by the interaction between activated T cells and antigen-presenting cells via CD40-CD40 ligand (CD40L).	263-267	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	281-286	CD40L	CD40 Ligand	C0167627	T116|T129	Protein	42-51	infection	Infection, NOS	C0009450	T047	-1000	Binding	NA	FALSE	NA
20509	GE11_train	9663467.s0	Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.	0-14	Thrombopoietin	Thrombopoietin	C0040052	T116|T123	Protein	85-90	c-Mpl	Thrombopoietin Receptor	C1706293	T192|T129|T116	Protein	102-110	leukemia	LEUKAEMIA	C0023418	T191	-645	Binding	NA	TRUE	NA
20510	GE11_train	9710600.s4	In contrast, a mutant of Tax termed M22, which does not induce NF-kappaB, fails to activate either IKKalpha or IKKbeta.	25-28	Tax	Paclitaxel	C0144576	T109|T121	Protein	111-118	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Protein	15-21	mutant	Mutant	C0596988	T049	-1000	Increase	Forward	FALSE	negation
20511	GE11_train	9710600.s4	In contrast, a mutant of Tax termed M22, which does not induce NF-kappaB, fails to activate either IKKalpha or IKKbeta.	25-28	Tax	Paclitaxel	C0144576	T109|T121	Protein	99-107	IKKalpha	conserved helix-loop-helix ubiquitous kinase	C0754623	T116|T123	Protein	15-21	mutant	Mutant	C0596988	T049	-1000	Increase	Forward	FALSE	negation
20517	GE11_train	9722600.s9	Using Tax mutants that fail to activate either ATF- or NF-kappaB-dependent promoters and different 5' truncation mutants of the E2F-1 promoter, we show that the Tax-dependent transcriptional control of the E2F1 gene involves, at least in part, the ATF binding site located in the E2F-1 promoter.	161-164	Tax	Paclitaxel	C0144576	T109|T121	Protein	206-210	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	10-17	mutants	mutants	C0596988	T049	-861	Regulation	Forward	TRUE	NA
20518	GE11_train	9722600.s9	Using Tax mutants that fail to activate either ATF- or NF-kappaB-dependent promoters and different 5' truncation mutants of the E2F-1 promoter, we show that the Tax-dependent transcriptional control of the E2F1 gene involves, at least in part, the ATF binding site located in the E2F-1 promoter.	161-164	Tax	Paclitaxel	C0144576	T109|T121	Protein	206-210	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	102-112	truncation	Truncation	C1706395	T049	-645	Regulation	Forward	FALSE	NA
20519	GE11_train	9722600.s9	Using Tax mutants that fail to activate either ATF- or NF-kappaB-dependent promoters and different 5' truncation mutants of the E2F-1 promoter, we show that the Tax-dependent transcriptional control of the E2F1 gene involves, at least in part, the ATF binding site located in the E2F-1 promoter.	161-164	Tax	Paclitaxel	C0144576	T109|T121	Protein	206-210	E2F1	E2F1 Transcription Factor	C1384539	T116|T123	Protein	113-120	mutants	mutants	C0596988	T049	-812	Regulation	Forward	FALSE	NA
20535	GE11_train	9729045.s5	Expression of CD30 by these cells is induced by CD40L but is inhibited by B cell receptor coengagement and/or exposure to IL-6 and IL-12.	48-53	CD40L	CD40 Ligand	C0167627	T116|T129	Protein	14-18	CD30	Antigens, CD30	C0054950	T116|T129	Protein	110-118	exposure	Exposure NOS	C0274281	T037	-1000	Increase	Backward	FALSE	NA
20537	GE11_train	9817603.s10	In addition, Ras(G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the beta-casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5-mediated gene expression.	13-22	Ras(G12V)	Proto-Oncogene Proteins p21(ras)	C0080058	T116|T126	Protein	147-158	beta-casein	beta-Caseins	C0005198	T116|T123	Protein	175-181	mutant	Mutant	C0596988	T049	-645	Increase	Forward	TRUE	NA
20538	GE11_train	9817603.s10	In addition, Ras(G12V) complemented signaling by an erythropoietin receptor mutant defective in Ras activation and augmented the activation of the beta-casein promoter by the mutant erythropoietin receptor signaling, suggesting a possible role of Ras in Stat5-mediated gene expression.	13-22	Ras(G12V)	Proto-Oncogene Proteins p21(ras)	C0080058	T116|T126	Protein	147-158	beta-casein	beta-Caseins	C0005198	T116|T123	Protein	76-82	mutant	Mutant	C0596988	T049	-645	Increase	Forward	FALSE	NA
20539	GE11_train	9817603.s7	Coincidentally, a deletion of this region enhanced the IL-2-induced expression of beta-casein.	55-59	IL-2	Interleukin-2	C0021756	T116|T129	Protein	82-93	beta-casein	beta-Caseins	C0005198	T116|T123	Protein	18-26	deletion	Deletion	C1442161	T049	-1000	Increase	Forward	TRUE	NA
20540	GE11_train	9817603.s9	In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2-induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM.	74-80	RasN17	Proto-Oncogene Proteins p21(ras)	C0080058	T116|T126	Protein	214-217	CIS	Suppressor of Cytokine Signaling Proteins	C1564682	T116|T123	Protein	43-60	dominant negative	Dominant Negative	C1512032	T049	-901	Decrease	Forward	TRUE	NA
20541	GE11_train	9817603.s9	In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2-induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM.	74-80	RasN17	Proto-Oncogene Proteins p21(ras)	C0080058	T116|T126	Protein	222-225	OSM	oncostatin M	C0069535	T116|T121	Protein	43-60	dominant negative	Dominant Negative	C1512032	T049	-901	Decrease	Forward	TRUE	NA
20542	GE11_train	9817603.s9	In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2-induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM.	97-101	IL-2	Interleukin-2	C0021756	T116|T129	Protein	214-217	CIS	Suppressor of Cytokine Signaling Proteins	C1564682	T116|T123	Protein	43-60	dominant negative	Dominant Negative	C1512032	T049	-901	Increase	Forward	FALSE	NA
20543	GE11_train	9817603.s9	In apparent contradiction, expression of a dominant negative form of Ras, RasN17, also inhibited IL-2-induced activation of the promoter containing the minimal beta-casein STAT5 element as well as the promoters of CIS and OSM.	97-101	IL-2	Interleukin-2	C0021756	T116|T129	Protein	222-225	OSM	oncostatin M	C0069535	T116|T121	Protein	43-60	dominant negative	Dominant Negative	C1512032	T049	-901	Increase	Forward	FALSE	NA
20544	GE11_train	9819382.s10	Collectively, we have identified the RALDH2 gene as a first example of direct transcriptional target genes regulated by TAL1 and LMO in T-ALL.	120-124	TAL1	T-Cell Acute Lymphocytic Leukemia Protein 1	C4319825	T116|T123	Protein	37-43	RALDH2	RALDH2 protein, mouse	C1173684	T116|T126	Protein	136-141	T-ALL	T-ALL	C1961099	T191	-1000	Regulation	Backward	TRUE	NA
20545	GE11_train	9819382.s10	Collectively, we have identified the RALDH2 gene as a first example of direct transcriptional target genes regulated by TAL1 and LMO in T-ALL.	120-124	TAL1	T-Cell Acute Lymphocytic Leukemia Protein 1	C4319825	T116|T123	Protein	37-43	RALDH2	RALDH2 protein, mouse	C1173684	T116|T126	Protein	136-141	T-ALL	t-all	C0023493	T191	-1000	Regulation	Backward	TRUE	NA
20547	GE11_train	9819382.s9	Furthermore, a TAL1 mutant not binding to DNA also activated the transcription of RALDH2 in the presence of LMO and GATA3.	15-19	TAL1	T-Cell Acute Lymphocytic Leukemia Protein 1	C4319825	T116|T123	Protein	82-88	RALDH2	RALDH2 protein, mouse	C1173684	T116|T126	Protein	20-26	mutant	Mutant	C0596988	T049	-861	Increase	Forward	TRUE	NA
20553	GE11_train	9840924.s2	Here we show that the activation of the IL-2 promoter by Tpl-2 is inhibited by mutant signaling molecules that inhibit the mitogen-activated protein kinase (MAPK) or the calcineurin/NFAT pathways and is promoted by combinations of signaling molecules that activate these pathways.	57-62	Tpl-2	MAP3K8 protein, human	C1307220	T116|T126	Protein	40-44	IL-2	Interleukin-2	C0021756	T116|T129	Protein	79-85	mutant	Mutant	C0596988	T049	-660	Increase	Backward	TRUE	NA
20555	GE11_train	9840924.s5	However, it was only the IL-2 promoter whose activation by Tpl-2 was fully blocked by the dominant negative mutant MEK1S218/222A and the MEK1/MEK2 inhibitor PD098059.	59-64	Tpl-2	MAP3K8 protein, human	C1307220	T116|T126	Protein	25-29	IL-2	Interleukin-2	C0021756	T116|T129	Protein	90-114	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-717	Increase	Backward	TRUE	NA
20556	GE11_train	9840924.s9	While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.	81-86	Tpl-2	MAP3K8 protein, human	C1307220	T116|T126	Protein	28-32	IL-2	Interleukin-2	C0021756	T116|T129	Protein	112-136	dominant negative mutant	Dominant-Negative Mutant	C1512032	T049	-717	Increase	Backward	TRUE	NA
20575	GE11_train	9915863.s0	Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.	8-13	Egr-2	Early Growth Response Protein 2	C0064419	T116|T123	Protein	34-44	Fas ligand	Tumor Necrosis Factor Ligand Superfamily Member 6	C0253023	T116|T123	Protein	100-103	gld	GLD	C0023521	T047	-660	Regulation	Forward	FALSE	negation
20576	GE11_train	9915863.s9	Thus, Egr-2, in addition to Egr-3, regulates FasL expression in activated normal T cells, and Egr-2 is likely to play a direct role in aberrant fasL up-regulation in lpr/lpr and gld/gld CD4(-)CD8(-) T cells.	28-33	Egr-3	Early Growth Response Protein 3	C1571614	T116|T123	Protein	45-49	FasL	Tumor Necrosis Factor Ligand Superfamily Member 6	C0253023	T116|T123	Protein	178-181	gld	GLD	C0023521	T047	-660	Regulation	Forward	FALSE	NA
20577	GE11_train	9915863.s9	Thus, Egr-2, in addition to Egr-3, regulates FasL expression in activated normal T cells, and Egr-2 is likely to play a direct role in aberrant fasL up-regulation in lpr/lpr and gld/gld CD4(-)CD8(-) T cells.	6-11	Egr-2	Early Growth Response Protein 2	C0064419	T116|T123	Protein	45-49	FasL	Tumor Necrosis Factor Ligand Superfamily Member 6	C0253023	T116|T123	Protein	178-181	gld	GLD	C0023521	T047	-660	Regulation	Forward	FALSE	NA
20578	GE11_train	9973520.s5	Briefly, we found that 1) rheumatoid synovial cells highly expressed CD44; 2) cross-linking of CD44 markedly but transiently augmented VCAM-1 expression and its mRNA transcription much more than did IL-1beta and TNF-alpha; 3) hyaluronan, especially when fragmented, also up-regulated VCAM-1; 4) CD44 activated the transcription factor AP-1; and 5) the integrin-dependent adhesive function of RA synovial cells to T cells was also amplified by CD44 cross-linking.	295-299	CD44	CD44 Antigens	C0243982	T116|T129|T192	Protein	335-339	AP-1	Transcription Factor AP-1	C0085828	T116|T123	Protein	254-264	fragmented	Fragmented	C0332472	T190	-1000	Increase	Forward	FALSE	NA
20579	GE11_train	PMC-1310901-15-DISCUSSION.s9	Methylation of CpG sites is a common mechanism of silencing genes in leukemia and has also been shown for another IRF, IRF-7 (35) and for PU.1 (36), an interacting partner of IRF-4.	138-142	PU.1	proto-oncogene protein Spi-1	C0246120	T116|T123	Protein	175-180	IRF-4	Interferon Regulatory Factor 4	C0299544	T116|T123	Protein	69-77	leukemia	LEUKAEMIA	C0023418	T191	-1000	Binding	NA	FALSE	NA
20583	GE11_train	PMC-1447668-06-Results.s22	These data indicate that Foxp3 is capable of repressing the expression of Tax from an infectious HTLV-I molecular clone.	25-30	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	74-77	Tax	Paclitaxel	C0144576	T109|T121	Protein	86-96	infectious	Infection, NOS	C0009450	T047	-566	Decrease	Forward	TRUE	NA
20584	GE11_train	PMC-1447668-06-Results.s22	These data indicate that Foxp3 is capable of repressing the expression of Tax from an infectious HTLV-I molecular clone.	25-30	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	74-77	Tax	Paclitaxel	C0144576	T109|T121	Protein	86-96	infectious	Infections	C3714514	T046	-566	Decrease	Forward	TRUE	NA
20599	GE11_train	PMC-2065877-00-TIAB.s0	EBV Latent Membrane Protein 1 Activates Akt, NFkappaB, and Stat3 in B Cell Lymphomas	4-29	Latent Membrane Protein 1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	40-43	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Protein	68-84	B Cell Lymphomas	B-Cell Lymphomas	C0079731	T191	-1000	Increase	Forward	TRUE	NA
20600	GE11_train	PMC-2065877-00-TIAB.s0	EBV Latent Membrane Protein 1 Activates Akt, NFkappaB, and Stat3 in B Cell Lymphomas	4-29	Latent Membrane Protein 1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	59-64	Stat3	Stat3 protein	C0253050	T116|T123	Protein	68-84	B Cell Lymphomas	B-Cell Lymphomas	C0079731	T191	-1000	Increase	Forward	TRUE	NA
20601	GE11_train	PMC-2065877-01-Introduction.s23	In contrast, both LMP1-positive and -negative lymphoma cells were independent of IL4 co-stimulation for survival and proliferation in vitro with a complete absence of activated Stat6, the IL4 target.	188-191	IL4	Interleukin-4	C0021758	T116|T129	Protein	177-182	Stat6	STAT6 Transcription Factor	C0297893	T116|T123	Protein	117-130	proliferation	Proliferation	C0334094	T046	-1000	Regulation	Backward	FALSE	NA
20602	GE11_train	PMC-2065877-01-Introduction.s23	In contrast, both LMP1-positive and -negative lymphoma cells were independent of IL4 co-stimulation for survival and proliferation in vitro with a complete absence of activated Stat6, the IL4 target.	188-191	IL4	Interleukin-4	C0021758	T116|T129	Protein	177-182	Stat6	STAT6 Transcription Factor	C0297893	T116|T123	Protein	156-163	absence	Absence	C1689985	T190	-861	Regulation	Backward	FALSE	NA
20610	GE11_train	PMC-2065877-09-Discussion.s25	In addition, LMP1 has been shown to stimulate IL10 expression in Burkitt lymphoma cell lines [61,62].	13-17	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	46-50	IL10	Interleukin-10	C0085295	T116|T129	Protein	65-81	Burkitt lymphoma	BURKITT LYMPHOMA	C0006413	T191	-694	Increase	Forward	TRUE	NA
20611	GE11_train	PMC-2065877-09-Discussion.s30	Our observations suggest that similar to CD40-induced proliferation, LMP1 induces proliferation through PI3K-mediated activation of Akt and activation of NFkappaB components such as cRel.	69-73	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	132-135	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Protein	54-67	proliferation	Proliferation	C0334094	T046	-827	Increase	Forward	FALSE	NA
20612	GE11_train	PMC-2065877-09-Discussion.s30	Our observations suggest that similar to CD40-induced proliferation, LMP1 induces proliferation through PI3K-mediated activation of Akt and activation of NFkappaB components such as cRel.	69-73	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	132-135	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Protein	82-95	proliferation	Proliferation	C0334094	T046	-1000	Increase	Forward	FALSE	NA
20613	GE11_train	PMC-2065877-09-Discussion.s30	Our observations suggest that similar to CD40-induced proliferation, LMP1 induces proliferation through PI3K-mediated activation of Akt and activation of NFkappaB components such as cRel.	69-73	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	182-186	cRel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	54-67	proliferation	Proliferation	C0334094	T046	-827	Increase	Forward	FALSE	NA
20614	GE11_train	PMC-2065877-09-Discussion.s30	Our observations suggest that similar to CD40-induced proliferation, LMP1 induces proliferation through PI3K-mediated activation of Akt and activation of NFkappaB components such as cRel.	69-73	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	182-186	cRel	Proto-Oncogene Proteins c-rel	C0072455	T116|T123	Protein	82-95	proliferation	Proliferation	C0334094	T046	-1000	Increase	Forward	FALSE	NA
20615	GE11_train	PMC-2065877-09-Discussion.s46	Although the activation of Akt and the lack of Fox01 in the lymphoma cells suggest that LMP1 affects bcl6 and GC formation through this pathway, regulation of other Forkhead targets involved in cell cycle progression, such as p27 and CyclinD2, likely contribute to malignant transformation.	88-92	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	101-105	bcl6	B-Cell Lymphoma 6 Protein	C0248007	T116|T123	Protein	275-289	transformation	Transformation	C1510411	T046	-861	Regulation	Forward	FALSE	NA
20684	GE11_train	PMC-2791889-09-Discussion.s16	A high antigenic activation during T. gondii infection or high antigen doses delivered in the presence of LPS, as seen in our system, may compensate for an absolute requirement for IL-12 in the induction of IL-10 by Th1 cells.	181-186	IL-12	Interleukin-12	C0123759	T116|T121|T129	Protein	207-212	IL-10	Interleukin-10	C0085295	T116|T129	Protein	45-54	infection	INFECTION	C3714514	T046	-827	Increase	Forward	FALSE	NA
20685	GE11_train	PMC-2791889-09-Discussion.s16	A high antigenic activation during T. gondii infection or high antigen doses delivered in the presence of LPS, as seen in our system, may compensate for an absolute requirement for IL-12 in the induction of IL-10 by Th1 cells.	181-186	IL-12	Interleukin-12	C0123759	T116|T121|T129	Protein	207-212	IL-10	Interleukin-10	C0085295	T116|T129	Protein	45-54	infection	Infection, NOS	C0009450	T047	-827	Increase	Forward	FALSE	NA
20686	GE11_train	PMC-2791889-09-Discussion.s19	However, a role for IFN-gamma in mediating IL-10 reactivation by Th1 cells during secondary infection with T. gondii has been suggested (Shaw etal., 2006).	20-29	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	43-48	IL-10	Interleukin-10	C0085295	T116|T129	Protein	82-101	secondary infection	Secondary Infection	C0442886	T047	-1000	Increase	Forward	TRUE	NA
20688	GE11_train	PMC-2791889-09-Discussion.s24	It is thus likely that in T. gondii infection invivo (Shaw etal., 2006), the requirement for IFN-gamma to induce IL-10, was for feedback upregulation of IL-12 by DCs, which in turn induced IL-10 in the Th1 cells.	93-102	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	113-118	IL-10	Interleukin-10	C0085295	T116|T129	Protein	36-45	infection	INFECTION	C3714514	T046	-827	Increase	Forward	TRUE	NA
20689	GE11_train	PMC-2791889-09-Discussion.s24	It is thus likely that in T. gondii infection invivo (Shaw etal., 2006), the requirement for IFN-gamma to induce IL-10, was for feedback upregulation of IL-12 by DCs, which in turn induced IL-10 in the Th1 cells.	93-102	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	113-118	IL-10	Interleukin-10	C0085295	T116|T129	Protein	36-45	infection	Infection, NOS	C0009450	T047	-827	Increase	Forward	TRUE	NA
20702	GE13_devel	PMC-2222968-04-Results.s18	Similarly pre-existing iTreg cells did not decrease FOXP3 expression upon IL-4 exposure (Figure S3B).	74-78	IL-4	Interleukin-4	C0021758	T116|T129	Protein	52-57	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	79-87	exposure	Exposure NOS	C0274281	T037	-827	Decrease	Backward	FALSE	NA
20709	GE13_devel	PMC-2222968-04-Results.s8	The IL-4-mediated prevention of FOXP3 expression was not caused by interferences of the receptor signaling, because the phosphorylation of SMAD2 or STAT6 was not affected by the addition of IL-4 and/or TGF-beta, which demonstrates that IL-4 as well as TGF-beta signaling were functional under these conditions (Figure 5C).	190-194	IL-4	Interleukin-4	C0021758	T116|T129	Protein	139-144	SMAD2	SMAD2 protein	C0528860	T116|T123	Protein	299-309	conditions	condition	C0012634	T047	-966	Regulation	Backward	FALSE	negation
20710	GE13_devel	PMC-2222968-04-Results.s8	The IL-4-mediated prevention of FOXP3 expression was not caused by interferences of the receptor signaling, because the phosphorylation of SMAD2 or STAT6 was not affected by the addition of IL-4 and/or TGF-beta, which demonstrates that IL-4 as well as TGF-beta signaling were functional under these conditions (Figure 5C).	190-194	IL-4	Interleukin-4	C0021758	T116|T129	Protein	148-153	STAT6	STAT6 Transcription Factor	C0297893	T116|T123	Protein	299-309	conditions	condition	C0012634	T047	-966	Regulation	Backward	FALSE	negation
20711	GE13_devel	PMC-2222968-04-Results.s8	The IL-4-mediated prevention of FOXP3 expression was not caused by interferences of the receptor signaling, because the phosphorylation of SMAD2 or STAT6 was not affected by the addition of IL-4 and/or TGF-beta, which demonstrates that IL-4 as well as TGF-beta signaling were functional under these conditions (Figure 5C).	202-210	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	139-144	SMAD2	SMAD2 protein	C0528860	T116|T123	Protein	299-309	conditions	condition	C0012634	T047	-966	Regulation	Backward	FALSE	negation
20712	GE13_devel	PMC-2222968-04-Results.s8	The IL-4-mediated prevention of FOXP3 expression was not caused by interferences of the receptor signaling, because the phosphorylation of SMAD2 or STAT6 was not affected by the addition of IL-4 and/or TGF-beta, which demonstrates that IL-4 as well as TGF-beta signaling were functional under these conditions (Figure 5C).	202-210	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	148-153	STAT6	STAT6 Transcription Factor	C0297893	T116|T123	Protein	299-309	conditions	condition	C0012634	T047	-966	Regulation	Backward	FALSE	negation
20713	GE13_devel	PMC-2222968-04-Results.s8	The IL-4-mediated prevention of FOXP3 expression was not caused by interferences of the receptor signaling, because the phosphorylation of SMAD2 or STAT6 was not affected by the addition of IL-4 and/or TGF-beta, which demonstrates that IL-4 as well as TGF-beta signaling were functional under these conditions (Figure 5C).	4-8	IL-4	Interleukin-4	C0021758	T116|T129	Protein	32-37	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	299-309	conditions	condition	C0012634	T047	-966	Decrease	Forward	FALSE	NA
20729	GE13_devel	PMC-2222968-06-Results.s10	To investigate the effect of GATA3 on iTreg, CD4+CD62L+CD25- cells were isolated, activated with OVA in the presence or absence of TGF-beta, and Foxp3 expression was analyzed after 4 d.	29-34	GATA3	GATA3 protein, human	C1307598	T116|T123	Protein	145-150	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	120-127	absence	Absence	C1689985	T190	-1000	Regulation	Forward	FALSE	negation
20733	GE13_devel	PMC-2222968-07-Results.s9	This mutation increased luciferase activity by 3-fold in memory CD4+CD45RO+ T cells, whereas no difference was observed in naive (GATA3-) CD4+CD45RA+ T cells, revealing a repressor activity of GATA3 on the FOXP3 promoter (Figure 8C).	193-198	GATA3	GATA3 protein, human	C1307598	T116|T123	Protein	206-211	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	5-13	mutation	Mutation	C1705285	T049	-1000	Decrease	Forward	FALSE	NA
20734	GE13_devel	PMC-2674207-00-TIAB.s2	GATA-3 plays a critical role in regulating the expression of the cytokines interleukin (IL)-4, IL-5, and IL-13 from T helper-2 (Th2) cells and therefore is a key mediator of allergic diseases.	0-6	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	105-110	IL-13	Interleukin-13	C0214743	T116|T129	Protein	174-191	allergic diseases	Allergic Diseases	C0020517	T046	-1000	Regulation	Forward	FALSE	NA
20735	GE13_devel	PMC-2674207-00-TIAB.s2	GATA-3 plays a critical role in regulating the expression of the cytokines interleukin (IL)-4, IL-5, and IL-13 from T helper-2 (Th2) cells and therefore is a key mediator of allergic diseases.	0-6	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	105-110	IL-13	Interleukin-13	C0214743	T116|T129	Protein	174-191	allergic diseases	Allergic Diseases	C0851444	T047	-1000	Regulation	Forward	FALSE	NA
20736	GE13_devel	PMC-2674207-00-TIAB.s2	GATA-3 plays a critical role in regulating the expression of the cytokines interleukin (IL)-4, IL-5, and IL-13 from T helper-2 (Th2) cells and therefore is a key mediator of allergic diseases.	0-6	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	75-93	interleukin (IL)-4	Interleukin-4	C0021758	T129|T116	Protein	174-191	allergic diseases	Allergic Diseases	C0020517	T046	-1000	Regulation	Forward	FALSE	NA
20737	GE13_devel	PMC-2674207-00-TIAB.s2	GATA-3 plays a critical role in regulating the expression of the cytokines interleukin (IL)-4, IL-5, and IL-13 from T helper-2 (Th2) cells and therefore is a key mediator of allergic diseases.	0-6	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	75-93	interleukin (IL)-4	Interleukin-4	C0021758	T129|T116	Protein	174-191	allergic diseases	Allergic Diseases	C0851444	T047	-1000	Regulation	Forward	FALSE	NA
20738	GE13_devel	PMC-2674207-00-TIAB.s2	GATA-3 plays a critical role in regulating the expression of the cytokines interleukin (IL)-4, IL-5, and IL-13 from T helper-2 (Th2) cells and therefore is a key mediator of allergic diseases.	0-6	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	95-99	IL-5	Interleukin-5	C0021759	T116|T129	Protein	174-191	allergic diseases	Allergic Diseases	C0020517	T046	-1000	Regulation	Forward	FALSE	NA
20739	GE13_devel	PMC-2674207-00-TIAB.s2	GATA-3 plays a critical role in regulating the expression of the cytokines interleukin (IL)-4, IL-5, and IL-13 from T helper-2 (Th2) cells and therefore is a key mediator of allergic diseases.	0-6	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	95-99	IL-5	Interleukin-5	C0021759	T116|T129	Protein	174-191	allergic diseases	Allergic Diseases	C0851444	T047	-1000	Regulation	Forward	FALSE	NA
20743	GE13_devel	PMC-2674207-20-Discussion.s4	We have also previously reported that GATA-3 knockdown using siRNA results in suppression of anti-CD3/CD28-stimulated IL-4/IL-5 mRNA induction, thus implicating an essential role for GATA-3 in the transcription of these genes [12].	183-189	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	118-122	IL-4	Interleukin-4	C0021758	T116|T129	Protein	78-89	suppression	Suppression	C0221103	T046	-1000	Regulation	Backward	FALSE	NA
20744	GE13_devel	PMC-2674207-20-Discussion.s4	We have also previously reported that GATA-3 knockdown using siRNA results in suppression of anti-CD3/CD28-stimulated IL-4/IL-5 mRNA induction, thus implicating an essential role for GATA-3 in the transcription of these genes [12].	183-189	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	123-127	IL-5	Interleukin-5	C0021759	T116|T129	Protein	78-89	suppression	Suppression	C0221103	T046	-1000	Regulation	Backward	FALSE	NA
20748	GE13_devel	PMC-2806624-02-RESULTS.s6	Deficiency of RUNX1 or RUNX3 resulted in markedly reduced TGF-beta-mediated induction of FOXP3 mRNA in naive CD4+ T cells compared with control cells transfected with scrambled siRNA.	58-66	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	89-94	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	0-10	Deficiency	Deficiency	C0162429	T047	-1000	Increase	Forward	TRUE	reverse
20749	GE13_devel	PMC-2806624-03-RESULTS.s14	Amplification of PCR products from the FOXP3 promoter region with the predicted RUNX binding sites showed that RUNX1, RUNX3, and CBFbeta were immunoprecipitated together with the FOXP3 promoter (Fig. 3 C).	111-116	RUNX1	acute myeloid leukemia 1 protein	C0215508	T116|T123	Protein	179-184	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	0-13	Amplification	Amplification	C1705759	T049	-1000	Binding	NA	FALSE	NA
20750	GE13_devel	PMC-2806624-03-RESULTS.s14	Amplification of PCR products from the FOXP3 promoter region with the predicted RUNX binding sites showed that RUNX1, RUNX3, and CBFbeta were immunoprecipitated together with the FOXP3 promoter (Fig. 3 C).	118-123	RUNX3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	179-184	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	0-13	Amplification	Amplification	C1705759	T049	-1000	Binding	NA	FALSE	NA
20751	GE13_devel	PMC-2806624-03-RESULTS.s14	Amplification of PCR products from the FOXP3 promoter region with the predicted RUNX binding sites showed that RUNX1, RUNX3, and CBFbeta were immunoprecipitated together with the FOXP3 promoter (Fig. 3 C).	129-136	CBFbeta	Core Binding Factor beta Subunit	C0285599	T116|T123	Protein	179-184	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	0-13	Amplification	Amplification	C1705759	T049	-1000	Binding	NA	FALSE	NA
20752	GE13_devel	PMC-2806624-03-RESULTS.s4	After the pull-down with oligonucleotides containing the wild-type binding sequences, but not mutant sequences, RUNX binding to the FOXP3 promoter oligonucleotides was detected by Western blot (Fig. 3 A).	112-116	RUNX	Core Binding Factor alpha Subunits	C0137833	T116|T123	Protein	132-137	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	94-100	mutant	Mutant	C0596988	T049	-660	Binding	NA	FALSE	negation
20753	GE13_devel	PMC-2806624-03-RESULTS.s7	The biotinylated FOXP3 promoter oligonucleotides were linked to a streptavidin-coated microtiter plate, and bound RUNX1 or RUNX3 was detected by using anti-RUNX antibodies and a peroxidase-labeled secondary antibody.	17-22	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	114-119	RUNX1	acute myeloid leukemia 1 protein	C0215508	T116|T123	Protein	197-206	secondary	secondary	C0027627	T191	-645	Binding	NA	FALSE	NA
20754	GE13_devel	PMC-2806624-03-RESULTS.s7	The biotinylated FOXP3 promoter oligonucleotides were linked to a streptavidin-coated microtiter plate, and bound RUNX1 or RUNX3 was detected by using anti-RUNX antibodies and a peroxidase-labeled secondary antibody.	17-22	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	123-128	RUNX3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	197-206	secondary	secondary	C0027627	T191	-645	Binding	NA	FALSE	NA
20755	GE13_devel	PMC-2806624-04-RESULTS.s8	However, mutating the -53 site in combination with one of the other two sites led to a significant decrease in luciferase activity, with the greatest reduction observed when all three binding sites were mutated (Fig. 4 B), suggesting that the identified binding sites have redundant functions and RUNX binding to more than one site is necessary for the full activation of the FOXP3 promoter.	297-301	RUNX	Core Binding Factor alpha Subunits	C0137833	T116|T123	Protein	376-381	FOXP3	FOXP3 protein	C4282118	T116|T123	Protein	203-210	mutated	Mutated	C1705285	T049	-1000	Binding	NA	FALSE	NA
20756	GE13_devel	PMC-2806624-05-RESULTS.s8	The induction of Foxp3 was again significantly lower in CbfbF/F CD4-cre CD4+ T cells even in the presence of retinoic acid, demonstrating that deficiency in Runx binding to DNA affects the TGF-beta induction of Foxp3 in T reg cells (Fig. 5 A).	189-197	TGF-beta	Transforming Growth Factor beta	C0040690	T116|T123	Protein	211-216	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	143-153	deficiency	Deficiency	C0162429	T047	-1000	Increase	Forward	TRUE	NA
20760	GE13_devel	PMC-3062687-00-TIAB.s4	Moreover, the foodborne pathogen Escherichia coli O157:H7 virulence protein NleH1 specifically inhibited RPS3 S209 phosphorylation and blocked RPS3 function, thereby promoting bacterial colonization and diarrhea but decreasing mortality in a gnotobiotic piglet infection model.	76-81	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	105-109	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	203-211	diarrhea	DIARRHOEA	C0011991	T184	-1000	Regulation	Forward	FALSE	NA
20761	GE13_devel	PMC-3062687-00-TIAB.s4	Moreover, the foodborne pathogen Escherichia coli O157:H7 virulence protein NleH1 specifically inhibited RPS3 S209 phosphorylation and blocked RPS3 function, thereby promoting bacterial colonization and diarrhea but decreasing mortality in a gnotobiotic piglet infection model.	76-81	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	105-109	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	261-270	infection	INFECTION	C3714514	T046	-645	Regulation	Forward	FALSE	NA
20762	GE13_devel	PMC-3062687-00-TIAB.s4	Moreover, the foodborne pathogen Escherichia coli O157:H7 virulence protein NleH1 specifically inhibited RPS3 S209 phosphorylation and blocked RPS3 function, thereby promoting bacterial colonization and diarrhea but decreasing mortality in a gnotobiotic piglet infection model.	76-81	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	105-109	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	261-270	infection	Infection, NOS	C0009450	T047	-645	Regulation	Forward	FALSE	NA
20764	GE13_devel	PMC-3062687-00-TIAB.s4	Moreover, the foodborne pathogen Escherichia coli O157:H7 virulence protein NleH1 specifically inhibited RPS3 S209 phosphorylation and blocked RPS3 function, thereby promoting bacterial colonization and diarrhea but decreasing mortality in a gnotobiotic piglet infection model.	76-81	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	143-147	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	203-211	diarrhea	DIARRHOEA	C0011991	T184	-1000	Increase	Forward	FALSE	NA
20765	GE13_devel	PMC-3062687-00-TIAB.s4	Moreover, the foodborne pathogen Escherichia coli O157:H7 virulence protein NleH1 specifically inhibited RPS3 S209 phosphorylation and blocked RPS3 function, thereby promoting bacterial colonization and diarrhea but decreasing mortality in a gnotobiotic piglet infection model.	76-81	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	143-147	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	261-270	infection	INFECTION	C3714514	T046	-645	Increase	Forward	FALSE	NA
20766	GE13_devel	PMC-3062687-00-TIAB.s4	Moreover, the foodborne pathogen Escherichia coli O157:H7 virulence protein NleH1 specifically inhibited RPS3 S209 phosphorylation and blocked RPS3 function, thereby promoting bacterial colonization and diarrhea but decreasing mortality in a gnotobiotic piglet infection model.	76-81	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	143-147	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	261-270	infection	Infection, NOS	C0009450	T047	-645	Increase	Forward	FALSE	NA
20767	GE13_devel	PMC-3062687-00-TIAB.s5	Thus, the IKKbeta-dependent modification of a specific amino acid in RPS3 promotes specific NF-kappaB functions that underlie the molecular pathogenetic mechanisms of E. coli O157:H7.	10-17	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Protein	69-73	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	140-152	pathogenetic	Pathogenesis	C0699748	T046	-589	Regulation	Forward	FALSE	NA
20773	GE13_devel	PMC-3062687-05-Results.s7	We measured the association of RPS3 with importin-alpha in 293T cells overexpressing wild-type IkappaBalpha or an IkappaBalpha mutant (SSAA) resistant to IKKbeta-induced phosphorylation and degradation.	154-161	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Protein	114-126	IkappaBalpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	127-133	mutant	Mutant	C0596988	T049	-861	Regulation	Backward	FALSE	negation
20774	GE13_devel	PMC-3062687-06-Results.s9	Compared with the wild-type protein, the S209A mutation reduced IKKbeta-mediated RPS3 phosphorylation (Fig. 4c).	64-71	IKKbeta	IkappaB Kinase beta	C0663912	T116|T126	Protein	81-85	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	47-55	mutation	Mutation	C1705285	T049	-861	Regulation	Forward	TRUE	reverse
20775	GE13_devel	PMC-3062687-07-Results.s20	Interleukin 8 (IL-8) secretion induced by either T cell receptor (TCR) agonist stimulation or PMA+I was decreased as a consequence of reduced RPS3/p65 recruitment to the IL8 kappaB sites in the presence of S209A mutant compared to wild-type RPS3 (Supplementary Fig. 10).	142-146	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	170-173	IL8	Interleukin-8	C0079633	T116|T129	Protein	212-218	mutant	Mutant	C0596988	T049	-861	Binding	NA	TRUE	reverse
20790	GE13_devel	PMC-3062687-08-Results.s8	To determine if NleH1 inhibits RPS3 phosphorylation, we infected HeLa cells with E. coli O157:H7 strains possessing or lacking either nleH1 (deltanleH1) or with a strain lacking a functional T3SS unable to inject NleH1 into mammalian cells (deltaescN).	16-21	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	31-35	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	105-115	possessing	possess	C0850310	T048	-966	Regulation	Forward	FALSE	negation
20791	GE13_devel	PMC-3062687-08-Results.s8	To determine if NleH1 inhibits RPS3 phosphorylation, we infected HeLa cells with E. coli O157:H7 strains possessing or lacking either nleH1 (deltanleH1) or with a strain lacking a functional T3SS unable to inject NleH1 into mammalian cells (deltaescN).	16-21	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	31-35	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	163-169	strain	Strain	C0080194	T037	-861	Regulation	Forward	FALSE	negation
20795	GE13_devel	PMC-3062687-08-Results.s8	To determine if NleH1 inhibits RPS3 phosphorylation, we infected HeLa cells with E. coli O157:H7 strains possessing or lacking either nleH1 (deltanleH1) or with a strain lacking a functional T3SS unable to inject NleH1 into mammalian cells (deltaescN).	16-21	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	31-35	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	97-104	strains	Strains	C0080194	T037	-1000	Regulation	Forward	FALSE	negation
20802	GE13_devel	PMC-3062687-09-Results.s6	These data demonstrate that NleH1 inhibits RPS3 S209 phosphorylation both in vitro and in vivo, which might benefit the bacterium in colonization and transmission.	28-33	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	43-47	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	150-162	transmission	Transmission	C0242781	T046	-1000	Regulation	Forward	FALSE	NA
20809	GE13_devel	PMC-3062687-10-Results.s12	Complementing deltanleH mutant with wild-type NleH1 almost abolished TNF-induced RPS3 S209 phosphorylation whereas complementing with K159A failed to inhibit RPS3 phosphorylation (Fig. 7c).	46-51	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	81-85	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	24-30	mutant	Mutant	C0596988	T049	-827	Regulation	Forward	TRUE	reverse
20813	GE13_devel	PMC-3062687-10-Results.s12	Complementing deltanleH mutant with wild-type NleH1 almost abolished TNF-induced RPS3 S209 phosphorylation whereas complementing with K159A failed to inhibit RPS3 phosphorylation (Fig. 7c).	69-72	TNF	Tumor Necrosis Factors	C0041368	T116|T129	Protein	81-85	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	24-30	mutant	Mutant	C0596988	T049	-827	Regulation	Forward	TRUE	reverse
20814	GE13_devel	PMC-3062687-10-Results.s19	Thus, during infection NleH1 is sufficiently potent to inhibit RPS3 nuclear translocation even in cells expressing constitutively-activated IKKbeta.	23-28	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	63-67	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	13-22	infection	INFECTION	C3714514	T046	-694	Regulation	Forward	TRUE	NA
20815	GE13_devel	PMC-3062687-10-Results.s19	Thus, during infection NleH1 is sufficiently potent to inhibit RPS3 nuclear translocation even in cells expressing constitutively-activated IKKbeta.	23-28	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	63-67	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	13-22	infection	Infection, NOS	C0009450	T047	-694	Regulation	Forward	TRUE	NA
20819	GE13_devel	PMC-3062687-10-Results.s2	To explore the mechanism by which NleH1 inhibits RPS3 S209 phosphorylation, we first performed an in vitro kinase assay with purified wild-type His-NleH1 protein and a mutant His-NleH1 (K159A) protein, confirming that NleH1 is autophosphorylated and the K159A is an NleH1 kinase-dead mutant (Fig. 7a).	34-39	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	49-53	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	168-174	mutant	Mutant	C0596988	T049	-1000	Regulation	Forward	FALSE	negation
20820	GE13_devel	PMC-3062687-10-Results.s2	To explore the mechanism by which NleH1 inhibits RPS3 S209 phosphorylation, we first performed an in vitro kinase assay with purified wild-type His-NleH1 protein and a mutant His-NleH1 (K159A) protein, confirming that NleH1 is autophosphorylated and the K159A is an NleH1 kinase-dead mutant (Fig. 7a).	34-39	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	49-53	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	284-290	mutant	Mutant	C0596988	T049	-812	Regulation	Forward	FALSE	negation
20832	GE13_devel	PMC-3062687-11-Discussion.s19	By selectively inhibiting RPS3 and its attendant NF-kappaB function with NleH1, the pathogen achieves the ability to increase colonization and diarrhea yet limiting the mortality of the host.	73-78	NleH1	NleH protein, E coli	C3179763	T116|T123	Protein	26-30	RPS3	RPS3 protein, human	C3657987	T116|T123	Protein	143-151	diarrhea	DIARRHOEA	C0011991	T184	-1000	Decrease	Backward	FALSE	NA
20834	GE13_devel	PMC-3333881-00-TIAB.s3	We report that in single round HIV-1 infection, or single-pulse PMA stimulation, the HIV-1 Tat transactivator activated NF-kappaB by hijacking the inhibitor IkappaB-alpha and by preventing the repressor binding to the NF-kappaB complex.	91-94	Tat	tat Protein	C0039341	T116|T123	Protein	157-170	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	31-46	HIV-1 infection	HIV 1 infection	C0276500	T047	-884	Regulation	Forward	TRUE	NA
20835	GE13_devel	PMC-3333881-00-TIAB.s7	Our results support a novel mechanism of NF-kappaB activation via physical interaction of Tat with IkappaB-alpha and p65, and may contribute to further insights into the deregulation of the inflammatory response by HIV-1.	90-93	Tat	tat Protein	C0039341	T116|T123	Protein	99-112	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	190-211	inflammatory response	Inflammatory Response	C1155266	T046	-1000	Binding	NA	FALSE	NA
20845	GE13_devel	PMC-3333881-12-RESULTS.s20	To this end, the association of IkappaB-alpha with p65 was analysed in vivo at 0 and 240 min after short-pulse PMA, which corresponded to the time of un-stimulated condition and post-activation de novo synthesis of IkappaB-alpha, respectively.	32-45	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	51-54	p65	RELA protein, human	C1567060	T116|T123	Protein	164-173	condition	condition	C0012634	T047	-827	Binding	NA	FALSE	negation
20854	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	334-337	p65	RELA protein, human	C1567060	T116|T123	Protein	202-211	infection	INFECTION	C3714514	T046	-861	Regulation	Backward	TRUE	NA
20855	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	334-337	p65	RELA protein, human	C1567060	T116|T123	Protein	202-211	infection	Infection, NOS	C0009450	T047	-861	Regulation	Backward	TRUE	NA
20856	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	334-337	p65	RELA protein, human	C1567060	T116|T123	Protein	319-328	infection	INFECTION	C3714514	T046	-861	Regulation	Backward	TRUE	NA
20857	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	334-337	p65	RELA protein, human	C1567060	T116|T123	Protein	319-328	infection	Infection, NOS	C0009450	T047	-861	Regulation	Backward	TRUE	NA
20858	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	334-337	p65	RELA protein, human	C1567060	T116|T123	Protein	456-463	absence	Absence	C1689985	T190	-1000	Regulation	Backward	TRUE	reverse
20859	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	362-365	p65	RELA protein, human	C1567060	T116|T123	Protein	202-211	infection	INFECTION	C3714514	T046	-861	Increase	Backward	TRUE	NA
20860	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	362-365	p65	RELA protein, human	C1567060	T116|T123	Protein	202-211	infection	Infection, NOS	C0009450	T047	-861	Increase	Backward	TRUE	NA
20861	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	362-365	p65	RELA protein, human	C1567060	T116|T123	Protein	319-328	infection	INFECTION	C3714514	T046	-861	Increase	Backward	TRUE	NA
20862	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	362-365	p65	RELA protein, human	C1567060	T116|T123	Protein	319-328	infection	Infection, NOS	C0009450	T047	-861	Increase	Backward	TRUE	NA
20863	GE13_devel	PMC-3333881-12-RESULTS.s6	The progressive increase in NF-kappaB activity, as measured by p65-p50 binding to an NF-kappaB consensus oligonucleotide (Figure 1B) and nuclear p65 (Figure 1C, nucleus), was observed at 1- to 3-h post-infection in both Tat-positive (no siRNA or siRNA control) and Tat-negative (siRNA Tat) cells; however, at 12-h post-infection, the p65 DNA binding and nuclear p65 persisted elevated in presence of Tat (no siRNA and siRNA control), while they dropped in absence of Tat (siRNA Tat) (Figure 1B and C).	400-403	Tat	tat Protein	C0039341	T116|T123	Protein	362-365	p65	RELA protein, human	C1567060	T116|T123	Protein	456-463	absence	Absence	C1689985	T190	-1000	Increase	Backward	TRUE	reverse
20864	GE13_devel	PMC-3333881-13-RESULTS.s6	Next, we evaluated whether Tat counteracted the IkappaB-alpha-mediated inhibition of p65 binding to DNA by incubating in vitro translated p65 and IkappaB-alpha proteins with the NF-kappaB probe in presence or absence of Tat followed by EMSA.	27-30	Tat	tat Protein	C0039341	T116|T123	Protein	85-88	p65	RELA protein, human	C1567060	T116|T123	Protein	209-216	absence	Absence	C1689985	T190	-1000	Regulation	Forward	FALSE	negation
20865	GE13_devel	PMC-3333881-13-RESULTS.s6	Next, we evaluated whether Tat counteracted the IkappaB-alpha-mediated inhibition of p65 binding to DNA by incubating in vitro translated p65 and IkappaB-alpha proteins with the NF-kappaB probe in presence or absence of Tat followed by EMSA.	48-61	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	85-88	p65	RELA protein, human	C1567060	T116|T123	Protein	209-216	absence	Absence	C1689985	T190	-1000	Regulation	Forward	FALSE	negation
20868	GE13_devel	PMC-3333881-14-RESULTS.s3	The p65 protein was coimmunoprecipitated with wild-type Tat or the mutants Tat T,N(23,24)A, Tat K(50,51)A and Tat R(49-57)A at similar levels, while a significant decrease in coimmunoprecipitation was observed for Tat C(22,25,27)A (Figure 4A).	4-7	p65	RELA protein, human	C1567060	T116|T123	Protein	214-230	Tat C(22,25,27)A	tat peptide (17-25), Human immunodeficiency virus 1	C1100939	T116	Protein	67-74	mutants	mutants	C0596988	T049	-694	Binding	NA	FALSE	NA
20869	GE13_devel	PMC-3333881-14-RESULTS.s3	The p65 protein was coimmunoprecipitated with wild-type Tat or the mutants Tat T,N(23,24)A, Tat K(50,51)A and Tat R(49-57)A at similar levels, while a significant decrease in coimmunoprecipitation was observed for Tat C(22,25,27)A (Figure 4A).	4-7	p65	RELA protein, human	C1567060	T116|T123	Protein	56-59	Tat	tat Protein	C0039341	T116|T123	Protein	67-74	mutants	mutants	C0596988	T049	-694	Binding	NA	FALSE	NA
20870	GE13_devel	PMC-3333881-14-RESULTS.s4	Consistently, GST-pull down of in vitro translated proteins showed the direct binding of p65 to wild-type Tat, or the mutants Tat T,N(23,24)A, Tat K(50,51)A and Tat R(49-57)A, and lack of binding to Tat C(22,25,27)A (Figure 4B).	89-92	p65	RELA protein, human	C1567060	T116|T123	Protein	106-109	Tat	tat Protein	C0039341	T116|T123	Protein	118-125	mutants	mutants	C0596988	T049	-694	Binding	NA	FALSE	NA
20871	GE13_devel	PMC-3333881-14-RESULTS.s4	Consistently, GST-pull down of in vitro translated proteins showed the direct binding of p65 to wild-type Tat, or the mutants Tat T,N(23,24)A, Tat K(50,51)A and Tat R(49-57)A, and lack of binding to Tat C(22,25,27)A (Figure 4B).	89-92	p65	RELA protein, human	C1567060	T116|T123	Protein	199-215	Tat C(22,25,27)A	tat peptide (17-25), Human immunodeficiency virus 1	C1100939	T116	Protein	118-125	mutants	mutants	C0596988	T049	-694	Binding	NA	FALSE	NA
20878	GE13_devel	PMC-3333881-14-RESULTS.s8	To address the effect of Tat on the p65 DNA-binding affinity, purified recombinant p65 protein was incubated with 32P-labeled-NF-kappaB double-stranded oligonucleotide in presence or absence of wild-type Tat or Tat C(22,25,27)A, and p65 DNA-binding was analysed by EMSA.	25-28	Tat	tat Protein	C0039341	T116|T123	Protein	36-39	p65	RELA protein, human	C1567060	T116|T123	Protein	183-190	absence	Absence	C1689985	T190	-1000	Regulation	Forward	FALSE	negation
20882	GE13_devel	PMC-3333881-15-RESULTS.s17	As additional findings, IkappaB-alpha was chromatin-immunoprecipitated at the NF-kappaB enhancers in absence of Tat, and it was significantly removed in presence of Tat, or following IkappaB-alpha RNA interference (Figure 5J), indicating that Tat displaced IkappaB-alpha from promoters.	165-168	Tat	tat Protein	C0039341	T116|T123	Protein	24-37	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	101-108	absence	Absence	C1689985	T190	-1000	Regulation	Backward	FALSE	NA
20883	GE13_devel	PMC-3333881-15-RESULTS.s17	As additional findings, IkappaB-alpha was chromatin-immunoprecipitated at the NF-kappaB enhancers in absence of Tat, and it was significantly removed in presence of Tat, or following IkappaB-alpha RNA interference (Figure 5J), indicating that Tat displaced IkappaB-alpha from promoters.	243-246	Tat	tat Protein	C0039341	T116|T123	Protein	257-270	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	101-108	absence	Absence	C1689985	T190	-1000	Regulation	Forward	FALSE	NA
20884	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	0-3	Tat	tat Protein	C0039341	T116|T123	Protein	46-56	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Forward	FALSE	NA
20885	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	0-3	Tat	tat Protein	C0039341	T116|T123	Protein	58-62	CSF3	Granulocyte Colony-Stimulating Factor	C0079459	T116|T129	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Forward	FALSE	NA
20886	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	0-3	Tat	tat Protein	C0039341	T116|T123	Protein	64-67	LTA	lipoteichoic acid	C0065067	T109	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Forward	FALSE	NA
20887	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	0-3	Tat	tat Protein	C0039341	T116|T123	Protein	69-75	NFKBIA	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Forward	FALSE	NA
20888	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	0-3	Tat	tat Protein	C0039341	T116|T123	Protein	80-84	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Forward	FALSE	NA
20889	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	104-120	Tat C(22,25,27)A	tat peptide (17-25), Human immunodeficiency virus 1	C1100939	T116	Protein	46-56	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20890	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	104-120	Tat C(22,25,27)A	tat peptide (17-25), Human immunodeficiency virus 1	C1100939	T116	Protein	58-62	CSF3	Granulocyte Colony-Stimulating Factor	C0079459	T116|T129	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20891	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	104-120	Tat C(22,25,27)A	tat peptide (17-25), Human immunodeficiency virus 1	C1100939	T116	Protein	64-67	LTA	lipoteichoic acid	C0065067	T109	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20892	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	104-120	Tat C(22,25,27)A	tat peptide (17-25), Human immunodeficiency virus 1	C1100939	T116	Protein	69-75	NFKBIA	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20893	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	104-120	Tat C(22,25,27)A	tat peptide (17-25), Human immunodeficiency virus 1	C1100939	T116	Protein	80-84	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20894	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	125-138	Tat R(49-57)A	tat peptide (49-57), Human immunodeficiency virus 1	C1506764	T116|T123	Protein	46-56	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20895	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	125-138	Tat R(49-57)A	tat peptide (49-57), Human immunodeficiency virus 1	C1506764	T116|T123	Protein	58-62	CSF3	Granulocyte Colony-Stimulating Factor	C0079459	T116|T129	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20896	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	125-138	Tat R(49-57)A	tat peptide (49-57), Human immunodeficiency virus 1	C1506764	T116|T123	Protein	64-67	LTA	lipoteichoic acid	C0065067	T109	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20897	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	125-138	Tat R(49-57)A	tat peptide (49-57), Human immunodeficiency virus 1	C1506764	T116|T123	Protein	69-75	NFKBIA	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20898	GE13_devel	PMC-3333881-15-RESULTS.s3	Tat significantly increased the expression of MIP-1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C(22,25,27)A and Tat R(49-57)A were ineffective (Figure 5A-E).	125-138	Tat R(49-57)A	tat peptide (49-57), Human immunodeficiency virus 1	C1506764	T116|T123	Protein	80-84	TLR2	Toll-Like Receptor 2	C0754728	T116|T192	Protein	96-103	mutants	mutants	C0596988	T049	-660	Increase	Backward	TRUE	reverse
20899	GE13_devel	PMC-3333881-15-RESULTS.s8	Consistently with our findings, MIP-1alpha expression was increased in glial cells and lymph nodes of AIDS patients (57,58); moreover, MIP-1alpha production was induced by HIV-1 infection (59,60) and Tat protein (57,61,62).	200-203	Tat	tat Protein	C0039341	T116|T123	Protein	135-145	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	172-187	HIV-1 infection	HIV 1 infection	C0276500	T047	-1000	Increase	Backward	FALSE	NA
20900	GE13_devel	PMC-3333881-16-RESULTS.s1	We next analysed whether Tat affected the NF-kappaB activity and the expression of MIP-1alpha in the course of HIV-1 infection.	25-28	Tat	tat Protein	C0039341	T116|T123	Protein	83-93	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	111-126	HIV-1 infection	HIV 1 infection	C0276500	T047	-1000	Regulation	Forward	FALSE	negation
20901	GE13_devel	PMC-3333881-16-RESULTS.s11	Altogether these results indicated that in single round HIV-1 infection Tat associated with IkappaB-alpha and p65, and induced the p65-dependent activation of MIP-1alpha expression through occupancy of the MIP-1alpha promoter and increased recruitment of p65.	131-134	p65	RELA protein, human	C1567060	T116|T123	Protein	159-169	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	56-71	HIV-1 infection	HIV 1 infection	C0276500	T047	-694	Increase	Forward	TRUE	NA
20902	GE13_devel	PMC-3333881-16-RESULTS.s11	Altogether these results indicated that in single round HIV-1 infection Tat associated with IkappaB-alpha and p65, and induced the p65-dependent activation of MIP-1alpha expression through occupancy of the MIP-1alpha promoter and increased recruitment of p65.	206-216	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	255-258	p65	RELA protein, human	C1567060	T116|T123	Protein	56-71	HIV-1 infection	HIV 1 infection	C0276500	T047	-694	Binding	NA	TRUE	NA
20903	GE13_devel	PMC-3333881-16-RESULTS.s11	Altogether these results indicated that in single round HIV-1 infection Tat associated with IkappaB-alpha and p65, and induced the p65-dependent activation of MIP-1alpha expression through occupancy of the MIP-1alpha promoter and increased recruitment of p65.	72-75	Tat	tat Protein	C0039341	T116|T123	Protein	206-216	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	56-71	HIV-1 infection	HIV 1 infection	C0276500	T047	-694	Binding	NA	TRUE	NA
20904	GE13_devel	PMC-3333881-16-RESULTS.s11	Altogether these results indicated that in single round HIV-1 infection Tat associated with IkappaB-alpha and p65, and induced the p65-dependent activation of MIP-1alpha expression through occupancy of the MIP-1alpha promoter and increased recruitment of p65.	72-75	Tat	tat Protein	C0039341	T116|T123	Protein	255-258	p65	RELA protein, human	C1567060	T116|T123	Protein	56-71	HIV-1 infection	HIV 1 infection	C0276500	T047	-694	Regulation	Forward	TRUE	NA
20905	GE13_devel	PMC-3333881-16-RESULTS.s11	Altogether these results indicated that in single round HIV-1 infection Tat associated with IkappaB-alpha and p65, and induced the p65-dependent activation of MIP-1alpha expression through occupancy of the MIP-1alpha promoter and increased recruitment of p65.	72-75	Tat	tat Protein	C0039341	T116|T123	Protein	92-105	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	56-71	HIV-1 infection	HIV 1 infection	C0276500	T047	-694	Binding	NA	TRUE	NA
20912	GE13_devel	PMC-3333881-16-RESULTS.s6	Degradation of IkappaB-alpha was observed at 3-h post-infection, and was followed by de novo synthesis of IkappaB-alpha at 12 h independently of the Tat presence (Figure 6C).	149-152	Tat	tat Protein	C0039341	T116|T123	Protein	106-119	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	54-63	infection	INFECTION	C3714514	T046	-861	Regulation	Backward	TRUE	NA
20913	GE13_devel	PMC-3333881-16-RESULTS.s6	Degradation of IkappaB-alpha was observed at 3-h post-infection, and was followed by de novo synthesis of IkappaB-alpha at 12 h independently of the Tat presence (Figure 6C).	149-152	Tat	tat Protein	C0039341	T116|T123	Protein	106-119	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	54-63	infection	Infection, NOS	C0009450	T047	-861	Regulation	Backward	TRUE	NA
20916	GE13_devel	PMC-3333881-17-DISCUSSION.s23	The physiological relevance of Tat cross talk with NF-kappaB was demonstrated in the HIV-1 infection of human monocytes, where HIV-1-encoded Tat protein counteracted post-activation turn off of NF-kappaB, as shown by: (i) sustained NF-kappaB activity by Tat in presence of newly synthesized IkappaB-alpha; (ii) coimmunoprecipitation of Tat with IkappaB-alpha and p65; (iii) induction of MIP-1alpha expression dependent on Tat and p65; (iv) Tat occupancy of the MIP-1alpha NF-kappaB enhancer associated with increased recruitment of p65.	336-339	Tat	tat Protein	C0039341	T116|T123	Protein	345-358	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	85-100	HIV-1 infection	HIV 1 infection	C0276500	T047	-1000	Binding	NA	TRUE	NA
20917	GE13_devel	PMC-3333881-17-DISCUSSION.s23	The physiological relevance of Tat cross talk with NF-kappaB was demonstrated in the HIV-1 infection of human monocytes, where HIV-1-encoded Tat protein counteracted post-activation turn off of NF-kappaB, as shown by: (i) sustained NF-kappaB activity by Tat in presence of newly synthesized IkappaB-alpha; (ii) coimmunoprecipitation of Tat with IkappaB-alpha and p65; (iii) induction of MIP-1alpha expression dependent on Tat and p65; (iv) Tat occupancy of the MIP-1alpha NF-kappaB enhancer associated with increased recruitment of p65.	422-425	Tat	tat Protein	C0039341	T116|T123	Protein	387-397	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	85-100	HIV-1 infection	HIV 1 infection	C0276500	T047	-1000	Increase	Backward	TRUE	NA
20918	GE13_devel	PMC-3333881-17-DISCUSSION.s23	The physiological relevance of Tat cross talk with NF-kappaB was demonstrated in the HIV-1 infection of human monocytes, where HIV-1-encoded Tat protein counteracted post-activation turn off of NF-kappaB, as shown by: (i) sustained NF-kappaB activity by Tat in presence of newly synthesized IkappaB-alpha; (ii) coimmunoprecipitation of Tat with IkappaB-alpha and p65; (iii) induction of MIP-1alpha expression dependent on Tat and p65; (iv) Tat occupancy of the MIP-1alpha NF-kappaB enhancer associated with increased recruitment of p65.	430-433	p65	RELA protein, human	C1567060	T116|T123	Protein	387-397	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	85-100	HIV-1 infection	HIV 1 infection	C0276500	T047	-1000	Increase	Backward	TRUE	NA
20919	GE13_devel	PMC-3333881-17-DISCUSSION.s23	The physiological relevance of Tat cross talk with NF-kappaB was demonstrated in the HIV-1 infection of human monocytes, where HIV-1-encoded Tat protein counteracted post-activation turn off of NF-kappaB, as shown by: (i) sustained NF-kappaB activity by Tat in presence of newly synthesized IkappaB-alpha; (ii) coimmunoprecipitation of Tat with IkappaB-alpha and p65; (iii) induction of MIP-1alpha expression dependent on Tat and p65; (iv) Tat occupancy of the MIP-1alpha NF-kappaB enhancer associated with increased recruitment of p65.	440-443	Tat	tat Protein	C0039341	T116|T123	Protein	461-471	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	85-100	HIV-1 infection	HIV 1 infection	C0276500	T047	-1000	Binding	NA	TRUE	NA
20920	GE13_devel	PMC-3333881-17-DISCUSSION.s23	The physiological relevance of Tat cross talk with NF-kappaB was demonstrated in the HIV-1 infection of human monocytes, where HIV-1-encoded Tat protein counteracted post-activation turn off of NF-kappaB, as shown by: (i) sustained NF-kappaB activity by Tat in presence of newly synthesized IkappaB-alpha; (ii) coimmunoprecipitation of Tat with IkappaB-alpha and p65; (iii) induction of MIP-1alpha expression dependent on Tat and p65; (iv) Tat occupancy of the MIP-1alpha NF-kappaB enhancer associated with increased recruitment of p65.	461-471	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	532-535	p65	RELA protein, human	C1567060	T116|T123	Protein	85-100	HIV-1 infection	HIV 1 infection	C0276500	T047	-1000	Binding	NA	TRUE	NA
20923	GE13_devel	PMC-3333881-23-Caption-Figure_6.s0	In HIV-1 infection Tat sustains the NF-kappaB activity and enhances the MIP-1alpha expression via interaction with IkappaB-alpha and p65.	19-22	Tat	tat Protein	C0039341	T116|T123	Protein	115-128	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	3-18	HIV-1 infection	HIV 1 infection	C0276500	T047	-756	Binding	NA	TRUE	NA
20927	GE13_devel	PMC-3333881-24-Caption-Figure_7.s1	(A) In absence of Tat, IkappaB-alpha occupies the NF-kappaB enhancer of the MIP-1alpha promoter and likely interacts with transcriptional repressors, such as HDACs (65), to inhibit gene transcription.	23-36	IkappaB-alpha	NF-kappaB inhibitor alpha	C0126732	T116|T123	Protein	76-86	MIP-1alpha	Small Inducible Cytokine A3	C0128546	T116|T129	Protein	7-14	absence	Absence	C1689985	T190	-1000	Binding	NA	TRUE	NA
20928	GE13_train	PMC-1447668-01-Introduction.s6	Functional inactivation of Foxp3 by genetic mutations affecting the Foxp3 coding region, as demonstrated in IPEX, or repression of Foxp3 expression by the HTLV-I-encoded transactivator protein Tax, as recently reported in patients with HAM/TSP, results in loss of regulatory activity in CD4+CD25hi T cells [4,8,17].	193-196	Tax	Paclitaxel	C0144576	T109|T121	Protein	131-136	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	108-112	IPEX	IPEX	C0342288	T047	-1000	Decrease	Backward	FALSE	NA
20939	GE13_train	PMC-1447668-07-Results.s1	Although Foxp3 could down-regulate Tax-dependent transactivation of the HTLV-I LTR (Figure 4B) and inhibit Tax expression from an infectious molecular clone (Figure 5), Foxp3 failed to modulate Tax function in the absence of the viral promoter (Figure 4D).	9-14	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	107-110	Tax	Paclitaxel	C0144576	T109|T121	Protein	130-140	infectious	Infection, NOS	C0009450	T047	-589	Decrease	Forward	TRUE	NA
20940	GE13_train	PMC-1447668-07-Results.s1	Although Foxp3 could down-regulate Tax-dependent transactivation of the HTLV-I LTR (Figure 4B) and inhibit Tax expression from an infectious molecular clone (Figure 5), Foxp3 failed to modulate Tax function in the absence of the viral promoter (Figure 4D).	9-14	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	107-110	Tax	Paclitaxel	C0144576	T109|T121	Protein	130-140	infectious	Infections	C3714514	T046	-589	Decrease	Forward	TRUE	NA
20941	GE13_train	PMC-1447668-07-Results.s1	Although Foxp3 could down-regulate Tax-dependent transactivation of the HTLV-I LTR (Figure 4B) and inhibit Tax expression from an infectious molecular clone (Figure 5), Foxp3 failed to modulate Tax function in the absence of the viral promoter (Figure 4D).	9-14	Foxp3	FOXP3 protein	C4282118	T116|T123	Protein	107-110	Tax	Paclitaxel	C0144576	T109|T121	Protein	214-221	absence	Absence	C1689985	T190	-1000	Decrease	Forward	FALSE	NA
20945	GE13_train	PMC-1447668-07-Results.s13	As observed with NF-kappaB activation, deltaFKH was a more potent inhibitor of CREB activation in CD4+ T cells than in HEK 293T cells, further indicating that a cell type-specific mechanism of action may govern the function of this Foxp3 mutant.	39-47	deltaFKH	FOXP3 protein	C4282118	T116|T123	Protein	79-83	CREB	Cyclic AMP-Responsive DNA-Binding Protein	C0056695	T116|T123	Protein	238-244	mutant	Mutant	C0596988	T049	-861	Decrease	Forward	FALSE	NA
20948	GE13_train	PMC-2065877-07-Results.s11	Activated p-mTOR was not increased in LMP1 transgenic lymphocytes or lymphoma cells, indicating that this pathway is not affected by LMP1-induced Akt activation and does not contribute to lymphoma development (Figure 6B).	133-137	LMP1	LMP1 EBV latent membrane protein	C1334346	T116|T123	Protein	146-149	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Protein	188-196	lymphoma	LYMPHOMA	C0024299	T191	-694	Increase	Forward	FALSE	NA
20949	GE13_train	PMC-2065877-07-Results.s16	However, considering that Akt activation did not induce FoxO1 degradation in LMP1 transgenic B cells, Akt may not be the sole regulator of FoxO1, and it may be that progression to lymphoma requires modulation of multiple pathways.	102-105	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Protein	139-144	FoxO1	Forkhead Box Protein O1	C4255371	T116|T123	Protein	165-176	progression	Progression	C0242656	T046	-1000	Regulation	Forward	FALSE	NA
20950	GE13_train	PMC-2065877-07-Results.s16	However, considering that Akt activation did not induce FoxO1 degradation in LMP1 transgenic B cells, Akt may not be the sole regulator of FoxO1, and it may be that progression to lymphoma requires modulation of multiple pathways.	102-105	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Protein	139-144	FoxO1	Forkhead Box Protein O1	C4255371	T116|T123	Protein	180-188	lymphoma	LYMPHOMA	C0024299	T191	-1000	Regulation	Forward	FALSE	NA
20951	GE13_train	PMC-2065877-07-Results.s5	The Akt target glycogen synthase kinase 3 (GSK3) is inactivated by phosphorylation; however, increased phosphorylated GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples (Figure 6A).	4-7	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Protein	15-41	glycogen synthase kinase 3	Glycogen Synthase Kinase 3	C0244989	T116|T126	Protein	199-207	lymphoma	LYMPHOMA	C0024299	T191	-694	Binding	NA	FALSE	NA
20952	GE13_train	PMC-2065877-07-Results.s5	The Akt target glycogen synthase kinase 3 (GSK3) is inactivated by phosphorylation; however, increased phosphorylated GSK3 was not detected in the transgenic lymphocytes and was almost absent in the lymphoma samples (Figure 6A).	4-7	Akt	Proto-Oncogene Proteins c-akt	C0164786	T116|T126	Protein	43-47	GSK3	Glycogen Synthase Kinase 3	C0244989	T116|T126	Protein	199-207	lymphoma	LYMPHOMA	C0024299	T191	-694	Binding	NA	FALSE	NA
20954	GE13_train	PMC-2626671-04-RESULTS_AND_DISCUSSION.s9	Our data seemed most consistent with a model in which TCR signals induce T-bet, which in turn induces IFN-gamma (17) and possibly granzyme B; subsequently, Eomes is induced during the period of clonal expansion in IL-2 and activates perforin expression.	156-161	Eomes	Eomesodermin Homolog, human	C3641001	T116	Protein	233-241	perforin	perforin	C0070410	T116|T123	Protein	194-210	clonal expansion	Clonal Expansion	C1516670	T046	-1000	Increase	Forward	FALSE	NA
20955	GE13_train	PMC-2626671-04-RESULTS_AND_DISCUSSION.s9	Our data seemed most consistent with a model in which TCR signals induce T-bet, which in turn induces IFN-gamma (17) and possibly granzyme B; subsequently, Eomes is induced during the period of clonal expansion in IL-2 and activates perforin expression.	73-78	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	102-111	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	194-210	clonal expansion	Clonal Expansion	C1516670	T046	-1000	Increase	Forward	FALSE	NA
20956	GE13_train	PMC-2626671-04-RESULTS_AND_DISCUSSION.s9	Our data seemed most consistent with a model in which TCR signals induce T-bet, which in turn induces IFN-gamma (17) and possibly granzyme B; subsequently, Eomes is induced during the period of clonal expansion in IL-2 and activates perforin expression.	73-78	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	130-140	granzyme B	granzyme B	C0061878	T116|T126	Protein	194-210	clonal expansion	Clonal Expansion	C1516670	T046	-1000	Increase	Forward	FALSE	NA
20957	GE13_train	PMC-2626671-05-RESULTS_AND_DISCUSSION.s10	However, Eo-VP16 did not induce GzmB mRNA expression in either WT or T-bet-deficient cells; thus, the partial T-bet dependence of GzmB mRNA expression cannot be compensated for by Eo-VP16.	110-115	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	130-134	GzmB	granzyme B	C0061878	T116|T126	Protein	116-126	dependence	Dependence	C0439857	T048	-812	Increase	Forward	FALSE	NA
20959	GE13_train	PMC-2626671-06-RESULTS_AND_DISCUSSION.s12	Runx3 bound to the Prf1 and Gzmb transcription start sites (TSS); to a known IL-2 responsive enhancer located near -1 kb of the Prf1 gene (23); to the distal CTL-specific DNase I hypersensitive site 9 in the Prf1 locus (24); to the Ifng promoter near the TSS, as previously reported for Th1 cells (10); and to several DNase I hypersensitive sites in the Ifng locus (Fig. 3 D and not depicted) (25).	0-5	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	19-23	Prf1	perforin	C0070410	T116|T123	Protein	179-193	hypersensitive	Hypersensitive	C0020517	T046	-793	Binding	NA	FALSE	NA
20960	GE13_train	PMC-2626671-06-RESULTS_AND_DISCUSSION.s12	Runx3 bound to the Prf1 and Gzmb transcription start sites (TSS); to a known IL-2 responsive enhancer located near -1 kb of the Prf1 gene (23); to the distal CTL-specific DNase I hypersensitive site 9 in the Prf1 locus (24); to the Ifng promoter near the TSS, as previously reported for Th1 cells (10); and to several DNase I hypersensitive sites in the Ifng locus (Fig. 3 D and not depicted) (25).	0-5	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	19-23	Prf1	perforin	C0070410	T116|T123	Protein	326-340	hypersensitive	Hypersensitive	C0020517	T046	-804	Binding	NA	FALSE	NA
20961	GE13_train	PMC-2626671-06-RESULTS_AND_DISCUSSION.s12	Runx3 bound to the Prf1 and Gzmb transcription start sites (TSS); to a known IL-2 responsive enhancer located near -1 kb of the Prf1 gene (23); to the distal CTL-specific DNase I hypersensitive site 9 in the Prf1 locus (24); to the Ifng promoter near the TSS, as previously reported for Th1 cells (10); and to several DNase I hypersensitive sites in the Ifng locus (Fig. 3 D and not depicted) (25).	0-5	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	28-32	Gzmb	granzyme B	C0061878	T116|T126	Protein	179-193	hypersensitive	Hypersensitive	C0020517	T046	-793	Binding	NA	FALSE	NA
20962	GE13_train	PMC-2626671-06-RESULTS_AND_DISCUSSION.s12	Runx3 bound to the Prf1 and Gzmb transcription start sites (TSS); to a known IL-2 responsive enhancer located near -1 kb of the Prf1 gene (23); to the distal CTL-specific DNase I hypersensitive site 9 in the Prf1 locus (24); to the Ifng promoter near the TSS, as previously reported for Th1 cells (10); and to several DNase I hypersensitive sites in the Ifng locus (Fig. 3 D and not depicted) (25).	0-5	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	28-32	Gzmb	granzyme B	C0061878	T116|T126	Protein	326-340	hypersensitive	Hypersensitive	C0020517	T046	-804	Binding	NA	FALSE	NA
20971	GE13_train	PMC-2626671-06-RESULTS_AND_DISCUSSION.s7	We previously reported that Th1 cell differentiation was regulated through a feed-forward loop in which T-bet is up-regulated early and induces Runx3, after which T-bet and Runx3 cooperate to induce IFN-gamma and silence IL-4, thus promoting stable differentiation toward the Th1 lineage (15, 22).	163-168	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	199-208	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	213-220	silence	silence	C0858952	T048	-660	Increase	Forward	FALSE	NA
20972	GE13_train	PMC-2626671-06-RESULTS_AND_DISCUSSION.s7	We previously reported that Th1 cell differentiation was regulated through a feed-forward loop in which T-bet is up-regulated early and induces Runx3, after which T-bet and Runx3 cooperate to induce IFN-gamma and silence IL-4, thus promoting stable differentiation toward the Th1 lineage (15, 22).	163-168	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	221-225	IL-4	Interleukin-4	C0021758	T116|T129	Protein	213-220	silence	silence	C0858952	T048	-660	Decrease	Forward	FALSE	NA
20973	GE13_train	PMC-2626671-06-RESULTS_AND_DISCUSSION.s7	We previously reported that Th1 cell differentiation was regulated through a feed-forward loop in which T-bet is up-regulated early and induces Runx3, after which T-bet and Runx3 cooperate to induce IFN-gamma and silence IL-4, thus promoting stable differentiation toward the Th1 lineage (15, 22).	173-178	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	199-208	IFN-gamma	Interferon Type II	C0021745	T116|T121|T129	Protein	213-220	silence	silence	C0858952	T048	-660	Increase	Forward	FALSE	NA
20974	GE13_train	PMC-2626671-06-RESULTS_AND_DISCUSSION.s7	We previously reported that Th1 cell differentiation was regulated through a feed-forward loop in which T-bet is up-regulated early and induces Runx3, after which T-bet and Runx3 cooperate to induce IFN-gamma and silence IL-4, thus promoting stable differentiation toward the Th1 lineage (15, 22).	173-178	Runx3	Core Binding Factor Alpha 3 Subunit	C1097317	T116|T123	Protein	221-225	IL-4	Interleukin-4	C0021758	T116|T129	Protein	213-220	silence	silence	C0858952	T048	-660	Decrease	Forward	FALSE	NA
20975	GE13_train	PMC-2626671-07-RESULTS_AND_DISCUSSION.s15	T-bet had no role in perforin expression under our culture conditions, and Eo-VP16 did not affect granzyme B expression when expressed in T-bet-/- or Runx3-/- cells.	0-5	T-bet	T-box transcription factor TBX21	C0913648	T116	Protein	21-29	perforin	perforin	C0070410	T116|T123	Protein	59-69	conditions	condition	C0012634	T047	-827	Regulation	Forward	FALSE	negation
20980	GE13_train	PMC-2791889-03-Results.s4	In contrast, in the absence of STAT4, the percentage of cells expressing IFN-gamma was dramatically diminished as expected and resulted in an increase in the percentage of cells expressing IL-4, but not IL-10 (Figure 2A), suggesting that STAT4 contributes to IL-10 expression by Th1 cells.	238-243	STAT4	STAT4 protein	C0255034	T116|T123	Protein	259-264	IL-10	Interleukin-10	C0085295	T116|T129	Protein	20-27	absence	Absence	C1689985	T190	-1000	Increase	Forward	FALSE	NA
20981	GE13_train	PMC-2791889-03-Results.s6	The absence of STAT6 did not impair the differentiation of IL-10-producing Th1 cells in the presence of IL-12 and OVA (Figure 2A).	104-109	IL-12	Interleukin-12	C0123759	T116|T121|T129	Protein	59-64	IL-10	Interleukin-10	C0085295	T116|T129	Protein	4-11	absence	Absence	C1689985	T190	-1000	Increase	Backward	FALSE	NA
20982	GE13_train	PMC-2791889-03-Results.s6	The absence of STAT6 did not impair the differentiation of IL-10-producing Th1 cells in the presence of IL-12 and OVA (Figure 2A).	114-117	OVA	Ovalbumin	C0029923	T116|T123	Protein	59-64	IL-10	Interleukin-10	C0085295	T116|T129	Protein	4-11	absence	Absence	C1689985	T190	-1000	Increase	Backward	FALSE	NA
20984	GE13_train	PMC-2791889-05-Results.s4	Repeated high antigen dose stimulation in the absence of exogenously added IL-12 resulted in the production of IL-10 by Th1 cells, suggesting that repeated strong TCR triggering may overcome the need for IL-12 for IL-10 induction (Figures 4C and 4D).	204-209	IL-12	Interleukin-12	C0123759	T116|T121|T129	Protein	214-219	IL-10	Interleukin-10	C0085295	T116|T129	Protein	46-53	absence	Absence	C1689985	T190	-1000	Increase	Forward	FALSE	NA
20985	GE13_train	PMC-2791889-05-Results.s6	Thus, IL-12 is essential during both primary and secondary antigenic stimulation for production of IL-10 by Th1 cells.	6-11	IL-12	Interleukin-12	C0123759	T116|T121|T129	Protein	99-104	IL-10	Interleukin-10	C0085295	T116|T129	Protein	49-58	secondary	secondary	C0027627	T191	-660	Increase	Forward	TRUE	NA
21019	GE13_train	PMC-2791889-08-Results.s8	In contrast, high amounts of GATA-3 mRNA expression were only observed under Th2 cell differentiation conditions (low-dose antigen) (Figure 6B), and this expression was markedly downregulated by both increasing antigen dose and coculture in IL-12 (Figure 6B).	241-246	IL-12	Interleukin-12	C0123759	T116|T121|T129	Protein	29-35	GATA-3	GATA3 protein, human	C1307598	T116|T123	Protein	102-112	conditions	condition	C0012634	T047	-779	Decrease	Backward	TRUE	NA
21020	GE13_train	PMC-3148254-02-Results.s3	We also found that the recruitment of HOIP to CD40 was TRAF2-dependent and that overexpression of a truncated HOIP mutant partially inhibited CD40-mediated NF-kappaB activation.	38-42	HOIP	RNF31 protein, human	C3181371	T116|T123	Protein	46-50	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	115-121	mutant	Mutant	C0596988	T049	-827	Binding	NA	TRUE	NA
21021	GE13_train	PMC-3148254-02-Results.s3	We also found that the recruitment of HOIP to CD40 was TRAF2-dependent and that overexpression of a truncated HOIP mutant partially inhibited CD40-mediated NF-kappaB activation.	55-60	TRAF2	TNF receptor-associated factor 2	C0258441	T116|T123	Protein	46-50	CD40	CD40 Antigens	C0054959	T116|T129|T192	Protein	115-121	mutant	Mutant	C0596988	T049	-827	Regulation	Backward	TRUE	NA
21022	GE13_train	PMC-3245220-01-Introduction.s34	PKCalpha induces IL-1alpha, iNOS and TNFalpha mRNA production after lipopolysaccharide (LPS) exposure [29].	0-8	PKCalpha	Protein Kinase C Alpha	C0256371	T116|T126	Protein	17-26	IL-1alpha	IL1A protein, human	C1702299	T116|T123	Protein	93-101	exposure	Exposure NOS	C0274281	T037	-861	Increase	Forward	TRUE	NA
21023	GE13_train	PMC-3245220-01-Introduction.s34	PKCalpha induces IL-1alpha, iNOS and TNFalpha mRNA production after lipopolysaccharide (LPS) exposure [29].	0-8	PKCalpha	Protein Kinase C Alpha	C0256371	T116|T126	Protein	28-32	iNOS	Nitric Oxide Synthase Type II	C1533698	T116|T126	Protein	93-101	exposure	Exposure NOS	C0274281	T037	-861	Increase	Forward	TRUE	NA
21024	GE13_train	PMC-3245220-01-Introduction.s34	PKCalpha induces IL-1alpha, iNOS and TNFalpha mRNA production after lipopolysaccharide (LPS) exposure [29].	0-8	PKCalpha	Protein Kinase C Alpha	C0256371	T116|T126	Protein	37-45	TNFalpha	Tumor Necrosis Factor-alpha	C1456820	T116|T129	Protein	93-101	exposure	Exposure NOS	C0274281	T037	-861	Increase	Forward	TRUE	NA
21026	GE13_train	PMC-3245220-11-Discussion.s7	Consistent with these findings the dominant negative PKCalpha constructs also inhibited NF-kappaB p65 phosphorylation at Ser276 but not at Ser536 resulting in reduced NF-kappaB transcriptional activation and M-CSF-induced MDM survival.	53-61	PKCalpha	Protein Kinase C Alpha	C0256371	T116|T126	Protein	98-101	p65	RELA protein, human	C1567060	T116|T123	Protein	35-52	dominant negative	Dominant Negative	C1512032	T049	-734	Regulation	Forward	TRUE	NA